Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23408.Triglycerides in VLDL,ACY1,Aminoacylase-1,29478,0.191547069320271,0.00420628579426801,0.183302749163506,0.199791389477037,0
NMR metabolomics,X23408.Triglycerides in VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,0.284207242675837,0.00566670014669651,0.273100510388312,0.295313974963362,0
NMR metabolomics,X23408.Triglycerides in VLDL,ADIPOQ,Adiponectin,24966,-0.233177101473962,0.00454780941848514,-0.242090807934192,-0.224263395013731,0
NMR metabolomics,X23408.Triglycerides in VLDL,AFM,Afamin,24966,0.0585285970475105,0.00132871554884695,0.0559243145717705,0.0611328795232506,0
NMR metabolomics,X23408.Triglycerides in VLDL,AGR3,Anterior gradient protein 3,28764,0.171872886164018,0.00408217568034345,0.163871821830545,0.179873950497491,0
NMR metabolomics,X23408.Triglycerides in VLDL,AGRP,Agouti-related protein,29786,0.297500369596477,0.00331172780780591,0.291009383093177,0.303991356099776,0
NMR metabolomics,X23408.Triglycerides in VLDL,APCS,Serum amyloid P-component,24726,0.110593749170966,0.00235518148923437,0.105977593452066,0.115209904889865,0
NMR metabolomics,X23408.Triglycerides in VLDL,ASGR1,Asialoglycoprotein receptor 1,29218,0.0903897913384486,0.00203545190001145,0.0864003056144262,0.094379277062471,0
NMR metabolomics,X23408.Triglycerides in VLDL,BCHE,Cholinesterase,24528,0.0883748814758084,0.00190620101878939,0.0846387274789812,0.0921110354726356,0
NMR metabolomics,X23408.Triglycerides in VLDL,C9,Complement component C9,24951,-0.171987257726549,0.0036044083202553,-0.179051898034249,-0.164922617418849,0
NMR metabolomics,X23408.Triglycerides in VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,0.205149849481814,0.00506137494385985,0.195229554591848,0.215070144371779,0
NMR metabolomics,X23408.Triglycerides in VLDL,CCL16,C-C motif chemokine 16,29820,0.147316481997357,0.00359227052781786,0.140275631762834,0.15435733223188,0
NMR metabolomics,X23408.Triglycerides in VLDL,CCL23,C-C motif chemokine 23,29581,0.141195125452096,0.00281865654051785,0.135670558632681,0.146719692271511,0
NMR metabolomics,X23408.Triglycerides in VLDL,CCL27,C-C motif chemokine 27,29478,0.246064743628034,0.00408186950807195,0.238064279392213,0.254065207863855,0
NMR metabolomics,X23408.Triglycerides in VLDL,CCN1,CCN family member 1,29301,0.391598380592822,0.00481086014191726,0.382169094714664,0.40102766647098,0
NMR metabolomics,X23408.Triglycerides in VLDL,CD4,T-cell surface glycoprotein CD4,29383,0.103299535890199,0.00202470884278917,0.0993311065583325,0.107267965222066,0
NMR metabolomics,X23408.Triglycerides in VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,0.342957813683922,0.007188803564799,0.328867758696916,0.357047868670928,0
NMR metabolomics,X23408.Triglycerides in VLDL,CES1,Liver carboxylesterase 1,29489,0.332069749300119,0.00536678143340222,0.321550857690651,0.342588640909587,0
NMR metabolomics,X23408.Triglycerides in VLDL,CFH,Complement factor H,23693,0.0669943529219079,0.00159759173835627,0.0638630731147296,0.0701256327290862,0
NMR metabolomics,X23408.Triglycerides in VLDL,CFI,Complement factor I,24966,0.0581353866927641,0.00136178042422286,0.0554662970612873,0.0608044763242409,0
NMR metabolomics,X23408.Triglycerides in VLDL,CFP,Properdin,24966,0.0645401977720872,0.00157969307104629,0.0614439993528364,0.0676363961913379,0
NMR metabolomics,X23408.Triglycerides in VLDL,CHMP6,Charged multivesicular body protein 6,24922,0.168198282549023,0.00385848668206153,0.160635648652182,0.175760916445864,0
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN3,Contactin-3,29443,0.100739286167999,0.00220220324919959,0.0964229677995676,0.10505560453643,0
NMR metabolomics,X23408.Triglycerides in VLDL,CPM,Carboxypeptidase M,29584,0.114023569863768,0.0023270956914567,0.109462462308513,0.118584677419023,0
NMR metabolomics,X23408.Triglycerides in VLDL,CRIP2,Cysteine-rich protein 2,29218,0.107730786380237,0.00248482816645391,0.102860523173988,0.112601049586487,0
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL6,C-X-C motif chemokine 6,29786,0.237624753564618,0.00524870301275707,0.227337295659614,0.247912211469622,0
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,29036,0.496235966330429,0.00998505220888007,0.476665264001024,0.515806668659834,0
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB1,DnaJ homolog subfamily B member 1,29349,0.297985700981272,0.00587820651800638,0.28646441620598,0.309506985756565,0
NMR metabolomics,X23408.Triglycerides in VLDL,DSG2,Desmoglein-2,29443,-0.0876515586455855,0.0018378584981438,-0.0912537613019474,-0.0840493559892237,0
NMR metabolomics,X23408.Triglycerides in VLDL,ENO3,Beta-enolase,24240,0.168488188023693,0.00412897902231836,0.160395389139949,0.176580986907437,0
NMR metabolomics,X23408.Triglycerides in VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.0672739360077589,0.00170761913572135,0.063927002501745,0.0706208695137727,0
NMR metabolomics,X23408.Triglycerides in VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.0608372913841578,0.00133090166428748,0.0582287241221543,0.0634458586461612,0
NMR metabolomics,X23408.Triglycerides in VLDL,ERP44,Endoplasmic reticulum resident protein 44,29301,0.0705159285315679,0.00177692307408715,0.067033159306357,0.0739986977567787,0
NMR metabolomics,X23408.Triglycerides in VLDL,F10,Coagulation factor X,24951,0.0741452884476117,0.00189231996856277,0.0704363413092286,0.0778542355859947,0
NMR metabolomics,X23408.Triglycerides in VLDL,F7,Coagulation factor VII,29544,0.122786849446558,0.00204137125831451,0.118785761780262,0.126787937112855,0
NMR metabolomics,X23408.Triglycerides in VLDL,F9,Coagulation factor IX,29545,0.0529792371264029,0.00124571755468095,0.0505376307192283,0.0554208435335776,0
NMR metabolomics,X23408.Triglycerides in VLDL,FGF21,Fibroblast growth factor 21,29674,0.327811664156212,0.00814821380112435,0.311841165106009,0.343782163206416,0
NMR metabolomics,X23408.Triglycerides in VLDL,FGFR2,Fibroblast growth factor receptor 2,29566,0.0595753573548397,0.00152005772534378,0.0565960442131659,0.0625546704965135,0
NMR metabolomics,X23408.Triglycerides in VLDL,FLI1,Friend leukemia integration 1 transcription factor,28797,0.310085179609315,0.00756751267308598,0.295252854770066,0.324917504448563,0
NMR metabolomics,X23408.Triglycerides in VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,24804,0.233779866750249,0.00584940297783968,0.222315036913683,0.245244696586814,0
NMR metabolomics,X23408.Triglycerides in VLDL,FURIN,Furin,29566,0.131712126261495,0.00223872633942487,0.127324222636223,0.136100029886768,0
NMR metabolomics,X23408.Triglycerides in VLDL,GCG,Pro-glucagon,28797,0.525319791806152,0.00823454273871148,0.509180088038277,0.541459495574027,0
NMR metabolomics,X23408.Triglycerides in VLDL,GHR,Growth hormone receptor,24381,0.111808516088485,0.00190454141607487,0.108075614912978,0.115541417263991,0
NMR metabolomics,X23408.Triglycerides in VLDL,GPR37,Prosaposin receptor GPR37,28916,0.22335227510247,0.00448852290583907,0.214554770207025,0.232149779997914,0
NMR metabolomics,X23408.Triglycerides in VLDL,GRP,Gastrin-releasing peptide,24240,0.150958533715535,0.00370239105179864,0.14370184725401,0.158215220177061,0
NMR metabolomics,X23408.Triglycerides in VLDL,GSTA1,Glutathione S-transferase A1,29426,0.254107490469573,0.00575392321419887,0.242829800969744,0.265385179969403,0
NMR metabolomics,X23408.Triglycerides in VLDL,GSTA3,Glutathione S-transferase A3,28797,0.228883642167478,0.00524213032152817,0.218609066737282,0.239158217597673,0
NMR metabolomics,X23408.Triglycerides in VLDL,GUSB,Beta-glucuronidase,29604,0.182279150360918,0.00408360631519047,0.174275281983144,0.190283018738691,0
NMR metabolomics,X23408.Triglycerides in VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,0.30108130215706,0.00505188029707297,0.291179616774797,0.310982987539323,0
NMR metabolomics,X23408.Triglycerides in VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,0.11354184650683,0.00232472782450826,0.108985379970794,0.118098313042866,0
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,29761,-0.38663214230581,0.00831082983602871,-0.402921368784426,-0.370342915827193,0
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,29757,-0.187756986971671,0.00425792667702498,-0.19610252325864,-0.179411450684702,0
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF8,Immunoglobulin superfamily member 8,29478,0.0844062274586442,0.00209360500627559,0.080302761646344,0.0885096932709444,0
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF9,Protein turtle homolog A,24922,0.330677377131885,0.00548523751780446,0.319926311596989,0.341428442666782,0
NMR metabolomics,X23408.Triglycerides in VLDL,INHBC,Inhibin beta C chain,29443,0.145759206399162,0.00279092738605394,0.140288988722497,0.151229424075828,0
NMR metabolomics,X23408.Triglycerides in VLDL,KYNU,Kynureninase,29786,0.129759355061868,0.00311458432278103,0.123654769789217,0.135863940334519,0
NMR metabolomics,X23408.Triglycerides in VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,0.0586824636499035,0.00134048724938997,0.0560551086410991,0.0613098186587078,0
NMR metabolomics,X23408.Triglycerides in VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.088099642486411,0.00147125096806743,0.0852159905889989,0.0909832943838232,0
NMR metabolomics,X23408.Triglycerides in VLDL,LDLR,Low-density lipoprotein receptor,29500,0.425182048044197,0.00278071402494439,0.419731848555306,0.430632247533088,0
NMR metabolomics,X23408.Triglycerides in VLDL,LPL,Lipoprotein lipase,29478,-0.188715681923132,0.00313102838400991,-0.194852497555791,-0.182578866290472,0
NMR metabolomics,X23408.Triglycerides in VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,0.0552477111473329,0.00141211858255123,0.0524799587255325,0.0580154635691333,0
NMR metabolomics,X23408.Triglycerides in VLDL,MFGE8,Lactadherin,29443,0.254676176590981,0.00271869799379094,0.24934752852315,0.260004824658811,0
NMR metabolomics,X23408.Triglycerides in VLDL,MXRA8,Matrix remodeling-associated protein 8,24381,-0.0825960855688699,0.00210297920952716,-0.0867179248195432,-0.0784742463181967,0
NMR metabolomics,X23408.Triglycerides in VLDL,NCS1,Neuronal calcium sensor 1,29725,0.0810411858413049,0.00196477348821001,0.0771902298044133,0.0848921418781965,0
NMR metabolomics,X23408.Triglycerides in VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,29820,-0.0916751399915375,0.00234986691991664,-0.0962808791545741,-0.0870694008285009,0
NMR metabolomics,X23408.Triglycerides in VLDL,NPY,Pro-neuropeptide Y,29725,0.382120845074038,0.00408546687083583,0.3741133300072,0.390128360140877,0
NMR metabolomics,X23408.Triglycerides in VLDL,NRP1,Neuropilin-1,29628,-0.0928585590039764,0.00188722085364268,-0.096557511877116,-0.0891596061308367,0
NMR metabolomics,X23408.Triglycerides in VLDL,PAMR1,Inactive serine protease PAMR1,29443,0.0801033344930986,0.00189193478318901,0.0763951423180481,0.0838115266681491,0
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.110000888798133,0.0021559894432427,0.105775149489377,0.114226628106888,0
NMR metabolomics,X23408.Triglycerides in VLDL,PLAT,Tissue-type plasminogen activator,29736,0.148452470145128,0.00344298818168032,0.141704213309034,0.155200726981221,0
NMR metabolomics,X23408.Triglycerides in VLDL,PLTP,Phospholipid transfer protein,29702,-0.102381827959513,0.0024653636940389,-0.10721394079983,-0.0975497151191972,0
NMR metabolomics,X23408.Triglycerides in VLDL,PON3,Serum paraoxonase/lactonase 3,29581,-0.07673363461416,0.00195226006247288,-0.0805600643366068,-0.0729072048917131,0
NMR metabolomics,X23408.Triglycerides in VLDL,PRAP1,Proline-rich acidic protein 1,24938,0.156382419332531,0.0027193425911199,0.151052507853936,0.161712330811126,0
NMR metabolomics,X23408.Triglycerides in VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,29655,0.0892570359764804,0.00215715325699105,0.085029015592778,0.0934850563601829,0
NMR metabolomics,X23408.Triglycerides in VLDL,PROC,Vitamin K-dependent protein C,29545,0.0920700108431986,0.00174559562034619,0.0886486434273201,0.0954913782590771,0
NMR metabolomics,X23408.Triglycerides in VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,0.177228904355691,0.00405124255367965,0.169288468950478,0.185169339760903,0
NMR metabolomics,X23408.Triglycerides in VLDL,PTH,Parathyroid hormone,24195,0.306907177333142,0.00538766913032361,0.296347345837708,0.317467008828576,0
NMR metabolomics,X23408.Triglycerides in VLDL,RARRES2,Retinoic acid receptor responder protein 2,29628,0.183124370281594,0.00315785332422418,0.176934977766114,0.189313762797073,0
NMR metabolomics,X23408.Triglycerides in VLDL,RBP5,Retinol-binding protein 5,29349,0.15874082893955,0.00385102016027334,0.151192829425414,0.166288828453686,0
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA4,Kallistatin,24557,0.0730058645248201,0.00162660790829715,0.0698177130245577,0.0761940160250825,0
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA5,Plasma serine protease inhibitor,24644,0.099855042696216,0.00216485028595814,0.0956119361357381,0.104098149256694,0
NMR metabolomics,X23408.Triglycerides in VLDL,SERPIND1,Heparin cofactor 2,24914,0.0793822094052874,0.00193247023456256,0.0755945677455448,0.08316985106503,0
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINF1,Pigment epithelium-derived factor,24579,0.0756120204303277,0.00178798432060784,0.0721075711619364,0.0791164696987191,0
NMR metabolomics,X23408.Triglycerides in VLDL,SHBG,Sex hormone-binding globulin,24951,-0.146604499582963,0.00353415497047173,-0.153531443325088,-0.139677555840839,0
NMR metabolomics,X23408.Triglycerides in VLDL,SLC39A5,Zinc transporter ZIP5,29434,0.189801598568323,0.00360304410934,0.182739632114016,0.196863565022629,0
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD1,Mothers against decapentaplegic homolog 1,28797,0.28571280890925,0.0055579464456765,0.274819233875724,0.296606383942776,0
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD2,Mothers against decapentaplegic homolog 2,24793,0.186927799861609,0.00476593712738878,0.177586563091927,0.196269036631291,0
NMR metabolomics,X23408.Triglycerides in VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,29725,0.131217956395385,0.00218983474447792,0.126925880296209,0.135510032494562,0
NMR metabolomics,X23408.Triglycerides in VLDL,SNAPIN,SNARE-associated protein Snapin,24867,0.156061247561541,0.0039785709060441,0.148263248585695,0.163859246537388,0
NMR metabolomics,X23408.Triglycerides in VLDL,SNCA,Alpha-synuclein,24381,0.322203324712646,0.00793987795854166,0.306641163913904,0.337765485511388,0
NMR metabolomics,X23408.Triglycerides in VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,0.329193314464023,0.00783071128278281,0.313845120349769,0.344541508578277,0
NMR metabolomics,X23408.Triglycerides in VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,0.154429831619974,0.00286425662409495,0.148815888636747,0.1600437746032,0
NMR metabolomics,X23408.Triglycerides in VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,0.150775140423416,0.0035814098597818,0.143755577098243,0.157794703748588,0
NMR metabolomics,X23408.Triglycerides in VLDL,TFPI,Tissue factor pathway inhibitor,29435,0.0919096327207283,0.00217110417947008,0.0876542685289669,0.0961649969124896,0
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS15,Enteropeptidase,29349,0.319512566038577,0.00609725724404757,0.307561941840244,0.331463190236911,0
NMR metabolomics,X23408.Triglycerides in VLDL,TTR,Transthyretin,24707,0.0835085946881431,0.00171626262337664,0.0801447199463248,0.0868724694299613,0
NMR metabolomics,X23408.Triglycerides in VLDL,UPB1,Beta-ureidopropionase,24922,0.266600020450488,0.00625721489413591,0.254335879257982,0.278864161642994,0
NMR metabolomics,X23408.Triglycerides in VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,0.219130717448426,0.00462825483024971,0.210059337981136,0.228202096915715,0
NMR metabolomics,X23408.Triglycerides in VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,0.265481298949615,0.0053940576046108,0.254908946044578,0.276053651854653,0
NMR metabolomics,X23408.Triglycerides in VLDL,P4HB,Protein disulfide-isomerase,29313,0.103908260635222,0.00266774822664699,0.0986794741109936,0.10913704715945,1.1125369292536e-308
NMR metabolomics,X23408.Triglycerides in VLDL,GLA,Alpha-galactosidase A,24329,0.100386343326291,0.002584095650584,0.0953215158511466,0.105451170801436,1.11253692925482e-308
NMR metabolomics,X23408.Triglycerides in VLDL,NUMB,Protein numb homolog,24229,0.223095904956393,0.00574761942815968,0.2118305708772,0.234361239035585,1.11253692925795e-308
NMR metabolomics,X23408.Triglycerides in VLDL,NOS3,"Nitric oxide synthase, endothelial",28774,0.140803979890961,0.00364040472383055,0.133668786632253,0.147939173149669,1.11253692927545e-308
NMR metabolomics,X23408.Triglycerides in VLDL,LAT2,Linker for activation of T-cells family member 2,29349,0.329825486160941,0.00854392321214899,0.313079396665129,0.346571575656753,1.11253692949151e-308
NMR metabolomics,X23408.Triglycerides in VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,0.179623694535503,0.00467476767424942,0.170461149893974,0.188786239177032,1.11253716916425e-308
NMR metabolomics,X23408.Triglycerides in VLDL,LATS1,Serine/threonine-protein kinase LATS1,24229,0.226025056216047,0.00587121781965219,0.214517469289529,0.237532643142565,1.11253740066224e-308
NMR metabolomics,X23408.Triglycerides in VLDL,MTSS1,Protein MTSS 1,24805,0.291028882428847,0.00764076308340715,0.276052986785369,0.306004778072325,1.86176889468523e-308
NMR metabolomics,X23408.Triglycerides in VLDL,HEG1,Protein HEG homolog 1,24381,0.0713263082828712,0.0018756375102763,0.0676500587627296,0.0750025578030128,1.90577229990089e-307
NMR metabolomics,X23408.Triglycerides in VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,0.123856651250567,0.0032702309690022,0.117446998551323,0.130266303949811,1.93501075640218e-306
NMR metabolomics,X23408.Triglycerides in VLDL,CDHR2,Cadherin-related family member 2,29349,0.188858362049262,0.0049981190283407,0.179062048753714,0.19865467534481,4.03960151061301e-305
NMR metabolomics,X23408.Triglycerides in VLDL,PROS1,Vitamin K-dependent protein S,24966,0.0664865842430516,0.00175724740251353,0.0630423793341251,0.0699307891519782,1.17993585405576e-304
NMR metabolomics,X23408.Triglycerides in VLDL,NOMO1,Nodal modulator 1,29443,0.0612206856432366,0.00162279551534841,0.0580400064331537,0.0644013648533194,3.38541118831966e-304
NMR metabolomics,X23408.Triglycerides in VLDL,SORT1,Sortilin,29433,0.0966652753697363,0.00256710111393759,0.0916337571864186,0.101696793553054,4.22851687226798e-303
NMR metabolomics,X23408.Triglycerides in VLDL,SKAP1,Src kinase-associated phosphoprotein 1,29163,0.188299892888044,0.00502187777932043,0.178457012440576,0.198142773335512,1.4972900373758e-300
NMR metabolomics,X23408.Triglycerides in VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,0.361798669494975,0.00963527224058634,0.342913535903425,0.380683803086524,3.63524392610309e-300
NMR metabolomics,X23408.Triglycerides in VLDL,KDR,Vascular endothelial growth factor receptor 2,29566,0.0655676376295166,0.00175173049630044,0.0621342458567677,0.0690010294022654,1.26509266871051e-299
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.098438957552727,0.00263071957913593,-0.103595167927833,-0.0932827471776206,1.85949429956201e-299
NMR metabolomics,X23408.Triglycerides in VLDL,DTYMK,Thymidylate kinase,24922,0.176642959792777,0.00471870614337326,0.167394295751765,0.185891623833788,1.96257737082116e-298
NMR metabolomics,X23408.Triglycerides in VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,0.101937347825076,0.00273134173966921,0.0965839180153245,0.107290777634828,6.92291633064616e-298
NMR metabolomics,X23408.Triglycerides in VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,0.0817822698145753,0.00219227325630947,0.0774854142322087,0.0860791253969418,1.24956289539691e-297
NMR metabolomics,X23408.Triglycerides in VLDL,ATRN,"Attractin, Isoform 2",24966,0.0426548448366573,0.00114561476680478,0.0404094398937199,0.0449002497795947,2.37011595924087e-295
NMR metabolomics,X23408.Triglycerides in VLDL,CKB,Creatine kinase B-type,24938,-0.151937490442633,0.00408306919189017,-0.159940306058738,-0.143934674826528,5.17529458150748e-295
NMR metabolomics,X23408.Triglycerides in VLDL,SCLY,Selenocysteine lyase,29632,0.124168066502757,0.00334414332006782,0.117613545595424,0.13072258741009,5.40621967201124e-295
NMR metabolomics,X23408.Triglycerides in VLDL,FAM20A,Pseudokinase FAM20A,24922,0.0726333384237904,0.00195578397888643,0.068800001825173,0.0764666750224078,7.07619312580691e-294
NMR metabolomics,X23408.Triglycerides in VLDL,GH1,Somatotropin,29433,-0.453368727839747,0.0122468419924621,-0.477372538144973,-0.429364917534522,3.03737481072239e-293
NMR metabolomics,X23408.Triglycerides in VLDL,MAMDC4,Apical endosomal glycoprotein,24793,0.141786892142129,0.00382929320823761,0.134281477453984,0.149292306830275,3.818000449134e-292
NMR metabolomics,X23408.Triglycerides in VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,0.0557212427533521,0.00150685318772648,0.0527678105054082,0.058674675001296,2.80476670895779e-291
NMR metabolomics,X23408.Triglycerides in VLDL,CD300LG,CMRF35-like molecule 9,29443,-0.0956371306430413,0.00259325195128398,-0.100719904467558,-0.0905543568185247,4.25518603397553e-291
NMR metabolomics,X23408.Triglycerides in VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,0.139615311428859,0.00379594926480359,0.132175250869844,0.147055371987874,1.8285145303045e-289
NMR metabolomics,X23408.Triglycerides in VLDL,STAB2,Stabilin-2,24938,0.0711921357163802,0.00194472161309167,0.0673804813547206,0.0750037900780399,7.87683440714641e-286
NMR metabolomics,X23408.Triglycerides in VLDL,SNAP29,Synaptosomal-associated protein 29,29566,0.23015422308575,0.00630963536735136,0.217787337765741,0.242521108405758,5.50149787056701e-285
NMR metabolomics,X23408.Triglycerides in VLDL,ELN,Elastin,24922,0.0885545837368709,0.00242502445857955,0.083801535798055,0.0933076316756868,1.87003627601013e-284
NMR metabolomics,X23408.Triglycerides in VLDL,IL16,Pro-interleukin-16,29786,0.103969394554929,0.00285599907828765,0.0983716363614856,0.109567152748373,6.28544212369111e-284
NMR metabolomics,X23408.Triglycerides in VLDL,KLKB1,Plasma kallikrein,24454,0.0632879792574698,0.00173436540076101,0.0598886230719783,0.0666873354429614,6.42473503295221e-284
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.0747571706148597,0.00205855644647061,0.0707223999797773,0.0787919412499421,1.5020766842266e-282
NMR metabolomics,X23408.Triglycerides in VLDL,SYAP1,Synapse-associated protein 1,24381,0.144307535584895,0.00396699818148155,0.136532219149191,0.152082852020599,3.42882133386499e-282
NMR metabolomics,X23408.Triglycerides in VLDL,MYH9,Myosin-9,24938,0.283054576913242,0.00779277063548966,0.267780746467682,0.298328407358802,1.53787862797759e-281
NMR metabolomics,X23408.Triglycerides in VLDL,EEF1D,Elongation factor 1-delta,24922,0.228712684199828,0.00630399691991152,0.216356850236801,0.241068518162854,6.64954707464238e-281
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA1,Ephrin type-A receptor 1,29536,0.0831289049036902,0.00230046735072956,0.0786199888962602,0.0876378209111201,7.88992831246389e-280
NMR metabolomics,X23408.Triglycerides in VLDL,F11R,Junctional adhesion molecule A,29443,0.140144374516489,0.00388182566045446,0.132535996221999,0.14775275281098,2.57810406669724e-279
NMR metabolomics,X23408.Triglycerides in VLDL,NAA80,N-alpha-acetyltransferase 80,24195,0.301800675607379,0.00834152541135929,0.285451285801115,0.318150065413643,3.38448937480141e-279
NMR metabolomics,X23408.Triglycerides in VLDL,ADH1B,All-trans-retinol dehydrogenase,24381,0.188685930341681,0.00521584179153803,0.178462880430266,0.198908980253095,3.53813520514637e-279
NMR metabolomics,X23408.Triglycerides in VLDL,AMBP,Protein AMBP,29683,0.0501752949057224,0.00139045550013603,0.0474500021254558,0.0529005876859891,4.1845733171741e-279
NMR metabolomics,X23408.Triglycerides in VLDL,YES1,Tyrosine-protein kinase Yes,29349,0.282941035865748,0.00785486581417131,0.267545498869972,0.298336572861524,4.51496327289905e-278
NMR metabolomics,X23408.Triglycerides in VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,0.157846840606199,0.00438204951382801,0.149258023559096,0.166435657653302,5.83126087074813e-278
NMR metabolomics,X23408.Triglycerides in VLDL,MME,Neprilysin,29349,0.199165671327672,0.00554415570724201,0.188299126141478,0.210032216513867,1.30571774354639e-276
NMR metabolomics,X23408.Triglycerides in VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,0.14222837188585,0.00395928129477143,0.134468180548098,0.149988563223602,2.23376605134893e-275
NMR metabolomics,X23408.Triglycerides in VLDL,SORD,Sorbitol dehydrogenase,29595,0.168104648754664,0.00470657303026957,0.158879765615335,0.177329531893992,1.41001944465132e-273
NMR metabolomics,X23408.Triglycerides in VLDL,KHK,Ketohexokinase,24240,0.158505753898546,0.00442863032568059,0.149825638460212,0.167185869336879,1.98170988451446e-273
NMR metabolomics,X23408.Triglycerides in VLDL,DPY30,Protein dpy-30 homolog,29604,0.147420020117742,0.00413295730237546,0.139319423805087,0.155520616430398,7.17325196069769e-273
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,0.10761234995492,0.00301736970015009,0.101698305342626,0.113526394567214,9.55413020344758e-273
NMR metabolomics,X23408.Triglycerides in VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,24922,0.162416965737535,0.0045561970293275,0.153486819560053,0.171347111915017,1.69914519083906e-271
NMR metabolomics,X23408.Triglycerides in VLDL,MVK,Mevalonate kinase,28931,0.195640648193533,0.00550771702443215,0.184845522825646,0.20643577356142,1.52389098660213e-270
NMR metabolomics,X23408.Triglycerides in VLDL,SELPLG,P-selectin glycoprotein ligand 1,29434,0.0682320643266033,0.00192157797143486,0.0644657715025909,0.0719983571506156,1.88896235392135e-270
NMR metabolomics,X23408.Triglycerides in VLDL,GGT1,Glutathione hydrolase 1 proenzyme,29390,0.123524540520329,0.00347870237359375,0.116706283868085,0.130342797172572,1.8963629716085e-270
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL2,Angiopoietin-related protein 2,29491,0.0977905393685725,0.00275409232984984,0.0923925184020668,0.103188560335078,1.90627511030411e-270
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.144773818454349,0.00408330812530059,-0.152777102379939,-0.13677053452876,1.27525638008612e-269
NMR metabolomics,X23408.Triglycerides in VLDL,FYB1,FYN-binding protein 1,29400,0.224720503546238,0.00635873974845131,0.212257373639274,0.237183633453203,5.78669564091263e-268
NMR metabolomics,X23408.Triglycerides in VLDL,MLN,Promotilin,29434,0.217229390536836,0.00616037740489112,0.20515505082325,0.229303730250423,8.03938883725509e-267
NMR metabolomics,X23408.Triglycerides in VLDL,ABL1,Tyrosine-protein kinase ABL1,29349,0.165005090033379,0.0046795631745339,0.155833146211292,0.174177033855465,8.78732786033753e-267
NMR metabolomics,X23408.Triglycerides in VLDL,AP1G2,AP-1 complex subunit gamma-like 2,24793,0.19392156771688,0.00549825319465691,0.183144991455352,0.204698143978407,6.39979118218029e-266
NMR metabolomics,X23408.Triglycerides in VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,0.165870942341072,0.00470624875138999,0.156646694788347,0.175095189893796,2.22834666031006e-265
NMR metabolomics,X23408.Triglycerides in VLDL,PPY,Pancreatic prohormone,29400,0.247072973020878,0.00704324198151728,0.233268218737104,0.260877727304651,3.93268667260619e-264
NMR metabolomics,X23408.Triglycerides in VLDL,SARG,Specifically androgen-regulated gene protein,24820,0.264531250314526,0.00755125449087005,0.24973079151242,0.279331709116631,1.84648869689192e-262
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,0.0711525303006136,0.00204357105936272,0.0671471310242626,0.0751579295769645,2.15452392190296e-259
NMR metabolomics,X23408.Triglycerides in VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,0.214877714058813,0.00618691443935784,0.202751361757672,0.227004066359955,5.14090911262045e-259
NMR metabolomics,X23408.Triglycerides in VLDL,PYY,Peptide YY,24111,0.233326910418743,0.00671601284300145,0.22016352524646,0.246490295591026,4.24444904891038e-258
NMR metabolomics,X23408.Triglycerides in VLDL,NPPC,C-type natriuretic peptide,29434,0.114732793692519,0.00331444758482812,0.108236476426256,0.121229110958782,2.13969221422734e-257
NMR metabolomics,X23408.Triglycerides in VLDL,YTHDF3,YTH domain-containing family protein 3,28931,0.203529371110045,0.00589757576449534,0.191970122611634,0.215088619608456,8.64422819309867e-256
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL13,C-X-C motif chemokine 13,29694,0.144630322476325,0.00421266175882288,0.136373505429032,0.152887139523618,2.36211343070277e-253
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS8,Prostasin,29347,0.0975273671525635,0.00284278120892711,0.0919555159830663,0.103099218322061,6.2055939053622e-253
NMR metabolomics,X23408.Triglycerides in VLDL,IL18R1,Interleukin-18 receptor 1,29786,0.0779476602610809,0.00227252306771575,0.073493515048358,0.0824018054738037,6.62085639071927e-253
NMR metabolomics,X23408.Triglycerides in VLDL,CDHR5,Cadherin-related family member 5,29478,0.0923901183910673,0.00269339659201786,0.0871110610707123,0.0976691757114223,6.8648224299493e-253
NMR metabolomics,X23408.Triglycerides in VLDL,FCN2,Ficolin-2,29381,0.0968804108007544,0.00284132705209064,0.0913114097786568,0.102449411822852,6.18660739039378e-250
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA3F,Semaphorin-3F,29478,0.061970033031978,0.00182511774480484,0.0583928022521605,0.0655472638117955,6.44628390071801e-248
NMR metabolomics,X23408.Triglycerides in VLDL,SOST,Sclerostin,29433,0.0908005821539681,0.00268050445135101,0.0855467934293201,0.0960543708786161,8.81167784474292e-247
NMR metabolomics,X23408.Triglycerides in VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,24793,0.123140323132378,0.00362968327951441,0.11602614390453,0.130254502360226,1.20853011169056e-246
NMR metabolomics,X23408.Triglycerides in VLDL,TJAP1,Tight junction-associated protein 1,29566,0.194190422754947,0.00573735361386185,0.182945209671778,0.205435635838116,2.07685246260138e-246
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL17,C-X-C motif chemokine 17,29786,0.0982008165443882,0.0029104822168127,0.0924962713994353,0.103905361689341,6.12603384241701e-245
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RN,Interleukin-1 receptor antagonist protein,29379,0.125969249970044,0.00374081030797957,0.118637261766404,0.133301238173684,6.04765268000129e-244
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,0.196780018892884,0.00585842272448207,0.185297510352899,0.208262527432868,8.41845177036219e-242
NMR metabolomics,X23408.Triglycerides in VLDL,HJV,Hemojuvelin,24867,0.102910299338719,0.00306617487289155,0.0969005965878514,0.108920002089586,1.42787327354306e-241
NMR metabolomics,X23408.Triglycerides in VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,0.226068849909935,0.00675841987456795,0.212822346955782,0.239315352864088,8.42623530634017e-241
NMR metabolomics,X23408.Triglycerides in VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,0.114752222373542,0.00342536489231569,0.108038507184603,0.121465937562481,1.34234361026797e-240
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINF2,Alpha-2-antiplasmin,24515,0.0315746582211476,0.000944314969506068,0.0297238008809157,0.0334255155613795,9.80463911159491e-240
NMR metabolomics,X23408.Triglycerides in VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,0.0942020251185799,0.00281926634199162,0.0886762630882763,0.0997277871488835,1.73956201236879e-239
NMR metabolomics,X23408.Triglycerides in VLDL,TXLNA,Alpha-taxilin,29218,0.204803457315923,0.00614184742382953,0.192765436365217,0.216841478266628,2.61665789728831e-239
NMR metabolomics,X23408.Triglycerides in VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,0.109266730036703,0.00327241293327121,0.102852800687492,0.115680659385915,4.64280244096043e-239
NMR metabolomics,X23408.Triglycerides in VLDL,BTD,Biotinidase,24966,0.0477417619187425,0.001434319123158,0.0449304964373528,0.0505530274001322,9.92514967795805e-238
NMR metabolomics,X23408.Triglycerides in VLDL,MAPK9,Mitogen-activated protein kinase 9,29434,0.0989485397745792,0.0029778364368921,0.0931119803582707,0.104785099190888,1.04828749861428e-237
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,0.0826917497232801,0.00248893416404873,0.0778134387617446,0.0875700606848156,1.16141066673159e-237
NMR metabolomics,X23408.Triglycerides in VLDL,BPIFB1,BPI fold-containing family B member 1,29333,-0.145114095429614,0.00437083621458998,-0.15368093441021,-0.136547256449017,2.64279587290937e-237
NMR metabolomics,X23408.Triglycerides in VLDL,CTSD,Cathepsin D,27442,0.0934326778388648,0.00281724759754686,0.0879108725476729,0.0989544831300566,1.64722248691083e-236
NMR metabolomics,X23408.Triglycerides in VLDL,NHLRC3,NHL repeat-containing protein 3,23825,0.0733940772723136,0.00222295252671583,0.0690370903199506,0.0777510642246767,8.73708436921241e-234
NMR metabolomics,X23408.Triglycerides in VLDL,CD2AP,CD2-associated protein,29478,0.144918627091306,0.0044047000901701,0.136285414914572,0.153551839268039,3.56248953369668e-233
NMR metabolomics,X23408.Triglycerides in VLDL,CCL22,C-C motif chemokine 22,29169,0.117811557960921,0.00358511838582636,0.110784725924701,0.124838389997141,1.38566578973232e-232
NMR metabolomics,X23408.Triglycerides in VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,0.12545163520075,0.00381727870900529,0.1179697689311,0.1329335014704,1.50704917604688e-232
NMR metabolomics,X23408.Triglycerides in VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,0.221620668853933,0.0067475518030584,0.208395467319938,0.234845870387927,2.21737137070622e-232
NMR metabolomics,X23408.Triglycerides in VLDL,CES3,Carboxylesterase 3,29349,0.158717126691718,0.00483628080212779,0.149238016319548,0.168196237063889,5.15096444621325e-232
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,0.185363276651228,0.00564062253365427,0.174307656485266,0.196418896817191,7.16912586804126e-232
NMR metabolomics,X23408.Triglycerides in VLDL,CANT1,Soluble calcium-activated nucleotidase 1,29370,0.0459515347161636,0.00140298998229382,0.0432016743508677,0.0487013950814595,4.06085550910477e-231
NMR metabolomics,X23408.Triglycerides in VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,0.068148651618277,0.00207828856918337,0.0640752060226776,0.0722220972138764,6.80004053492661e-231
NMR metabolomics,X23408.Triglycerides in VLDL,ACE2,Angiotensin-converting enzyme 2,28916,0.116760974928703,0.00358620769219428,0.109732007852003,0.123789942005404,2.14557403672843e-228
NMR metabolomics,X23408.Triglycerides in VLDL,ARF6,ADP-ribosylation factor 6,24805,0.241474060712944,0.00741122675698021,0.226948056269262,0.256000065156625,4.71434786560457e-228
NMR metabolomics,X23408.Triglycerides in VLDL,BECN1,Beclin-1,24240,0.136172842877946,0.0041830102425112,0.127974142802624,0.144371542953268,1.47130204895533e-227
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJA2,DnaJ homolog subfamily A member 2,29704,0.184101466255213,0.00568022367341186,0.172968227855326,0.1952347046551,1.71538649345827e-226
NMR metabolomics,X23408.Triglycerides in VLDL,FN1,Fibronectin,24966,0.0602221002169586,0.00185655355800315,0.0565832552432724,0.0638609451906448,4.01793553563042e-226
NMR metabolomics,X23408.Triglycerides in VLDL,DKK1,Dickkopf-related protein 1,29694,0.133125973698805,0.00411737397618654,0.125055920705479,0.141196026692131,1.98976068072235e-225
NMR metabolomics,X23408.Triglycerides in VLDL,CLUL1,Clusterin-like protein 1,29435,-0.101163245082752,0.00312945495933551,-0.10729697680305,-0.0950295133624545,2.64125246248244e-225
NMR metabolomics,X23408.Triglycerides in VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,0.218770451978213,0.00676923229797292,0.205502756674186,0.23203814728224,1.70739059417435e-224
NMR metabolomics,X23408.Triglycerides in VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,29434,0.237697082878164,0.00736763638076718,0.22325651557186,0.252137650184467,1.93792929066388e-224
NMR metabolomics,X23408.Triglycerides in VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,0.252406212229865,0.00781591380899999,0.237087021164225,0.267725403295505,4.36468308837153e-224
NMR metabolomics,X23408.Triglycerides in VLDL,AP3S2,AP-3 complex subunit sigma-2,24845,0.105851735616573,0.00328226161622922,0.0994185028487637,0.112284968384382,1.45187564684904e-223
NMR metabolomics,X23408.Triglycerides in VLDL,EHBP1,EH domain-binding protein 1,24922,0.166963652539895,0.00518580486316046,0.1567994750081,0.177127830071689,7.33580201872861e-223
NMR metabolomics,X23408.Triglycerides in VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,0.0614170386081956,0.00191026821916154,0.057672912898639,0.0651611643177523,3.12155334220217e-222
NMR metabolomics,X23408.Triglycerides in VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,0.11901649114837,0.00371313350813629,0.111738749472423,0.126294232824317,1.39275253372251e-221
NMR metabolomics,X23408.Triglycerides in VLDL,EZR,Ezrin,29694,0.0534733712723541,0.00166854873699832,0.0502030157478373,0.0567437267968708,1.4162096323391e-221
NMR metabolomics,X23408.Triglycerides in VLDL,MTSS2,Protein MTSS 2,24793,0.221031781634802,0.00688655590930082,0.207534132052573,0.234529431217032,1.7067989279678e-221
NMR metabolomics,X23408.Triglycerides in VLDL,DCXR,L-xylulose reductase,29566,0.119209143863463,0.00372443678979154,0.111909247755471,0.126509039971454,5.15958191969074e-221
NMR metabolomics,X23408.Triglycerides in VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,0.158788874621014,0.00496317862497707,0.149061044516059,0.168516704725969,9.95540274540767e-221
NMR metabolomics,X23408.Triglycerides in VLDL,AXIN1,Axin-1,29434,0.211058663656364,0.0066057730907088,0.198111348398575,0.224005978914153,3.09275158988723e-220
NMR metabolomics,X23408.Triglycerides in VLDL,CEP20,Centrosomal protein 20,28797,0.164988733993944,0.00516309457060537,0.154869068635557,0.17510839935233,3.22073359572923e-220
NMR metabolomics,X23408.Triglycerides in VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,0.183826636347302,0.00575871684773452,0.172539551325743,0.195113721368862,4.35696765987601e-219
NMR metabolomics,X23408.Triglycerides in VLDL,DCTN1,Dynactin subunit 1,29725,0.143144730911056,0.0045068547703757,0.134311295561119,0.151978166260992,9.68867183025618e-218
NMR metabolomics,X23408.Triglycerides in VLDL,RTN4R,Reticulon-4 receptor,29725,0.0745938676782376,0.0023488298841386,0.0699901611053259,0.0791975742511492,1.08474030381188e-217
NMR metabolomics,X23408.Triglycerides in VLDL,THOP1,Thimet oligopeptidase,29343,0.0678894193137363,0.00214222344721987,0.0636906613571853,0.0720881772702872,9.3797570089179e-217
NMR metabolomics,X23408.Triglycerides in VLDL,KRT18,"Keratin, type I cytoskeletal 18",29349,0.178642382405179,0.00564021979637403,0.167587551604286,0.189697213206072,1.63388491357507e-216
NMR metabolomics,X23408.Triglycerides in VLDL,TARBP2,RISC-loading complex subunit TARBP2,28774,0.173646804068741,0.00548583567558327,0.162894566144598,0.184399041992884,3.47541855135337e-216
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP4,Metalloproteinase inhibitor 4,29443,-0.0885211878862325,0.00279809361523709,-0.0940054513720972,-0.0830369244003678,4.89994872879121e-216
NMR metabolomics,X23408.Triglycerides in VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,0.11293295462395,0.00358922959009803,0.105898064627358,0.119967844620543,1.12394140370691e-213
NMR metabolomics,X23408.Triglycerides in VLDL,HBEGF,Proheparin-binding EGF-like growth factor,29632,0.158619814434271,0.00504524315163669,0.148731137857064,0.168508491011479,1.89563184002079e-213
NMR metabolomics,X23408.Triglycerides in VLDL,CD63,CD63 antigen,29169,0.112092794848306,0.00356564424281806,0.105104132132382,0.119081457564229,2.32486061052061e-213
NMR metabolomics,X23408.Triglycerides in VLDL,CREG1,Protein CREG1,29079,0.083160054712982,0.00264538521137436,0.0779750996986882,0.0883450097272757,2.45716453686999e-213
NMR metabolomics,X23408.Triglycerides in VLDL,YOD1,Ubiquitin thioesterase OTU1,24111,0.136010255923196,0.00433060553096598,0.127522269082503,0.14449824276389,3.09279895942937e-212
NMR metabolomics,X23408.Triglycerides in VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,0.145187912805877,0.00463665486846456,0.136100069263687,0.154275756348068,1.10798502277056e-211
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC1B,C-type lectin domain family 1 member B,29694,0.208523748221565,0.00666426498270832,0.195461788855457,0.221585707587674,1.7602031147223e-211
NMR metabolomics,X23408.Triglycerides in VLDL,CEP85,Centrosomal protein of 85 kDa,28797,0.139073782551171,0.00444443477278179,0.130362690396519,0.147784874705823,2.11941335737423e-211
NMR metabolomics,X23408.Triglycerides in VLDL,COL18A1,Collagen alpha-1(XVIII) chain,29559,0.0506545357287821,0.00162740058548472,0.047464830581232,0.0538442408763321,2.58386602603345e-209
NMR metabolomics,X23408.Triglycerides in VLDL,PAXX,Protein PAXX,24381,0.0991374285218982,0.00318040941237086,0.0929038260736514,0.105371030970145,3.33819827671058e-209
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,24240,0.156601708048604,0.00504289101310696,0.146717641662915,0.166485774434294,1.18235371081466e-207
NMR metabolomics,X23408.Triglycerides in VLDL,NPL,N-acetylneuraminate lyase,24922,0.0965451779966022,0.00311943139079243,0.0904310924706491,0.102659263522555,2.08086551501803e-206
NMR metabolomics,X23408.Triglycerides in VLDL,PLXNA4,Plexin-A4,29434,0.175254794920363,0.00567358725188631,0.164134563906666,0.18637502593406,3.25761357277392e-206
NMR metabolomics,X23408.Triglycerides in VLDL,S100A4,Protein S100-A4,29566,0.122264329942466,0.00396119586591022,0.114500386045282,0.13002827383965,6.48126569036448e-206
NMR metabolomics,X23408.Triglycerides in VLDL,PLIN1,Perilipin-1,28774,0.0747851364209326,0.00242418238075066,0.0700337389546613,0.0795365338872039,1.27638713633568e-205
NMR metabolomics,X23408.Triglycerides in VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,0.231830422671901,0.00750569420564507,0.217119262028837,0.246541583314966,1.37054049318017e-205
NMR metabolomics,X23408.Triglycerides in VLDL,KAZN,Kazrin,24805,0.223433774712395,0.00724102037255842,0.209241374782181,0.23762617464261,3.45574139898843e-205
NMR metabolomics,X23408.Triglycerides in VLDL,HGF,Hepatocyte growth factor,29786,0.0736710144746116,0.00239173183566967,0.068983220076699,0.0783588088725241,4.0565714943441e-205
NMR metabolomics,X23408.Triglycerides in VLDL,COL4A1,Collagen alpha-1(IV) chain,29478,-0.0848901029361492,0.00275576652080685,-0.0902914053169306,-0.0794888005553678,4.10287688944754e-205
NMR metabolomics,X23408.Triglycerides in VLDL,CTBS,Di-N-acetylchitobiase,24653,0.0583507051656243,0.00189433447567518,0.054637809593301,0.0620636007379477,1.81040646963411e-204
NMR metabolomics,X23408.Triglycerides in VLDL,CTSO,Cathepsin O,29786,0.0648636852112874,0.00211002770832096,0.0607280309029783,0.0689993395195965,2.55886032110925e-204
NMR metabolomics,X23408.Triglycerides in VLDL,FUOM,Fucose mutarotase,24381,0.135808419393858,0.00442697804779152,0.127131542420187,0.14448529636753,8.16377239056774e-203
NMR metabolomics,X23408.Triglycerides in VLDL,STC1,Stanniocalcin-1,29694,0.0922012548236818,0.00302276522301388,0.0862766349865746,0.098125874660789,3.1205685705025e-201
NMR metabolomics,X23408.Triglycerides in VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,0.231540114034544,0.00757958039584261,0.216684136458693,0.246396091610396,3.30238365310205e-201
NMR metabolomics,X23408.Triglycerides in VLDL,MASP1,Mannan-binding lectin serine protease 1,29163,0.0499917094261907,0.00164295462162213,0.0467715183678113,0.0532119004845701,3.19272680784258e-200
NMR metabolomics,X23408.Triglycerides in VLDL,CPB2,Carboxypeptidase B2,24914,0.0477278923019685,0.00157156927398172,0.0446476165249643,0.0508081680789726,5.88410643566109e-199
NMR metabolomics,X23408.Triglycerides in VLDL,NUCB2,Nucleobindin-2,29652,0.0784047866861967,0.00259246652813333,0.0733235522910553,0.083486021081338,6.53179193036688e-198
NMR metabolomics,X23408.Triglycerides in VLDL,ISM1,Isthmin-1,29434,0.0826456540737464,0.00273536258914962,0.0772843433990132,0.0880069647484797,1.63428169407393e-197
NMR metabolomics,X23408.Triglycerides in VLDL,ERBIN,Erbin,29349,0.214860081186971,0.00711719227397755,0.200910384329975,0.228809778043967,3.45948068146076e-197
NMR metabolomics,X23408.Triglycerides in VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,28797,0.103849461459337,0.00344287402747057,0.0971014283654947,0.110597494553179,8.26586834535564e-197
NMR metabolomics,X23408.Triglycerides in VLDL,ATG16L1,Autophagy-related protein 16-1,24805,0.17903003239216,0.00593360769830664,0.167400161303479,0.190659903480841,1.95077190041591e-196
NMR metabolomics,X23408.Triglycerides in VLDL,AGRN,Agrin,29581,0.0721312412799999,0.00239540459264352,0.0674362482784186,0.0768262342815812,3.08472709054556e-196
NMR metabolomics,X23408.Triglycerides in VLDL,SELP,P-selectin,29594,0.118896089111827,0.0039502750562543,0.111153550001568,0.126638628222085,4.65361710933082e-196
NMR metabolomics,X23408.Triglycerides in VLDL,PDLIM7,PDZ and LIM domain protein 7,29581,0.261354207279921,0.00870596386331698,0.244290518107819,0.278417896452022,4.55814909724106e-195
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFC,Platelet-derived growth factor C,28797,0.0603693006049727,0.0020140689918965,0.0564217253808556,0.0643168758290898,2.10350917455997e-194
NMR metabolomics,X23408.Triglycerides in VLDL,DAB2,Disabled homolog 2,29725,0.230231123577288,0.00768680743707197,0.215164981000627,0.245297266153949,3.26482062638835e-194
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL10,C-X-C motif chemokine 10,29581,0.139188565255381,0.0046495102911136,0.130075525084799,0.148301605425964,5.25762762825108e-194
NMR metabolomics,X23408.Triglycerides in VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,0.155050905906188,0.00517112222142283,0.1449155063522,0.165186305460177,5.7832374081541e-194
NMR metabolomics,X23408.Triglycerides in VLDL,LEP,Leptin,29478,0.139862975074094,0.00467337257692345,0.130703164823324,0.149022785324864,6.89674374554767e-194
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,0.216035392918684,0.00722298561107431,0.201878341120978,0.230192444716389,1.18212551728252e-193
NMR metabolomics,X23408.Triglycerides in VLDL,TCTN3,Tectonic-3,24922,0.061968401971734,0.00207430354987849,0.0579027670139722,0.0660340369294958,1.06307553580148e-192
NMR metabolomics,X23408.Triglycerides in VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,0.217347017753077,0.00728604514837356,0.203066369262265,0.231627666243889,1.19852257489777e-192
NMR metabolomics,X23408.Triglycerides in VLDL,NFX1,Transcriptional repressor NF-X1,24111,0.14053628818074,0.00470590761451084,0.131312709256298,0.149759867105181,1.86169243664048e-192
NMR metabolomics,X23408.Triglycerides in VLDL,TGFB1,Transforming growth factor beta-1 proprotein,29760,0.0794871552195035,0.00266689362543945,0.0742600437136422,0.0847142667253648,2.26912807619826e-192
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R9B,Neurabin-2,29786,0.195457722953181,0.00655952033179573,0.182601063102861,0.2083143828035,2.81088990498621e-192
NMR metabolomics,X23408.Triglycerides in VLDL,BCR,Breakpoint cluster region protein,29434,0.189876625919827,0.00637434162975658,0.177382916325504,0.20237033551415,4.04295854675123e-192
NMR metabolomics,X23408.Triglycerides in VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,0.114228240579748,0.00384293358778198,0.106696090747695,0.1217603904118,2.82763876876525e-191
NMR metabolomics,X23408.Triglycerides in VLDL,IKBKG,NF-kappa-B essential modulator,29434,0.189559346240067,0.00637817161101448,0.177058129882478,0.202060562597655,2.85795809743712e-191
NMR metabolomics,X23408.Triglycerides in VLDL,SNAP23,Synaptosomal-associated protein 23,29478,0.179648605715675,0.00604564491013904,0.167799141691802,0.191498069739547,3.23669398119596e-191
NMR metabolomics,X23408.Triglycerides in VLDL,IL1R2,Interleukin-1 receptor type 2,29404,0.0411919138843881,0.00138631482248892,0.0384747368323098,0.0439090909364664,3.4976006372745e-191
NMR metabolomics,X23408.Triglycerides in VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,0.150207547040023,0.00504879102320539,0.140311916634541,0.160103177445506,3.69437016778053e-191
NMR metabolomics,X23408.Triglycerides in VLDL,TNIP1,TNFAIP3-interacting protein 1,24845,0.182769718441016,0.00615418479930004,0.170707516234388,0.194831920647644,1.72160939870716e-190
NMR metabolomics,X23408.Triglycerides in VLDL,OXT,Oxytocin-neurophysin 1,29694,0.286542095336195,0.00968098491323876,0.267567364906247,0.305516825766143,9.00138910576018e-190
NMR metabolomics,X23408.Triglycerides in VLDL,FETUB,Fetuin-B,29545,0.0679050172505966,0.00229771924949563,0.0634014875215851,0.072408546979608,3.40965279878145e-189
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFC,Vascular endothelial growth factor C,29566,0.114368488784791,0.00387320467399401,0.106777007623763,0.121959969945819,6.98055489309127e-189
NMR metabolomics,X23408.Triglycerides in VLDL,CD6,T-cell differentiation antigen CD6,29760,0.107987203554322,0.00366551544217606,0.100802793287657,0.115171613820987,4.69223819354836e-188
NMR metabolomics,X23408.Triglycerides in VLDL,PAK4,Serine/threonine-protein kinase PAK 4,28774,0.125484925570116,0.00426205961546257,0.117131288723809,0.133838562416422,9.67827118851174e-188
NMR metabolomics,X23408.Triglycerides in VLDL,LSP1,Lymphocyte-specific protein 1,29434,0.0821457989725317,0.0027983778302137,0.0766609784253128,0.0876306195197505,1.02649374132175e-186
NMR metabolomics,X23408.Triglycerides in VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,0.152534634986943,0.00518840570675991,0.142365359801694,0.162703910172192,1.0685251558417e-186
NMR metabolomics,X23408.Triglycerides in VLDL,CRELD1,Protein disulfide isomerase CRELD1,24381,0.0767593342643702,0.00261107950149586,0.0716416184414383,0.0818770500873021,1.07111087732562e-186
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4B,Eukaryotic translation initiation factor 4B,29218,0.118010008572034,0.00402757582247672,0.110115959959979,0.125904057184088,5.05048098990071e-186
NMR metabolomics,X23408.Triglycerides in VLDL,CRHBP,Corticotropin-releasing factor-binding protein,29454,0.0567685431737546,0.00193767720361744,0.0529706958546644,0.0605663904928448,5.28319046026471e-186
NMR metabolomics,X23408.Triglycerides in VLDL,CDH2,Cadherin-2,29478,0.072168484961135,0.00246463795886945,0.0673377945617509,0.0769991753605192,8.20857013333636e-186
NMR metabolomics,X23408.Triglycerides in VLDL,MUC13,Mucin-13,28774,0.104935271338245,0.00358542950649789,0.0979078295055092,0.111962713170981,1.4342780027796e-185
NMR metabolomics,X23408.Triglycerides in VLDL,RAB11FIP3,Rab11 family-interacting protein 3,24922,0.218785417478607,0.00747367573509382,0.204137013037823,0.233433821919391,3.03515118248159e-185
NMR metabolomics,X23408.Triglycerides in VLDL,CCL17,C-C motif chemokine 17,29414,0.185041641851171,0.00633408293262211,0.172626839303231,0.19745644439911,5.74678890288789e-185
NMR metabolomics,X23408.Triglycerides in VLDL,BACH1,Transcription regulator protein BACH1,29434,0.14955460331068,0.00513013287808259,0.139499542869638,0.159609663751722,3.27725777169139e-184
NMR metabolomics,X23408.Triglycerides in VLDL,SLA2,Src-like-adapter 2,24867,0.212771285210169,0.0072901741761343,0.198482543824946,0.227060026595393,3.72797069639072e-184
NMR metabolomics,X23408.Triglycerides in VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,0.0475173406726409,0.00163406843186238,0.0443145665461906,0.0507201147990912,2.59021364594496e-183
NMR metabolomics,X23408.Triglycerides in VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,0.140397414199216,0.00483622667315904,0.130918409919825,0.149876418478608,1.14132600300859e-182
NMR metabolomics,X23408.Triglycerides in VLDL,PSIP1,PC4 and SFRS1-interacting protein,29434,0.128823468638807,0.00444509628673913,0.120111079916798,0.137535857360815,4.15236471650867e-182
NMR metabolomics,X23408.Triglycerides in VLDL,STAT5B,Signal transducer and activator of transcription 5B,29349,0.277014324401716,0.00955917277707192,0.258278345758655,0.295750303044777,4.48388038755671e-182
NMR metabolomics,X23408.Triglycerides in VLDL,SELE,E-selectin,29820,0.101421486201749,0.00350781603033417,0.0945461667822939,0.108296805621204,2.62167419838839e-181
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL5,C-X-C motif chemokine 5,29384,0.228884228394091,0.00792017173963813,0.2133606917844,0.244407765003781,4.24065080488039e-181
NMR metabolomics,X23408.Triglycerides in VLDL,TANK,TRAF family member-associated NF-kappa-B activator,28931,0.141381751114027,0.00489232535023892,0.131792793427559,0.150970708800495,4.66722650645244e-181
NMR metabolomics,X23408.Triglycerides in VLDL,SRPK2,SRSF protein kinase 2,29434,0.16863590532389,0.00583903890184036,0.157191389076282,0.180080421571497,6.99356346173843e-181
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.0407582915659913,0.00141544763536511,0.0379840142006757,0.0435325689313069,7.82606133330033e-180
NMR metabolomics,X23408.Triglycerides in VLDL,OTUD7B,OTU domain-containing protein 7B,24867,0.126865681680861,0.00440200845570458,0.11823774510768,0.135493618254042,1.08869485220575e-179
NMR metabolomics,X23408.Triglycerides in VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,0.165586005737852,0.00575402812738832,0.154308110608171,0.176863900867533,1.44149300975428e-179
NMR metabolomics,X23408.Triglycerides in VLDL,CMIP,C-Maf-inducing protein,24793,0.166256934213542,0.00577589684844295,0.154936176390594,0.17757769203649,2.97748361560729e-179
NMR metabolomics,X23408.Triglycerides in VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,0.0790491956209243,0.00275139780103106,0.0736564559309034,0.0844419353109452,4.39517504337085e-179
NMR metabolomics,X23408.Triglycerides in VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.0448168617549562,0.00156090117265885,0.0417574954565449,0.0478762280533676,8.56000865899655e-179
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,0.189808881229286,0.00662647968187366,0.176820981052814,0.202796781405758,5.1767877173787e-178
NMR metabolomics,X23408.Triglycerides in VLDL,F13B,Coagulation factor XIII B chain,24833,0.0516146965923865,0.0018008507863882,0.0480850290510656,0.0551443641337074,9.11774808908338e-178
NMR metabolomics,X23408.Triglycerides in VLDL,NCK2,Cytoplasmic protein NCK2,29581,0.210413805948687,0.00735342069598638,0.196001101384554,0.224826510512821,1.17826626321999e-177
NMR metabolomics,X23408.Triglycerides in VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,28797,0.127748348101449,0.0044641730621589,0.118998568899618,0.136498127303281,1.29583017181605e-177
NMR metabolomics,X23408.Triglycerides in VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,0.182546226697635,0.00639591926478226,0.170010224938661,0.195082228456608,1.02938757039692e-176
NMR metabolomics,X23408.Triglycerides in VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,29434,0.0751613347666882,0.00263707639886573,0.0699926650249114,0.080330004508465,2.78104338984822e-176
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,0.196395575438583,0.00689225813381935,0.182886749496297,0.209904401380868,3.13903117111442e-176
NMR metabolomics,X23408.Triglycerides in VLDL,CCN2,CCN family member 2,29478,0.113085802654259,0.00397676960902898,0.105291334220562,0.120880271087955,1.68195128722338e-175
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD5,Programmed cell death protein 5,29694,0.114585654258791,0.00403301526464407,0.106680944340089,0.122490364177494,3.20594061439577e-175
NMR metabolomics,X23408.Triglycerides in VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,24240,0.203843939479338,0.00716370041769685,0.189803086660652,0.217884792298024,3.20603887561804e-175
NMR metabolomics,X23408.Triglycerides in VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,0.166831436887229,0.00586488426360754,0.155336263730558,0.1783266100439,3.5173611014919e-175
NMR metabolomics,X23408.Triglycerides in VLDL,SUGP1,SURP and G-patch domain-containing protein 1,24805,0.0793431438138393,0.00279249143420713,0.0738698606027933,0.0848164270248853,8.82316704382424e-175
NMR metabolomics,X23408.Triglycerides in VLDL,NT5E,5'-nucleotidase,29566,0.110991546612105,0.00391311111443093,0.10332184882782,0.118661244396389,1.23427583093049e-174
NMR metabolomics,X23408.Triglycerides in VLDL,FOXO1,Forkhead box protein O1,29434,0.168906615481615,0.0059581209214417,0.157228698475589,0.180584532487641,1.91544559710141e-174
NMR metabolomics,X23408.Triglycerides in VLDL,LAT,Linker for activation of T-cells family member 1,29786,0.149324986969576,0.00527183271190548,0.138992194854241,0.159657779084911,3.4827094539778e-174
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINH1,Serpin H1,24445,0.253894835475718,0.00896440816430863,0.236324595473673,0.271465075477763,1.16573690755812e-173
NMR metabolomics,X23408.Triglycerides in VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,0.136762884430612,0.00483002081058101,0.127296043641874,0.146229725219351,1.28897437259169e-173
NMR metabolomics,X23408.Triglycerides in VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,24793,0.224807269971691,0.00794928456540623,0.209226672223495,0.240387867719887,3.41139354033452e-173
NMR metabolomics,X23408.Triglycerides in VLDL,AAMDC,Mth938 domain-containing protein,24240,0.105338131877523,0.00372472493978167,0.0980376709955513,0.112638592759495,3.86655307130201e-173
NMR metabolomics,X23408.Triglycerides in VLDL,DOK2,Docking protein 2,29478,0.239323425858328,0.00847564406990268,0.222711163481319,0.255935688235337,4.21395089854716e-173
NMR metabolomics,X23408.Triglycerides in VLDL,PLSCR3,Phospholipid scramblase 3,24804,0.115954224892618,0.00410160248470404,0.107915084022598,0.123993365762638,4.4413473526956e-173
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINE1,Plasminogen activator inhibitor 1,29820,0.131799694864392,0.0046699374738314,0.122646617415683,0.140952772313102,5.7707102651903e-173
NMR metabolomics,X23408.Triglycerides in VLDL,TOP2B,DNA topoisomerase 2-beta,24229,0.156685674495045,0.0055496880666482,0.145808285884414,0.167563063105675,1.42586811577533e-172
NMR metabolomics,X23408.Triglycerides in VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,29349,0.165684227714552,0.00588679940104908,0.154146100888496,0.177222354540608,5.33907824159987e-172
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.0529664996833891,0.00188217463642082,0.0492774373960043,0.0566555619707739,5.93365434078473e-172
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF3,Immunoglobulin superfamily member 3,29349,0.0702099554620063,0.0025009212833433,0.0653081497466535,0.0751117611773592,3.77915274719814e-171
NMR metabolomics,X23408.Triglycerides in VLDL,HAO1,Hydroxyacid oxidase 1,29725,0.250282597457203,0.00892393913045231,0.232791676761516,0.267773518152889,7.50489163096897e-171
NMR metabolomics,X23408.Triglycerides in VLDL,VWA1,von Willebrand factor A domain-containing protein 1,29674,0.0823049428845388,0.00293803521829125,0.076546393856688,0.0880634919123897,1.84598732115726e-170
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE4,Ribonuclease 4,24194,0.0538349071627283,0.00191929434154836,0.0500730902532935,0.0575967240721631,2.17397140387393e-170
NMR metabolomics,X23408.Triglycerides in VLDL,CCL5,C-C motif chemokine 5,29594,0.195856007704414,0.00699580985273275,0.182144220393058,0.20956779501577,3.01088191974166e-170
NMR metabolomics,X23408.Triglycerides in VLDL,LBR,Delta(14)-sterol reductase LBR,29694,0.130116371741345,0.00465129641815609,0.120999830761759,0.139232912720931,5.39317494353602e-170
NMR metabolomics,X23408.Triglycerides in VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,0.149875013237586,0.00537272776456633,0.139344466819036,0.160405559656136,1.18320397303385e-168
NMR metabolomics,X23408.Triglycerides in VLDL,TPD52L2,Tumor protein D54,24381,0.21054976043646,0.0075520646931406,0.195747713637904,0.225351807235015,2.0633513451007e-168
NMR metabolomics,X23408.Triglycerides in VLDL,MINK1,Misshapen-like kinase 1,24845,0.1802493106599,0.00647334954293049,0.167561545555756,0.192937075764043,4.74896352977733e-168
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,0.210318273241208,0.00756686377815017,0.195487220236033,0.225149326246382,1.85965381442307e-167
NMR metabolomics,X23408.Triglycerides in VLDL,PCBP2,Poly(rC)-binding protein 2,24867,0.139704919085999,0.00504531158972199,0.129816108370144,0.149593729801854,3.06958922247553e-166
NMR metabolomics,X23408.Triglycerides in VLDL,CEP43,Centrosomal protein 43,28705,0.133999017918492,0.00485266464703572,0.124487795210302,0.143510240626682,1.12741217982181e-165
NMR metabolomics,X23408.Triglycerides in VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,0.0847648661974676,0.00307093168578286,0.0787458400933332,0.090783892301602,1.36751594878843e-165
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,0.174006809509708,0.0063045776594175,0.161649837297249,0.186363781722166,3.4563580956668e-165
NMR metabolomics,X23408.Triglycerides in VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,0.122529659265194,0.00444552895395266,0.113816422515447,0.131242896014941,9.31070641789196e-165
NMR metabolomics,X23408.Triglycerides in VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,29434,0.215449256030499,0.00783205384602009,0.2000984304923,0.230800081568699,1.67563159290368e-164
NMR metabolomics,X23408.Triglycerides in VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,0.181461676985692,0.00660319615756168,0.168519412516871,0.194403941454513,3.65562046305099e-164
NMR metabolomics,X23408.Triglycerides in VLDL,MEP1A,Meprin A subunit alpha,24805,0.138194867417498,0.00502562593570279,0.128344640583521,0.148045094251476,5.35327788531896e-164
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA5,Integrin alpha-5,29443,0.0479120555818671,0.00174656230713202,0.0444887934598884,0.0513353177038459,1.30009138425469e-163
NMR metabolomics,X23408.Triglycerides in VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,0.132611173351072,0.00484296031165203,0.123118971140234,0.14210337556191,1.33309101480111e-162
NMR metabolomics,X23408.Triglycerides in VLDL,CRELD2,Protein disulfide isomerase CRELD2,29536,0.0991933265919988,0.00362799732267797,0.09208245183955,0.106304201344448,1.46588171702502e-162
NMR metabolomics,X23408.Triglycerides in VLDL,HEXIM1,Protein HEXIM1,29434,0.154489482540336,0.00566599451385488,0.14338413329318,0.165594831787491,1.09990570476419e-161
NMR metabolomics,X23408.Triglycerides in VLDL,PSME1,Proteasome activator complex subunit 1,29192,0.0704863411276577,0.00258746964928865,0.065414900615052,0.0755577816402635,2.20217345175248e-161
NMR metabolomics,X23408.Triglycerides in VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,0.182063699111964,0.00668564253979169,0.168959839733972,0.195167558489956,2.95184733717105e-161
NMR metabolomics,X23408.Triglycerides in VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,0.211979129920579,0.00778980026484181,0.196711121401489,0.227247138439669,4.7855571907471e-161
NMR metabolomics,X23408.Triglycerides in VLDL,FABP5,Fatty acid-binding protein 5,29624,0.128749138963426,0.00474610885246678,0.119446765612591,0.138051512314261,4.26625480101196e-160
NMR metabolomics,X23408.Triglycerides in VLDL,OGFR,Opioid growth factor receptor,29349,0.0617569582869086,0.00227903740060328,0.0572900449817262,0.0662238715920911,9.70928940470093e-160
NMR metabolomics,X23408.Triglycerides in VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,0.144934738714663,0.00534871010210854,0.13445126691453,0.155418210514795,9.88752168942244e-160
NMR metabolomics,X23408.Triglycerides in VLDL,DLK1,Protein delta homolog 1,29820,0.105330954893342,0.00388822877598226,0.0977100264924169,0.112951883294267,1.1220555562771e-159
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,0.0530489113013805,0.00195890676914024,0.0492094540338656,0.0568883685688954,1.49120703038509e-159
NMR metabolomics,X23408.Triglycerides in VLDL,USO1,General vesicular transport factor p115,29349,0.169571676868423,0.00626235191061447,0.157297467123619,0.181845886613227,1.64273015017987e-159
NMR metabolomics,X23408.Triglycerides in VLDL,AKT1S1,Proline-rich AKT1 substrate 1,28774,0.126679771316676,0.00467874902768845,0.117509423222407,0.135850119410946,1.91244207764759e-159
NMR metabolomics,X23408.Triglycerides in VLDL,CCL13,C-C motif chemokine 13,29732,0.12989171014931,0.00481608725275416,0.120452179133912,0.139331241164708,2.65828065733834e-158
NMR metabolomics,X23408.Triglycerides in VLDL,NIT2,Omega-amidase NIT2,24813,0.140060076538909,0.00519906503861993,0.129869909063214,0.150250244014605,1.40512714417981e-157
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL7,Angiopoietin-related protein 7,29725,0.0693728926576792,0.00257836365128001,0.0643192999011704,0.074426485414188,1.45807721498119e-157
NMR metabolomics,X23408.Triglycerides in VLDL,RABEP1,Rab GTPase-binding effector protein 1,24381,0.146667437473532,0.00544704814810824,0.135991223103239,0.157343651843824,2.18749047218418e-157
NMR metabolomics,X23408.Triglycerides in VLDL,PXN,Paxillin,28774,0.0966327642847123,0.00359424502357492,0.0895880440385055,0.103677484530919,2.86846843264394e-157
NMR metabolomics,X23408.Triglycerides in VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,0.118345202206866,0.00440658331661719,0.109708298906296,0.126982105507436,1.22601850009227e-156
NMR metabolomics,X23408.Triglycerides in VLDL,EGLN1,Egl nine homolog 1,29434,0.10164689278185,0.00379300941491815,0.0942125943286099,0.109081191235089,2.54241873456196e-156
NMR metabolomics,X23408.Triglycerides in VLDL,PHACTR2,Phosphatase and actin regulator 2,24867,0.213570415246015,0.00796141178707915,0.19796604814334,0.22917478234869,2.72568047592733e-156
NMR metabolomics,X23408.Triglycerides in VLDL,STK11,Serine/threonine-protein kinase STK11,28916,0.136368607968427,0.00508969639628858,0.126392803031702,0.146344412905153,3.16126743377267e-156
NMR metabolomics,X23408.Triglycerides in VLDL,ASAH2,Neutral ceramidase,29218,0.0988428609810774,0.00369482423570298,0.0916010054790995,0.106084716483055,8.92302080366757e-156
NMR metabolomics,X23408.Triglycerides in VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,29604,0.0611558567383728,0.00228933599278071,0.0566687581925226,0.0656429552842229,2.29993282392758e-155
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM5,Tripartite motif-containing protein 5,29434,0.160070349436121,0.0059937046932368,0.148322688237377,0.171818010634865,2.82486218440451e-155
NMR metabolomics,X23408.Triglycerides in VLDL,CDC27,Cell division cycle protein 27 homolog,28797,0.113387459289216,0.00424795615224636,0.105061465230813,0.121713453347619,4.48683315703122e-155
NMR metabolomics,X23408.Triglycerides in VLDL,DAG1,Dystroglycan,29581,0.088256110537365,0.00331021516137667,0.0817680888210667,0.0947441322536633,8.8738546505617e-155
NMR metabolomics,X23408.Triglycerides in VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,0.191560782467107,0.00718941312922488,0.177469532733826,0.205652032200388,1.37338460413267e-154
NMR metabolomics,X23408.Triglycerides in VLDL,METAP2,Methionine aminopeptidase 2,29674,0.106822391035422,0.00400919952432958,0.0989643599677359,0.114680422103108,1.37950001098231e-154
NMR metabolomics,X23408.Triglycerides in VLDL,AP3B1,AP-3 complex subunit beta-1,24805,0.142653799585274,0.00534995196448501,0.132167893734883,0.153139705435665,1.83353490871249e-154
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFB,Platelet-derived growth factor subunit B,29581,0.158892539691317,0.0059773997186855,0.147176836242694,0.170608243139941,7.03596134542059e-154
NMR metabolomics,X23408.Triglycerides in VLDL,IDUA,Alpha-L-iduronidase,29725,0.0855267040583882,0.00321814918123511,0.0792191316631674,0.091834276453609,8.03119663891931e-154
NMR metabolomics,X23408.Triglycerides in VLDL,HCLS1,Hematopoietic lineage cell-specific protein,29786,0.103036370818859,0.00388084233465573,0.0954299198429334,0.110642821794784,1.5799747779356e-153
NMR metabolomics,X23408.Triglycerides in VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,0.190272374963906,0.00715989926562908,0.176238972403273,0.204305777524539,1.87807463297058e-153
NMR metabolomics,X23408.Triglycerides in VLDL,IL17RB,Interleukin-17 receptor B,29034,-0.0994868444364282,0.00375074727383696,-0.106838309093149,-0.0921353797797077,3.39765559193416e-153
NMR metabolomics,X23408.Triglycerides in VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,0.098764169195125,0.00371941522430325,0.0914741153554906,0.106054223034759,3.47625616931955e-153
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB6,DnaJ homolog subfamily B member 6,24170,0.157159621250844,0.0059197948985952,0.145556823249597,0.16876241925209,4.24057720321655e-153
NMR metabolomics,X23408.Triglycerides in VLDL,SH2B3,SH2B adapter protein 3,28797,0.181387056195724,0.00684554476468415,0.167969788456943,0.194804323934505,7.15924268226794e-153
NMR metabolomics,X23408.Triglycerides in VLDL,SEC31A,Protein transport protein Sec31A,24240,0.142490392319876,0.0053743493342362,0.131956667624773,0.153024117014979,1.03465936254176e-152
NMR metabolomics,X23408.Triglycerides in VLDL,FABP4,"Fatty acid-binding protein, adipocyte",29820,0.0923389669096061,0.00348817704141945,0.0855021399084239,0.0991757939107882,1.1897504172547e-152
NMR metabolomics,X23408.Triglycerides in VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,0.133524712368505,0.0050402633037581,0.123645796293139,0.143403628443871,1.61186319586178e-152
NMR metabolomics,X23408.Triglycerides in VLDL,CES2,Cocaine esterase,29349,0.100838618697409,0.00381408482833933,0.0933630124338635,0.108314224960954,3.01883606886221e-152
NMR metabolomics,X23408.Triglycerides in VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,0.143081901203785,0.00540867648867024,0.132480895285991,0.153682907121579,4.17552742000224e-152
NMR metabolomics,X23408.Triglycerides in VLDL,CNST,Consortin,29478,0.199389984874029,0.00755779677494228,0.184576703195142,0.214203266552916,1.2753817932519e-151
NMR metabolomics,X23408.Triglycerides in VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.0480884290689217,0.00182483795624091,0.0445117466746895,0.0516651114631539,6.49356293770023e-151
NMR metabolomics,X23408.Triglycerides in VLDL,GMPR,GMP reductase 1,29786,0.090960970764945,0.00346555108405128,0.0841684906402045,0.0977534508896855,3.94262274160494e-150
NMR metabolomics,X23408.Triglycerides in VLDL,SYTL4,Synaptotagmin-like protein 4,24922,0.133857184075295,0.00509612319650647,0.123868782610142,0.143845585540447,5.12037815566695e-150
NMR metabolomics,X23408.Triglycerides in VLDL,MMP10,Stromelysin-2,29439,-0.108139206768606,0.00412596212423462,-0.116226092532106,-0.100052321005106,1.08709594071133e-149
NMR metabolomics,X23408.Triglycerides in VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,28774,0.0511927917250105,0.00195313584493987,0.0473646454689284,0.0550209379810927,1.1561929259194e-149
NMR metabolomics,X23408.Triglycerides in VLDL,QDPR,Dihydropteridine reductase,29345,0.0788342048350239,0.00301015265070851,0.0729343056396352,0.0847341040304126,1.83882931892848e-149
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH1A1,Retinal dehydrogenase 1,29443,0.0973207161219711,0.00371716450774819,0.0900350736867846,0.104606358557158,2.22802461616871e-149
NMR metabolomics,X23408.Triglycerides in VLDL,DNMBP,Dynamin-binding protein,29218,0.111648399387821,0.00426749883281133,0.10328410167551,0.120012697100131,3.72949474043876e-149
NMR metabolomics,X23408.Triglycerides in VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,0.0918074236680647,0.00350549101480634,0.0849366612790442,0.0986781860570851,4.23658645602251e-149
NMR metabolomics,X23408.Triglycerides in VLDL,BID,BH3-interacting domain death agonist,29434,0.121667009154115,0.00465542614190522,0.112542373915981,0.130791644392249,7.42767799799322e-149
NMR metabolomics,X23408.Triglycerides in VLDL,GIT1,ARF GTPase-activating protein GIT1,24229,0.177406203546526,0.00680103785735083,0.164076169346119,0.190736237746934,5.94285829651308e-148
NMR metabolomics,X23408.Triglycerides in VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,0.165146323325299,0.00633533644543855,0.152729063892239,0.177563582758358,8.36512026512345e-148
NMR metabolomics,X23408.Triglycerides in VLDL,LYN,Tyrosine-protein kinase Lyn,29349,0.153220011122177,0.00588648486633449,0.141682500784162,0.164757521460193,1.10535462539829e-147
NMR metabolomics,X23408.Triglycerides in VLDL,STAMBP,STAM-binding protein,29163,0.116054362589503,0.00446353324318392,0.107305837432862,0.124802887746143,2.3434125660279e-147
NMR metabolomics,X23408.Triglycerides in VLDL,AMN,Protein amnionless,28931,0.0861873489742153,0.00331569838620642,0.0796885801372507,0.0926861178111799,2.87513415278818e-147
NMR metabolomics,X23408.Triglycerides in VLDL,EREG,Proepiregulin,29163,0.145512612752202,0.00560297767962556,0.134530776500136,0.156494449004268,5.02279050437925e-147
NMR metabolomics,X23408.Triglycerides in VLDL,FKBPL,FK506-binding protein-like,24805,0.107417799261726,0.00413431391967838,0.0993145439791563,0.115521054544296,7.31583449433916e-147
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.047143414679705,0.00181749057876814,0.0435811331453195,0.0507056962140906,1.04228804414754e-146
NMR metabolomics,X23408.Triglycerides in VLDL,SKAP2,Src kinase-associated phosphoprotein 2,29581,0.188665608536733,0.00727510827163906,0.17440639632432,0.202924820749145,1.23620860877177e-146
NMR metabolomics,X23408.Triglycerides in VLDL,CMC1,COX assembly mitochondrial protein homolog,24922,0.16434536511627,0.00633158406552724,0.151935460347837,0.176755269884703,1.36916402119631e-146
NMR metabolomics,X23408.Triglycerides in VLDL,RTBDN,Retbindin,29349,0.0535448365239395,0.0020699861744924,0.0494876636219344,0.0576020094259446,6.75154424887088e-146
NMR metabolomics,X23408.Triglycerides in VLDL,PGF,Placenta growth factor,29786,0.0473968549736529,0.00183300680193892,0.0438041616418526,0.0509895483054532,8.19651560000935e-146
NMR metabolomics,X23408.Triglycerides in VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,0.107473776501062,0.00416473025943901,0.0993109051925614,0.115636647809562,6.27582935141648e-145
NMR metabolomics,X23408.Triglycerides in VLDL,SRP14,Signal recognition particle 14 kDa protein,29349,0.107068864115255,0.00415427378986296,0.0989264874871232,0.115211240743386,7.2819492436274e-145
NMR metabolomics,X23408.Triglycerides in VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,0.113975188343269,0.00442278628197699,0.105306527230594,0.122643849455944,8.46549513989247e-145
NMR metabolomics,X23408.Triglycerides in VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,0.168076374905961,0.00652727074104932,0.155282924253505,0.180869825558418,1.38493056032606e-144
NMR metabolomics,X23408.Triglycerides in VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,0.109986654456798,0.00427625188160097,0.10160520076886,0.118368108144736,2.73409146189572e-144
NMR metabolomics,X23408.Triglycerides in VLDL,PLXNB3,Plexin-B3,29383,0.0849449621704474,0.0033059677436158,0.0784652653929604,0.0914246589479343,5.27762523347073e-144
NMR metabolomics,X23408.Triglycerides in VLDL,NAGK,N-acetyl-D-glucosamine kinase,24209,0.102296315637918,0.00397903448195274,0.0944974080532907,0.110095223222545,7.94790095538885e-144
NMR metabolomics,X23408.Triglycerides in VLDL,AZI2,5-azacytidine-induced protein 2,24867,0.0992070041171392,0.00386304635030179,0.0916354332705477,0.106778574963731,1.42122151133992e-143
NMR metabolomics,X23408.Triglycerides in VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.0521783376136094,0.00203646092925464,0.0481868741922703,0.0561698010349485,3.08729588196988e-143
NMR metabolomics,X23408.Triglycerides in VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.186971636139578,0.00729750850749731,-0.201274752814272,-0.172668519464883,3.27880113063648e-143
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFA,Vascular endothelial growth factor A,29683,0.103334212537247,0.00403336755164722,0.0954288121360189,0.111239612938476,3.31870009134365e-143
NMR metabolomics,X23408.Triglycerides in VLDL,BRAP,BRCA1-associated protein,24565,0.196584861441688,0.00766642471677732,0.181558668996804,0.211611053886571,3.94583243342553e-143
NMR metabolomics,X23408.Triglycerides in VLDL,TAX1BP1,Tax1-binding protein 1,24845,0.113118986545415,0.00441363142006173,0.104468268962094,0.121769704128736,5.18664271144884e-143
NMR metabolomics,X23408.Triglycerides in VLDL,SH2D1A,SH2 domain-containing protein 1A,29434,0.10208309422313,0.00399290048354537,0.0942570092753813,0.109909179170879,1.31389776542126e-142
NMR metabolomics,X23408.Triglycerides in VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,0.142993395677256,0.00559291827540411,0.132031275857464,0.153955515497048,2.46760307426988e-142
NMR metabolomics,X23408.Triglycerides in VLDL,GOLM2,Protein GOLM2,29694,0.0402792079824183,0.00157930854058005,0.0371837632428814,0.0433746527219552,5.98353460606106e-142
NMR metabolomics,X23408.Triglycerides in VLDL,RGCC,Regulator of cell cycle RGCC,24867,0.134817668834809,0.00528564388854003,0.12445780681327,0.145177530856347,1.11400972975812e-141
NMR metabolomics,X23408.Triglycerides in VLDL,NSFL1C,NSFL1 cofactor p47,29694,0.115468994215897,0.0045414998066876,0.10656765459479,0.124370333837005,4.3014058101005e-141
NMR metabolomics,X23408.Triglycerides in VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,0.17941887808436,0.00706121421868098,0.165578898215746,0.193258857952975,6.64299535710791e-141
NMR metabolomics,X23408.Triglycerides in VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,0.127399265312193,0.00501005782230804,0.117579551980469,0.137218978643917,8.33368253986166e-141
NMR metabolomics,X23408.Triglycerides in VLDL,SIAE,Sialate O-acetylesterase,29495,0.0825864491063839,0.00325692497714277,0.0762028761511841,0.0889700220615838,2.39800563768835e-140
NMR metabolomics,X23408.Triglycerides in VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,0.152669876955915,0.00602585591365238,0.140859199365156,0.164480554546674,4.06014359475803e-140
NMR metabolomics,X23408.Triglycerides in VLDL,MITD1,MIT domain-containing protein 1,29218,0.170759289977204,0.00674724814461665,0.157534683613755,0.183983896340652,8.40118412593395e-140
NMR metabolomics,X23408.Triglycerides in VLDL,SNX15,Sorting nexin-15,24381,0.095485970568591,0.00378136706101549,0.0880744911290006,0.102897450008181,6.63166462490711e-139
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT5,ADP-sugar pyrophosphatase,29443,0.0901148173718662,0.00357730509010608,0.0831032993952583,0.0971263353484742,1.49225045974887e-138
NMR metabolomics,X23408.Triglycerides in VLDL,VNN1,Pantetheinase,24951,0.128046101982372,0.00508786827499488,0.118073880163382,0.138018323801362,4.87324910199747e-138
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,0.0490694244972621,0.00195192087884086,0.045243659574734,0.0528951894197901,5.39468333621643e-138
NMR metabolomics,X23408.Triglycerides in VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,0.1016800601107,0.00404913362330723,0.0937437582090177,0.109616362012382,1.03191711757639e-137
NMR metabolomics,X23408.Triglycerides in VLDL,ANG,Angiogenin,29435,0.0591565784004016,0.00235670110949512,0.0545374442257912,0.0637757125750121,1.34919354350772e-137
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,0.134765504930563,0.00537304192744866,0.124234342752763,0.145296667108362,2.18799645658518e-137
NMR metabolomics,X23408.Triglycerides in VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.0574993330487194,0.00229291695820796,0.0530052158106318,0.061993450286807,2.48190525115979e-137
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,0.11550608401432,0.0046031889600061,0.106483833652709,0.124528334375932,3.06075707007541e-137
NMR metabolomics,X23408.Triglycerides in VLDL,GIP,Gastric inhibitory polypeptide,24240,0.0898641049120063,0.00358144449048612,0.0828444737106535,0.0968837361133591,3.47042426935955e-137
NMR metabolomics,X23408.Triglycerides in VLDL,GIGYF2,GRB10-interacting GYF protein 2,24867,0.133328552141684,0.00531617594789462,0.12290884728381,0.143748256999557,4.19228494791544e-137
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,0.0768637816910664,0.00306907286840217,0.0708483988689982,0.0828791645131347,5.7724705439979e-137
NMR metabolomics,X23408.Triglycerides in VLDL,COMMD1,COMM domain-containing protein 1,24240,0.107497543544619,0.00428946622912359,0.0990901897355369,0.115904897353701,7.36921226588117e-137
NMR metabolomics,X23408.Triglycerides in VLDL,CST3,Cystatin-C,29530,0.0495847902862559,0.00198127588311492,0.0457014895553506,0.0534680910171611,8.38148699969586e-137
NMR metabolomics,X23408.Triglycerides in VLDL,KRT5,"Keratin, type II cytoskeletal 5",28774,0.0891271105368229,0.00356216182317795,0.0821452733633941,0.0961089477102517,1.06218610263143e-136
NMR metabolomics,X23408.Triglycerides in VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,0.185305281161955,0.00739952860706563,0.170802205092106,0.199808357231804,1.10653980181392e-136
NMR metabolomics,X23408.Triglycerides in VLDL,MYDGF,Myeloid-derived growth factor,24922,0.174964170233584,0.00698992744889829,0.161263912433743,0.188664428033425,1.37544510727656e-136
NMR metabolomics,X23408.Triglycerides in VLDL,MTDH,Protein LYRIC,24229,0.163020723299165,0.00651246601431736,0.150256289911103,0.175785156687227,1.48993221984559e-136
NMR metabolomics,X23408.Triglycerides in VLDL,OPHN1,Oligophrenin-1,24845,0.188071825591649,0.00751884638907619,0.17333488666906,0.202808764514239,2.13549275707478e-136
NMR metabolomics,X23408.Triglycerides in VLDL,CRKL,Crk-like protein,29491,0.18491560112587,0.00741087818154831,0.170390279890036,0.199440922361705,5.2625990238981e-136
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS8,Galectin-8,29694,0.105726995804734,0.00423899938758487,0.0974185570050681,0.114035434604401,6.64334148894878e-136
NMR metabolomics,X23408.Triglycerides in VLDL,SH3GLB2,Endophilin-B2,24845,0.116009861162606,0.00465148741750217,0.106892945824302,0.125126776500911,1.26845719246169e-135
NMR metabolomics,X23408.Triglycerides in VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,0.0777576217997135,0.00312550213972447,0.0716316376058535,0.0838836059935735,3.21913190028754e-135
NMR metabolomics,X23408.Triglycerides in VLDL,ARSB,Arylsulfatase B,29349,0.0958404640556683,0.00385249191080988,0.088289579910481,0.103391348200856,3.29192700583395e-135
NMR metabolomics,X23408.Triglycerides in VLDL,DDHD2,Phospholipase DDHD2,24867,0.115422786596629,0.00463586640685335,0.106336488439196,0.124509084754061,3.56710556593454e-135
NMR metabolomics,X23408.Triglycerides in VLDL,FAM13A,Protein FAM13A,24805,0.117574620372502,0.00472563556178729,0.108312374671399,0.126836866073605,5.52586545394075e-135
NMR metabolomics,X23408.Triglycerides in VLDL,CCL11,Eotaxin,29786,0.0654225601118686,0.00263345182649184,0.0602609945319446,0.0705841256917926,7.31219746201269e-135
NMR metabolomics,X23408.Triglycerides in VLDL,TBCC,Tubulin-specific chaperone C,29218,0.140267496780152,0.00564990922482079,0.129193674699503,0.151341318860801,1.15821596210747e-134
NMR metabolomics,X23408.Triglycerides in VLDL,GASK1A,Golgi-associated kinase 1A,24111,0.0748157357880011,0.00301226174467109,0.0689117027684458,0.0807197688075564,1.75299681302623e-134
NMR metabolomics,X23408.Triglycerides in VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,0.131037507908276,0.00528424891725864,0.120680380030449,0.141394635786103,2.31099656391535e-134
NMR metabolomics,X23408.Triglycerides in VLDL,GORASP2,Golgi reassembly-stacking protein 2,24805,0.0819765761152126,0.00330596902961155,0.0754968768171739,0.0884562754132512,4.20834703380451e-134
NMR metabolomics,X23408.Triglycerides in VLDL,CSNK2A1,Casein kinase II subunit alpha,24867,-0.0779237176598618,0.00314337673498903,-0.0840847360604403,-0.0717626992592833,4.90747635784488e-134
NMR metabolomics,X23408.Triglycerides in VLDL,CD36,Platelet glycoprotein 4,24229,0.078594166416657,0.00317074967026657,0.0723794970629345,0.0848088357703795,5.75422926728072e-134
NMR metabolomics,X23408.Triglycerides in VLDL,LEFTY2,Left-right determination factor 2,29674,0.0897974095949606,0.00362910371275449,0.0826843663179618,0.0969104528719594,8.26738405724551e-134
NMR metabolomics,X23408.Triglycerides in VLDL,PON2,Serum paraoxonase/arylesterase 2,28916,0.0599888439914934,0.00242669365017784,0.0552325244371449,0.064745163545842,1.57693265383955e-133
NMR metabolomics,X23408.Triglycerides in VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,24229,0.156095612098862,0.00631018811867701,0.143727643386255,0.168463580811469,1.93678866728662e-133
NMR metabolomics,X23408.Triglycerides in VLDL,CIRBP,Cold-inducible RNA-binding protein,24805,0.165718843008563,0.00670420413947661,0.152578602895188,0.178859083121937,2.77147187035373e-133
NMR metabolomics,X23408.Triglycerides in VLDL,COCH,Cochlin,24922,0.0800250401211898,0.00323877094344059,0.0736770490720462,0.0863730311703333,3.48443319403653e-133
NMR metabolomics,X23408.Triglycerides in VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,29453,0.0861883041387393,0.00349169411847696,0.0793445836665245,0.0930320246109541,3.61485861870756e-133
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS9,Galectin-9,29453,0.0550544320575048,0.00223091426016703,0.0506818401075774,0.0594270240074322,4.16394263791898e-133
NMR metabolomics,X23408.Triglycerides in VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,0.0882275785920506,0.00357717875260577,0.0812163082369433,0.0952388489471579,1.03617918326757e-132
NMR metabolomics,X23408.Triglycerides in VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,0.087863527438584,0.00356742235035813,0.0808713796318821,0.0948556752452859,1.44500819849633e-132
NMR metabolomics,X23408.Triglycerides in VLDL,GLB1,Beta-galactosidase,29218,0.0720776426259944,0.00292676959588663,0.0663411742180566,0.0778141110339322,1.46345242406753e-132
NMR metabolomics,X23408.Triglycerides in VLDL,RAB27B,Ras-related protein Rab-27B,24922,0.141419126027632,0.00574997825317143,0.130149168651416,0.152689083403848,5.40431671639351e-132
NMR metabolomics,X23408.Triglycerides in VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,0.0570420697194607,0.00231975338531096,0.0524953530842512,0.0615887863546702,7.15602455980479e-132
NMR metabolomics,X23408.Triglycerides in VLDL,DBNL,Drebrin-like protein,29581,0.158404074942554,0.00646528091986227,0.145732124339624,0.171076025545484,2.96229571612438e-131
NMR metabolomics,X23408.Triglycerides in VLDL,HYOU1,Hypoxia up-regulated protein 1,29820,0.0381697967705771,0.00155810160231017,0.0351159176300491,0.041223675911105,3.11604623002371e-131
NMR metabolomics,X23408.Triglycerides in VLDL,MPHOSPH8,M-phase phosphoprotein 8,28916,0.12966831413592,0.00529304418118378,0.1192939475408,0.14004268073104,3.39753242065034e-131
NMR metabolomics,X23408.Triglycerides in VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,0.198940684321567,0.00812771101224617,0.183010370737564,0.214870997905569,5.38523282058002e-131
NMR metabolomics,X23408.Triglycerides in VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,0.0787891446086473,0.00322183537542734,0.0724743472728097,0.0851039419444848,9.06967018458235e-131
NMR metabolomics,X23408.Triglycerides in VLDL,AHSG,Alpha-2-HS-glycoprotein,24951,0.0460510493227785,0.00188198721099594,0.0423623543892265,0.0497397442563305,1.08922199001465e-130
NMR metabolomics,X23408.Triglycerides in VLDL,A1BG,Alpha-1B-glycoprotein,24966,0.0292611041833906,0.00119630578898026,0.0269163448369893,0.031605863529792,1.37493956976917e-130
NMR metabolomics,X23408.Triglycerides in VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,0.183158767501277,0.00749279072673036,0.168472897676885,0.197844637325668,1.99040778082966e-130
NMR metabolomics,X23408.Triglycerides in VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,0.151949036936296,0.00622812499423472,0.139741911947596,0.164156161924996,6.23409274334309e-130
NMR metabolomics,X23408.Triglycerides in VLDL,TDRKH,Tudor and KH domain-containing protein,28774,0.144774541204513,0.0059448406561353,0.133122653518488,0.156426428890538,1.11178767213723e-129
NMR metabolomics,X23408.Triglycerides in VLDL,OGA,Protein O-GlcNAcase,24805,0.120433250139338,0.00494802027164226,0.110735130406919,0.130131369871756,2.45812181217373e-129
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP45,Rho GTPase-activating protein 45,24381,0.140652965655036,0.00578073423557082,0.129322726553317,0.151983204756755,3.1836022909784e-129
NMR metabolomics,X23408.Triglycerides in VLDL,VAMP8,Vesicle-associated membrane protein 8,24229,0.15027989480627,0.00617892759757736,0.138169196715018,0.162390592897521,4.12577344967529e-129
NMR metabolomics,X23408.Triglycerides in VLDL,BAG4,BAG family molecular chaperone regulator 4,24229,0.0843075368834002,0.00346670393908259,0.0775127971627983,0.0911022766040021,4.34067249266417e-129
NMR metabolomics,X23408.Triglycerides in VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.0454193935578413,0.00186979490433662,0.0417545955453415,0.0490841915703411,4.52786095732775e-129
NMR metabolomics,X23408.Triglycerides in VLDL,NIT1,Deaminated glutathione amidase,24240,0.080568664475557,0.00331497181717221,0.0740713197138995,0.0870660092372146,6.15255775988504e-129
NMR metabolomics,X23408.Triglycerides in VLDL,PDLIM5,PDZ and LIM domain protein 5,24867,0.201268495453517,0.00828666952361906,0.185026623187223,0.21751036771981,8.28935514949188e-129
NMR metabolomics,X23408.Triglycerides in VLDL,TBC1D23,TBC1 domain family member 23,29349,0.152018273296379,0.00627419033211485,0.139720860245434,0.164315686347324,2.01053599545047e-128
NMR metabolomics,X23408.Triglycerides in VLDL,WASHC3,WASH complex subunit 3,24845,0.127865001879743,0.00527718772009541,0.117521713948356,0.13820828981113,3.3306760502384e-128
NMR metabolomics,X23408.Triglycerides in VLDL,GOLGA3,Golgin subfamily A member 3,24867,0.132222475317428,0.00545796701358026,0.121524859970811,0.142920090664045,3.66592214719866e-128
NMR metabolomics,X23408.Triglycerides in VLDL,PARP1,Poly [ADP-ribose] polymerase 1,29434,0.0953206654730712,0.0039442908100931,0.0875898554852887,0.103051475460854,8.78605086437245e-128
NMR metabolomics,X23408.Triglycerides in VLDL,CD99L2,CD99 antigen-like protein 2,29443,0.0409329482497246,0.00169445305777532,0.037611820256485,0.0442540762429643,1.10552064823668e-127
NMR metabolomics,X23408.Triglycerides in VLDL,SNCG,Gamma-synuclein,29218,0.112894878793636,0.00467471355757254,0.103732440220794,0.122057317366478,1.33111312654413e-127
NMR metabolomics,X23408.Triglycerides in VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,0.105327082879183,0.00435687913934109,0.0967875997660744,0.113866565992291,1.35258362673336e-127
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP3,Metalloproteinase inhibitor 3,29581,0.218551458460078,0.00908804966891699,0.200738881109001,0.236364035811155,1.43452948346944e-126
NMR metabolomics,X23408.Triglycerides in VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,0.18496086900428,0.00769266889795893,0.16988323796428,0.200038500044279,1.59320243060063e-126
NMR metabolomics,X23408.Triglycerides in VLDL,TALDO1,Transaldolase,24888,0.0749503399963441,0.00311721675595496,0.0688405951546723,0.0810600848380158,2.66688624824318e-126
NMR metabolomics,X23408.Triglycerides in VLDL,HS1BP3,HCLS1-binding protein 3,24240,0.151952637120885,0.00632249231315382,0.139560552187104,0.164344722054666,3.71111395757738e-126
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,0.139737169454949,0.00581649950825105,0.128336830418777,0.151137508491121,4.29488925413943e-126
NMR metabolomics,X23408.Triglycerides in VLDL,ELOA,Elongin-A,29349,0.0876222732301818,0.00365426579873251,0.0804599122646661,0.0947846341956976,7.67145617185084e-126
NMR metabolomics,X23408.Triglycerides in VLDL,TRAF2,TNF receptor-associated factor 2,29434,0.11806819390363,0.00492478185631874,0.108415621465245,0.127720766342014,8.31934669017055e-126
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL3,Angiopoietin-related protein 3,29518,0.0597361188072872,0.0024917422295892,0.0548523040372924,0.064619933577282,8.3847443131586e-126
NMR metabolomics,X23408.Triglycerides in VLDL,FUS,RNA-binding protein FUS,28765,0.0663218973071925,0.00276765260369065,0.0608972982039589,0.0717464964104262,1.15075263440982e-125
NMR metabolomics,X23408.Triglycerides in VLDL,STAT2,Signal transducer and activator of transcription 2,24229,0.130242493189218,0.00543070296577084,0.119598315376307,0.140886671002129,1.23270908598713e-125
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD1,Sushi domain-containing protein 1,28916,0.0819884615610408,0.00342543261843247,0.0752746136289132,0.0887023094931684,2.19206145696492e-125
NMR metabolomics,X23408.Triglycerides in VLDL,DGKA,Diacylglycerol kinase alpha,24229,0.0918471555748495,0.00383382743420904,0.0843328538037998,0.0993614573458992,2.24618463831692e-125
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL3,C-X-C motif chemokine 3,29453,0.157393046294206,0.00658452334107625,0.144487380545697,0.170298712042716,4.39291823060326e-125
NMR metabolomics,X23408.Triglycerides in VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,0.0807391400426319,0.00337515038748233,0.0741238452831666,0.0873544348020973,4.77594624846266e-125
NMR metabolomics,X23408.Triglycerides in VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,0.130181194265804,0.0054489260323801,0.119501299242339,0.140861089289269,6.23965842660329e-125
NMR metabolomics,X23408.Triglycerides in VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.0530220588350447,0.00221844726076468,0.0486739022039459,0.0573702154661435,8.42397678640627e-125
NMR metabolomics,X23408.Triglycerides in VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,24867,0.11298067734217,0.0047283506261003,0.103713110115013,0.122248244569327,8.97002669468428e-125
NMR metabolomics,X23408.Triglycerides in VLDL,IST1,IST1 homolog,24636,0.166237738129963,0.00695838363066441,0.152599306213861,0.179876170046066,1.01563050486825e-124
NMR metabolomics,X23408.Triglycerides in VLDL,GFRA1,GDNF family receptor alpha-1,29674,0.047224309929607,0.00198007536338567,0.0433433622173711,0.0511052576418429,1.51906656665508e-124
NMR metabolomics,X23408.Triglycerides in VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,0.0970666054086536,0.00406674249692538,0.0890957901146798,0.105037420702627,1.75209751336987e-124
NMR metabolomics,X23408.Triglycerides in VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,0.143196109067801,0.00600180370834677,0.131432573799441,0.15495964433616,2.20501446593934e-124
NMR metabolomics,X23408.Triglycerides in VLDL,GTPBP2,GTP-binding protein 2,24195,0.135086301371452,0.00566334907451468,0.123986137185403,0.1461864655575,2.58993519822772e-124
NMR metabolomics,X23408.Triglycerides in VLDL,SULT2A1,Bile salt sulfotransferase,29434,0.0933831082029257,0.00392039342464119,0.0856991370906289,0.101067079315222,3.12922243765073e-124
NMR metabolomics,X23408.Triglycerides in VLDL,ST13,Hsc70-interacting protein,24381,0.0932011190419287,0.00390977972944361,0.0855379507722192,0.100864287311638,3.56698637246912e-124
NMR metabolomics,X23408.Triglycerides in VLDL,THPO,Thrombopoietin,28916,0.0640849048620415,0.00270053040831075,0.0587918652617524,0.0693779444623305,2.64644119374032e-123
NMR metabolomics,X23408.Triglycerides in VLDL,TIA1,Nucleolysin TIA-1 isoform p40,28538,0.202280184093941,0.00853422418097301,0.185553104699234,0.219007263488648,5.2964684264685e-123
NMR metabolomics,X23408.Triglycerides in VLDL,C19orf12,Protein C19orf12,28774,0.106834258598605,0.00451376025178697,0.0979872885051029,0.115681228692108,1.13395306208504e-122
NMR metabolomics,X23408.Triglycerides in VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,0.243221230372622,0.0102726523830966,0.223086831701752,0.263355629043491,1.44253411414632e-122
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS2,Trypsin-2,29594,0.0885418927128779,0.00374521740190791,0.0812012666051384,0.0958825188206174,1.98467706428915e-122
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,24381,0.0643566809651118,0.00272266862891928,0.05902025045243,0.0696931114777936,3.77634673707404e-122
NMR metabolomics,X23408.Triglycerides in VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,0.0736584230114052,0.00312024590751046,0.0675427410326847,0.0797741049901257,4.77271978183559e-122
NMR metabolomics,X23408.Triglycerides in VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,0.119476976406401,0.00506350495010916,0.109552506704187,0.129401446108615,5.73861714132202e-122
NMR metabolomics,X23408.Triglycerides in VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,0.0942796553908429,0.00399268823756712,0.0864539864452114,0.102105324336474,6.28894726922205e-122
NMR metabolomics,X23408.Triglycerides in VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,0.119470501721605,0.00506618028173761,0.109540788369399,0.129400215073811,7.98337551949831e-122
NMR metabolomics,X23408.Triglycerides in VLDL,STIP1,Stress-induced-phosphoprotein 1,29386,0.106823702289536,0.00453320487962183,0.0979386207254769,0.115708783853594,1.19571927979709e-121
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINC1,Antithrombin-III,24914,0.0244016604067214,0.00103559576570823,0.0223718927059332,0.0264314281075095,1.97520646478856e-121
NMR metabolomics,X23408.Triglycerides in VLDL,C1S,Complement C1s subcomponent,24966,0.0343856346085874,0.00146530297670576,0.0315136407742441,0.0372576284429306,1.80819995561108e-120
NMR metabolomics,X23408.Triglycerides in VLDL,IFNLR1,Interferon lambda receptor 1,29434,0.0607836492136465,0.00259524672809583,0.0556969656265787,0.0658703328007143,3.28324586366737e-120
NMR metabolomics,X23408.Triglycerides in VLDL,SCG2,Secretogranin-2,29559,0.0534067670223717,0.00228388609102721,0.0489303502839584,0.0578831837607851,7.61012126562866e-120
NMR metabolomics,X23408.Triglycerides in VLDL,IGBP1,Immunoglobulin-binding protein 1,24867,0.099489993767996,0.00425113131872489,0.0911577763832952,0.107822211152697,7.84729655426197e-120
NMR metabolomics,X23408.Triglycerides in VLDL,PENK,Proenkephalin-A,24381,0.0505338119453374,0.00216545405495267,0.0462895219976302,0.0547781018930447,3.84361204939174e-119
NMR metabolomics,X23408.Triglycerides in VLDL,TWF2,Twinfilin-2,24938,0.137106703912262,0.00587627649970718,0.125589201972836,0.148624205851688,3.95231412582651e-119
NMR metabolomics,X23408.Triglycerides in VLDL,AMOT,Angiomotin,24381,0.0658398544694153,0.00282367333169318,0.0603054547392967,0.071374254199534,5.97027895005945e-119
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,0.0916264691636184,0.00393571594672977,0.083912465908028,0.0993404724192087,8.40321986848791e-119
NMR metabolomics,X23408.Triglycerides in VLDL,CASC3,Protein CASC3,24195,0.0684393369493136,0.00294120896104444,0.0626745673856665,0.0742041065129607,1.82563543804034e-118
NMR metabolomics,X23408.Triglycerides in VLDL,HMOX2,Heme oxygenase 2,28774,0.0760023344926117,0.00326949006038908,0.0695941339742491,0.0824105350109742,1.93650801815999e-118
NMR metabolomics,X23408.Triglycerides in VLDL,RBKS,Ribokinase,28795,0.0809222931306528,0.00348388145846306,0.0740938854720652,0.0877507007892404,2.93684138375895e-118
NMR metabolomics,X23408.Triglycerides in VLDL,RWDD1,RWD domain-containing protein 1,29694,0.103174544230423,0.00444275588732412,0.0944667426912675,0.111882345769578,3.02175091061019e-118
NMR metabolomics,X23408.Triglycerides in VLDL,CD5,T-cell surface glycoprotein CD5,29683,0.0558217265420949,0.00240799448915197,0.051102057343357,0.0605413957408328,7.75851933995327e-118
NMR metabolomics,X23408.Triglycerides in VLDL,ESM1,Endothelial cell-specific molecule 1,29454,-0.0556002867310652,0.00240015841400243,-0.0603045972225099,-0.0508959762396204,1.15338360054507e-117
NMR metabolomics,X23408.Triglycerides in VLDL,SPART,Spartin,24381,0.12549092379611,0.00542290961292322,0.11486202095478,0.136119826637439,3.29859647268427e-117
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R2,Protein phosphatase inhibitor 2,29478,0.129197113169538,0.0055887428530168,0.118243177177625,0.140151049161451,3.42413405109271e-117
NMR metabolomics,X23408.Triglycerides in VLDL,TXNDC5,Thioredoxin domain-containing protein 5,29694,0.109628789868446,0.00474677507717734,0.100325110717178,0.118932469019714,5.54505335100823e-117
NMR metabolomics,X23408.Triglycerides in VLDL,DOK1,Docking protein 1,24845,0.221039783978774,0.00957384179439105,0.202275054061768,0.239804513895781,1.03946852902291e-116
NMR metabolomics,X23408.Triglycerides in VLDL,GPC5,Glypican-5,29218,0.0907410958306031,0.00393808266592606,0.083022453805388,0.0984597378558181,1.93953226592723e-116
NMR metabolomics,X23408.Triglycerides in VLDL,GMPR2,GMP reductase 2,24381,0.108524768215443,0.00470863069252768,0.0992958520580892,0.117753684372798,2.69879580558561e-116
NMR metabolomics,X23408.Triglycerides in VLDL,GAS6,Growth arrest-specific protein 6,29639,-0.0410666409255448,0.00178380473020422,-0.044562898196745,-0.0375703836543445,2.95193284614798e-116
NMR metabolomics,X23408.Triglycerides in VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,0.136748320961999,0.00594257461895711,0.125100874708843,0.148395767215155,3.99020145789703e-116
NMR metabolomics,X23408.Triglycerides in VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,0.0913786342209737,0.00397152516476256,0.083594444898039,0.0991628235439083,4.06893354057036e-116
NMR metabolomics,X23408.Triglycerides in VLDL,MAVS,Mitochondrial antiviral-signaling protein,28797,0.147813528262079,0.00642600468546327,0.135218559078571,0.160408497445587,4.9171676559142e-116
NMR metabolomics,X23408.Triglycerides in VLDL,CPB1,Carboxypeptidase B,29820,0.0950690412893238,0.00413423222110891,0.0869659461359503,0.103172136442697,5.28822156998192e-116
NMR metabolomics,X23408.Triglycerides in VLDL,CNPY4,Protein canopy homolog 4,29349,0.120570142815689,0.00524311807734841,0.110293631384087,0.130846654247292,5.44850170195268e-116
NMR metabolomics,X23408.Triglycerides in VLDL,MOCS2,Molybdopterin synthase catalytic subunit,24381,0.108196590797711,0.00471322676536579,0.0989586663375945,0.117434515257828,2.15476377765082e-115
NMR metabolomics,X23408.Triglycerides in VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,0.110964125266356,0.00483733215242453,0.101482954247603,0.120445296285108,3.21490181249946e-115
NMR metabolomics,X23408.Triglycerides in VLDL,HSPA1A,Heat shock 70 kDa protein 1A,29536,0.11363887260834,0.00496360353436287,0.103910209680988,0.123367535535691,5.30906089162051e-115
NMR metabolomics,X23408.Triglycerides in VLDL,ORM1,Alpha-1-acid glycoprotein 1,24846,0.0320742741241132,0.00140264684685425,0.0293250863042788,0.0348234619439475,1.51193862835907e-114
NMR metabolomics,X23408.Triglycerides in VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,0.16700174330696,0.00731039745499898,0.152673364295162,0.181330122318758,1.64994253719098e-114
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM40,E3 ubiquitin ligase TRIM40,24195,0.11580096818541,0.00506986297260912,0.105864036759096,0.125737899611724,2.90560388687461e-114
NMR metabolomics,X23408.Triglycerides in VLDL,MCAM,Cell surface glycoprotein MUC18,29594,-0.0530459620362193,0.00232937136457905,-0.0576115299107943,-0.0484803941616444,8.16655506909529e-114
NMR metabolomics,X23408.Triglycerides in VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0589065940441188,0.00258508360883598,0.0538398301708003,0.0639733579174373,9.04473828606983e-114
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,0.137879264826118,0.00605810663342604,0.126005375824603,0.149753153827633,1.18623490542078e-113
NMR metabolomics,X23408.Triglycerides in VLDL,GHRL,Appetite-regulating hormone,29478,0.128447606670966,0.00565583578107418,0.11736216854006,0.139533044801871,3.30354135336124e-113
NMR metabolomics,X23408.Triglycerides in VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.0604437894707019,0.00266108659171246,0.0552280597509454,0.0656595191904583,4.65871584869939e-113
NMR metabolomics,X23408.Triglycerides in VLDL,YJU2,Splicing factor YJU2,24793,0.0517015496001029,0.00227646056873179,0.0472396868853886,0.0561634123148172,4.93403635363958e-113
NMR metabolomics,X23408.Triglycerides in VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,28931,0.0951596577268907,0.00419320147009343,0.0869409828455076,0.103378332608274,5.01848164095284e-113
NMR metabolomics,X23408.Triglycerides in VLDL,FGF19,Fibroblast growth factor 19,29581,0.122359783448331,0.00539756128177727,0.111780563336047,0.132939003560614,8.22630840086224e-113
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,0.13209955881865,0.00582873844357745,0.120675231469239,0.143523886168062,9.47042324932058e-113
NMR metabolomics,X23408.Triglycerides in VLDL,APOA2,Apolipoprotein A-II,24951,-0.0768962706164714,0.00339044614732778,-0.0835415450652338,-0.0702509961677089,9.70177002234979e-113
NMR metabolomics,X23408.Triglycerides in VLDL,ICA1,Islet cell autoantigen 1,28931,0.126329479335855,0.00557437168996229,0.115403710823529,0.137255247848181,1.00812905213972e-112
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RL2,Interleukin-1 receptor-like 2,28931,0.0624104389213852,0.00275607160278698,0.0570085385799227,0.0678123392628476,1.50079607245979e-112
NMR metabolomics,X23408.Triglycerides in VLDL,CD207,C-type lectin domain family 4 member K,28835,0.0612034207591555,0.00270730381925244,0.0558971052734207,0.0665097362448903,3.51929672520722e-112
NMR metabolomics,X23408.Triglycerides in VLDL,FLT4,Vascular endothelial growth factor receptor 3,29566,0.0531412755566194,0.00235294306010662,0.0485295071588104,0.0577530439544283,5.40577230303648e-112
NMR metabolomics,X23408.Triglycerides in VLDL,ADD1,Alpha-adducin,24381,0.110844931492532,0.00490792963875055,0.101225389400581,0.120464473584484,8.58028150137442e-112
NMR metabolomics,X23408.Triglycerides in VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,0.139206402465755,0.0061809920958167,0.127091657957954,0.151321146973556,2.24252971431587e-111
NMR metabolomics,X23408.Triglycerides in VLDL,CTSZ,Cathepsin Z,29487,0.0498047123764016,0.00221212758487575,0.0454689423100451,0.054140482442758,2.61015390479037e-111
NMR metabolomics,X23408.Triglycerides in VLDL,GZMA,Granzyme A,29786,0.0546651880143678,0.00242859764411124,0.0499051366319098,0.0594252393968259,2.88239647640743e-111
NMR metabolomics,X23408.Triglycerides in VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",29566,0.0964223784827826,0.00428602309101274,0.0880217732243976,0.104822983741168,3.82203287310138e-111
NMR metabolomics,X23408.Triglycerides in VLDL,UBXN1,UBX domain-containing protein 1,24381,0.108815306061574,0.00483610484798484,0.0993365405595236,0.118294071563624,5.53500864560959e-111
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA11,Annexin A11,29373,0.105136835546915,0.00467920341589589,0.0959655968517594,0.114308074242071,7.20134190203474e-111
NMR metabolomics,X23408.Triglycerides in VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,0.0917706773185606,0.00408606113985853,0.0837619974844379,0.0997793571526833,9.31620476429152e-111
NMR metabolomics,X23408.Triglycerides in VLDL,LPP,Lipoma-preferred partner,24111,0.104871107344442,0.00466565407232151,0.095726425362692,0.114015789326192,9.53767574765671e-111
NMR metabolomics,X23408.Triglycerides in VLDL,CHMP1A,Charged multivesicular body protein 1a,29218,0.124739360634625,0.00555650958850171,0.113848601841161,0.135630119428088,1.12687791751351e-110
NMR metabolomics,X23408.Triglycerides in VLDL,MAX,Protein max,28774,0.165411164800248,0.0073710380918407,0.15096393014024,0.179858399460256,1.40660691675895e-110
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,0.135955170379581,0.00605920312540319,0.124079132253791,0.147831208505371,2.12055252680828e-110
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4A,C-type lectin domain family 4 member A,29434,-0.0548954812405118,0.00245168838736774,-0.0597007904797525,-0.050090172001271,4.02440115221456e-110
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN3,Ataxin-3,24845,0.0970543479218912,0.00433151239032355,0.0885645836368571,0.105544112206925,4.19554744048787e-110
NMR metabolomics,X23408.Triglycerides in VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,29581,0.060640451602281,0.0027118844080065,0.0553251581625883,0.0659557450419738,7.6973067891057e-110
NMR metabolomics,X23408.Triglycerides in VLDL,CPA1,Carboxypeptidase A1,29820,0.0950985666578399,0.00426027972429305,0.0867484183982255,0.103448714917454,1.78111988783557e-109
NMR metabolomics,X23408.Triglycerides in VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,0.122535615376545,0.00549004644764097,0.111775124339169,0.133296106413922,1.96477783160507e-109
NMR metabolomics,X23408.Triglycerides in VLDL,AP2B1,AP-2 complex subunit beta,24195,0.0762774241980294,0.00342141018799157,0.0695714602295659,0.0829833881664929,5.28509533513344e-109
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,0.123721680175385,0.00555272806000419,0.112838333177777,0.134605027172993,6.55313259616732e-109
NMR metabolomics,X23408.Triglycerides in VLDL,MGLL,Monoglyceride lipase,29536,0.135079495791889,0.00607645738662047,0.123169639314113,0.146989352269666,1.37375474527869e-108
NMR metabolomics,X23408.Triglycerides in VLDL,RILPL2,RILP-like protein 2,24922,0.152752474374842,0.00686844169174025,0.139290328659031,0.166214620090653,1.61493831163246e-108
NMR metabolomics,X23408.Triglycerides in VLDL,NUDC,Nuclear migration protein nudC,29786,0.0986023041337905,0.00443721043914297,0.0899053716730703,0.107299236594511,1.61938389852271e-108
NMR metabolomics,X23408.Triglycerides in VLDL,GYS1,"Glycogen [starch] synthase, muscle",28916,0.144581320760251,0.00650842944235377,0.131824799053238,0.157337842467265,2.01480140110586e-108
NMR metabolomics,X23408.Triglycerides in VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,0.124468385580644,0.00560178396228534,0.113488889014565,0.135447882146724,2.70198828806413e-108
NMR metabolomics,X23408.Triglycerides in VLDL,APOC1,Apolipoprotein C-I,24914,0.058337135720252,0.00262645488345937,0.0531892841486716,0.0634849872918323,3.00468306863403e-108
NMR metabolomics,X23408.Triglycerides in VLDL,FIS1,Mitochondrial fission 1 protein,29453,0.11981940837573,0.00540153335200665,0.109232403005797,0.130406413745663,3.90659583937685e-108
NMR metabolomics,X23408.Triglycerides in VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,0.0840012939248757,0.00378798527635589,0.0765768427832181,0.0914257450665332,4.5614170122663e-108
NMR metabolomics,X23408.Triglycerides in VLDL,RFC4,Replication factor C subunit 4,24793,0.0330424138818828,0.00149191582054087,0.0301182588736227,0.0359665688901429,1.2187741620497e-107
NMR metabolomics,X23408.Triglycerides in VLDL,DLG4,Disks large homolog 4,24845,0.110224350832181,0.0049771450185331,0.100469146595856,0.119979555068506,1.25405102772066e-107
NMR metabolomics,X23408.Triglycerides in VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,0.121753487313682,0.00550179018307634,0.110969978554852,0.132536996072511,1.29288070408045e-107
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN2L,Ataxin-2-like protein,24867,0.0747571344027398,0.00337646393199051,0.0681392650960384,0.0813750037094412,1.40872473208821e-107
NMR metabolomics,X23408.Triglycerides in VLDL,F2,Prothrombin,24966,0.02300011192221,0.00103889118547418,0.0209638851986806,0.0250363386457394,1.44381687311561e-107
NMR metabolomics,X23408.Triglycerides in VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,0.0488085508031382,0.00220462156874055,0.0444874925284067,0.0531296090778696,1.45728736472716e-107
NMR metabolomics,X23408.Triglycerides in VLDL,CETN3,Centrin-3,24805,0.120448204042998,0.00544051530092986,0.109784794053176,0.131111614032821,1.46540785760507e-107
NMR metabolomics,X23408.Triglycerides in VLDL,CCL7,C-C motif chemokine 7,29434,0.0908926995938106,0.00411409624279639,0.0828290709579297,0.0989563282296915,2.75642911213635e-107
NMR metabolomics,X23408.Triglycerides in VLDL,IMPACT,Protein IMPACT,24845,0.0863448380339242,0.00390799256906793,0.0786851725985511,0.0940045034692974,3.85624218827382e-107
NMR metabolomics,X23408.Triglycerides in VLDL,VSNL1,Visinin-like protein 1,24845,0.0591949554727289,0.00267928725732939,0.0539435524483633,0.0644463584970945,3.93033752766213e-107
NMR metabolomics,X23408.Triglycerides in VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,0.148413195351672,0.00673146828241721,0.135219517518135,0.16160687318521,7.38859089731797e-107
NMR metabolomics,X23408.Triglycerides in VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,24229,0.0895346008469953,0.00405778259143964,0.0815813469677736,0.097487854726217,7.76393969532303e-107
NMR metabolomics,X23408.Triglycerides in VLDL,GRAP2,GRB2-related adapter protein 2,29478,0.196689944972891,0.00895525263912743,0.179137649800201,0.214242240145581,4.56033492093485e-106
NMR metabolomics,X23408.Triglycerides in VLDL,RBM17,Splicing factor 45,24867,0.117807987908711,0.00536545548622233,0.107291695155715,0.128324280661707,7.57836324737805e-106
NMR metabolomics,X23408.Triglycerides in VLDL,TP53,Cellular tumor antigen p53,28797,0.0671972270141241,0.00306272410834089,0.061194287761776,0.0732001662664723,7.90311173755004e-106
NMR metabolomics,X23408.Triglycerides in VLDL,CD226,CD226 antigen,24229,0.0649258549952363,0.00295732111357178,0.0591295056126356,0.070722204377837,8.49049392810857e-106
NMR metabolomics,X23408.Triglycerides in VLDL,FOXJ3,Forkhead box protein J3,24229,0.0683199371487746,0.00311255789446563,0.062219323675622,0.0744205506219273,9.35736431744358e-106
NMR metabolomics,X23408.Triglycerides in VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,0.0739273612290867,0.00337222110810286,0.0673178078572051,0.0805369146009683,1.58801132366041e-105
NMR metabolomics,X23408.Triglycerides in VLDL,SPRY2,Protein sprouty homolog 2,28931,0.141804145201575,0.00647684299251176,0.129109532936252,0.154498757466898,2.13033085474263e-105
NMR metabolomics,X23408.Triglycerides in VLDL,CD69,Early activation antigen CD69,29344,0.134468908304747,0.0061460429449876,0.122422664132571,0.146515152476923,2.86982485130496e-105
NMR metabolomics,X23408.Triglycerides in VLDL,RRAS,Ras-related protein R-Ras,24195,0.200561702238928,0.00917723811117647,0.182574315541022,0.218549088936834,7.33354972267658e-105
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM24,Transcription intermediary factor 1-alpha,24396,0.0996979764948427,0.00456257550553195,0.0907553285040001,0.108640624485685,7.67513073984428e-105
NMR metabolomics,X23408.Triglycerides in VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,29683,0.0962270416786652,0.00441258463021204,0.0875783758034496,0.104875707553881,1.31084127489105e-104
NMR metabolomics,X23408.Triglycerides in VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,0.116643334933267,0.00535078529424969,0.106155795756537,0.127130874109996,1.65333286359028e-104
NMR metabolomics,X23408.Triglycerides in VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,0.075639977086941,0.00347454631614964,0.0688298663072877,0.0824500878665943,4.38517910093005e-104
NMR metabolomics,X23408.Triglycerides in VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,0.0440079872008518,0.00202187351521672,0.040045115111027,0.0479708592906766,4.78455114242923e-104
NMR metabolomics,X23408.Triglycerides in VLDL,SPARC,SPARC,29566,0.10715240842231,0.00492924555490852,0.0974910871346889,0.11681372970993,5.85065807618675e-104
NMR metabolomics,X23408.Triglycerides in VLDL,DFFA,DNA fragmentation factor subunit alpha,29786,0.102597863966783,0.00472074139073658,0.0933452108409391,0.111850517092626,6.37911018821854e-104
NMR metabolomics,X23408.Triglycerides in VLDL,CRADD,Death domain-containing protein CRADD,29163,0.115161575821821,0.00531000577496467,0.10475396450289,0.125569187140751,1.76769609585393e-103
NMR metabolomics,X23408.Triglycerides in VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,0.129913637199142,0.00598596762151582,0.118181140660971,0.141646133737313,1.83499307495547e-103
NMR metabolomics,X23408.Triglycerides in VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,0.117250911413276,0.0054074055791242,0.106652396478193,0.12784942634836,1.90228748545625e-103
NMR metabolomics,X23408.Triglycerides in VLDL,NUB1,NEDD8 ultimate buster 1,29434,0.127070192661529,0.0058700886510677,0.115564818905436,0.138575566417621,4.13710540469611e-103
NMR metabolomics,X23408.Triglycerides in VLDL,PLG,Plasminogen,24421,0.0336843990775554,0.00155552972482035,0.0306355608169075,0.0367332373382033,5.13102909797406e-103
NMR metabolomics,X23408.Triglycerides in VLDL,SUOX,"Sulfite oxidase, mitochondrial",24867,0.0949599152549016,0.00438871756945417,0.0863580288187714,0.103561801691032,7.13347076755922e-103
NMR metabolomics,X23408.Triglycerides in VLDL,KLK10,Kallikrein-10,29466,0.0605991807119143,0.0028037945765335,0.0551037433419086,0.06609461808192,8.49106998953142e-103
NMR metabolomics,X23408.Triglycerides in VLDL,NEXN,Nexilin,24951,0.104515325702134,0.00483319678625874,0.095042260001067,0.113988391403201,9.30061474224124e-103
NMR metabolomics,X23408.Triglycerides in VLDL,SDC4,Syndecan-4,29478,0.0699862120377174,0.00324706188957057,0.0636219707341591,0.0763504533412758,3.01652102618458e-102
NMR metabolomics,X23408.Triglycerides in VLDL,IL18,Interleukin-18,29335,0.0693923240012282,0.00322482449266723,0.0630716679956005,0.075712980006856,6.4742922280171e-102
NMR metabolomics,X23408.Triglycerides in VLDL,EGF,Pro-epidermal growth factor,29379,0.155597184541654,0.00723839002757859,0.1414099400876,0.169784428995708,1.03127816588218e-101
NMR metabolomics,X23408.Triglycerides in VLDL,F12,Coagulation factor XII,24966,0.0627074921040231,0.00291660847128773,0.0569909395002992,0.0684240447077471,1.29832581956595e-101
NMR metabolomics,X23408.Triglycerides in VLDL,CCL3,C-C motif chemokine 3,29434,0.0911304025957185,0.0042430797914338,0.0828139662045083,0.0994468389869288,1.52742693977942e-101
NMR metabolomics,X23408.Triglycerides in VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,29349,0.0848762712454153,0.00395252627221866,0.0771293197518668,0.0926232227389639,1.65313479306404e-101
NMR metabolomics,X23408.Triglycerides in VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,29478,0.0542988900470106,0.00252998249773493,0.0493401243514501,0.059257655742571,2.10471314651141e-101
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFA,Platelet-derived growth factor subunit A,29820,0.108008918919517,0.00503284222270625,0.0981445481630123,0.117873289676021,2.12177519660496e-101
NMR metabolomics,X23408.Triglycerides in VLDL,APPL2,DCC-interacting protein 13-beta,24381,0.168920840339037,0.00786691310250856,0.15350169065812,0.184339990019953,2.45822225038247e-101
NMR metabolomics,X23408.Triglycerides in VLDL,FMNL1,Formin-like protein 1,28774,0.0923474543082327,0.00430635422940736,0.0839070000185943,0.100787908597871,3.19636833136777e-101
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,0.045910655200397,0.00214213663257844,0.0417120674005432,0.0501092430002507,3.96517833314637e-101
NMR metabolomics,X23408.Triglycerides in VLDL,CCL4,C-C motif chemokine 4,29498,0.0980502756792193,0.00457607891062486,0.0890811610143946,0.107019390344044,4.45185692433617e-101
NMR metabolomics,X23408.Triglycerides in VLDL,OCLN,Occludin,24867,0.0660223762001506,0.00308281068073927,0.0599800672659017,0.0720646851343996,7.68867148031075e-101
NMR metabolomics,X23408.Triglycerides in VLDL,PF4,Platelet factor 4,24822,0.146060994176891,0.00682405133259954,0.132685853564996,0.159436134788786,1.00299481022902e-100
NMR metabolomics,X23408.Triglycerides in VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,0.066157542387699,0.00309229328105881,0.0600966475568238,0.0722184372185743,1.26722767377908e-100
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,0.14024534453371,0.00655703092169491,0.127393563927187,0.153097125140232,1.37929642613565e-100
NMR metabolomics,X23408.Triglycerides in VLDL,UROD,Uroporphyrinogen decarboxylase,24381,0.103786054456428,0.00485655201642615,0.094267212504233,0.113304896408624,2.10869705305894e-100
NMR metabolomics,X23408.Triglycerides in VLDL,TP53I3,Quinone oxidoreductase PIG3,23906,0.0800864510628481,0.00374830238864394,0.072739778381106,0.0874331237445902,2.40417082008855e-100
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH9,Protocadherin-9,24805,0.0507688791381748,0.00237703884133606,0.0461098830091562,0.0554278752671935,2.63374364120796e-100
NMR metabolomics,X23408.Triglycerides in VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,0.146314783363984,0.00685202359328829,0.132884817121139,0.159744749606829,2.88667676521213e-100
NMR metabolomics,X23408.Triglycerides in VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,0.114885998017991,0.00538023814236202,0.104340731258961,0.12543126477702,3.05022854160421e-100
NMR metabolomics,X23408.Triglycerides in VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,-0.0685555084676282,0.00321440703714296,-0.0748557462604284,-0.062255270674828,3.56286388148103e-100
NMR metabolomics,X23408.Triglycerides in VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.0663155680296808,0.00311150270461916,0.0602170227286273,0.0724141133307344,6.8176767236637e-100
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS1,Galectin-1,29478,0.0511038112138218,0.00240207446775027,0.0463957452570312,0.0558118771706123,1.09279275733136e-99
NMR metabolomics,X23408.Triglycerides in VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,0.0791571435261756,0.0037191817982044,0.071867547201695,0.0864467398506563,1.25875346978132e-99
NMR metabolomics,X23408.Triglycerides in VLDL,PRKG1,cGMP-dependent protein kinase 1,24381,0.187596909174242,0.00881436632756919,0.170320751172207,0.204873067176278,1.3148911683879e-99
NMR metabolomics,X23408.Triglycerides in VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,0.146522845898412,0.00689201584404104,0.133014494844092,0.160031196952732,1.56118315043125e-99
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6AP2,Renin receptor,28797,0.0605323697994579,0.00284776250459015,0.0549507552904613,0.0661139843084546,1.6864420886694e-99
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,0.0656797895823069,0.00309019828033497,0.0596230009528503,0.0717365782117634,1.71086751781232e-99
NMR metabolomics,X23408.Triglycerides in VLDL,TADA3,Transcriptional adapter 3,24793,0.0590863442727613,0.00277853339689631,0.0536404188148446,0.0645322697306781,1.84384599912e-99
NMR metabolomics,X23408.Triglycerides in VLDL,CETN2,Centrin-2,28774,0.100611649342099,0.00473695448666988,0.0913272185482263,0.109896080135972,2.38092807203759e-99
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINE2,Glia-derived nexin,24922,0.0960989518571094,0.00452278371271509,0.0872342957801878,0.104963607934031,2.63449851973934e-99
NMR metabolomics,X23408.Triglycerides in VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,0.0992451284250874,0.00467131363123764,0.0900893537078616,0.108400903142313,2.86190469924095e-99
NMR metabolomics,X23408.Triglycerides in VLDL,GLOD4,Glyoxalase domain-containing protein 4,29408,0.0527540154502617,0.00248556972308703,0.0478822987930111,0.0576257321075123,3.18125997468966e-99
NMR metabolomics,X23408.Triglycerides in VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,0.0852239610668835,0.00401549495170505,0.0773535909615416,0.0930943311722253,3.32155563359769e-99
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4G,C-type lectin domain family 4 member G,29434,0.0494971834013191,0.00233277496576764,0.0449249444684146,0.0540694223342237,3.59872925317556e-99
NMR metabolomics,X23408.Triglycerides in VLDL,TMED8,Protein TMED8,24805,0.153122427313526,0.00722004615896567,0.138971136841953,0.167273717785099,6.10749824108183e-99
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB3A2,Secretoglobin family 3A member 2,29536,-0.121779617704731,0.00574705119324509,-0.133043838043492,-0.110515397365971,6.45941516298079e-99
NMR metabolomics,X23408.Triglycerides in VLDL,ESYT2,Extended synaptotagmin-2,24845,0.122497378739834,0.00577718059036724,0.111174104782714,0.133820652696954,6.65899773202476e-99
NMR metabolomics,X23408.Triglycerides in VLDL,MAP2,Microtubule-associated protein 2,24845,0.0687873693032716,0.00324578344090508,0.0624256337590976,0.0751491048474456,8.34594508703529e-99
NMR metabolomics,X23408.Triglycerides in VLDL,KIFBP,KIF-binding protein,29349,0.122162397080755,0.00577305936466159,0.110847200726018,0.133477593435492,1.20100265065435e-98
NMR metabolomics,X23408.Triglycerides in VLDL,CASP10,Caspase-10,28774,0.106078911094458,0.00501565166119465,0.0962482338385166,0.1159095883504,1.56912223588266e-98
NMR metabolomics,X23408.Triglycerides in VLDL,PPBP,Platelet basic protein,24816,0.125612936884637,0.00593748784643626,0.113975460705622,0.137250413063652,1.80649176457529e-98
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC59,Leucine-rich repeat-containing protein 59,24922,0.070659509520662,0.00334054130470137,0.0641120485634473,0.0772069704778766,1.93856377320798e-98
NMR metabolomics,X23408.Triglycerides in VLDL,COMT,Catechol O-methyltransferase,28591,0.124885023906976,0.00590872822456031,0.113303916586838,0.136466131227115,2.11973355743521e-98
NMR metabolomics,X23408.Triglycerides in VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,0.125743701956301,0.00595629757374797,0.114069358711755,0.137418045200847,3.49931563244188e-98
NMR metabolomics,X23408.Triglycerides in VLDL,SMAD3,Mothers against decapentaplegic homolog 3,24793,0.0759773268669447,0.0036027745971272,0.0689158886565754,0.0830387650773141,7.34262862992738e-98
NMR metabolomics,X23408.Triglycerides in VLDL,YWHAQ,14-3-3 protein theta,24381,0.109295440828179,0.00518848335876839,0.0991260134449926,0.119464868211365,1.23714939725326e-97
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP5,Microfibrillar-associated protein 5,29820,0.0602579204601573,0.00286422578985871,0.0546440379120343,0.0658718030082804,1.50613618325664e-97
NMR metabolomics,X23408.Triglycerides in VLDL,ATOX1,Copper transport protein ATOX1,29566,0.105247934124809,0.00500655004595529,0.0954350960347365,0.115060772214881,2.13226313526302e-97
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPT1,Angiopoietin-1,29322,0.123897267288331,0.00590275144619995,0.112327874453779,0.135466660122883,4.22344949095531e-97
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA4D,Semaphorin-4D,29694,0.0440706459457521,0.00210127934296437,0.0399521384335419,0.0481891534579623,5.82520553042293e-97
NMR metabolomics,X23408.Triglycerides in VLDL,C3,Complement C3,23779,0.0686232939836844,0.00326942885113057,0.0622152134354685,0.0750313745319003,6.21906866171077e-97
NMR metabolomics,X23408.Triglycerides in VLDL,STK24,Serine/threonine-protein kinase 24,28774,0.091047492519656,0.00434250235633188,0.0825361879012455,0.0995587971380665,7.03691065871831e-97
NMR metabolomics,X23408.Triglycerides in VLDL,PALM2,Paralemmin-2,24845,0.0557297862432934,0.00266012217863165,0.0505159467731754,0.0609436257134114,1.28482936251634e-96
NMR metabolomics,X23408.Triglycerides in VLDL,EHD3,EH domain-containing protein 3,24240,0.172354535557846,0.00825351424855644,0.156177647630675,0.188531423485017,5.41165043168812e-96
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,0.0799053331442566,0.00383874178000757,0.0723813992554418,0.0874292670330715,1.57414708277126e-95
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.0891417435393021,0.0042854982101903,0.0807421670473291,0.0975413200312751,2.07251430655017e-95
NMR metabolomics,X23408.Triglycerides in VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,0.124633363811175,0.00598854402879525,0.112895817514737,0.136370910107614,2.1972536422609e-95
NMR metabolomics,X23408.Triglycerides in VLDL,APOF,Apolipoprotein F,24951,-0.0364767341869049,0.00175641715794374,-0.0399193118164747,-0.0330341565573352,5.40723685161141e-95
NMR metabolomics,X23408.Triglycerides in VLDL,NFASC,Neurofascin,29786,0.0412469572281257,0.00198877800734441,0.0373489523337306,0.0451449621225207,7.10467169142841e-95
NMR metabolomics,X23408.Triglycerides in VLDL,CASP7,Caspase-7,24845,0.122333689785968,0.00590069021404972,0.110768336966431,0.133899042605506,1.12824904463537e-94
NMR metabolomics,X23408.Triglycerides in VLDL,OTUD6B,Deubiquitinase OTUD6B,24805,0.085035284410332,0.0041021027271442,0.0769951630651294,0.0930754057555347,1.18883081433701e-94
NMR metabolomics,X23408.Triglycerides in VLDL,GPI,Glucose-6-phosphate isomerase,24951,0.0687727579749582,0.00331845333329958,0.062268589441691,0.0752769265082254,1.31172686879678e-94
NMR metabolomics,X23408.Triglycerides in VLDL,TBCB,Tubulin-folding cofactor B,29218,0.14578646094068,0.00705052259992401,0.131967436644829,0.159605485236531,2.62605082081335e-94
NMR metabolomics,X23408.Triglycerides in VLDL,CACYBP,Calcyclin-binding protein,24329,0.149269024738911,0.0072285618269855,0.13510104355802,0.163437005919803,6.26383665192999e-94
NMR metabolomics,X23408.Triglycerides in VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,0.0510503539226897,0.0024744750927869,0.0462003827408274,0.055900325104552,8.92738695779571e-94
NMR metabolomics,X23408.Triglycerides in VLDL,DNM3,Dynamin-3,24867,0.0795077531953173,0.00385526837283491,0.0719514271845609,0.0870640792060737,1.03711473260719e-93
NMR metabolomics,X23408.Triglycerides in VLDL,JAM3,Junctional adhesion molecule C,24381,0.0733828167472412,0.0035585432363293,0.0664080720040358,0.0803575614904467,1.10922444023399e-93
NMR metabolomics,X23408.Triglycerides in VLDL,BAG6,Large proline-rich protein BAG6,28916,0.0526266773463881,0.0025538202906186,0.0476211895767756,0.0576321651160005,1.1202908236111e-93
NMR metabolomics,X23408.Triglycerides in VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.0434955237943361,0.0021108828828021,0.039358193344044,0.0476328542446283,1.14588536509988e-93
NMR metabolomics,X23408.Triglycerides in VLDL,TSC22D1,TSC22 domain family protein 1,24867,0.0964745737196603,0.00468154615115717,0.0872987432633922,0.105650404175928,1.42753077751332e-93
NMR metabolomics,X23408.Triglycerides in VLDL,DTNB,Dystrobrevin beta,24752,0.0628707900008603,0.00305330665806849,0.0568863089510461,0.0688552710506746,2.00665526647566e-93
NMR metabolomics,X23408.Triglycerides in VLDL,KLK13,Kallikrein-13,28845,0.0636158141790301,0.00309386650448328,0.0575518358302429,0.0696797925278174,2.81506913899502e-93
NMR metabolomics,X23408.Triglycerides in VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,0.150341883523162,0.00731407841465981,0.136006289830428,0.164677477215895,4.26980591252617e-93
NMR metabolomics,X23408.Triglycerides in VLDL,CD22,B-cell receptor CD22,29786,0.0601512004215096,0.00293575974544385,0.0543971113204397,0.0659052895225796,1.17397836568683e-92
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB2,DnaJ homolog subfamily B member 2,24381,0.077118478120891,0.00376320806392215,0.0697425903156036,0.0844943659261784,1.50779136272208e-92
NMR metabolomics,X23408.Triglycerides in VLDL,HPSE,Heparanase,24688,0.134934087905075,0.00659982128038576,0.121998438195519,0.147869737614631,3.85587438840628e-92
NMR metabolomics,X23408.Triglycerides in VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,0.109389258785399,0.00535516413742377,0.0988931370760485,0.11988538049475,4.18641952918523e-92
NMR metabolomics,X23408.Triglycerides in VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,29478,0.0967127244194882,0.00473989503712323,0.0874225301467267,0.10600291869225,6.6635997631002e-92
NMR metabolomics,X23408.Triglycerides in VLDL,PKD2,Polycystin-2,24111,0.084558740374571,0.00414743386133355,0.0764297700063573,0.0926877107427848,1.26293641932832e-91
NMR metabolomics,X23408.Triglycerides in VLDL,POSTN,Periostin,24938,-0.0543130851258864,0.00266485871821496,-0.0595362082135877,-0.0490899620381851,1.37070615116923e-91
NMR metabolomics,X23408.Triglycerides in VLDL,ERP29,Endoplasmic reticulum resident protein 29,24381,0.170213404253716,0.00835257896485995,0.15384234948259,0.186584459024841,1.5038679847724e-91
NMR metabolomics,X23408.Triglycerides in VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,0.0667372365335316,0.00328204544505186,0.06030442746123,0.0731700456058333,2.69636090912294e-91
NMR metabolomics,X23408.Triglycerides in VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,0.0932438828359086,0.00458983311296183,0.0842478099345034,0.102239955737314,3.92835161936454e-91
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.0407864377566907,0.00200989692297508,0.0368470397876595,0.0447258357257218,6.14551623006943e-91
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP25,Rho GTPase-activating protein 25,28797,0.0853986388781823,0.00420942716493617,0.0771481616349074,0.0936491161214572,7.17656178745554e-91
NMR metabolomics,X23408.Triglycerides in VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,0.0807603550370221,0.00398174465355473,0.0729561355160548,0.0885645745579894,7.56533901208231e-91
NMR metabolomics,X23408.Triglycerides in VLDL,BIN2,Bridging integrator 2,29443,0.128008566062978,0.00631559920909326,0.115629991613155,0.140387140512801,1.01415116928886e-90
NMR metabolomics,X23408.Triglycerides in VLDL,CTF1,Cardiotrophin-1,28916,0.120093334756676,0.00592653446519172,0.1084773272049,0.131709342308452,1.14943734149142e-90
NMR metabolomics,X23408.Triglycerides in VLDL,DYNLT1,Dynein light chain Tctex-type 1,24195,0.114051867539677,0.0056363087284402,0.103004702431934,0.12509903264742,2.68502420079001e-90
NMR metabolomics,X23408.Triglycerides in VLDL,HNMT,Histamine N-methyltransferase,29082,0.0668248109150458,0.00330565096709511,0.0603457350195394,0.0733038868105522,2.998933659599e-90
NMR metabolomics,X23408.Triglycerides in VLDL,FAM172A,Cotranscriptional regulator FAM172A,24240,0.0874285016876019,0.00432185056517671,0.0789576745798556,0.0958993287953483,3.00432863240525e-90
NMR metabolomics,X23408.Triglycerides in VLDL,APOD,Apolipoprotein D,23787,-0.0618877903741315,0.00305991390951175,-0.0678852216367745,-0.0558903591114884,3.3657907149542e-90
NMR metabolomics,X23408.Triglycerides in VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,0.0876613678845116,0.00433537004593729,0.0791640425944745,0.0961586931745487,3.4571647464675e-90
NMR metabolomics,X23408.Triglycerides in VLDL,VAV3,Guanine nucleotide exchange factor VAV3,24101,0.14106597688561,0.00697592347476013,0.12739316687508,0.154738786896139,3.52869723119974e-90
NMR metabolomics,X23408.Triglycerides in VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,24240,0.104364854445789,0.00516363606591139,0.0942441277566022,0.114485581134975,4.29320359045855e-90
NMR metabolomics,X23408.Triglycerides in VLDL,DIABLO,"Diablo homolog, mitochondrial",29395,0.155138005835893,0.00768173880992805,0.140081797768434,0.170194213903352,4.37301906372436e-90
NMR metabolomics,X23408.Triglycerides in VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,0.125409295928963,0.00622196902869012,0.113214236632731,0.137604355225196,1.24026741313664e-89
NMR metabolomics,X23408.Triglycerides in VLDL,RAB33A,Ras-related protein Rab-33A,24111,0.0941656625087566,0.00467147156193857,0.085009578247357,0.103321746770156,1.26622609230349e-89
NMR metabolomics,X23408.Triglycerides in VLDL,SPON2,Spondin-2,29311,-0.0492157425515848,0.00244608544014431,-0.0540100700142676,-0.0444214150889019,1.97646982885533e-89
NMR metabolomics,X23408.Triglycerides in VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,0.106209328359471,0.00527575409147833,0.0958688503401735,0.116549806378769,2.00978802968305e-89
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,0.157865239224076,0.00784833344395348,0.142482505673927,0.173247972774225,2.18749430957301e-89
NMR metabolomics,X23408.Triglycerides in VLDL,BMPER,BMP-binding endothelial regulator protein,24381,0.0323062154833907,0.00160509014797125,0.029160238793367,0.0354521921734143,2.26633635064265e-89
NMR metabolomics,X23408.Triglycerides in VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,0.0808912861288314,0.00402271651047922,0.0730067617682921,0.0887758104893707,2.47323815677812e-89
NMR metabolomics,X23408.Triglycerides in VLDL,THTPA,Thiamine-triphosphatase,24755,0.124530065951812,0.00619496447912152,0.112387935572734,0.13667219633089,3.6681224814457e-89
NMR metabolomics,X23408.Triglycerides in VLDL,PMVK,Phosphomevalonate kinase,28757,0.154743802886421,0.00770335449888289,0.139645228068611,0.169842377704232,3.86134242137947e-89
NMR metabolomics,X23408.Triglycerides in VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,0.15777894876808,0.00785540341824421,0.142382358068321,0.173175539467839,4.04992326747345e-89
NMR metabolomics,X23408.Triglycerides in VLDL,GP1BB,Platelet glycoprotein Ib beta chain,24111,0.0963115338914873,0.00480367179216686,0.0868963371788402,0.105726730604134,1.07766179637836e-88
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB6,Serpin B6,29623,0.0832015400322988,0.00415310944088567,0.0750614455281629,0.0913416345364347,1.08846255816065e-88
NMR metabolomics,X23408.Triglycerides in VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,0.103856189785607,0.0051875478708207,0.0936885959587985,0.114023783612416,1.47269948637356e-88
NMR metabolomics,X23408.Triglycerides in VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.0893381884661128,0.00446074199650718,0.0805951341529587,0.0980812427792669,1.63166984741642e-88
NMR metabolomics,X23408.Triglycerides in VLDL,CDNF,Cerebral dopamine neurotrophic factor,29349,0.0457145680712805,0.00228539670661981,0.0412351905263057,0.0501939456162553,2.0220498994418e-88
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,0.080751842009716,0.00403956023238933,0.0728343039542329,0.0886693800651991,2.61236131989487e-88
NMR metabolomics,X23408.Triglycerides in VLDL,CCL8,C-C motif chemokine 8,29683,0.084772718646374,0.00424527426498343,0.0764519810870065,0.0930934562057415,3.91417897609463e-88
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB14,DnaJ homolog subfamily B member 14,24805,0.0901423517979002,0.00451287353782679,0.0812971196637597,0.0989875839320407,4.53050141211762e-88
NMR metabolomics,X23408.Triglycerides in VLDL,LACTB2,Endoribonuclease LACTB2,29478,0.0923552026866053,0.00462733403112244,0.0832856279856053,0.101424777387605,4.8228302879459e-88
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB1,Leukocyte elastase inhibitor,29354,0.124801775233476,0.00626069083020272,0.112530821206279,0.137072729260673,7.85410475024097e-88
NMR metabolomics,X23408.Triglycerides in VLDL,CD244,Natural killer cell receptor 2B4,29786,0.037781841112409,0.00189951571648123,0.0340587903081057,0.0415048919167122,1.83074123889436e-87
NMR metabolomics,X23408.Triglycerides in VLDL,DDT,D-dopachrome decarboxylase,24938,0.0571170464874654,0.00287046526925509,0.0514909345597255,0.0627431584152054,2.01570296657749e-87
NMR metabolomics,X23408.Triglycerides in VLDL,STX8,Syntaxin-8,29434,0.0674660475898253,0.00339427393097513,0.0608132706851141,0.0741188244945366,2.44016101772221e-87
NMR metabolomics,X23408.Triglycerides in VLDL,SLMAP,Sarcolemmal membrane-associated protein,24805,0.116312457047549,0.00584813213522089,0.104850118062516,0.127774796032582,2.44258468408643e-87
NMR metabolomics,X23408.Triglycerides in VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,-0.043641860096876,0.00219676015200567,-0.0479475099948071,-0.0393362101989449,2.95151526388993e-87
NMR metabolomics,X23408.Triglycerides in VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,0.102825582491799,0.00517358443418147,0.0926853570008036,0.112965807982795,3.27002258564245e-87
NMR metabolomics,X23408.Triglycerides in VLDL,MIF,Macrophage migration inhibitory factor,29386,0.0948297331555029,0.00477454575659837,0.08547162347257,0.104187842838436,3.278108792303e-87
NMR metabolomics,X23408.Triglycerides in VLDL,CCL2,C-C motif chemokine 2,29169,0.0731631190414041,0.00368423795562095,0.065942012648387,0.0803842254344212,3.51845521820682e-87
NMR metabolomics,X23408.Triglycerides in VLDL,STX4,Syntaxin-4,29349,0.0826361241427835,0.00416164669402237,0.0744792966224996,0.0907929516630673,3.61719055713797e-87
NMR metabolomics,X23408.Triglycerides in VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,0.066024742210264,0.00332314478342148,0.0595113784347578,0.0725381059857701,3.64980084114042e-87
NMR metabolomics,X23408.Triglycerides in VLDL,NACC1,Nucleus accumbens-associated protein 1,24793,0.0769498147690861,0.00387454920331562,0.0693556983305875,0.0845439312075847,4.27439622348623e-87
NMR metabolomics,X23408.Triglycerides in VLDL,VASP,Vasodilator-stimulated phosphoprotein,24951,0.101281968576117,0.00510061815099939,0.091284757000158,0.111279180152076,4.53546896296156e-87
NMR metabolomics,X23408.Triglycerides in VLDL,CCT5,T-complex protein 1 subunit epsilon,28797,0.0630884115409482,0.0031820811719214,0.0568515324439822,0.0693252906379141,6.74099958530768e-87
NMR metabolomics,X23408.Triglycerides in VLDL,RILP,Rab-interacting lysosomal protein,29632,0.0826901937987823,0.00417236898635123,0.0745123505855339,0.0908680370120307,7.54117690152637e-87
NMR metabolomics,X23408.Triglycerides in VLDL,IL7,Interleukin-7,29434,0.0896532974585159,0.00452395220075327,0.0807863511450395,0.0985202437719923,7.76516472167805e-87
NMR metabolomics,X23408.Triglycerides in VLDL,RASSF2,Ras association domain-containing protein 2,28797,0.0777354585844138,0.00392535200110352,0.0700417686622509,0.0854291485065767,1.05202171845148e-86
NMR metabolomics,X23408.Triglycerides in VLDL,CEMIP2,Cell surface hyaluronidase,24229,0.046147005232307,0.00232931135479619,0.0415815549769065,0.0507124554877075,1.15340010544575e-86
NMR metabolomics,X23408.Triglycerides in VLDL,CALCA,Calcitonin,29163,0.0863153154075969,0.00436240748440979,0.0777649967381537,0.0948656340770401,1.45114700277525e-86
NMR metabolomics,X23408.Triglycerides in VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.13177079318313,0.00666153221696917,0.118714190037871,0.14482739632839,1.58871603355819e-86
NMR metabolomics,X23408.Triglycerides in VLDL,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.0649333371212557,0.0032806388758026,0.0585032849246826,0.0713633893178288,1.59407182415861e-86
NMR metabolomics,X23408.Triglycerides in VLDL,FOXO3,Forkhead box protein O3,28797,0.133904323565919,0.00677316554205377,0.120628919103493,0.147179728028344,2.03081398893641e-86
NMR metabolomics,X23408.Triglycerides in VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,0.0668037140130395,0.00337785430857357,0.0601831195682353,0.0734243084578437,2.25951745849531e-86
NMR metabolomics,X23408.Triglycerides in VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.0527881091549189,0.00267192700364915,0.0475511322277666,0.0580250860820713,2.56783982238449e-86
NMR metabolomics,X23408.Triglycerides in VLDL,ERMAP,Erythroid membrane-associated protein,24229,0.0620476334200899,0.00314172556644627,0.0558898513098552,0.0682054155303246,3.8600143733881e-86
NMR metabolomics,X23408.Triglycerides in VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,0.124355901487434,0.00630008636560552,0.112007732210847,0.136704070764021,4.56182092621141e-86
NMR metabolomics,X23408.Triglycerides in VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,0.138397499273482,0.00701834675021504,0.124641539643061,0.152153458903904,5.28830712802919e-86
NMR metabolomics,X23408.Triglycerides in VLDL,ATG4A,Cysteine protease ATG4A,28797,0.08145171559753,0.00413590616983821,0.0733453395046471,0.0895580916904128,8.95625843199165e-86
NMR metabolomics,X23408.Triglycerides in VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,0.134645923767325,0.00683854659258773,0.121242372445853,0.148049475088797,1.24641403881441e-85
NMR metabolomics,X23408.Triglycerides in VLDL,SCARA5,Scavenger receptor class A member 5,29694,0.0415321243998594,0.00211290195381122,0.0373908365703894,0.0456734122293294,1.78303910538485e-85
NMR metabolomics,X23408.Triglycerides in VLDL,APP,Amyloid-beta precursor protein,29395,0.0918492250042997,0.00467297918621953,0.0826901857993094,0.10100826420929,1.84290406933258e-85
NMR metabolomics,X23408.Triglycerides in VLDL,CIAPIN1,Anamorsin,29566,0.0864034290247248,0.0043980290189542,0.0777832921475745,0.095023565901875,2.19850911490921e-85
NMR metabolomics,X23408.Triglycerides in VLDL,HSPB1,Heat shock protein beta-1,29039,0.0948027656625225,0.00482660299966568,0.0853426237831777,0.104262907541867,2.44133188392979e-85
NMR metabolomics,X23408.Triglycerides in VLDL,WDR46,WD repeat-containing protein 46,24793,0.0497717214538918,0.00253289791164246,0.0448072415470726,0.0547362013607111,2.57640281318163e-85
NMR metabolomics,X23408.Triglycerides in VLDL,IL10RB,Interleukin-10 receptor subunit beta,29581,0.0400080922346749,0.00203955691178881,0.0360105606875688,0.044005623781781,3.92564523864223e-85
NMR metabolomics,X23408.Triglycerides in VLDL,REEP4,Receptor expression-enhancing protein 4,24867,0.0857684119976332,0.00436972758933188,0.0772037459225427,0.0943330780727236,3.94846793244016e-85
NMR metabolomics,X23408.Triglycerides in VLDL,SCRG1,Scrapie-responsive protein 1,24922,0.0379533963393181,0.00193458807636471,0.0341616037096432,0.0417451889689929,4.73354535161738e-85
NMR metabolomics,X23408.Triglycerides in VLDL,CEBPB,CCAAT/enhancer-binding protein beta,28916,0.051864560086691,0.00264583733116417,0.0466787189176093,0.0570504012557728,5.27351386834832e-85
NMR metabolomics,X23408.Triglycerides in VLDL,F11,Coagulation factor XI,24606,0.0427405267773839,0.00217944322782477,0.0384688180508474,0.0470122355039205,5.58593277289675e-85
NMR metabolomics,X23408.Triglycerides in VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,24240,0.127014415821994,0.0064764140838255,0.114320644217697,0.139708187426292,5.59321271833311e-85
NMR metabolomics,X23408.Triglycerides in VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,0.0722520303619664,0.00368604080333904,0.0650273903874219,0.079476670336511,6.8335314397956e-85
NMR metabolomics,X23408.Triglycerides in VLDL,MPI,Mannose-6-phosphate isomerase,29349,0.117491172362291,0.00599964998489427,0.105731858391899,0.129250486332684,7.52832161450278e-85
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4E,Eukaryotic translation initiation factor 4E,24229,0.124844067666698,0.00637735897619971,0.112344444073346,0.137343691260049,1.11638301803485e-84
NMR metabolomics,X23408.Triglycerides in VLDL,CASP2,Caspase-2,29434,0.0930946509389081,0.00476651222555515,0.08375228697682,0.102437014900996,2.05345170622843e-84
NMR metabolomics,X23408.Triglycerides in VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.0577470283912076,0.00295754554098998,0.0519502391308672,0.0635438176515479,2.87797291223071e-84
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2L1,Bcl-2-like protein 1,24845,0.136727491541029,0.00700520806843912,0.122997283726888,0.15045769935517,3.30567501210362e-84
NMR metabolomics,X23408.Triglycerides in VLDL,LARP1,La-related protein 1,24793,0.0860227882710009,0.00441705965069548,0.0773653513556378,0.094680225186364,7.56600134465728e-84
NMR metabolomics,X23408.Triglycerides in VLDL,C2,Complement C2,29545,0.031858349070305,0.00163938914351749,0.0286451463490107,0.0350715517915993,1.35082942653142e-83
NMR metabolomics,X23408.Triglycerides in VLDL,CTRB1,Chymotrypsinogen B,29443,0.0759470185886578,0.00390907089682304,0.0682852396308847,0.083608797546431,1.48346726851151e-83
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,0.128425981375784,0.00661154496337435,0.11546735324757,0.141384609503997,1.61388027908764e-83
NMR metabolomics,X23408.Triglycerides in VLDL,PARK7,Parkinson disease protein 7,29443,0.0711658798809751,0.00366583032573393,0.0639808524425366,0.0783509073194136,1.98323932905289e-83
NMR metabolomics,X23408.Triglycerides in VLDL,MESD,LRP chaperone MESD,29443,0.165337891767844,0.00851870230909144,0.148641235242025,0.182034548293664,2.1620519404831e-83
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB9,Serpin B9,29218,0.045213429738781,0.00233080634663392,0.0406450492993785,0.0497818101781835,2.67570118265242e-83
NMR metabolomics,X23408.Triglycerides in VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,0.146962028319798,0.00757960418849664,0.132106004110344,0.161818052529251,3.93987728572418e-83
NMR metabolomics,X23408.Triglycerides in VLDL,CERT,Ceramide transfer protein,28774,0.0835442010267479,0.00431390599979271,0.0750889452671542,0.0919994567863416,5.02973303172152e-83
NMR metabolomics,X23408.Triglycerides in VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",24852,0.0545513454389908,0.00281587055659496,0.0490322391480647,0.060070451729917,5.36733491609691e-83
NMR metabolomics,X23408.Triglycerides in VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,0.0880039935451423,0.00454457543941561,0.0790966256838877,0.0969113614063969,6.29480420829099e-83
NMR metabolomics,X23408.Triglycerides in VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,0.0906987919529803,0.00468791140822088,0.0815104855928674,0.0998870983130932,9.11149188523495e-83
NMR metabolomics,X23408.Triglycerides in VLDL,CD74,HLA class II histocompatibility antigen gamma chain,29694,0.0469920735125105,0.00243577794568624,0.0422179487389655,0.0517661982860555,1.99037827628019e-82
NMR metabolomics,X23408.Triglycerides in VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,0.0413895828439847,0.00214954749919663,0.0371764697455593,0.0456026959424101,4.07069970818871e-82
NMR metabolomics,X23408.Triglycerides in VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,0.0784051222435955,0.00407187387488103,0.0704242494488287,0.0863859950383624,4.19047227541023e-82
NMR metabolomics,X23408.Triglycerides in VLDL,TREH,Trehalase,24938,0.101483618955515,0.0052703837466136,0.0911536668121529,0.111813571098878,5.01417141240812e-82
NMR metabolomics,X23408.Triglycerides in VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,29736,0.0440811834336391,0.00229172773217469,0.0395893970785767,0.0485729697887015,5.95325497565059e-82
NMR metabolomics,X23408.Triglycerides in VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,0.0996074873327748,0.00517542069947672,0.0894636627618005,0.109751311903749,5.97736146054899e-82
NMR metabolomics,X23408.Triglycerides in VLDL,GGCT,Gamma-glutamylcyclotransferase,24904,0.0648826541343135,0.00337230134616875,0.0582729434958228,0.0714923647728043,6.75542611760072e-82
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA4,Protein disulfide-isomerase A4,24938,0.0822105508324603,0.00427392148751989,0.0738336647169213,0.0905874369479993,7.3427307093602e-82
NMR metabolomics,X23408.Triglycerides in VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,0.127671081416035,0.0066376919727977,0.114661205149351,0.140680957682718,7.56216602927104e-82
NMR metabolomics,X23408.Triglycerides in VLDL,AGXT,Serine--pyruvate aminotransferase,29478,0.104005057250786,0.00541273964821907,0.0933960875402762,0.114614026961295,8.80740401922896e-82
NMR metabolomics,X23408.Triglycerides in VLDL,SUGT1,Protein SGT1 homolog,28797,0.108720378481187,0.0056668420071297,0.0976133681472128,0.119827388815161,1.5856242383737e-81
NMR metabolomics,X23408.Triglycerides in VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,0.0880738719658874,0.00459197885629459,0.07907359340755,0.0970741505242247,1.75743719457339e-81
NMR metabolomics,X23408.Triglycerides in VLDL,TMEM106A,Transmembrane protein 106A,24793,0.0954367687160036,0.00497337611892951,0.0856889515229018,0.105184585909105,1.76735742140486e-81
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.0619848288766758,0.00323283708367023,0.0556484681926821,0.0683211895606694,2.46915559657888e-81
NMR metabolomics,X23408.Triglycerides in VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,0.126494706054061,0.00660638314867356,0.113546195082661,0.139443217025461,3.19159487336269e-81
NMR metabolomics,X23408.Triglycerides in VLDL,TBC1D5,TBC1 domain family member 5,29434,0.105019096719186,0.00548643530186315,0.0942656835275343,0.115772509910838,3.54799687992553e-81
NMR metabolomics,X23408.Triglycerides in VLDL,MYO9B,Unconventional myosin-IXb,28931,0.0888105124054669,0.00464197062540989,0.0797122499796635,0.0979087748312703,4.33352849045304e-81
NMR metabolomics,X23408.Triglycerides in VLDL,JPT2,Jupiter microtubule associated homolog 2,24805,0.117853523017699,0.00616451845571328,0.105771066844501,0.129935979190897,6.83364593390139e-81
NMR metabolomics,X23408.Triglycerides in VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,0.137484013383682,0.00719530068497684,0.123381224041127,0.151586802726236,8.60528628214182e-81
NMR metabolomics,X23408.Triglycerides in VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,0.0566154220432543,0.00296348105535845,0.0508069991747517,0.0624238449117569,9.05399072704966e-81
NMR metabolomics,X23408.Triglycerides in VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.0495998035749657,0.00259636788184814,0.0445109225265433,0.054688684623388,9.19691231597884e-81
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL16,C-X-C motif chemokine 16,29786,0.0315691270298489,0.00165478960834305,0.0283257393974965,0.0348125146622013,1.17943848773362e-80
NMR metabolomics,X23408.Triglycerides in VLDL,MSTN,Growth/differentiation factor 8,28916,0.0704980871671499,0.00369548004480652,0.0632549462793291,0.0777412280549707,1.23269753331121e-80
NMR metabolomics,X23408.Triglycerides in VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,0.0838781057918894,0.00439934318948577,0.0752553931404973,0.0925008184432815,1.46549257064905e-80
NMR metabolomics,X23408.Triglycerides in VLDL,TXNDC9,Thioredoxin domain-containing protein 9,24845,0.0714138652283997,0.00374622352500789,0.0640712671193842,0.0787564633374152,1.93000324718799e-80
NMR metabolomics,X23408.Triglycerides in VLDL,MICALL2,MICAL-like protein 2,24195,0.0915799132831208,0.00481044162784272,0.0821514476925491,0.101008378873693,3.20999047778587e-80
NMR metabolomics,X23408.Triglycerides in VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.122575778601893,0.00644384375695266,0.109945844838265,0.13520571236552,3.3911898461294e-80
NMR metabolomics,X23408.Triglycerides in VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,0.0443461928431252,0.00233547659443738,0.0397686587180279,0.0489237269682225,6.46237317842993e-80
NMR metabolomics,X23408.Triglycerides in VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,0.0899235345813159,0.00474388286236625,0.080625524171078,0.0992215449915538,1.21285368054924e-79
NMR metabolomics,X23408.Triglycerides in VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,0.080306889143044,0.00424653934796901,0.0719836720210247,0.0886301062650633,3.41147529496062e-79
NMR metabolomics,X23408.Triglycerides in VLDL,GMFG,Glia maturation factor gamma,24922,0.0953368429614472,0.00504926559977474,0.0854402823858887,0.105233403537006,5.78859428688226e-79
NMR metabolomics,X23408.Triglycerides in VLDL,CPA2,Carboxypeptidase A2,29577,0.0864529283162035,0.00458419905261475,0.0774678981730786,0.0954379584593284,7.21996310768215e-79
NMR metabolomics,X23408.Triglycerides in VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.043356956171179,0.00230367990045622,0.0388417435662848,0.0478721687760732,1.47253339565168e-78
NMR metabolomics,X23408.Triglycerides in VLDL,GET3,ATPase GET3,24922,0.0729457964819176,0.00387928774307803,0.0653423925054847,0.0805492004583505,2.44858330792212e-78
NMR metabolomics,X23408.Triglycerides in VLDL,CASP3,Caspase-3,29820,0.116105123949218,0.00617829047326776,0.103995674621613,0.128214573276823,2.47328505084373e-78
NMR metabolomics,X23408.Triglycerides in VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,0.0401198277552967,0.00213598861933539,0.0359332900613993,0.044306365449194,3.6659474931558e-78
NMR metabolomics,X23408.Triglycerides in VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,0.0529373215642953,0.00281915310228504,0.0474117814838166,0.058462861644774,3.98231667577483e-78
NMR metabolomics,X23408.Triglycerides in VLDL,PPP3R1,Calcineurin subunit B type 1,29218,0.0539561175762337,0.00287587723542421,0.0483193981948023,0.0595928369576652,4.48263224936026e-78
NMR metabolomics,X23408.Triglycerides in VLDL,DBI,Acyl-CoA-binding protein,29329,0.103289587613752,0.00550748065548727,0.0924949255289972,0.114084249698507,5.1045857593489e-78
NMR metabolomics,X23408.Triglycerides in VLDL,CD164,Sialomucin core protein 24,29443,0.035266587219742,0.00188198181804206,0.0315779028563796,0.0389552715831045,6.7613529682302e-78
NMR metabolomics,X23408.Triglycerides in VLDL,ZNRD2,Protein ZNRD2,24805,0.0905539784627273,0.00483459134844029,0.0810781794197843,0.10002977750567,9.63077630131033e-78
NMR metabolomics,X23408.Triglycerides in VLDL,F2R,Proteinase-activated receptor 1,29536,0.0753320954726252,0.00402755180233078,0.0674380939400569,0.0832260970051936,1.28727375109659e-77
NMR metabolomics,X23408.Triglycerides in VLDL,CD72,B-cell differentiation antigen CD72,24381,0.0563171108259075,0.00301302812897291,0.0504115756931207,0.0622226459586944,2.03275823168484e-77
NMR metabolomics,X23408.Triglycerides in VLDL,SPINT2,Kunitz-type protease inhibitor 2,29581,0.0533817857012095,0.00286679425457711,0.0477628689622383,0.0590007024401806,6.01889729958855e-77
NMR metabolomics,X23408.Triglycerides in VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,0.12852457822835,0.00689952319774264,0.115001512760774,0.142047643695926,6.34838418022665e-77
NMR metabolomics,X23408.Triglycerides in VLDL,FAM3B,Protein FAM3B,29349,0.0465814306840092,0.00250381629310044,0.0416739507495323,0.051488910618486,8.23349603446626e-77
NMR metabolomics,X23408.Triglycerides in VLDL,CCL18,C-C motif chemokine 18,29166,0.0917326623563186,0.00493775239185246,0.0820546676682878,0.101410657044349,1.34661474406345e-76
NMR metabolomics,X23408.Triglycerides in VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,0.063945887530255,0.00344050857367753,0.0572024907258471,0.070689284334663,1.41901515581605e-76
NMR metabolomics,X23408.Triglycerides in VLDL,AIF1,Allograft inflammatory factor 1,28797,0.0685104536728767,0.00368954466478447,0.0612789461298991,0.0757419612158542,1.61019139116442e-76
NMR metabolomics,X23408.Triglycerides in VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,24381,0.114065569860972,0.00613965762403995,0.102031840917854,0.12609929880409,1.62182093444974e-76
NMR metabolomics,X23408.Triglycerides in VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,0.104635015156983,0.00563514737781349,0.0935901262964689,0.115679904017498,1.97105857065413e-76
NMR metabolomics,X23408.Triglycerides in VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,0.0796890083034501,0.00429526388186741,0.07127029109499,0.0881077255119102,2.11590167284141e-76
NMR metabolomics,X23408.Triglycerides in VLDL,TTF2,Transcription termination factor 2,24195,0.0641494968915613,0.00345580578873338,0.0573761175456439,0.0709228762374787,2.1827687460645e-76
NMR metabolomics,X23408.Triglycerides in VLDL,NRGN,Neurogranin,24951,0.119158212832557,0.00642142486786677,0.106572220091538,0.131744205573576,2.36931682586011e-76
NMR metabolomics,X23408.Triglycerides in VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,0.086928907429476,0.00468649857018168,0.0777433702319199,0.0961144446270321,2.8351430886627e-76
NMR metabolomics,X23408.Triglycerides in VLDL,PQBP1,Polyglutamine-binding protein 1,28797,0.0725812174250878,0.0039185296459034,0.0649008993191171,0.0802615355310585,3.76720066287262e-76
NMR metabolomics,X23408.Triglycerides in VLDL,MENT,Protein MENT,24381,-0.029539212142722,0.00159565670067454,-0.0326666992760441,-0.0264117250093999,5.46419576125082e-76
NMR metabolomics,X23408.Triglycerides in VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,0.0796360518487169,0.00430259626602753,0.0712029631673029,0.0880691405301308,5.8710549881079e-76
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA3,Annexin A3,29640,0.0905367232789051,0.00489575855162967,0.080941036517711,0.100132410040099,6.30933435726321e-76
NMR metabolomics,X23408.Triglycerides in VLDL,DCTD,Deoxycytidylate deaminase,24381,0.123102801441736,0.0066806983031387,0.110008632767584,0.136196970115888,2.61107348699664e-75
NMR metabolomics,X23408.Triglycerides in VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.0411972716942148,0.00223716860071736,-0.0455821221516208,-0.0368124212368088,2.6126400906723e-75
NMR metabolomics,X23408.Triglycerides in VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,0.0579043164154673,0.00314554903228168,0.0517390403121952,0.0640695925187394,3.67115848222926e-75
NMR metabolomics,X23408.Triglycerides in VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,0.103171230041424,0.00560612340921967,0.0921832281593539,0.114159231923495,3.90766156078115e-75
NMR metabolomics,X23408.Triglycerides in VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,0.0818690947877508,0.0044523552662428,0.0731424784659149,0.0905957111095867,4.33139043984651e-75
NMR metabolomics,X23408.Triglycerides in VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0528707241895068,0.00287639580034376,0.0472329884208331,0.0585084599581806,4.97044177153945e-75
NMR metabolomics,X23408.Triglycerides in VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,0.105603277219347,0.00574546461123534,0.0943421665813254,0.116864387857368,4.97600671859245e-75
NMR metabolomics,X23408.Triglycerides in VLDL,CTSS,Cathepsin S,23389,0.0315855009946849,0.00171996385305143,0.0282143718427041,0.0349566301466657,8.56373574521501e-75
NMR metabolomics,X23408.Triglycerides in VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,29581,-0.0264091153274346,0.00143953860825526,-0.0292306109996149,-0.0235876196552543,9.32321929585398e-75
NMR metabolomics,X23408.Triglycerides in VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.0586725391440783,0.00319881814390746,0.0524028555820197,0.0649422227061369,1.22643106100562e-74
NMR metabolomics,X23408.Triglycerides in VLDL,PNMA1,Paraneoplastic antigen Ma1,24240,0.0729703974874361,0.00397860681107817,0.0651723281377229,0.0807684668371493,1.25460634875538e-74
NMR metabolomics,X23408.Triglycerides in VLDL,SCARF1,Scavenger receptor class F member 1,29820,0.0545731478897535,0.00297756065296672,0.0487371290099387,0.0604091667695682,1.26969786187317e-74
NMR metabolomics,X23408.Triglycerides in VLDL,NPDC1,Neural proliferation differentiation and control protein 1,29478,0.0412482246691976,0.00225137318669342,0.0368355332232785,0.0456609161151167,1.45182125379877e-74
NMR metabolomics,X23408.Triglycerides in VLDL,NBN,Nibrin,28931,0.067596256043225,0.00368966017147903,0.0603645221071261,0.0748279899793239,1.50261840346857e-74
NMR metabolomics,X23408.Triglycerides in VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,0.0777270014273164,0.00425170043947265,0.06939366856595,0.0860603342886828,3.01137136140764e-74
NMR metabolomics,X23408.Triglycerides in VLDL,STXBP1,Syntaxin-binding protein 1,24867,0.0997788576413301,0.00545765978002043,0.0890818444724901,0.11047587081017,3.50747455916742e-74
NMR metabolomics,X23408.Triglycerides in VLDL,KITLG,Kit ligand,29478,-0.0478813753102583,0.00262120325256353,-0.0530189336852829,-0.0427438169352338,3.89654053687245e-74
NMR metabolomics,X23408.Triglycerides in VLDL,CDC37,Hsp90 co-chaperone Cdc37,29566,0.107280417055909,0.0058746791795929,0.0957660458639072,0.118794788247911,4.28895816772322e-74
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,0.12771712462053,0.0069948305408479,0.114007256760468,0.141426992480592,5.37088695145993e-74
NMR metabolomics,X23408.Triglycerides in VLDL,DXO,Decapping and exoribonuclease protein,24845,0.0585119906652485,0.00320708568030652,0.0522261027318478,0.0647978785986493,6.94678900547862e-74
NMR metabolomics,X23408.Triglycerides in VLDL,PSMG3,Proteasome assembly chaperone 3,29434,0.0644789588620206,0.00354228402996026,0.0575360821632985,0.0714218355607427,1.24814530486781e-73
NMR metabolomics,X23408.Triglycerides in VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,29454,0.0665498031339396,0.00365672547053314,0.0593826212116947,0.0737169850561846,1.32540732892957e-73
NMR metabolomics,X23408.Triglycerides in VLDL,LAP3,Cytosol aminopeptidase,28931,0.0622065685430002,0.00341886605852289,0.0555055910682954,0.0689075460177051,1.45386259932689e-73
NMR metabolomics,X23408.Triglycerides in VLDL,TSNAX,Translin-associated protein X,24111,0.0504437209728856,0.00277123660827227,0.045012097220672,0.0558753447250993,1.53177199889024e-73
NMR metabolomics,X23408.Triglycerides in VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.152590796340816,0.00839097673057667,0.136144481948886,0.169037110732746,1.70521633707496e-73
NMR metabolomics,X23408.Triglycerides in VLDL,AKT2,RAC-beta serine/threonine-protein kinase,24867,0.161786116744291,0.00890065517645427,0.144340832598441,0.179231400890141,2.35226970277492e-73
NMR metabolomics,X23408.Triglycerides in VLDL,RP2,Protein XRP2,29349,0.053325126247033,0.00294082512960937,0.0475611089929986,0.0590891435010673,4.41347480340737e-73
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,24922,0.0363606874252797,0.00200623012414603,0.0324284763819535,0.040292898468606,6.08053271262406e-73
NMR metabolomics,X23408.Triglycerides in VLDL,FGL1,Fibrinogen-like protein 1,24951,-0.0813104456294113,0.00448914679307744,-0.0901091733438431,-0.0725117179149795,7.42606587006878e-73
NMR metabolomics,X23408.Triglycerides in VLDL,RNASEH2A,Ribonuclease H2 subunit A,24867,0.0620738049124527,0.00343041507707108,0.0553501913613934,0.0687974184635121,1.02064106593656e-72
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,28916,0.141018843181534,0.00780354415009891,0.125723896647341,0.156313789715728,1.35167253941842e-72
NMR metabolomics,X23408.Triglycerides in VLDL,IL32,Interleukin-32,29434,-0.0552012488114689,0.00306299833632667,-0.0612047255506692,-0.0491977720722687,3.20728155979258e-72
NMR metabolomics,X23408.Triglycerides in VLDL,CRYBB1,Beta-crystallin B1,24922,0.0826449979109139,0.00459924273135842,0.0736304821574514,0.0916595136643764,9.63442026713411e-72
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTSL2,ADAMTS-like protein 2,24938,0.0415916087485886,0.00231544930393177,0.0370533281128823,0.0461298893842949,1.08296373301398e-71
NMR metabolomics,X23408.Triglycerides in VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,24111,0.0875411920968445,0.00487401846211553,0.077988115911098,0.0970942682825909,1.15990982106813e-71
NMR metabolomics,X23408.Triglycerides in VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.136331117549058,0.00760289091546748,0.121429451354741,0.151232783743374,1.99519133071874e-71
NMR metabolomics,X23408.Triglycerides in VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,0.0963524707745987,0.00537541004517761,0.0858166670860505,0.106888274463147,2.13836660504207e-71
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL1,Growth-regulated alpha protein,29420,0.119868119215031,0.00669465311379563,0.106746599111992,0.132989639318071,2.57799588259256e-71
NMR metabolomics,X23408.Triglycerides in VLDL,IFT20,Intraflagellar transport protein 20 homolog,24195,0.0546083001380916,0.00304977852667024,0.048630734225818,0.0605858660503653,3.07469825526419e-71
NMR metabolomics,X23408.Triglycerides in VLDL,FAM3C,Protein FAM3C,29433,0.0377299464315633,0.00210870390526508,0.0335968867772437,0.0418630060858829,3.22168462279743e-71
NMR metabolomics,X23408.Triglycerides in VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,0.0355520534342969,0.00198588898571406,0.0316597110222973,0.0394443958462964,3.25269277501578e-71
NMR metabolomics,X23408.Triglycerides in VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,0.0705628891919874,0.00394437983332917,0.0628319047186622,0.0782938736653125,4.08982941026637e-71
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJC9,DnaJ homolog subfamily C member 9,24805,0.0960760359174174,0.00537111247202517,0.0855486554722481,0.106603416362587,4.13030801577401e-71
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP1,Metalloproteinase inhibitor 1,29173,0.0357025975049172,0.00199699594974222,0.0317884854434224,0.0396167095664119,4.18666384291591e-71
NMR metabolomics,X23408.Triglycerides in VLDL,BLMH,Bleomycin hydrolase,29820,0.0398612251772501,0.00223557314249055,0.0354795018179686,0.0442429485365316,9.57106137673126e-71
NMR metabolomics,X23408.Triglycerides in VLDL,TBCA,Tubulin-specific chaperone A,24381,0.107505009471454,0.0060309664494606,0.0956843152305116,0.119325703712397,1.25930028555381e-70
NMR metabolomics,X23408.Triglycerides in VLDL,BGLAP,Osteocalcin,24938,0.111171796679858,0.00624044461939265,0.098940525225848,0.123403068133867,1.48872114283315e-70
NMR metabolomics,X23408.Triglycerides in VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,0.129381244600703,0.00727618251613421,0.11511992686908,0.143642562332326,2.68973324899318e-70
NMR metabolomics,X23408.Triglycerides in VLDL,SMTN,Smoothelin,24776,0.118285427459769,0.00665441950596054,0.105242765228086,0.131328089691452,2.99319889502255e-70
NMR metabolomics,X23408.Triglycerides in VLDL,BPIFB2,BPI fold-containing family B member 2,24852,0.0811929954789402,0.0045701975433048,0.0722354082940627,0.0901505826638176,3.54075042142105e-70
NMR metabolomics,X23408.Triglycerides in VLDL,MMP7,Matrilysin,28870,0.0623309884682628,0.00351176901568579,0.0554479211975187,0.069214055739007,4.12965240052657e-70
NMR metabolomics,X23408.Triglycerides in VLDL,PECAM1,Platelet endothelial cell adhesion molecule,29443,0.0375157099911496,0.00211583299127278,0.033368677328255,0.0416627426540443,5.59891522664808e-70
NMR metabolomics,X23408.Triglycerides in VLDL,ACYP1,Acylphosphatase-1,24297,0.0819202526880968,0.00462105804167303,0.0728629789264176,0.0909775264497759,7.08216675567091e-70
NMR metabolomics,X23408.Triglycerides in VLDL,EGFL7,Epidermal growth factor-like protein 7,28797,0.0493780330602027,0.00278691465244466,0.0439156803414111,0.0548403857789942,7.18623309692352e-70
NMR metabolomics,X23408.Triglycerides in VLDL,IMMT,MICOS complex subunit MIC60,24793,0.0554772462917103,0.00313237076082916,0.0493377996004852,0.0616166929829355,9.29731314578391e-70
NMR metabolomics,X23408.Triglycerides in VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,0.0356820599509013,0.00201818948951243,0.0317264085514569,0.0396377113503457,1.36500748093723e-69
NMR metabolomics,X23408.Triglycerides in VLDL,FGF23,Fibroblast growth factor 23,29693,0.0705303127618122,0.00399364507835009,0.062702768408246,0.0783578571153784,1.91168799941144e-69
NMR metabolomics,X23408.Triglycerides in VLDL,CFB,Complement factor B,24538,0.0408672417918824,0.00231293625163062,0.0363338867386864,0.0454005968450784,1.95923951768275e-69
NMR metabolomics,X23408.Triglycerides in VLDL,PVR,Poliovirus receptor,29694,0.0459758649591381,0.00260393189947315,0.0408721584361707,0.0510795714821055,2.06175267285347e-69
NMR metabolomics,X23408.Triglycerides in VLDL,BOLA2_BOLA2B,BolA-like protein 2,24240,0.0679790815598689,0.00384830200970955,0.0604364096208382,0.0755217534988997,2.13775749572515e-69
NMR metabolomics,X23408.Triglycerides in VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.0715359291436523,0.00405377989470788,0.0635905205500249,0.0794813377372798,2.51181601373924e-69
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,0.0522223022218409,0.00295958246403927,0.046421520592324,0.0580230838513579,2.51417524990394e-69
NMR metabolomics,X23408.Triglycerides in VLDL,CDCP1,CUB domain-containing protein 1,29218,0.0645710542110691,0.00365987174774982,0.0573977055854795,0.0717444028366588,2.63931968988475e-69
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G4A,Cytosolic phospholipase A2,29581,0.108470071875332,0.00615180470919933,0.0964125346453014,0.120527609105363,3.15374348488132e-69
NMR metabolomics,X23408.Triglycerides in VLDL,SCARB2,Lysosome membrane protein 2,28762,0.0394538817511617,0.00223762920597129,0.035068128507458,0.0438396349948654,3.24071512643422e-69
NMR metabolomics,X23408.Triglycerides in VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,0.0793549807633608,0.00450749664378371,0.0705202873415448,0.0881896741851769,5.18439550925805e-69
NMR metabolomics,X23408.Triglycerides in VLDL,CTSE,Cathepsin E,24381,0.0647893123808012,0.00367896660738255,0.0575785378303314,0.072000086931271,5.45597099425717e-69
NMR metabolomics,X23408.Triglycerides in VLDL,CNDP1,Beta-Ala-His dipeptidase,29594,0.0568282123545448,0.00322964816528738,0.0504981019505816,0.0631583227585081,5.96289175410866e-69
NMR metabolomics,X23408.Triglycerides in VLDL,CEP170,Centrosomal protein of 170 kDa,24240,0.0956767059606966,0.00543691966973018,0.0850203434080254,0.106333068513368,6.90032216762017e-69
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT16,U8 snoRNA-decapping enzyme,24769,0.108292332458418,0.00615922792479149,0.0962202457258262,0.120364419191009,8.84801851550393e-69
NMR metabolomics,X23408.Triglycerides in VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,0.106942149041219,0.00608456760670945,0.0950163965320685,0.118867901550369,9.8218808676203e-69
NMR metabolomics,X23408.Triglycerides in VLDL,TMSB10,Thymosin beta-10,29443,0.0935740799125562,0.00533411637139285,0.0831192118246262,0.104028948000486,1.51513821499632e-68
NMR metabolomics,X23408.Triglycerides in VLDL,XCL1,Lymphotactin,29725,0.0684090511058312,0.00390033273575047,0.0607643989437603,0.0760537032679022,1.59205839543891e-68
NMR metabolomics,X23408.Triglycerides in VLDL,FCN1,Ficolin-1,24919,0.0691546052900744,0.00394413238590221,0.061424105813706,0.0768851047664427,2.04874035861859e-68
NMR metabolomics,X23408.Triglycerides in VLDL,MCEMP1,Mast cell-expressed membrane protein 1,24229,0.111754627733606,0.0063742640105916,0.099261070272846,0.124248185194365,2.15531242022767e-68
NMR metabolomics,X23408.Triglycerides in VLDL,KLF4,Krueppel-like factor 4,24101,0.049081954395112,0.00280042788991508,0.0435931157308785,0.0545707930593456,2.38642991513426e-68
NMR metabolomics,X23408.Triglycerides in VLDL,APOM,Apolipoprotein M,29545,0.0341219098346077,0.00194922603822173,0.0303014267996931,0.0379423928695222,2.88648039368452e-68
NMR metabolomics,X23408.Triglycerides in VLDL,IL12A_IL12B,Interleukin-12,29349,0.0954365336031644,0.00545589558811366,0.0847429782504616,0.106130088955867,3.63675956335468e-68
NMR metabolomics,X23408.Triglycerides in VLDL,FEN1,Flap endonuclease 1,28797,0.0774645780426511,0.0044307667879849,0.0687802751382007,0.0861488809471015,4.3193501231992e-68
NMR metabolomics,X23408.Triglycerides in VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,0.04415729031198,0.00252717714183177,0.0392040231139897,0.0491105575099703,6.02462832876677e-68
NMR metabolomics,X23408.Triglycerides in VLDL,EPPK1,Epiplakin,24240,0.0907725801476013,0.00519681373912334,0.0805868252189196,0.100958335076283,6.67100492065312e-68
NMR metabolomics,X23408.Triglycerides in VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,0.0733687919516039,0.00420476578734022,0.0651274510084171,0.0816101328947907,7.83911484424551e-68
NMR metabolomics,X23408.Triglycerides in VLDL,HEPH,Hephaestin,24922,0.0324492017216681,0.00186182709535755,0.0288000206147673,0.0360983828285689,1.26005496038788e-67
NMR metabolomics,X23408.Triglycerides in VLDL,RAB10,Ras-related protein Rab-10,24922,0.0656821330872328,0.00377012474925557,0.0582926885786919,0.0730715775957737,1.42068937125345e-67
NMR metabolomics,X23408.Triglycerides in VLDL,GGACT,Gamma-glutamylaminecyclotransferase,24922,0.0869383629670127,0.00499224364065774,0.0771535654313236,0.0967231605027019,1.60464550986332e-67
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF6,SLAM family member 6,28797,0.0468601366766123,0.00269209736026648,0.04158362585049,0.0521366475027346,1.63276368138112e-67
NMR metabolomics,X23408.Triglycerides in VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,0.0464618825509186,0.00267070918840185,0.041227292541651,0.0516964725601862,1.88131087546406e-67
NMR metabolomics,X23408.Triglycerides in VLDL,MRI1,Methylthioribose-1-phosphate isomerase,24195,0.0833037934176755,0.00479722029871242,0.0739012416321992,0.0927063452031518,3.88199596625255e-67
NMR metabolomics,X23408.Triglycerides in VLDL,OPLAH,5-oxoprolinase,24240,0.0839657872055238,0.00483637507370465,0.0744864920610627,0.0934450823499849,4.1305367860309e-67
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS3BP,Galectin-3-binding protein,24966,0.0371086354726556,0.00213764934700107,0.0329188427525335,0.0412984281927777,4.14362530816594e-67
NMR metabolomics,X23408.Triglycerides in VLDL,PTGR1,Prostaglandin reductase 1,24922,0.0995762146905325,0.00575050382910118,0.0883052271854941,0.110847202195571,8.76055770729807e-67
NMR metabolomics,X23408.Triglycerides in VLDL,ARSA,Arylsulfatase A,29443,0.054410356995794,0.00314991384766961,0.0482365258543615,0.0605841881372264,1.58396375819667e-66
NMR metabolomics,X23408.Triglycerides in VLDL,NID1,Nidogen-1,29518,0.0460420988099038,0.00266700305038173,0.0408147728311556,0.051269424788652,1.8765144175884e-66
NMR metabolomics,X23408.Triglycerides in VLDL,CD274,Programmed cell death 1 ligand 1,29218,0.0415285382224851,0.00240871291536474,0.0368074609083702,0.0462496155366,2.78734356209725e-66
NMR metabolomics,X23408.Triglycerides in VLDL,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.064831302525065,0.00376233182101674,0.0574571321558722,0.0722054728942578,3.25665384502085e-66
NMR metabolomics,X23408.Triglycerides in VLDL,ADM,Pro-adrenomedullin,29725,0.0321871285979172,0.00186871549689127,0.0285244462240103,0.035849810971824,3.66672893484667e-66
NMR metabolomics,X23408.Triglycerides in VLDL,ING1,Inhibitor of growth protein 1,28719,0.0557445299863437,0.00323626868397512,0.0494014433657524,0.0620876166069349,3.71520901782068e-66
NMR metabolomics,X23408.Triglycerides in VLDL,GP5,Platelet glycoprotein V,24381,0.0438904422780336,0.00254784346443296,0.038896669087745,0.0488842154683222,4.14142191189853e-66
NMR metabolomics,X23408.Triglycerides in VLDL,BAP18,Chromatin complexes subunit BAP18,24845,0.0804020030824235,0.00467148379586312,0.0712458948425318,0.0895581113223153,5.28592696978264e-66
NMR metabolomics,X23408.Triglycerides in VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,0.0528053853035885,0.00307164288578467,0.0467849652474505,0.0588258053597264,7.5960838952302e-66
NMR metabolomics,X23408.Triglycerides in VLDL,GIPC3,PDZ domain-containing protein GIPC3,24805,0.118731658021594,0.00691650790101152,0.105175302535612,0.132288013507577,1.13623939168569e-65
NMR metabolomics,X23408.Triglycerides in VLDL,ITPA,Inosine triphosphate pyrophosphatase,24111,0.081505242998769,0.0047545148912008,0.0721863938120155,0.0908240921855226,1.74358074210196e-65
NMR metabolomics,X23408.Triglycerides in VLDL,DBN1,Drebrin,24229,0.0619066946485321,0.0036166041211529,0.0548181505710725,0.0689952387259918,2.67009096241683e-65
NMR metabolomics,X23408.Triglycerides in VLDL,GP6,Platelet glycoprotein VI,29400,0.105577606765639,0.00618698750109601,0.0934511112634905,0.117704102267787,5.61534707143209e-65
NMR metabolomics,X23408.Triglycerides in VLDL,TST,Thiosulfate sulfurtransferase,28706,0.0907817510165483,0.00532162647050025,0.0803513631343678,0.101212138898729,6.26509897522213e-65
NMR metabolomics,X23408.Triglycerides in VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.14428593712986,0.00846186272750968,0.127700686183941,0.160871188075779,7.01028709006594e-65
NMR metabolomics,X23408.Triglycerides in VLDL,BDNF,Brain-derived neurotrophic factor,24938,0.0997692439950599,0.00585638744595816,0.0882907246009819,0.111247763389138,1.03345931807393e-64
NMR metabolomics,X23408.Triglycerides in VLDL,GBP1,Guanylate-binding protein 1,24816,0.0774819268510094,0.0045513807780216,0.068561220526087,0.0864026331759317,1.27394169597457e-64
NMR metabolomics,X23408.Triglycerides in VLDL,AFP,Alpha-fetoprotein,29132,0.0813928638920044,0.0047855364901529,0.0720132123713047,0.090772515412704,1.4674736873886e-64
NMR metabolomics,X23408.Triglycerides in VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,0.0593889007158945,0.00349010395918484,0.0525482969558922,0.0662295044758968,1.50187552976523e-64
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,0.029225514038903,0.00171882382616754,0.0258566193396146,0.0325944087381914,1.58363619993399e-64
NMR metabolomics,X23408.Triglycerides in VLDL,SOD1,Superoxide dismutase [Cu-Zn],28826,0.0577058315194104,0.00339470902050586,0.0510522018392189,0.0643594611996019,1.73133423517582e-64
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,28967,0.052252674112805,0.00308752664861718,0.0462011218815154,0.0583042263440947,6.10208415915226e-64
NMR metabolomics,X23408.Triglycerides in VLDL,UMOD,Uromodulin,29750,-0.0642045794387182,0.00379668830621399,-0.0716460885188976,-0.0567630703585388,7.46814858335325e-64
NMR metabolomics,X23408.Triglycerides in VLDL,BMP6,Bone morphogenetic protein 6,28884,0.0490657686213748,0.0029023443808045,0.0433771736349979,0.0547543636077516,8.30695329002465e-64
NMR metabolomics,X23408.Triglycerides in VLDL,FRMD4B,FERM domain-containing protein 4B,24111,0.0837053302884569,0.00495042179229063,0.0740025035755673,0.0934081570013465,9.05322386435177e-64
NMR metabolomics,X23408.Triglycerides in VLDL,LEPR,Leptin receptor,29478,-0.0369142570057056,0.00218447226856426,-0.0411958226520916,-0.0326326913593197,9.22525885807459e-64
NMR metabolomics,X23408.Triglycerides in VLDL,MSR1,Macrophage scavenger receptor types I and II,29694,0.0545311397241255,0.00323013897671713,0.0482000673297599,0.060862212118491,1.21085900581468e-63
NMR metabolomics,X23408.Triglycerides in VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,24966,-0.0309798102563935,0.00183440669429768,-0.0345752473772169,-0.0273843731355701,1.24112442276669e-63
NMR metabolomics,X23408.Triglycerides in VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,-0.0234342864336338,0.00138930762454826,-0.0261573293777484,-0.0207112434895192,1.55343851077654e-63
NMR metabolomics,X23408.Triglycerides in VLDL,SH3BP1,SH3 domain-binding protein 1,24805,0.0568963624259449,0.00337567278193195,0.0502800437733583,0.0635126810785316,2.18105237520536e-63
NMR metabolomics,X23408.Triglycerides in VLDL,FAP,Prolyl endopeptidase FAP,29820,0.0325518875092462,0.00193339609217545,0.0287624311685823,0.0363413438499101,2.58138562588283e-63
NMR metabolomics,X23408.Triglycerides in VLDL,PTX3,Pentraxin-related protein PTX3,29434,-0.0585217699604338,0.00347966278826362,-0.0653419090254305,-0.0517016308954371,3.54300430776755e-63
NMR metabolomics,X23408.Triglycerides in VLDL,BAG3,BAG family molecular chaperone regulator 3,29169,0.0474034718292301,0.00282010835469306,0.0418760594540317,0.0529308842044285,4.15270512181954e-63
NMR metabolomics,X23408.Triglycerides in VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,24922,0.0299594983020715,0.00178286134557195,0.0264650900647505,0.0334539065393925,5.06265310753398e-63
NMR metabolomics,X23408.Triglycerides in VLDL,SDHB,Succinate dehydrogenase,24805,0.0814079504180581,0.00484635327830724,0.0719090979925759,0.0909068028435403,5.65299416046771e-63
NMR metabolomics,X23408.Triglycerides in VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.143042939547295,0.00853557977654947,0.126313203185258,0.159772675909332,9.61046336535469e-63
NMR metabolomics,X23408.Triglycerides in VLDL,BLNK,B-cell linker protein,24229,0.0471305255965562,0.00281139595914138,0.0416201895166391,0.0526408616764733,1.00913500068444e-62
NMR metabolomics,X23408.Triglycerides in VLDL,ABCA2,ATP-binding cassette sub-family A member 2,24111,0.0430559412751464,0.00257146598139495,0.0380158679516124,0.0480960145986805,1.42126945732829e-62
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL11,C-X-C motif chemokine 11,29694,0.0925899482187705,0.00554011170811822,0.0817313292708588,0.103448567166682,2.0465478986864e-62
NMR metabolomics,X23408.Triglycerides in VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,0.0490392617457528,0.00293912077208956,0.0432785850324573,0.0547999384590484,3.6754832539154e-62
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC3B,Tetranectin,24381,0.0251359581157673,0.00150914431996103,0.0221780352486437,0.0280938809828909,6.05046625750889e-62
NMR metabolomics,X23408.Triglycerides in VLDL,KLRD1,Natural killer cells antigen CD94,29786,0.0542447955874927,0.00326326976093651,0.0478487868560571,0.0606408043189282,9.04855592595327e-62
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN9,Septin-9,29349,0.0331848339701909,0.00199718475957069,0.0292703518414323,0.0370993160989494,1.02600605102458e-61
NMR metabolomics,X23408.Triglycerides in VLDL,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.0819157870516141,0.00494896241984095,0.0722158207087259,0.0916157533945024,3.29918692162056e-61
NMR metabolomics,X23408.Triglycerides in VLDL,CTSL,Cathepsin L1,29478,0.0283156880518301,0.0017122591962285,0.0249596600272222,0.031671716076438,3.74796025752492e-61
NMR metabolomics,X23408.Triglycerides in VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,0.138953398135612,0.00840298454918503,0.122483548419209,0.155423247852014,3.79613863606456e-61
NMR metabolomics,X23408.Triglycerides in VLDL,CCS,Copper chaperone for superoxide dismutase,29218,0.0551635239070594,0.00333726242866293,0.0486224895468801,0.0617045582672388,4.2608898392557e-61
NMR metabolomics,X23408.Triglycerides in VLDL,FADD,FAS-associated death domain protein,29478,0.0886597620010822,0.00536521196347888,0.0781439465526636,0.0991755774495008,4.57290768872419e-61
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA9,Serpin A9,29227,0.0839596157820224,0.00508729045762487,0.0739885264850776,0.0939307050789671,6.50515644430077e-61
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.078737266010516,0.00477420698225397,0.0693798203252982,0.0880947116957338,7.77359401785106e-61
NMR metabolomics,X23408.Triglycerides in VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,24845,0.0369601662255188,0.00224149106117572,0.0325668437456143,0.0413534887054232,9.25067803010133e-61
NMR metabolomics,X23408.Triglycerides in VLDL,S100P,Protein S100-P,28916,0.0621145761030356,0.00376933993462432,0.054726669831172,0.0695024823748993,9.85180908416709e-61
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA2,Integrin alpha-2,24381,0.0398549954230019,0.00241818117526644,0.0351153603194797,0.0445946305265241,1.06423187104046e-60
NMR metabolomics,X23408.Triglycerides in VLDL,CXADR,Coxsackievirus and adenovirus receptor,29434,0.0594416351693608,0.00360996237329794,0.0523661089176968,0.0665171614210247,1.20351128902305e-60
NMR metabolomics,X23408.Triglycerides in VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,0.0545666254570173,0.00332133880691162,0.0480568013954705,0.0610764495185641,2.4685642539053e-60
NMR metabolomics,X23408.Triglycerides in VLDL,ASS1,Argininosuccinate synthase,24111,0.0918358103995605,0.00559007312275234,0.0808792670789659,0.102792353720155,2.55122750519173e-60
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.0263211708100907,0.00160456493515628,0.0231762235371844,0.029466118082997,3.31412858675742e-60
NMR metabolomics,X23408.Triglycerides in VLDL,NFAT5,Nuclear factor of activated T-cells 5,24229,0.0998655910919335,0.00608964593761709,0.087929885054204,0.111801297129663,4.08583520917931e-60
NMR metabolomics,X23408.Triglycerides in VLDL,CPXM1,Probable carboxypeptidase X1,29566,0.0790370090932011,0.00483021258976349,0.0695697924172646,0.0885042257691375,6.44447324925973e-60
NMR metabolomics,X23408.Triglycerides in VLDL,NPC2,NPC intracellular cholesterol transporter 2,24609,0.0368038481907847,0.00224823114837029,0.0323973151399789,0.0412103812415905,6.48574722604432e-60
NMR metabolomics,X23408.Triglycerides in VLDL,FGF2,Fibroblast growth factor 2,29434,0.0776962584682949,0.0047484135320604,0.0683893679454565,0.0870031489911332,6.51239370541996e-60
NMR metabolomics,X23408.Triglycerides in VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,24867,0.0442409165973422,0.00270320905734782,0.0389426268449405,0.0495392063497439,6.87650205670228e-60
NMR metabolomics,X23408.Triglycerides in VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,0.0611178909499312,0.00373445313470194,0.0537983628059154,0.068437419093947,7.01869636708669e-60
NMR metabolomics,X23408.Triglycerides in VLDL,LONP1,"Lon protease homolog, mitochondrial",24240,0.100442662391331,0.00614056103059837,0.0884071627713579,0.112478162011304,8.08527606382086e-60
NMR metabolomics,X23408.Triglycerides in VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,28931,0.0754143297653138,0.00462095443300998,0.0663572590766143,0.0844714004540134,1.31298653889458e-59
NMR metabolomics,X23408.Triglycerides in VLDL,ABHD14B,Protein ABHD14B,29121,0.0657745900837784,0.00403304787021125,0.0578698162581643,0.0736793639093924,1.56771130036254e-59
NMR metabolomics,X23408.Triglycerides in VLDL,C1R,Complement C1r subcomponent,24966,0.022274437856548,0.00136730183420681,0.0195945262615027,0.0249543494515934,2.32411041663472e-59
NMR metabolomics,X23408.Triglycerides in VLDL,CCN4,CCN family member 4,29725,0.0459186592829528,0.00282076570290779,0.0403899585052536,0.0514473600606521,2.52293867775757e-59
NMR metabolomics,X23408.Triglycerides in VLDL,SWAP70,Switch-associated protein 70,24805,0.0410216446514955,0.0025250822267483,0.0360724834870689,0.0459708058159222,4.84070966050878e-59
NMR metabolomics,X23408.Triglycerides in VLDL,ENTR1,Endosome-associated-trafficking regulator 1,24240,0.0679072008529529,0.0041822400533259,0.0597100103484341,0.0761043913574716,5.65449366310428e-59
NMR metabolomics,X23408.Triglycerides in VLDL,PKN3,Serine/threonine-protein kinase N3,24445,0.0863010169982991,0.00532036620332162,0.0758730992397887,0.0967289347568095,7.2931436369052e-59
NMR metabolomics,X23408.Triglycerides in VLDL,KLB,Beta-klotho,28774,-0.0845862266332316,0.00521708793466583,-0.0948117189851767,-0.0743607342812866,7.4120805700741e-59
NMR metabolomics,X23408.Triglycerides in VLDL,EFNA4,Ephrin-A4,29169,0.0350866720548563,0.00216455314043257,0.0308441478996084,0.0393291962101041,7.79706019183372e-59
NMR metabolomics,X23408.Triglycerides in VLDL,APOE,Apolipoprotein E,24966,0.0830589937755232,0.00512237494914144,0.073019138875206,0.0930988486758405,7.90852612295597e-59
NMR metabolomics,X23408.Triglycerides in VLDL,DPT,Dermatopontin,29820,0.0300260031395164,0.00185437452403587,0.0263914290724061,0.0336605772066267,1.0235052382107e-58
NMR metabolomics,X23408.Triglycerides in VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,0.0509827403835744,0.00314706793583554,0.0448144872293367,0.0571509935378121,1.02581857035602e-58
NMR metabolomics,X23408.Triglycerides in VLDL,TCOF1,Treacle protein,24922,0.035711955332194,0.00220650740042333,0.0313872008273642,0.0400367098370237,1.28531448197749e-58
NMR metabolomics,X23408.Triglycerides in VLDL,CD40LG,CD40 ligand,29786,0.0883940348977656,0.00546730250341531,0.0776781219910716,0.0991099478044597,1.51269183008852e-58
NMR metabolomics,X23408.Triglycerides in VLDL,MZT1,Mitotic-spindle organizing protein 1,28797,0.0597833773350601,0.00370238015861897,0.0525267122241669,0.0670400424459533,2.14398289388412e-58
NMR metabolomics,X23408.Triglycerides in VLDL,IFNGR2,Interferon gamma receptor 2,29218,0.0591712916456747,0.00366632968236563,0.0519852854682381,0.0663572978231113,2.42413441487752e-58
NMR metabolomics,X23408.Triglycerides in VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,0.0455163219812863,0.00282183633592649,0.0399855227628704,0.0510471211997023,3.10381816131307e-58
NMR metabolomics,X23408.Triglycerides in VLDL,NADK,NAD kinase,29478,0.0613177873572891,0.00380314408701371,0.0538636249467422,0.0687719497678359,3.12741549621915e-58
NMR metabolomics,X23408.Triglycerides in VLDL,RAB2B,Ras-related protein Rab-2B,24793,0.0701555458975526,0.004354231924239,0.0616212513260442,0.078689840469061,4.14666015865214e-58
NMR metabolomics,X23408.Triglycerides in VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,29327,0.0500051743388117,0.00310645411457088,0.0439165242742527,0.0560938244033706,4.73807678413701e-58
NMR metabolomics,X23408.Triglycerides in VLDL,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.0532112185800175,0.00330656027045962,0.0467303604499167,0.0596920767101184,5.15138563660126e-58
NMR metabolomics,X23408.Triglycerides in VLDL,CA13,Carbonic anhydrase 13,29114,0.118036309673845,0.00733632844833026,0.103657105915118,0.132415513432572,5.39934258270934e-58
NMR metabolomics,X23408.Triglycerides in VLDL,DYNLT3,Dynein light chain Tctex-type 3,24793,0.0493660454548968,0.00307481985130849,0.0433393985463322,0.0553926923634614,1.03256941112593e-57
NMR metabolomics,X23408.Triglycerides in VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,24523,0.0631560244876747,0.00393486239896074,0.0554436941857116,0.0708683547896377,1.11867226195144e-57
NMR metabolomics,X23408.Triglycerides in VLDL,CCL24,C-C motif chemokine 24,29536,0.0933881185768195,0.00582835540888417,0.0819645419754065,0.104811695178232,1.54288212751657e-57
NMR metabolomics,X23408.Triglycerides in VLDL,DPP4,Dipeptidyl peptidase 4,28990,0.0338161774564654,0.00211106526476818,0.0296784895375197,0.037953865375411,1.67583621198392e-57
NMR metabolomics,X23408.Triglycerides in VLDL,GLO1,Lactoylglutathione lyase,28916,0.0652797643707238,0.00407579742289906,0.0572912014218416,0.0732683273196059,1.73531304585482e-57
NMR metabolomics,X23408.Triglycerides in VLDL,AK2,"Adenylate kinase 2, mitochondrial",24845,0.119783731347687,0.00747846163909274,0.105125946535065,0.134441516160308,1.88241425397519e-57
NMR metabolomics,X23408.Triglycerides in VLDL,GDF2,Growth/differentiation factor 2,29478,0.0401270136606363,0.00250811247754533,0.0352111132046475,0.0450429141166252,2.27044129416171e-57
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC80,Coiled-coil domain-containing protein 80,29478,0.0395981245336928,0.00247821529244507,0.0347408225605005,0.0444554265068852,3.14140019859358e-57
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAL,Integrin alpha-L,24229,0.0490821007326354,0.00307536512101098,0.0430543850954538,0.0551098163698169,4.763378891812e-57
NMR metabolomics,X23408.Triglycerides in VLDL,TPP1,Tripeptidyl-peptidase 1,29286,0.051519067331089,0.00323040131214662,0.0451874807592816,0.0578506539028964,5.10137765006135e-57
NMR metabolomics,X23408.Triglycerides in VLDL,SLC27A4,Long-chain fatty acid transport protein 4,28774,0.0754692041081187,0.00473320274196587,0.0661921267338656,0.0847462814823718,5.45067885430389e-57
NMR metabolomics,X23408.Triglycerides in VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.0271197137715569,0.00170096484031477,0.0237858226845399,0.0304536048585738,5.46997604366878e-57
NMR metabolomics,X23408.Triglycerides in VLDL,DCTN2,Dynactin subunit 2,29349,0.105581113699091,0.0066327070673259,0.092581007847132,0.118581219551049,8.19178815412609e-57
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM1,Intercellular adhesion molecule 1,29391,0.0322786081391274,0.00202910368906891,0.0283015649085523,0.0362556513697025,9.65690885612585e-57
NMR metabolomics,X23408.Triglycerides in VLDL,GSR,"Glutathione reductase, mitochondrial",24867,0.0253877981760349,0.00159732251414678,0.0222570460483073,0.0285185503037626,1.32659665694043e-56
NMR metabolomics,X23408.Triglycerides in VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,28797,0.0400260403127708,0.00252181471813634,0.0350832834652236,0.044968797160318,1.72279121622117e-56
NMR metabolomics,X23408.Triglycerides in VLDL,SNX9,Sorting nexin-9,29478,0.0762478317539785,0.00480455528471338,0.0668309033959403,0.0856647601120167,1.75609267283828e-56
NMR metabolomics,X23408.Triglycerides in VLDL,PARD3,Partitioning defective 3 homolog,24445,0.0829671568913794,0.00522613553543839,0.0727239312419201,0.0932103825408386,1.79728272181123e-56
NMR metabolomics,X23408.Triglycerides in VLDL,FGR,Tyrosine-protein kinase Fgr,28774,0.063472277337287,0.00400006536777741,0.0556321492164433,0.0713124054581307,1.83912706682882e-56
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJC21,DnaJ homolog subfamily C member 21,24845,0.0429228315679677,0.00270682366408995,0.0376174571863514,0.048228205949584,2.36852260800741e-56
NMR metabolomics,X23408.Triglycerides in VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,0.0313183217793441,0.00197507245087617,0.0274471797756268,0.0351894637830614,2.43268500532678e-56
NMR metabolomics,X23408.Triglycerides in VLDL,SFRP4,Secreted frizzled-related protein 4,24381,0.0462478558560749,0.00291680812846195,0.0405309119242895,0.0519647997878603,2.4596311824387e-56
NMR metabolomics,X23408.Triglycerides in VLDL,UNC79,Protein unc-79 homolog,24016,0.0627374198898854,0.00395802145122775,0.054979697845479,0.0704951419342918,2.68469337441019e-56
NMR metabolomics,X23408.Triglycerides in VLDL,TPK1,Thiamin pyrophosphokinase 1,24922,0.0307608732226615,0.0019422908281237,0.026953983199539,0.0345677632457839,3.23159646695517e-56
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS3,Galectin-3,29544,0.0331880178978277,0.00209707347470034,0.029077753887415,0.0372982819082403,3.51326473484406e-56
NMR metabolomics,X23408.Triglycerides in VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.0976810926038566,0.00617985117627553,0.0855685842983565,0.109793600909357,4.78982313859098e-56
NMR metabolomics,X23408.Triglycerides in VLDL,SCRN1,Secernin-1,29434,0.0621263407846873,0.00393138757560112,0.0544208211365091,0.0698318604328655,5.07399409051811e-56
NMR metabolomics,X23408.Triglycerides in VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.0597937047670649,0.00378818735065643,0.0523688575597783,0.0672185519743515,6.85531978491415e-56
NMR metabolomics,X23408.Triglycerides in VLDL,ESAM,Endothelial cell-selective adhesion molecule,29820,0.0353119678699427,0.00224159971009488,0.0309184324381567,0.0397055033017287,1.09893467924463e-55
NMR metabolomics,X23408.Triglycerides in VLDL,GRK5,G protein-coupled receptor kinase 5,28916,0.0576866687639037,0.0036618362942944,0.0505094696270867,0.0648638679007208,1.1087517534091e-55
NMR metabolomics,X23408.Triglycerides in VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,28797,0.0837137713427029,0.00532009481585429,0.0732863855036285,0.0941411571817773,1.47542820623356e-55
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA2,Annexin A2,23907,0.0787149116865092,0.00501076582683426,0.068893810665914,0.0885360127071043,2.47760645297769e-55
NMR metabolomics,X23408.Triglycerides in VLDL,CBLN4,Cerebellin-4,29725,0.0350984135506508,0.00223562917500765,0.0307165803676358,0.0394802467336657,2.54213592775828e-55
NMR metabolomics,X23408.Triglycerides in VLDL,MATN2,Matrilin-2,29497,0.0328703417462318,0.00209458001813219,0.0287649649106927,0.0369757185817709,2.82604446073172e-55
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH7,Protocadherin-7,24805,0.0384903464954417,0.00245539098726674,0.0336777801603989,0.0433029128304845,4.07115906836982e-55
NMR metabolomics,X23408.Triglycerides in VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,28774,0.0565525251589378,0.00361344789191327,0.0494701672907878,0.0636348830270878,5.55364090987433e-55
NMR metabolomics,X23408.Triglycerides in VLDL,GNAS,Neuroendocrine secretory protein 55,24867,0.0976292954646496,0.00623628340441462,0.0854061799919969,0.109852410937302,5.62091451697677e-55
NMR metabolomics,X23408.Triglycerides in VLDL,SNAP25,Synaptosomal-associated protein 25,24101,0.0522667772991564,0.00333913787166538,0.0457220670706922,0.0588114875276205,5.93524177415041e-55
NMR metabolomics,X23408.Triglycerides in VLDL,BTC,Probetacellulin,28797,0.0819111594398318,0.00523984253836321,0.0716410680646399,0.0921812508150237,7.3704416098656e-55
NMR metabolomics,X23408.Triglycerides in VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,24922,0.0656137899039342,0.00419604559497378,0.0573895405377856,0.0738380392700828,7.42643733828989e-55
NMR metabolomics,X23408.Triglycerides in VLDL,IL12B,Interleukin-12 subunit beta,29786,0.0597268657469273,0.00383291644959593,0.0522143495057193,0.0672393819881354,1.57001679905961e-54
NMR metabolomics,X23408.Triglycerides in VLDL,CALB2,Calretinin,28774,0.0334835354217633,0.00215140671761503,0.0292667782552378,0.0377002925882888,2.14691316179003e-54
NMR metabolomics,X23408.Triglycerides in VLDL,ASAH1,Acid ceramidase,24732,0.051148232677325,0.00328557293455929,0.0447085097255888,0.0575879556290613,2.1939050938096e-54
NMR metabolomics,X23408.Triglycerides in VLDL,MEP1B,Meprin A subunit beta,29478,0.12791227114773,0.00822432534454012,0.111792593472431,0.144031948823029,2.50092631978792e-54
NMR metabolomics,X23408.Triglycerides in VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,24240,-0.0667561367502425,0.00429534363540269,-0.0751750102756318,-0.0583372632248532,3.31982645106751e-54
NMR metabolomics,X23408.Triglycerides in VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,0.090183884452077,0.00580709212598187,0.0788019838851526,0.101565785019002,3.57097633995524e-54
NMR metabolomics,X23408.Triglycerides in VLDL,STXBP3,Syntaxin-binding protein 3,28797,0.0478593283401454,0.00308611221470518,0.0418105483993232,0.0539081082809675,5.07103423130939e-54
NMR metabolomics,X23408.Triglycerides in VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,0.04253704689691,0.00274553692969955,0.0371557945146989,0.0479182992791212,7.00141604602917e-54
NMR metabolomics,X23408.Triglycerides in VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,0.0634447117986885,0.00410079391360283,0.055407155728027,0.07148226786935,8.86064350698382e-54
NMR metabolomics,X23408.Triglycerides in VLDL,GLRX,Glutaredoxin-1,29291,0.0610098430248643,0.00394846875150022,0.0532708442719239,0.0687488417778048,1.20057157800444e-53
NMR metabolomics,X23408.Triglycerides in VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.0549792610080406,0.00356109162582145,0.0479995214214306,0.0619590005946507,1.58679568552881e-53
NMR metabolomics,X23408.Triglycerides in VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,0.0773093404747759,0.00500928123515472,0.0674911492538727,0.0871275316956792,1.59277347932251e-53
NMR metabolomics,X23408.Triglycerides in VLDL,NGRN,Neugrin,24845,0.0241332050705204,0.00156339750583612,0.0210689459590816,0.0271974641819592,1.65224638167334e-53
NMR metabolomics,X23408.Triglycerides in VLDL,CSTB,Cystatin-B,29030,0.0461680135897206,0.00299449886336166,0.0402987958175317,0.0520372313619094,2.03085537650667e-53
NMR metabolomics,X23408.Triglycerides in VLDL,DCTN6,Dynactin subunit 6,28774,0.0773888276244498,0.00502439872177204,0.0675410061297766,0.087236649119123,2.56784116113562e-53
NMR metabolomics,X23408.Triglycerides in VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,0.0792149891018805,0.00515235723493188,0.0691163689214141,0.089313609282347,3.92410751495437e-53
NMR metabolomics,X23408.Triglycerides in VLDL,PRG2,Bone marrow proteoglycan,24938,-0.0562204463000271,0.00365675229439089,-0.0633876807970333,-0.049053211803021,4.26117469439496e-53
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA6,Integrin alpha-6,29434,0.0563614276218076,0.00366944557094462,0.0491693143027561,0.063553540940859,4.90457901314956e-53
NMR metabolomics,X23408.Triglycerides in VLDL,TNF,Tumor necrosis factor,28868,0.0412456708391559,0.002693136272289,0.0359671237454695,0.0465242179328424,9.77710096026678e-53
NMR metabolomics,X23408.Triglycerides in VLDL,FST,Follistatin,29536,0.0544397982794312,0.00355719804039915,0.0474676901202489,0.0614119064386135,1.14365964260501e-52
NMR metabolomics,X23408.Triglycerides in VLDL,ACRBP,Acrosin-binding protein,24793,0.0418259903489169,0.00273409018109588,0.036467173593969,0.0471848071038648,1.37268846130036e-52
NMR metabolomics,X23408.Triglycerides in VLDL,CCL15,C-C motif chemokine 15,29820,0.0473954166430281,0.00309940977286571,0.0413205734882113,0.0534702597978448,1.3748460716599e-52
NMR metabolomics,X23408.Triglycerides in VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,0.0947823907668496,0.00621176778178513,0.0826073259145507,0.106957455619148,2.31264161921515e-52
NMR metabolomics,X23408.Triglycerides in VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,0.0749565709025921,0.00491578680424513,0.0653216287662717,0.0845915130389126,2.9638084037369e-52
NMR metabolomics,X23408.Triglycerides in VLDL,POMC,Pro-opiomelanocortin,24240,0.0760762799036891,0.00498941622667858,0.0662970240993991,0.0858555357079791,2.99022652357176e-52
NMR metabolomics,X23408.Triglycerides in VLDL,APOL1,Apolipoprotein L1,24951,0.064540133126042,0.00423384449751607,0.0562417979109105,0.0728384683411735,3.1117917681405e-52
NMR metabolomics,X23408.Triglycerides in VLDL,MIA,Melanoma-derived growth regulatory protein,29566,0.0395696952666893,0.00260048851303238,0.0344727377811458,0.0446666527522328,4.34854065007669e-52
NMR metabolomics,X23408.Triglycerides in VLDL,RGS10,Regulator of G-protein signaling 10,24867,0.0640403018123298,0.00420820691773055,0.0557922162535779,0.0722883873710817,4.61636383390947e-52
NMR metabolomics,X23408.Triglycerides in VLDL,CCL25,C-C motif chemokine 25,29786,0.0526496853139228,0.00346113091530414,0.0458658687199267,0.0594335019079189,4.64386798028128e-52
NMR metabolomics,X23408.Triglycerides in VLDL,GDNF,Glial cell line-derived neurotrophic factor,28774,0.0409433975546646,0.00269815572180405,0.0356550123399287,0.0462317827694006,8.27403390845452e-52
NMR metabolomics,X23408.Triglycerides in VLDL,PPM1F,Protein phosphatase 1F,24922,0.0563151728681309,0.00371952965977891,0.0490248947349643,0.0636054510012976,1.48773562052874e-51
NMR metabolomics,X23408.Triglycerides in VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,0.0543643798514089,0.0035935095637737,0.0473211011064124,0.0614076585964054,1.63996210245512e-51
NMR metabolomics,X23408.Triglycerides in VLDL,PTGDS,Prostaglandin-H2 D-isomerase,29291,0.0324734205976624,0.00214685580420974,0.0282655832214113,0.0366812579739135,1.70810194857037e-51
NMR metabolomics,X23408.Triglycerides in VLDL,ADA,Adenosine deaminase,29786,0.0370622168997081,0.00245057773019911,0.0322590845485179,0.0418653492508984,1.75180066075754e-51
NMR metabolomics,X23408.Triglycerides in VLDL,CD83,CD83 antigen,29434,0.0361678617420782,0.00239545161035591,0.0314727765857806,0.0408629468983758,2.57821467937268e-51
NMR metabolomics,X23408.Triglycerides in VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.0932754412049771,0.00618304630828384,0.0811566704407408,0.105394211969213,3.39666225168071e-51
NMR metabolomics,X23408.Triglycerides in VLDL,CORO1A,Coronin-1A,28847,0.0947013704552581,0.00629035283255668,0.082372278903447,0.107030462007069,5.00387242027213e-51
NMR metabolomics,X23408.Triglycerides in VLDL,DKK4,Dickkopf-related protein 4,29169,0.0486418450074093,0.00323125297642123,0.0423085891736237,0.0549751008411949,5.08979044793239e-51
NMR metabolomics,X23408.Triglycerides in VLDL,LAMB1,Laminin subunit beta-1,24240,0.0323203614275093,0.00214779264252769,0.028110687848155,0.0365300350068635,6.03249265736926e-51
NMR metabolomics,X23408.Triglycerides in VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,0.0733570465639377,0.00487988891612126,0.06379246428834,0.0829216288395354,6.95782789980838e-51
NMR metabolomics,X23408.Triglycerides in VLDL,ENO2,Gamma-enolase,29694,0.0692088283103078,0.00461100059581139,0.0601712671425175,0.0782463894780981,9.77186754950151e-51
NMR metabolomics,X23408.Triglycerides in VLDL,CD84,SLAM family member 5,29434,0.0330396546372301,0.0022014578301724,0.0287247972900922,0.037354511984368,1.00199360111891e-50
NMR metabolomics,X23408.Triglycerides in VLDL,STX16,Syntaxin-16,28797,0.0613859837863847,0.00409273488532754,0.0533642234111428,0.0694077441616267,1.1626979245071e-50
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC134,Coiled-coil domain-containing protein 134,24793,0.0515418039942862,0.00343568232481243,0.0448078666376538,0.0582757413509185,1.19085520190139e-50
NMR metabolomics,X23408.Triglycerides in VLDL,CCL26,C-C motif chemokine 26,29434,0.0941007368749475,0.0062789168823035,0.0817940597856326,0.106407413964262,1.37771708030531e-50
NMR metabolomics,X23408.Triglycerides in VLDL,GGH,Gamma-glutamyl hydrolase,28984,0.0359513927285095,0.00240083454228569,0.0312457570256296,0.0406570284313894,1.66498213574245e-50
NMR metabolomics,X23408.Triglycerides in VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,0.0708078089680629,0.00473120563490574,0.0615346459236476,0.0800809720124781,2.02780200441697e-50
NMR metabolomics,X23408.Triglycerides in VLDL,ARFIP1,Arfaptin-1,24867,0.0725671412475111,0.00485624713487432,0.0630488968631574,0.0820853856318648,2.85895649511203e-50
NMR metabolomics,X23408.Triglycerides in VLDL,MMP1,Interstitial collagenase,28424,0.0962711918112183,0.00644748808858304,0.0836341151575956,0.108908268464841,3.18524334804749e-50
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,0.0756259336011757,0.00507504462797175,0.0656788461303511,0.0855730210720003,4.94154432405551e-50
NMR metabolomics,X23408.Triglycerides in VLDL,TLR3,Toll-like receptor 3,29786,0.0640055166082983,0.00430305229859586,0.0555715341030504,0.0724394991135462,7.29730055777485e-50
NMR metabolomics,X23408.Triglycerides in VLDL,ERI1,3'-5' exoribonuclease 1,24445,0.0355836353457011,0.00239386299194375,0.0308916638814914,0.0402756068099109,9.24461923312974e-50
NMR metabolomics,X23408.Triglycerides in VLDL,PDZD2,PDZ domain-containing protein 2,24111,0.0631110555501125,0.00424677618534119,0.0547873742268438,0.0714347368733813,9.81666223603441e-50
NMR metabolomics,X23408.Triglycerides in VLDL,NID2,Nidogen-2,29443,0.0766956657938854,0.00516317122498271,0.0665758501929193,0.0868154813948515,9.87272899605589e-50
NMR metabolomics,X23408.Triglycerides in VLDL,ARAF,Serine/threonine-protein kinase A-Raf,24445,0.0708444798282859,0.00477402038280128,0.0614873998779954,0.0802015597785764,1.33669519792579e-49
NMR metabolomics,X23408.Triglycerides in VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,0.0670447079392859,0.00451933436259725,0.0581868125885953,0.0759026032899765,1.43455103654694e-49
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G15,Phospholipase A2 group XV,29566,0.0277088910128032,0.0018688456896308,0.0240459534611268,0.0313718285644795,1.48338702972679e-49
NMR metabolomics,X23408.Triglycerides in VLDL,DMD,Dystrophin,24240,0.0541062304064858,0.00364904505949222,0.0469541020898811,0.0612583587230906,1.60443662982074e-49
NMR metabolomics,X23408.Triglycerides in VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.0292728540887298,0.00198251792235008,0.0253871189609236,0.0331585892165359,3.65759406950146e-49
NMR metabolomics,X23408.Triglycerides in VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,24922,0.0336925965805465,0.00228117633905021,0.0292214909560081,0.0381637022050849,3.7023904562929e-49
NMR metabolomics,X23408.Triglycerides in VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.0421918125207266,0.00285766981912146,0.0365907796752485,0.0477928453662047,4.07445059360274e-49
NMR metabolomics,X23408.Triglycerides in VLDL,PAEP,Glycodelin,29218,-0.136630304671129,0.00928342377173906,-0.154825815263737,-0.11843479407852,7.43223320416442e-49
NMR metabolomics,X23408.Triglycerides in VLDL,IGF1R,Insulin-like growth factor 1 receptor,29349,0.022526059441506,0.00153181362149019,0.0195237047433853,0.0255284141396268,8.87043302079205e-49
NMR metabolomics,X23408.Triglycerides in VLDL,SERPING1,Plasma protease C1 inhibitor,24914,0.019490222079483,0.00132529832005087,0.0168926373721833,0.0220878067867827,9.41007815734836e-49
NMR metabolomics,X23408.Triglycerides in VLDL,SFRP1,Secreted frizzled-related protein 1,29120,0.0448033335115454,0.00305152755839995,0.0388223394970815,0.0507843275260093,1.25043615288405e-48
NMR metabolomics,X23408.Triglycerides in VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,0.0395095003638875,0.00269567359750797,0.0342259801127719,0.0447930206150031,1.81137784620608e-48
NMR metabolomics,X23408.Triglycerides in VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,0.0286973779883316,0.00195789204980471,0.0248599095707144,0.0325348464059489,1.95403726496436e-48
NMR metabolomics,X23408.Triglycerides in VLDL,CDA,Cytidine deaminase,24890,0.0482821834816142,0.0032965599371609,0.0418209260047788,0.0547434409584495,2.2648930596612e-48
NMR metabolomics,X23408.Triglycerides in VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.0451728886811221,0.00308819445054021,0.0391200275580633,0.0512257498041809,2.79191891145838e-48
NMR metabolomics,X23408.Triglycerides in VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.100888437416012,0.00690739968686268,0.0873499340297609,0.114426940802263,3.813224243965e-48
NMR metabolomics,X23408.Triglycerides in VLDL,SCRIB,Protein scribble homolog,24240,0.0931373806765837,0.006388142901837,0.0806166205889832,0.105658140764184,6.03591004702883e-48
NMR metabolomics,X23408.Triglycerides in VLDL,AMOTL2,Angiomotin-like protein 2,24711,0.0497380949885408,0.00341265983437959,0.0430492817131568,0.0564269082639248,6.44653956825473e-48
NMR metabolomics,X23408.Triglycerides in VLDL,CD46,Membrane cofactor protein,29331,0.029361732945729,0.00201785636733368,0.025406734465755,0.033316731425703,8.45617006356975e-48
NMR metabolomics,X23408.Triglycerides in VLDL,TREML2,Trem-like transcript 2 protein,29443,0.0347442771627164,0.0023899343994245,0.0300600057398443,0.0394285485855884,1.02260771315146e-47
NMR metabolomics,X23408.Triglycerides in VLDL,BST2,Bone marrow stromal antigen 2,29694,0.0537410845860279,0.00369763973567939,0.0464937107040963,0.0609884584679595,1.07808767256064e-47
NMR metabolomics,X23408.Triglycerides in VLDL,SPAG1,Sperm-associated antigen 1,24867,0.0593777456968564,0.0040846326583593,0.0513718656864722,0.0673836257072407,1.11076244192914e-47
NMR metabolomics,X23408.Triglycerides in VLDL,APLP1,Amyloid-like protein 1,29478,-0.0524863954792814,0.00362310901045729,-0.0595876891397777,-0.0453851018187851,2.1446855402713e-47
NMR metabolomics,X23408.Triglycerides in VLDL,DENR,Density-regulated protein,24229,0.0586656525014446,0.00405507587605771,0.0507177037843715,0.0666136012185178,3.07383048741e-47
NMR metabolomics,X23408.Triglycerides in VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,-0.116796880826617,0.00808661076843691,-0.132646637932754,-0.100947123720481,4.02058709048059e-47
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX6,Peroxiredoxin-6,29725,-0.0607986164932038,0.00421394467078083,-0.0690579480479342,-0.0525392849384733,4.97894262164704e-47
NMR metabolomics,X23408.Triglycerides in VLDL,DSCAM,Down syndrome cell adhesion molecule,24867,0.0363953653738521,0.00252187411707718,0.0314524921043809,0.0413382386433234,5.05390562011511e-47
NMR metabolomics,X23408.Triglycerides in VLDL,NECTIN2,Nectin-2,29433,0.0302519882595394,0.00209895070633133,0.02613804487513,0.0343659316439488,6.20486835873721e-47
NMR metabolomics,X23408.Triglycerides in VLDL,LGMN,Legumain,29581,0.0363389925336615,0.002524555772727,0.0313908632191166,0.0412871218482064,8.10281835684254e-47
NMR metabolomics,X23408.Triglycerides in VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,0.0973738522329883,0.00676766480526027,0.0841092292146782,0.110638475251298,8.8920065864677e-47
NMR metabolomics,X23408.Triglycerides in VLDL,SLIT2,Slit homolog 2 protein,28774,0.0527054687417273,0.00366885068184142,0.0455145214053181,0.0598964160781365,1.23292783566023e-46
NMR metabolomics,X23408.Triglycerides in VLDL,CLTA,Clathrin light chain A,28916,0.0476002470969476,0.00331538228848599,0.041102097811515,0.0540983963823801,1.3854842364176e-46
NMR metabolomics,X23408.Triglycerides in VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,0.0595294515794625,0.0041479268972104,0.0513995148609301,0.0676593882979949,1.59766822493809e-46
NMR metabolomics,X23408.Triglycerides in VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,0.0304703995620016,0.00212578168875073,0.0263038674520502,0.0346369316719531,2.06086570434468e-46
NMR metabolomics,X23408.Triglycerides in VLDL,MDK,Midkine,29455,0.0512550227633669,0.00358181263817881,0.0442346699925365,0.0582753755341974,2.71838430925194e-46
NMR metabolomics,X23408.Triglycerides in VLDL,PSAP,Prosaposin,24761,0.0287061608430721,0.00200775978180064,0.0247709516707428,0.0326413700154013,3.4603080092312e-46
NMR metabolomics,X23408.Triglycerides in VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.0895478227219916,0.00627694176981743,0.0772450168531495,0.101850628590834,5.4497361849054e-46
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,0.0329498143011882,0.00231324160790182,0.0284158607497006,0.0374837678526757,6.96129783148652e-46
NMR metabolomics,X23408.Triglycerides in VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,0.0596618614848861,0.00420893837896888,0.0514123422621071,0.0679113807076651,1.85740427055684e-45
NMR metabolomics,X23408.Triglycerides in VLDL,C1RL,Complement C1r subcomponent-like protein,24925,0.019499964635549,0.00137648623037504,0.0168020516240139,0.0221978776470841,2.21710916814949e-45
NMR metabolomics,X23408.Triglycerides in VLDL,RPL14,60S ribosomal protein L14,24240,0.0401780505531731,0.00284451582651141,0.0346027995332108,0.0457533015731355,4.03941853145747e-45
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,0.0385816475204598,0.00273476339333736,0.0332215112695186,0.043941783771401,4.74710791733031e-45
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,24381,0.0368721081553029,0.00261515446403472,0.0317464054057948,0.0419978109048109,5.75583674600169e-45
NMR metabolomics,X23408.Triglycerides in VLDL,CCL19,C-C motif chemokine 19,29694,0.122018119603499,0.00865957796719173,0.105045346787804,0.138990892419195,6.06361621724476e-45
NMR metabolomics,X23408.Triglycerides in VLDL,HRG,Histidine-rich glycoprotein,24833,0.0311870727672039,0.00221455718613047,0.0268465406823881,0.0355276048520196,7.2184165557739e-45
NMR metabolomics,X23408.Triglycerides in VLDL,IMPA1,Inositol monophosphatase 1,29218,0.0603704551852103,0.00429579197113655,0.0519507029217826,0.0687902074486379,1.02728715752912e-44
NMR metabolomics,X23408.Triglycerides in VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,0.0508244316014167,0.00361798436414158,0.0437331822476992,0.0579156809551341,1.10563225367773e-44
NMR metabolomics,X23408.Triglycerides in VLDL,TPMT,Thiopurine S-methyltransferase,28797,0.0719844223597269,0.00513225660833041,0.0619251994073993,0.0820436453120545,1.5179657368615e-44
NMR metabolomics,X23408.Triglycerides in VLDL,NCAM2,Neural cell adhesion molecule 2,29443,-0.0266233587796458,0.00190003131295227,-0.0303474201530322,-0.0228992974062593,1.8282977194985e-44
NMR metabolomics,X23408.Triglycerides in VLDL,NPPB,Natriuretic peptides B,28916,-0.132296164200058,0.00944211079891968,-0.150802701365941,-0.113789627034175,1.85922718938573e-44
NMR metabolomics,X23408.Triglycerides in VLDL,PLXNB2,Plexin-B2,29701,0.0235389247181661,0.00168207840517634,0.0202420510440205,0.0268357983923117,2.34844235871535e-44
NMR metabolomics,X23408.Triglycerides in VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,0.0676452284473555,0.00483736207167558,0.0581639987868714,0.0771264581078396,2.89903613823831e-44
NMR metabolomics,X23408.Triglycerides in VLDL,PTGES2,Prostaglandin E synthase 2,24037,0.0542628073338048,0.00388795495628943,0.0466424156194775,0.0618831990481321,4.26191025835163e-44
NMR metabolomics,X23408.Triglycerides in VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.0900931528783685,0.00645935572597033,0.0774328156554667,0.10275349010127,4.76360599654621e-44
NMR metabolomics,X23408.Triglycerides in VLDL,DDX58,Antiviral innate immune response receptor RIG-I,28797,0.0558292453104764,0.00401237680623476,0.0479649867702563,0.0636935038506965,7.20023911960356e-44
NMR metabolomics,X23408.Triglycerides in VLDL,TF,Serotransferrin,24966,0.0212003077067239,0.00152505907028597,0.0182111919289634,0.0241894234844844,9.05973134099211e-44
NMR metabolomics,X23408.Triglycerides in VLDL,CD302,CD302 antigen,29349,0.0297875491376447,0.00214985076771698,0.0255738416329194,0.03400125664237,1.61316107006831e-43
NMR metabolomics,X23408.Triglycerides in VLDL,TPR,Nucleoprotein TPR,24111,0.0467112544805587,0.00337008257621444,0.0401058926311784,0.053316616329939,1.61345293086296e-43
NMR metabolomics,X23408.Triglycerides in VLDL,MAGED1,Melanoma-associated antigen D1,28797,0.0472237978212976,0.00341033771604083,0.0405395358978576,0.0539080597447376,1.82250899199099e-43
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS27,Serine protease 27,29395,0.0392816214612901,0.00283716643078269,0.033720775256956,0.0448424676656242,1.85833921983702e-43
NMR metabolomics,X23408.Triglycerides in VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.0609450318648103,0.00440737486737522,0.0523065771247549,0.0695834866048657,2.49894220467965e-43
NMR metabolomics,X23408.Triglycerides in VLDL,BOLA1,BolA-like protein 1,24101,0.0532860994970877,0.00385761045721477,0.0457251830009467,0.0608470159932286,3.10056355140397e-43
NMR metabolomics,X23408.Triglycerides in VLDL,HSPB6,Heat shock protein beta-6,29725,0.0372412459967779,0.00270823339742235,0.0319331085378301,0.0425493834557257,6.7877487149585e-43
NMR metabolomics,X23408.Triglycerides in VLDL,MARCO,Macrophage receptor MARCO,29478,0.0254606292992754,0.00185420304940838,0.021826391322435,0.0290948672761159,8.93180410741498e-43
NMR metabolomics,X23408.Triglycerides in VLDL,STK4,Serine/threonine-protein kinase 4,29478,0.0836790027568502,0.0060946659045972,0.0717334575838397,0.0956245479298607,9.10878554325356e-43
NMR metabolomics,X23408.Triglycerides in VLDL,C7orf50,Uncharacterized protein C7orf50,24845,0.0216259721612598,0.00157508384759387,0.0185388078199758,0.0247131365025438,9.61421317506353e-43
NMR metabolomics,X23408.Triglycerides in VLDL,CCL14,C-C motif chemokine 14,29435,0.0382902504573602,0.00279050600774736,0.0328208586821754,0.043759642232545,1.02054629756092e-42
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,29725,0.0520531134563377,0.00379458654358389,0.0446157238309132,0.0594905030817621,1.07319796210618e-42
NMR metabolomics,X23408.Triglycerides in VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,24571,0.0542785973219042,0.00395685490898502,0.0465231617002935,0.0620340329435148,1.14440133600648e-42
NMR metabolomics,X23408.Triglycerides in VLDL,KIF22,Kinesin-like protein KIF22,24111,0.118873803608507,0.0086781559465969,0.101864617953177,0.135882989263837,1.5056879273304e-42
NMR metabolomics,X23408.Triglycerides in VLDL,INSL5,Insulin-like peptide INSL5,24805,0.0943604633021045,0.00689802927293382,0.0808403259271542,0.107880600677055,1.92435126982831e-42
NMR metabolomics,X23408.Triglycerides in VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.033893605639612,0.00248634135655228,-0.0387668346984544,-0.0290203765807695,3.70172003705539e-42
NMR metabolomics,X23408.Triglycerides in VLDL,WAS,Wiskott-Aldrich syndrome protein,28931,0.0641695185785813,0.00472106399883423,0.0549162331408662,0.0734228040162964,5.99766712492599e-42
NMR metabolomics,X23408.Triglycerides in VLDL,FXN,"Frataxin, mitochondrial",29725,0.070118416271778,0.00516550157443565,0.0599940331858841,0.0802427993576719,7.57702126874426e-42
NMR metabolomics,X23408.Triglycerides in VLDL,PNLIP,Pancreatic triacylglycerol lipase,24951,0.0604759148363677,0.00445715073425483,0.0517398993972282,0.0692119302755072,8.69041590781023e-42
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA4,Annexin A4,29341,0.068772523725128,0.00507390698891367,0.0588276660268572,0.0787173814233988,1.00020228666598e-41
NMR metabolomics,X23408.Triglycerides in VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,-0.0373395945459584,0.00275897702909855,-0.0427471895229916,-0.0319319995689253,1.3152297943378e-41
NMR metabolomics,X23408.Triglycerides in VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,0.0386699476628329,0.00286121446890065,0.0330619673037877,0.0442779280218782,1.79833998374957e-41
NMR metabolomics,X23408.Triglycerides in VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,0.0405359735330102,0.00300062977036074,0.0346547391831031,0.0464172078829172,1.8354609594667e-41
NMR metabolomics,X23408.Triglycerides in VLDL,EFCAB2,Dynein regulatory complex protein 8,24445,0.0333263263912386,0.00246998831049885,0.0284851493026609,0.0381675034798163,2.43506791887818e-41
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.0403692135981923,0.00299680347729868,0.0344954787826869,0.0462429484136977,3.09626103974934e-41
NMR metabolomics,X23408.Triglycerides in VLDL,BGN,Biglycan,28750,-0.113766713358529,0.00844880464253293,-0.130326370457894,-0.0972070562591646,3.33277127014309e-41
NMR metabolomics,X23408.Triglycerides in VLDL,LBP,Lipopolysaccharide-binding protein,29594,-0.0553324160336901,0.0041129458979087,-0.0633937899935911,-0.047271042073789,3.89451682727202e-41
NMR metabolomics,X23408.Triglycerides in VLDL,SF3B4,Splicing factor 3B subunit 4,29349,0.0689814335493854,0.0051322736676384,0.0589221771608141,0.0790406899379567,4.61852264424892e-41
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP1,Rho GTPase-activating protein 1,28797,0.0437556786664304,0.00325588379006402,0.0373741464379049,0.0501372108949559,4.75435984256058e-41
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1F,V-type proton ATPase subunit F,28719,0.0627467370125589,0.00467529534578222,0.0535831581348258,0.0719103158902921,6.06140922771531e-41
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,0.034035491657461,0.00253555542833141,0.0290658030179314,0.0390051802969906,6.1881100906916e-41
NMR metabolomics,X23408.Triglycerides in VLDL,C4BPB,C4b-binding protein beta chain,29566,0.0378416401843122,0.00282655079266554,0.0323016006306877,0.0433816797379367,9.35409120024945e-41
NMR metabolomics,X23408.Triglycerides in VLDL,HPCAL1,Hippocalcin-like protein 1,29786,0.069149828102003,0.00516978886676718,0.0590170419231394,0.0792826142808667,1.09850285286689e-40
NMR metabolomics,X23408.Triglycerides in VLDL,DNM1,Dynamin-1,24805,0.107988332393408,0.00807203029873789,0.0921671530078816,0.123809511778934,1.12402690602476e-40
NMR metabolomics,X23408.Triglycerides in VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,0.0450553206135629,0.00337163778436733,0.0384469105562029,0.0516637306709228,1.37342055298392e-40
NMR metabolomics,X23408.Triglycerides in VLDL,CA14,Carbonic anhydrase 14,29725,-0.0334870899281558,0.00250802324450027,-0.0384028154873763,-0.0285713643689352,1.5098377747039e-40
NMR metabolomics,X23408.Triglycerides in VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.0820752628453769,0.00614747604267887,0.0700262098017263,0.0941243158890275,1.61994850310769e-40
NMR metabolomics,X23408.Triglycerides in VLDL,RBP2,Retinol-binding protein 2,29349,-0.0722508873966708,0.00541364163433006,-0.0828616249999578,-0.0616401497933839,1.63926676001334e-40
NMR metabolomics,X23408.Triglycerides in VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,24867,0.0495900514044821,0.00371858790542496,0.0423016191098492,0.056878483699115,1.97601684477429e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.0214664884565917,0.00161000566161566,0.018310877359825,0.0246220995533584,2.04227387449069e-40
NMR metabolomics,X23408.Triglycerides in VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,0.0537072856828313,0.0040341498636132,0.0458003519501495,0.0616142194155132,2.55191022853016e-40
NMR metabolomics,X23408.Triglycerides in VLDL,HDGF,Hepatoma-derived growth factor,29688,0.08769011922186,0.006589411644907,0.0747748723978423,0.100605366045878,2.72370175174719e-40
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB8,Serpin B8,29786,0.0527853405596322,0.00396804677783509,0.0450079688750754,0.0605627122441889,2.91351975340668e-40
NMR metabolomics,X23408.Triglycerides in VLDL,RARRES1,Retinoic acid receptor responder protein 1,28797,0.03139470919383,0.00236141743276019,0.0267663310256201,0.03602308736204,3.25872042474713e-40
NMR metabolomics,X23408.Triglycerides in VLDL,SLITRK2,SLIT and NTRK-like protein 2,29725,0.0366361735249653,0.00275837605573764,0.0312297564557195,0.042042590594211,3.8436150410507e-40
NMR metabolomics,X23408.Triglycerides in VLDL,ENAH,Protein enabled homolog,28931,0.0446526579544076,0.00336196415493899,0.0380632082107272,0.0512421076980881,3.87520878713742e-40
NMR metabolomics,X23408.Triglycerides in VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",29478,0.0684049691905585,0.00515765386071087,0.0582959676235652,0.0785139707575518,4.95540237951353e-40
NMR metabolomics,X23408.Triglycerides in VLDL,MNDA,Myeloid cell nuclear differentiation antigen,29426,0.0907659417581218,0.00685863368342488,0.077323019738609,0.104208863777635,7.2776960918003e-40
NMR metabolomics,X23408.Triglycerides in VLDL,MMP3,Stromelysin-1,29443,-0.0457454088015895,0.00345858146932189,-0.0525242284814604,-0.0389665891217185,8.001870431245e-40
NMR metabolomics,X23408.Triglycerides in VLDL,CASP8,Caspase-8,29632,0.0573712606213341,0.00433775088315291,0.0488692688903544,0.0658732523523138,8.05224152862209e-40
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,0.0215800459279423,0.00163208640137801,0.0183811565812414,0.0247789352746432,8.43892419619046e-40
NMR metabolomics,X23408.Triglycerides in VLDL,PTN,Pleiotrophin,28916,0.0465871845666888,0.00352678594199009,0.0396746841203882,0.0534996850129893,1.00794136545177e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL8,Interleukin-8,29218,0.063093454386569,0.00478012137892143,0.053724416483883,0.072462492289255,1.15307333786537e-39
NMR metabolomics,X23408.Triglycerides in VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.0914839082788841,0.00693611013672719,0.0778891324108988,0.105078684146869,1.30508220476606e-39
NMR metabolomics,X23408.Triglycerides in VLDL,DHPS,Deoxyhypusine synthase,24793,0.0378317781566884,0.00287776344771804,0.032191361799161,0.0434721945142158,2.42237186568428e-39
NMR metabolomics,X23408.Triglycerides in VLDL,COL2A1,Collagen alpha-1(II) chain,24240,0.0749864881298963,0.00570635137985694,0.0638020394253767,0.0861709368344159,2.61695617853582e-39
NMR metabolomics,X23408.Triglycerides in VLDL,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.034968190012216,0.00266463918386596,0.0297454972118388,0.0401908828125933,3.14960604898133e-39
NMR metabolomics,X23408.Triglycerides in VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,25976,-0.0288646130736094,0.00220081893467703,-0.0331782181855764,-0.0245510079616424,3.58106093521267e-39
NMR metabolomics,X23408.Triglycerides in VLDL,AK1,Adenylate kinase isoenzyme 1,29478,0.058050449318589,0.00443030185062347,0.049367057691367,0.066733840945811,4.0697250332357e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,0.0759060085638582,0.00580694831852047,0.0645243898595581,0.0872876272681583,6.43766323265388e-39
NMR metabolomics,X23408.Triglycerides in VLDL,RPE,Ribulose-phosphate 3-epimerase,24445,0.0651397989413802,0.00498730403309128,0.0553646830365213,0.0749149148462391,7.41132916025995e-39
NMR metabolomics,X23408.Triglycerides in VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,0.108689100747186,0.00832287081605323,0.0923762739477218,0.12500192754665,7.5779732154538e-39
NMR metabolomics,X23408.Triglycerides in VLDL,IL6R,Interleukin-6 receptor subunit alpha,29361,0.0311729038427207,0.00238939381995333,0.0264896919556122,0.0358561157298292,8.54745940922578e-39
NMR metabolomics,X23408.Triglycerides in VLDL,XRCC4,DNA repair protein XRCC4,28774,0.0340716165520915,0.00261235803177529,0.0289513948098119,0.0391918382943711,9.0378086040459e-39
NMR metabolomics,X23408.Triglycerides in VLDL,WFDC1,WAP four-disulfide core domain protein 1,24326,0.0500654206070201,0.00383788518084747,0.0425431656525591,0.0575876755614812,9.1521179586669e-39
NMR metabolomics,X23408.Triglycerides in VLDL,CTSF,Cathepsin F,29566,0.036786219839597,0.00282731426966217,0.0312446838710592,0.0423277558081349,1.35252012216607e-38
NMR metabolomics,X23408.Triglycerides in VLDL,MTUS1,Microtubule-associated tumor suppressor 1,24445,0.0516111023558819,0.00396715007580831,0.0438354882072976,0.0593867165044662,1.44931035204518e-38
NMR metabolomics,X23408.Triglycerides in VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,24764,0.0376647343682035,0.00289563931309409,0.0319892813145391,0.0433401874218679,1.4860607369569e-38
NMR metabolomics,X23408.Triglycerides in VLDL,SMS,Spermine synthase,24101,0.0587978484505487,0.0045203786391477,0.0499379063178192,0.0676577905832782,1.50019640543502e-38
NMR metabolomics,X23408.Triglycerides in VLDL,NEK7,Serine/threonine-protein kinase Nek7,24445,0.0688422294173503,0.00529815152210116,0.058457852434032,0.0792266064006686,1.78371714229489e-38
NMR metabolomics,X23408.Triglycerides in VLDL,RANBP1,Ran-specific GTPase-activating protein,24240,0.0481260500777116,0.00370432950307363,0.0408655642516873,0.0553865359037359,1.83024255770231e-38
NMR metabolomics,X23408.Triglycerides in VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0222446217016017,0.00171342328556754,0.0188863120618893,0.0256029313413141,1.95972508846903e-38
NMR metabolomics,X23408.Triglycerides in VLDL,TGFA,Protransforming growth factor alpha,29434,0.0427741860294884,0.00329505152292846,0.0363158850445486,0.0492324870144282,1.9911637655943e-38
NMR metabolomics,X23408.Triglycerides in VLDL,IFNAR1,Interferon alpha/beta receptor 1,24805,0.0234977350561998,0.00181025835767782,0.0199496286751513,0.0270458414372483,2.1109804166002e-38
NMR metabolomics,X23408.Triglycerides in VLDL,SBSN,Suprabasin,24905,-0.0315939381368986,0.00243601323499315,-0.0363685240774852,-0.026819352196312,2.42525492359549e-38
NMR metabolomics,X23408.Triglycerides in VLDL,CBS,Cystathionine beta-synthase,24240,0.0469654229014381,0.00362127636697249,0.039867721222172,0.0540631245807042,2.45145256505428e-38
NMR metabolomics,X23408.Triglycerides in VLDL,CBLIF,Cobalamin binding intrinsic factor,29433,0.0679052591357062,0.0052492908526069,0.0576166490645967,0.0781938692068158,3.57984077551115e-38
NMR metabolomics,X23408.Triglycerides in VLDL,FABP2,"Fatty acid-binding protein, intestinal",29478,-0.0715382361172744,0.00553059187309963,-0.0823781961885496,-0.0606982760459991,3.62874721550057e-38
NMR metabolomics,X23408.Triglycerides in VLDL,CD1C,T-cell surface glycoprotein CD1c,29566,0.0221392420476579,0.00171364780033285,0.0187804923590055,0.0254979917363102,4.43892239477438e-38
NMR metabolomics,X23408.Triglycerides in VLDL,NCF2,Neutrophil cytosol factor 2,29395,0.0756251173316564,0.00585362503662772,0.0641520122598661,0.0870982224034467,4.4450738932045e-38
NMR metabolomics,X23408.Triglycerides in VLDL,HLA_E,,29434,0.0264091484625256,0.0020461516169431,0.0223986912933171,0.030419605631734,5.2306629556923e-38
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,0.0322448598655713,0.00250762393582961,0.0273299169513453,0.0371598027797974,9.72755736209172e-38
NMR metabolomics,X23408.Triglycerides in VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,24788,0.0391744052384273,0.00304933537682757,0.0331977078998452,0.0451511025770093,1.18147500817287e-37
NMR metabolomics,X23408.Triglycerides in VLDL,STX7,Syntaxin-7,24229,0.0450765731930792,0.00350964106754262,0.0381976767006957,0.0519554696854627,1.2392646338221e-37
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL4,Angiopoietin-related protein 4,29536,-0.0408824696464702,0.00318513885919669,-0.0471253418104957,-0.0346395974824447,1.30988310370005e-37
NMR metabolomics,X23408.Triglycerides in VLDL,CCL20,C-C motif chemokine 20,29786,0.0793286087126486,0.00618527429388672,0.0672054710966306,0.0914517463286666,1.48606497931178e-37
NMR metabolomics,X23408.Triglycerides in VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,0.0494557454898258,0.00385815720948078,0.0418937573592435,0.0570177336204081,1.62932237513397e-37
NMR metabolomics,X23408.Triglycerides in VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,0.037336729712474,0.00291331078726989,0.031626640569425,0.043046818855523,1.68993314514507e-37
NMR metabolomics,X23408.Triglycerides in VLDL,APRT,Adenine phosphoribosyltransferase,29192,0.0430740735847839,0.00336691861809064,0.0364749130933263,0.0496732340762416,2.25201376607896e-37
NMR metabolomics,X23408.Triglycerides in VLDL,KLK7,Kallikrein-7,23801,0.0353846461207596,0.00276567699882204,0.0299639192030684,0.0408053730384508,2.34601334616252e-37
NMR metabolomics,X23408.Triglycerides in VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,0.0445707776434582,0.00348497182111119,0.0377402328740803,0.0514013224128361,2.35802983288969e-37
NMR metabolomics,X23408.Triglycerides in VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,0.0338797997280698,0.00264978489725445,0.0286862213294511,0.0390733781266886,2.47268951862538e-37
NMR metabolomics,X23408.Triglycerides in VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,0.0381625843969177,0.00298483144065657,0.0323123147732308,0.0440128540206046,2.60855541934527e-37
NMR metabolomics,X23408.Triglycerides in VLDL,COLEC12,Collectin-12,29454,0.0237322918828024,0.00185929302873034,0.0200880775464909,0.0273765062191138,3.26337255496366e-37
NMR metabolomics,X23408.Triglycerides in VLDL,SPRR3,Small proline-rich protein 3,24845,0.061257048640684,0.00479962025654833,0.0518497929378493,0.0706643043435187,3.45825561833475e-37
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,0.0427980340919014,0.00335466469571672,0.0362228912882967,0.0493731768955062,3.69106534316094e-37
NMR metabolomics,X23408.Triglycerides in VLDL,PIGR,Polymeric immunoglobulin receptor,29115,0.032517951087377,0.00255101450220556,0.0275179626630541,0.0375179395116999,4.06898748791683e-37
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,0.0349491897153951,0.00274396238807733,0.0295710234347635,0.0403273559960266,4.63661524089672e-37
NMR metabolomics,X23408.Triglycerides in VLDL,PPL,Periplakin,24229,0.0293221049146128,0.00231145140097314,0.0247916601687055,0.0338525496605202,9.30699767214221e-37
NMR metabolomics,X23408.Triglycerides in VLDL,AMIGO2,Amphoterin-induced protein 2,29349,0.0204614499124162,0.00161752881855933,0.01729109342804,0.0236318063967925,1.39742259288123e-36
NMR metabolomics,X23408.Triglycerides in VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.0452105065826337,0.00357393624178717,0.0382055915487308,0.0522154216165365,1.39907946676556e-36
NMR metabolomics,X23408.Triglycerides in VLDL,VCAM1,Vascular cell adhesion protein 1,29545,-0.0243421812008697,0.00192609743329431,-0.0281173321701266,-0.0205670302316129,1.61880394063244e-36
NMR metabolomics,X23408.Triglycerides in VLDL,STX6,Syntaxin-6,28797,0.0599759112019149,0.00474646172901688,0.0506728462130419,0.069278976190788,1.67312260335995e-36
NMR metabolomics,X23408.Triglycerides in VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,0.0590818842706186,0.00467735433945931,0.0499142697652784,0.0682494987759589,1.83310005290417e-36
NMR metabolomics,X23408.Triglycerides in VLDL,FSHB,Follitropin subunit beta,24240,0.0577907029970014,0.00457555731097816,0.0488226106674842,0.0667587953265186,1.87270167017412e-36
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,0.0301789493153604,0.00239037608506381,0.0254938121886353,0.0348640864420854,1.90635866286305e-36
NMR metabolomics,X23408.Triglycerides in VLDL,PER3,Period circadian protein homolog 3,24229,0.107043696707352,0.00848103001281704,0.0904208778822303,0.123666515532473,2.09200220298686e-36
NMR metabolomics,X23408.Triglycerides in VLDL,BPIFA2,BPI fold-containing family A member 2,23405,-0.0988741280116211,0.00783634375244482,-0.114233361766413,-0.0835148942568293,2.22532531118793e-36
NMR metabolomics,X23408.Triglycerides in VLDL,NAA10,N-alpha-acetyltransferase 10,24111,0.0453771238905712,0.00359817363664495,0.0383247035627471,0.0524295442183953,2.38795842210703e-36
NMR metabolomics,X23408.Triglycerides in VLDL,CHCHD6,MICOS complex subunit MIC25,24793,0.0258151843720166,0.00204898509256331,0.0217991735905925,0.0298311951534407,2.76278039486782e-36
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL1,Fc receptor-like protein 1,29478,0.0401996500282135,0.0032020567042144,0.0339236188879533,0.0464756811684737,4.65596805654857e-36
NMR metabolomics,X23408.Triglycerides in VLDL,LAMA4,Laminin subunit alpha-4,29581,0.0295790328784496,0.00235672099118654,0.024959859735724,0.0341982060211752,4.85527263967372e-36
NMR metabolomics,X23408.Triglycerides in VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.0475392803826283,0.00380167289684256,0.0400880015048169,0.0549905592604397,9.06462568430653e-36
NMR metabolomics,X23408.Triglycerides in VLDL,ROBO2,Roundabout homolog 2,29694,0.0203222219977633,0.00163283261329716,0.0171218700757009,0.0235225739198257,1.80323035291242e-35
NMR metabolomics,X23408.Triglycerides in VLDL,VGF,Neurosecretory protein VGF,24867,0.0266801065654884,0.00214444455529891,0.0224769952371025,0.0308832178938742,1.98367143563047e-35
NMR metabolomics,X23408.Triglycerides in VLDL,PMM2,Phosphomannomutase 2,24111,0.0527928953504479,0.00424832040545539,0.0444661873557553,0.0611196033451405,2.40057169885159e-35
NMR metabolomics,X23408.Triglycerides in VLDL,EDF1,Endothelial differentiation-related factor 1,24867,0.0596680431577019,0.00480693226149252,0.0502464559251766,0.0690896303902272,2.8298911206078e-35
NMR metabolomics,X23408.Triglycerides in VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,0.0296670760134212,0.00239447839032237,0.0249738983683894,0.034360253658453,3.6246491080558e-35
NMR metabolomics,X23408.Triglycerides in VLDL,CSNK1D,Casein kinase I isoform delta,24229,0.0559016428155246,0.00451539668051264,0.0470514653217199,0.0647518203093294,4.270772328649e-35
NMR metabolomics,X23408.Triglycerides in VLDL,FRZB,Secreted frizzled-related protein 3,29123,0.0224594124365803,0.00181619728339855,0.0188996657611192,0.0260191591120415,4.87882305713075e-35
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTSL4,ADAMTS-like protein 4,24240,0.0210118633659348,0.00169877599955694,0.0176822624068032,0.0243414643250665,4.91756169008679e-35
NMR metabolomics,X23408.Triglycerides in VLDL,LTA,Lymphotoxin-alpha,29434,0.0349284129032871,0.00282843742845084,0.0293846755435234,0.0404721502630507,6.02008212457857e-35
NMR metabolomics,X23408.Triglycerides in VLDL,ELOB,Elongin-B,24111,0.0345420466673834,0.00280129700543804,0.0290515045367248,0.0400325887980419,7.8821713867694e-35
NMR metabolomics,X23408.Triglycerides in VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,-0.0379390982422644,0.00308079984247515,-0.0439774659335157,-0.0319007305510131,9.18762475440437e-35
NMR metabolomics,X23408.Triglycerides in VLDL,TXN,Thioredoxin,24647,0.0380966257074892,0.00309444699989203,0.0320315095877008,0.0441617418272775,9.96459260160633e-35
NMR metabolomics,X23408.Triglycerides in VLDL,C5,Complement C5,24966,0.0131765348608521,0.0010706981377869,0.0110779665107898,0.0152751032109145,1.05394867053247e-34
NMR metabolomics,X23408.Triglycerides in VLDL,THBD,Thrombomodulin,29478,0.0248563140392775,0.00202031716046572,0.0208964924047647,0.0288161356737903,1.05971046361254e-34
NMR metabolomics,X23408.Triglycerides in VLDL,APOA1,Apolipoprotein A-I,24966,-0.0238842245656841,0.00194091462342049,-0.0276884172275882,-0.0200800319037799,1.06483420658203e-34
NMR metabolomics,X23408.Triglycerides in VLDL,GAST,Gastrin,24845,0.113172947986646,0.00920301596177676,0.0951350367015632,0.131210859271728,1.18036534548775e-34
NMR metabolomics,X23408.Triglycerides in VLDL,NTRK3,NT-3 growth factor receptor,29694,-0.0187512091655789,0.00152777185381156,-0.0217456419990496,-0.0157567763321082,1.52337708106102e-34
NMR metabolomics,X23408.Triglycerides in VLDL,CIT,Citron Rho-interacting kinase,24195,0.0393001704768609,0.00320400686834978,0.0330203170148954,0.0455800239388265,1.74751086922556e-34
NMR metabolomics,X23408.Triglycerides in VLDL,DAPK2,Death-associated protein kinase 2,24229,0.0465159265222033,0.00379250036112598,0.0390826258143964,0.0539492272300102,1.76210383698255e-34
NMR metabolomics,X23408.Triglycerides in VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,24805,0.0984671669684751,0.00803339326950384,0.0827217161602476,0.114212617776703,1.93340848369017e-34
NMR metabolomics,X23408.Triglycerides in VLDL,AGR2,Anterior gradient protein 2 homolog,28553,0.0869577195741812,0.00711822767962707,0.0730059933221122,0.10090944582625,3.10168861886669e-34
NMR metabolomics,X23408.Triglycerides in VLDL,PSME2,Proteasome activator complex subunit 2,29081,0.0311662594973268,0.00255425261516904,0.0261599243715954,0.0361725946230581,3.6897153359178e-34
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB103A_DEFB103B,Beta-defensin 103,24109,0.0355538529331017,0.00291938059016491,0.0298318669763785,0.0412758388898249,5.09110180728864e-34
NMR metabolomics,X23408.Triglycerides in VLDL,SV2A,Synaptic vesicle glycoprotein 2A,24195,0.0530948325407822,0.00437850567477048,0.044512961418232,0.0616767036633323,9.60995601849893e-34
NMR metabolomics,X23408.Triglycerides in VLDL,BSG,Basigin,29760,0.0175303464906987,0.00144848460125487,0.0146913166722392,0.0203693763091583,1.22849069841363e-33
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINI2,Serpin I2,24805,0.0485586250964598,0.00401156354636247,0.0406959605455893,0.0564212896473302,1.2415577956414e-33
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPTL1,Angiopoietin-related protein 1,29030,0.0248921293726332,0.00205833108271273,0.0208578004505162,0.0289264582947502,1.3794528205677e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CTSC,Dipeptidyl peptidase 1,29446,0.0369645797372366,0.00305889137669573,0.0309691526389129,0.0429600068355602,1.53519028252455e-33
NMR metabolomics,X23408.Triglycerides in VLDL,MANSC1,MANSC domain-containing protein 1,29566,-0.0234904054789982,0.00194506605759609,-0.0273027349518866,-0.0196780760061099,1.67751688302286e-33
NMR metabolomics,X23408.Triglycerides in VLDL,ECI2,Enoyl-CoA delta isomerase 2,24111,0.0527262677231839,0.00436475772138873,0.044171342589262,0.0612811928571058,1.68385825166631e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CRYM,Ketimine reductase mu-crystallin,24101,0.0649148921878058,0.00539431329903443,0.0543420381216983,0.0754877462539133,2.9353092018811e-33
NMR metabolomics,X23408.Triglycerides in VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,0.0316505238342975,0.00263289088154518,0.0264900577064689,0.036810989962126,3.41765613896943e-33
NMR metabolomics,X23408.Triglycerides in VLDL,SMARCA2,Probable global transcription activator SNF2L2,28774,0.0621023593192967,0.00516997769964327,0.0519692030279959,0.0722355156105975,3.68481669866059e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CHI3L1,Chitinase-3-like protein 1,28935,0.0666345333395818,0.00555395566013567,0.0557487802457159,0.0775202864334477,4.37938234824671e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CA4,Carbonic anhydrase 4,29820,-0.0200729004972147,0.00167723807318932,-0.0233602871206658,-0.0167855138737637,6.2329973633322e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CA2,Carbonic anhydrase 2,29368,0.0579557663616069,0.00484279364236977,0.0484638908225622,0.0674476419006516,6.28015105572378e-33
NMR metabolomics,X23408.Triglycerides in VLDL,C7,Complement component C7,24374,-0.0274541779480698,0.00229589666082393,-0.0319541354032847,-0.0229542204928549,7.29440070676094e-33
NMR metabolomics,X23408.Triglycerides in VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,24681,0.0510633871119963,0.00427319219186559,0.0426879304159398,0.0594388438080529,8.02802504730681e-33
NMR metabolomics,X23408.Triglycerides in VLDL,TREML1,Trem-like transcript 1 protein,24951,0.044511092375951,0.00372793289936252,0.0372043438932005,0.0518178408587016,9.00805742612156e-33
NMR metabolomics,X23408.Triglycerides in VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,0.0411652587152736,0.00345523937487411,0.0343929895405203,0.0479375278900268,1.19124207788505e-32
NMR metabolomics,X23408.Triglycerides in VLDL,CD101,Immunoglobulin superfamily member 2,24805,0.0360150773139237,0.00302700401362737,0.0300821494472141,0.0419480051806334,1.48799223118823e-32
NMR metabolomics,X23408.Triglycerides in VLDL,FOLR2,Folate receptor beta,29694,-0.0245484779350417,0.00206600084468228,-0.028597839590619,-0.0204991162794645,1.7371330605383e-32
NMR metabolomics,X23408.Triglycerides in VLDL,CASP9,Caspase-9,24229,0.0528679970314756,0.00445237629783404,0.0441413394877209,0.0615946545752303,1.98519816092597e-32
NMR metabolomics,X23408.Triglycerides in VLDL,RNASET2,Ribonuclease T2,29697,0.0221888714410005,0.0018734821025052,0.0185168465200903,0.0258608963619107,2.744577727669e-32
NMR metabolomics,X23408.Triglycerides in VLDL,GRSF1,G-rich sequence factor 1,23862,0.0675491833502707,0.00570946280587108,0.0563586362507634,0.078739730449778,3.31783748655031e-32
NMR metabolomics,X23408.Triglycerides in VLDL,SNX5,Sorting nexin-5,24240,0.024945175436817,0.00211154676930887,0.0208065437689716,0.0290838071046624,4.06331535814041e-32
NMR metabolomics,X23408.Triglycerides in VLDL,KIT,Mast/stem cell growth factor receptor Kit,29545,-0.02444051090914,0.00207345096934783,-0.0285044748090617,-0.0203765470092182,5.35040676720886e-32
NMR metabolomics,X23408.Triglycerides in VLDL,PPME1,Protein phosphatase methylesterase 1,29349,0.0496475856178393,0.00421385503702766,0.041388429745265,0.0579067414904135,5.70719932100289e-32
NMR metabolomics,X23408.Triglycerides in VLDL,LACRT,Extracellular glycoprotein lacritin,24732,0.04144637461315,0.00351944035267015,0.0345482715219165,0.0483444777043835,6.28656449221236e-32
NMR metabolomics,X23408.Triglycerides in VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.0762195225045492,0.00647248428288619,0.0635334533100923,0.0889055916990061,6.34748153542527e-32
NMR metabolomics,X23408.Triglycerides in VLDL,COL15A1,Collagen alpha-1(XV) chain,24938,0.0220299684983654,0.00187145056079439,0.0183619253992084,0.0256980115975224,6.64268500353702e-32
NMR metabolomics,X23408.Triglycerides in VLDL,PALM,Paralemmin-1,24657,0.0248488014331176,0.00211304158687061,0.0207072399228512,0.028990362943384,7.65673565600764e-32
NMR metabolomics,X23408.Triglycerides in VLDL,GIMAP8,GTPase IMAP family member 8,24016,0.0423674069151821,0.00360392183610199,0.0353037201164222,0.049431093713942,8.05029838051757e-32
NMR metabolomics,X23408.Triglycerides in VLDL,LY75,Lymphocyte antigen 75,29434,0.0322238480103963,0.00274192968774154,0.0268496658224229,0.0375980301983697,8.10102025465624e-32
NMR metabolomics,X23408.Triglycerides in VLDL,CPQ,Carboxypeptidase Q,24920,0.0306433438439401,0.00260708397279115,0.0255334592572695,0.0357532284306108,8.18630053875558e-32
NMR metabolomics,X23408.Triglycerides in VLDL,COL6A3,Collagen alpha-3(VI) chain,29820,0.0288821478500546,0.00246823206483378,0.0240444130029804,0.0337198826971288,1.4671803281847e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CTSB,Cathepsin B,29480,-0.043270569141599,0.00370129102276841,-0.0505250995462251,-0.0360160387369729,1.66994767751122e-31
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS22,Brain-specific serine protease 4,24229,0.0289291248399688,0.00247426359907673,0.0240795681857784,0.0337786814941592,1.70178153415548e-31
NMR metabolomics,X23408.Triglycerides in VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,0.0564971316094162,0.0048328986985446,0.0470246501602688,0.0659696130585636,1.73241585552405e-31
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.0353720509968944,0.00302700822226603,0.0294391148812529,0.0413049871125358,1.82876129953852e-31
NMR metabolomics,X23408.Triglycerides in VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,0.0409106732886314,0.00350581749343694,0.034039271001495,0.0477820755757678,2.21783682494728e-31
NMR metabolomics,X23408.Triglycerides in VLDL,S100A12,Protein S100-A12,29023,0.0616460679763243,0.00529049169630654,0.0512767042515635,0.0720154317010852,2.62477026364733e-31
NMR metabolomics,X23408.Triglycerides in VLDL,CLSTN3,Calsyntenin-3,24845,0.0251405823142641,0.00215764088933527,0.020911606171167,0.0293695584573612,2.70759633283297e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.0546336100025184,0.00471203430288233,0.045398022768869,0.0638691972361678,5.12737492230241e-31
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,0.0532846385957054,0.00460984525369269,0.0442493418984678,0.0623199352929431,7.76399056605106e-31
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS7_LGALS7B,Galectin-7,29320,0.034134202885286,0.0029595996491867,0.0283333875728801,0.039935018197692,1.04330126694887e-30
NMR metabolomics,X23408.Triglycerides in VLDL,CSDE1,Cold shock domain-containing protein E1,24111,0.0964920035425134,0.0083694171072717,0.0800879460122609,0.112896061072766,1.1326707795098e-30
NMR metabolomics,X23408.Triglycerides in VLDL,TEK,Angiopoietin-1 receptor,29566,0.0177651520314698,0.00154135050436202,0.0147441050429203,0.0207861990200194,1.13874035152623e-30
NMR metabolomics,X23408.Triglycerides in VLDL,ROBO1,Roundabout homolog 1,29497,0.0195889416049415,0.00170012262885184,0.0162567012523919,0.0229211819574911,1.18794694750589e-30
NMR metabolomics,X23408.Triglycerides in VLDL,DGKZ,Diacylglycerol kinase zeta,28931,0.0288393070903684,0.00250602765685345,0.0239274928829356,0.0337511212978011,1.40212877394655e-30
NMR metabolomics,X23408.Triglycerides in VLDL,SPOCK1,Testican-1,29218,0.0208955346109811,0.0018165523340529,0.0173350920362374,0.0244559771857248,1.48528213098401e-30
NMR metabolomics,X23408.Triglycerides in VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,0.0354804886173191,0.00308496283240803,0.0294339614657994,0.0415270157688388,1.56339572582243e-30
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.0298343098194418,0.00259550298024555,0.0247471239781605,0.034921495660723,1.67722291389451e-30
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,0.0274374945139767,0.00239080847673449,0.0227515098995771,0.0321234791283763,2.0154497298523e-30
NMR metabolomics,X23408.Triglycerides in VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,0.0282472789320068,0.00246224103845617,0.0234212864966327,0.0330732713673809,2.11348496917993e-30
NMR metabolomics,X23408.Triglycerides in VLDL,REG4,Regenerating islet-derived protein 4,29497,0.0402289355114886,0.00350740890455972,0.0333544140585516,0.0471034569644257,2.17295724695703e-30
NMR metabolomics,X23408.Triglycerides in VLDL,CD80,T-lymphocyte activation antigen CD80,24922,0.0276167223316052,0.00241821829158984,0.0228770144800891,0.0323564301831213,3.93622109927651e-30
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,0.0348003203910657,0.00305955179847813,0.0288035988660485,0.0407970419160828,6.48340608939238e-30
NMR metabolomics,X23408.Triglycerides in VLDL,C1QA,Complement C1q subcomponent subunit A,29646,-0.0182144838557206,0.00160200217653307,-0.0213544081217254,-0.0150745595897157,6.81756597174841e-30
NMR metabolomics,X23408.Triglycerides in VLDL,SEL1L,Protein sel-1 homolog 1,24240,0.0256996764559448,0.0022601621569125,0.0212697586283963,0.0301295942834933,6.96581299457313e-30
NMR metabolomics,X23408.Triglycerides in VLDL,C2orf69,UPF0565 protein C2orf69,24195,0.0479041581075412,0.00421476395404716,0.0396432207576087,0.0561650954574736,7.37016554236173e-30
NMR metabolomics,X23408.Triglycerides in VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,0.0382926016830626,0.00338479765132933,0.0316583982864571,0.0449268050796681,1.30568760817398e-29
NMR metabolomics,X23408.Triglycerides in VLDL,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0447949892767112,0.0039631434582816,-0.0525627504549432,-0.0370272280984793,1.46109521967772e-29
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA12,Serpin A12,28628,0.0892372989766187,0.00789495447056265,0.0737631882143159,0.104711409738921,1.46378093831197e-29
NMR metabolomics,X23408.Triglycerides in VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,24240,0.0246513076292976,0.00218309233965051,0.0203724466435826,0.0289301686150126,1.70480658786727e-29
NMR metabolomics,X23408.Triglycerides in VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,28774,0.0508762293889242,0.00450742507456723,0.0420416762427724,0.059710782535076,1.75100114617269e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CDH5,Cadherin-5,29820,-0.0241482271112237,0.00214295099867909,-0.0283484110686348,-0.0199480431538127,2.14865343749008e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CAT,Catalase,24587,0.0425183604906033,0.00378293267694183,0.0351038124437973,0.0499329085374093,3.07372168592891e-29
NMR metabolomics,X23408.Triglycerides in VLDL,ASGR2,Asialoglycoprotein receptor 2,24951,0.0206205538032046,0.00184283026732893,0.0170086064792398,0.0242325011271693,5.37520114463988e-29
NMR metabolomics,X23408.Triglycerides in VLDL,BRDT,Bromodomain testis-specific protein,24111,0.0291313249504456,0.00260589204413372,0.0240237765439435,0.0342388733569477,6.08647173939442e-29
NMR metabolomics,X23408.Triglycerides in VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,0.0300830782486409,0.00269344870911319,0.024803918778779,0.0353622377185027,6.79603909914651e-29
NMR metabolomics,X23408.Triglycerides in VLDL,SCT,Secretin,24195,0.0370176070199723,0.0033184570199072,0.0305134312609541,0.0435217827789904,7.95458996262927e-29
NMR metabolomics,X23408.Triglycerides in VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,0.0427776935053288,0.00383595251671076,0.0352592265725757,0.0502961604380819,8.22041252143419e-29
NMR metabolomics,X23408.Triglycerides in VLDL,CST5,Cystatin-D,28890,0.0436818673535761,0.00392232148419667,0.0359941172445506,0.0513696174626016,9.51134841090549e-29
NMR metabolomics,X23408.Triglycerides in VLDL,SFTPD,Pulmonary surfactant-associated protein D,29478,0.0524480786153087,0.00471714677702203,0.0432024709323455,0.0616936862982719,1.1615776721074e-28
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.0371590018272284,0.00334688545360286,0.0305991063381668,0.0437188973162901,1.39341002110051e-28
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX1,Peroxiredoxin-1,28669,-0.0704572865459536,0.00637045319503409,-0.0829433748082204,-0.0579711982836868,2.23805887812864e-28
NMR metabolomics,X23408.Triglycerides in VLDL,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.0256357245815085,0.00232087510336307,0.0210868093789169,0.0301846397841002,2.61055007574166e-28
NMR metabolomics,X23408.Triglycerides in VLDL,GRN,Progranulin,29313,0.0192299415350478,0.00174143856273625,0.0158167219520848,0.0226431611180109,2.70826546386892e-28
NMR metabolomics,X23408.Triglycerides in VLDL,NRP2,Neuropilin-2,29443,-0.022301833324734,0.00202293892180411,-0.0262667936114701,-0.018336873037998,3.30723537402202e-28
NMR metabolomics,X23408.Triglycerides in VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,0.0267323014593194,0.00242525767972287,0.0219787964070625,0.0314858065115762,3.38314023292123e-28
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,29394,0.023340011815496,0.00211941676191491,0.0191859549621427,0.0274940686688492,3.77763830204221e-28
NMR metabolomics,X23408.Triglycerides in VLDL,RGMB,RGM domain family member B,29694,0.0209237502201392,0.00190041397765033,0.0171989388239445,0.0246485616163339,3.87288473478553e-28
NMR metabolomics,X23408.Triglycerides in VLDL,CDH1,Cadherin-1,28477,0.0310749875314506,0.00283169859044921,0.0255248582941701,0.036625116768731,5.80082176731196e-28
NMR metabolomics,X23408.Triglycerides in VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.0445675669296116,0.00406163770279424,0.0366067570321349,0.0525283768270883,5.84265819511259e-28
NMR metabolomics,X23408.Triglycerides in VLDL,LPA,Apolipoprotein(a),24484,-0.138415897099783,0.0126249202525101,-0.163160740794702,-0.113671053404863,6.63271072007433e-28
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA3,Protein disulfide-isomerase A3,24381,0.0194126005215906,0.00177274019348021,0.0159380297423693,0.0228871713008118,7.66376795875894e-28
NMR metabolomics,X23408.Triglycerides in VLDL,LIPF,Gastric triacylglycerol lipase,24240,0.0472549952843945,0.00432162818756449,0.0387846040367681,0.0557253865320209,9.15162421887803e-28
NMR metabolomics,X23408.Triglycerides in VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.0511553650501641,0.00468268689754673,0.0419772987309725,0.0603334313693557,1.02398066839734e-27
NMR metabolomics,X23408.Triglycerides in VLDL,CFC1,Cryptic protein,28797,0.0362461302770473,0.00332286664493279,0.029733311652979,0.0427589489011155,1.19450700421685e-27
NMR metabolomics,X23408.Triglycerides in VLDL,VIT,Vitrin,24922,0.0289742912113581,0.00266285552565292,0.0237550943810784,0.0341934880416379,1.63923135973072e-27
NMR metabolomics,X23408.Triglycerides in VLDL,AHCY,Adenosylhomocysteinase,29478,0.0518148774704928,0.00476352674284309,0.0424783650545203,0.0611513898864652,1.66591303427726e-27
NMR metabolomics,X23408.Triglycerides in VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,24240,0.0393964888593985,0.00362541574031995,0.0322906740083714,0.0465023037104256,1.92076176709609e-27
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,0.0247065327416361,0.00227418990010856,0.0202491205374233,0.0291639449458489,1.92930659280361e-27
NMR metabolomics,X23408.Triglycerides in VLDL,KLK4,Kallikrein-4,29725,-0.0481305502221632,0.00444083720560461,-0.0568345911451482,-0.0394265092991781,2.55330382915107e-27
NMR metabolomics,X23408.Triglycerides in VLDL,CD276,CD276 antigen,29454,-0.0274126830716901,0.00253839050043734,-0.0323879284525473,-0.0224374376908329,3.9021390634974e-27
NMR metabolomics,X23408.Triglycerides in VLDL,CAPG,Macrophage-capping protein,29174,0.0444125599423367,0.0041151392047389,0.0363468871010485,0.052478232783625,4.2035166253642e-27
NMR metabolomics,X23408.Triglycerides in VLDL,CD28,T-cell-specific surface glycoprotein CD28,28797,0.0277928361107335,0.00257812634957904,0.0227397084655586,0.0328459637559084,4.80669507333183e-27
NMR metabolomics,X23408.Triglycerides in VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,0.0340200403744131,0.0031753454925742,0.0277963632089677,0.0402437175398585,1.00717665154015e-26
NMR metabolomics,X23408.Triglycerides in VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0299430703741328,0.00279640454467638,0.0244621174665671,0.0354240232816985,1.04889872087785e-26
NMR metabolomics,X23408.Triglycerides in VLDL,IL17D,Interleukin-17D,28931,0.0258032555576813,0.00241197401180403,0.0210757864945454,0.0305307246208172,1.16684676325054e-26
NMR metabolomics,X23408.Triglycerides in VLDL,CRH,Corticoliberin,28751,0.0656116383007087,0.00613399896748709,0.053589000324434,0.0776342762769834,1.18785308777154e-26
NMR metabolomics,X23408.Triglycerides in VLDL,ZBP1,Z-DNA-binding protein 1,24229,0.0307062262979876,0.00287848293866603,0.0250643997382022,0.0363480528577731,1.65435722397041e-26
NMR metabolomics,X23408.Triglycerides in VLDL,GAS2,Growth arrest-specific protein 2,24445,0.0398031773855944,0.00373827857698878,0.0324761513746964,0.0471302033964924,2.04759065839433e-26
NMR metabolomics,X23408.Triglycerides in VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.0401829260189857,0.00377499714312371,0.0327839316184632,0.0475819204195082,2.10825883650314e-26
NMR metabolomics,X23408.Triglycerides in VLDL,IGHMBP2,DNA-binding protein SMUBP-2,24111,0.0418872460487652,0.0039407626039715,0.0341633513449811,0.0496111407525493,2.49253770142371e-26
NMR metabolomics,X23408.Triglycerides in VLDL,ECE1,Endothelin-converting enzyme 1,28774,0.0264044391916329,0.00249177855013321,0.0215205532333718,0.031288325149894,3.45289685853317e-26
NMR metabolomics,X23408.Triglycerides in VLDL,CD93,Complement component C1q receptor,28353,-0.0235463887774522,0.00222221624931905,-0.0279019326261175,-0.0191908449287869,3.48521153678455e-26
NMR metabolomics,X23408.Triglycerides in VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,0.0282033202240093,0.00267116101017357,0.0229678446440691,0.0334387958039495,5.17774056421093e-26
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,-0.0183275798263516,0.00173824607590834,-0.0217345421351319,-0.0149206175175712,6.03352115919011e-26
NMR metabolomics,X23408.Triglycerides in VLDL,AGT,Angiotensinogen,24951,0.0171836494529732,0.00163314310221765,0.0139826889726266,0.0203846099333198,7.76344107102761e-26
NMR metabolomics,X23408.Triglycerides in VLDL,TAFA5,Chemokine-like protein TAFA-5,29349,0.0268610245720637,0.00255562101337551,0.0218520073858477,0.0318700417582797,8.5831186277915e-26
NMR metabolomics,X23408.Triglycerides in VLDL,CD300A,CMRF35-like molecule 8,24381,0.0222665888495669,0.00212052479562396,0.0181103602501439,0.0264228174489898,9.7511941934135e-26
NMR metabolomics,X23408.Triglycerides in VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,0.0184182106241715,0.00175725396882019,0.0149739928452839,0.0218624284030591,1.17021414386042e-25
NMR metabolomics,X23408.Triglycerides in VLDL,RABEPK,Rab9 effector protein with kelch motifs,28797,0.0435302028256477,0.00416356046628805,0.0353696243117231,0.0516907813395723,1.54380043423956e-25
NMR metabolomics,X23408.Triglycerides in VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,0.0399017420727578,0.00382008967084487,0.0324143663179018,0.0473891178276137,1.70792405397044e-25
NMR metabolomics,X23408.Triglycerides in VLDL,VWC2,Brorin,29114,0.0293898594600986,0.00281552638274976,0.0238714277499091,0.0349082911702882,1.83468347638217e-25
NMR metabolomics,X23408.Triglycerides in VLDL,S100A14,Protein S100-A14,24867,0.0389927935023393,0.00374052567449458,0.0316613631803299,0.0463242238243487,2.16426540842352e-25
NMR metabolomics,X23408.Triglycerides in VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,-0.0176016566844402,0.00169016755518386,-0.0209143850926006,-0.0142889282762798,2.36432148218044e-25
NMR metabolomics,X23408.Triglycerides in VLDL,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.0252093774778063,0.00242110821283039,-0.0299547495749539,-0.0204640053806587,2.4152459241402e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CRYGD,Gamma-crystallin D,24845,0.0712489444716436,0.00684433828468005,0.0578340414336707,0.0846638475096165,2.5193446960749e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CILP,Cartilage intermediate layer protein 1,24938,0.040057332881831,0.00385227425405898,0.0325068753438754,0.0476077904197866,2.84137686555741e-25
NMR metabolomics,X23408.Triglycerides in VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0289450826042692,0.00278905924571093,0.0234785264826758,0.0344116387258626,3.45447818993362e-25
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,0.0358795184119233,0.00346554541973992,0.029087049389233,0.0426719874346135,4.55224759041701e-25
NMR metabolomics,X23408.Triglycerides in VLDL,EGFR,Epidermal growth factor receptor,29820,0.0119749136968398,0.00115705195142275,0.00970709187205115,0.0142427355216284,4.63873180288365e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CX3CL1,Fractalkine,29218,-0.0246724118737948,0.00238493164997858,-0.0293468779077528,-0.0199979458398367,4.86481438407432e-25
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,29349,0.0153052171160339,0.00147950632707599,0.012405384714965,0.0182050495171028,4.87834557882968e-25
NMR metabolomics,X23408.Triglycerides in VLDL,DKK3,Dickkopf-related protein 3,29820,-0.0214895884266929,0.00207777162394843,-0.0255620208096318,-0.017417156043754,4.98347944452659e-25
NMR metabolomics,X23408.Triglycerides in VLDL,SLC16A1,Monocarboxylate transporter 1,28774,0.0419913165538543,0.00408103750218055,0.0339924830495804,0.0499901500581282,8.68779385205454e-25
NMR metabolomics,X23408.Triglycerides in VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,0.02698801248912,0.00262325529146106,0.0218464321178564,0.0321295928603837,8.95424967383412e-25
NMR metabolomics,X23408.Triglycerides in VLDL,CD248,Endosialin,24938,-0.0292657472916153,0.00284580795352476,-0.0348435308805238,-0.0236879637027068,9.34302602463408e-25
NMR metabolomics,X23408.Triglycerides in VLDL,SCN4B,Sodium channel subunit beta-4,24240,0.0310709724679282,0.00302238749011633,0.0251470929873002,0.0369948519485562,9.72240793502054e-25
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB6,Integrin beta-6,28931,0.0220218563728007,0.00214736493837507,0.0178130210935856,0.0262306916520159,1.2347286415888e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CFHR5,Complement factor H-related protein 5,24623,0.0303018705013501,0.00295605927402205,0.0245079943242669,0.0360957466784334,1.31583646178049e-24
NMR metabolomics,X23408.Triglycerides in VLDL,STAM,Signal transducing adapter molecule 1,24793,0.0267110362215758,0.00260684434714476,0.0216016213011721,0.0318204511419795,1.37383871887502e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,24938,-0.0238993442468383,0.00233692524327734,-0.0284797177236619,-0.0193189707700147,1.68090941451227e-24
NMR metabolomics,X23408.Triglycerides in VLDL,RCOR1,REST corepressor 1,28916,0.0322025560018616,0.00315285770053107,0.0260229549088207,0.0383821570949025,1.89331033491988e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CR1,Complement receptor type 1,24903,0.0259407313624097,0.00254116084670645,0.0209600561028651,0.0309214066219544,2.03530786121802e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SNX2,Sorting nexin-2,24793,0.0587212620647553,0.00575243180273409,0.0474464957313965,0.0699960283981141,2.03933384360281e-24
NMR metabolomics,X23408.Triglycerides in VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,29400,0.0608465086125814,0.00596183772465947,0.0491613066722489,0.072531710552914,2.04733165591714e-24
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBR2,TGF-beta receptor type-2,29566,0.0235853639759203,0.00231289437415028,0.0190520910025857,0.0281186369492548,2.2364590625837e-24
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD2,Sushi domain-containing protein 2,29443,-0.0204671726371986,0.00201705515436341,-0.0244206007397509,-0.0165137445346463,3.74263425522279e-24
NMR metabolomics,X23408.Triglycerides in VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,-0.0301605314723575,0.00297893218219434,-0.0359992385494584,-0.0243218243952566,4.70653276948189e-24
NMR metabolomics,X23408.Triglycerides in VLDL,CENPF,Centromere protein F,24445,0.0388171471923716,0.00383818314564273,0.0312943082269119,0.0463399861578314,5.37129237752837e-24
NMR metabolomics,X23408.Triglycerides in VLDL,JAM2,Junctional adhesion molecule B,29694,0.0190379845897278,0.00188559245656474,0.0153422233748609,0.0227337458045947,6.2546323413251e-24
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM4,Intercellular adhesion molecule 4,29434,-0.0374448342397301,0.0037155905483862,-0.044727391714567,-0.0301622767648932,7.57485223083697e-24
NMR metabolomics,X23408.Triglycerides in VLDL,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.018541453589369,0.00184228362541464,0.0149305776835563,0.0221523294951817,8.81882503089497e-24
NMR metabolomics,X23408.Triglycerides in VLDL,MET,Hepatocyte growth factor receptor,29507,-0.0140330513012116,0.00139575283681708,-0.0167687268613731,-0.0112973757410501,9.62319540641676e-24
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.0407949176980755,0.00406123961446328,0.0328348880537274,0.0487549473424235,1.05768417190279e-23
NMR metabolomics,X23408.Triglycerides in VLDL,VAMP5,Vesicle-associated membrane protein 5,28916,0.0383522493225506,0.0038184254127543,0.0308681355135522,0.045836363131549,1.06784949979717e-23
NMR metabolomics,X23408.Triglycerides in VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.024297333471329,0.00242165431451427,-0.029043775927777,-0.019550891014881,1.206611101553e-23
NMR metabolomics,X23408.Triglycerides in VLDL,FES,Tyrosine-protein kinase Fes/Fps,28797,0.0335897936190456,0.00335136312253183,0.0270211218988832,0.040158465339208,1.32413021524027e-23
NMR metabolomics,X23408.Triglycerides in VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,0.0210026440058977,0.0021011061631839,0.0168844759260572,0.0251208120857381,1.73107063014176e-23
NMR metabolomics,X23408.Triglycerides in VLDL,CA6,Carbonic anhydrase 6,29372,-0.0445528981513461,0.00446172555010221,-0.0532978802295464,-0.0358079160731457,1.92136497973415e-23
NMR metabolomics,X23408.Triglycerides in VLDL,FABP6,Gastrotropin,28872,0.0395168352940308,0.00397145661236223,0.0317327803338008,0.0473008902542607,2.74363755162781e-23
NMR metabolomics,X23408.Triglycerides in VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,0.0277213352251789,0.00278580256725487,0.0222611621933594,0.0331815082569984,2.76200640970952e-23
NMR metabolomics,X23408.Triglycerides in VLDL,GPR15L,Protein GPR15L,24805,0.0430172953072871,0.00432539257340325,0.0345395258634167,0.0514950647511574,2.92311646235286e-23
NMR metabolomics,X23408.Triglycerides in VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,28719,0.029694502619783,0.00299438991562607,0.0238254983851559,0.0355635068544101,3.83692176401435e-23
NMR metabolomics,X23408.Triglycerides in VLDL,GC,Vitamin D-binding protein,24966,0.0181472380966497,0.00183010525335239,0.014560231800079,0.0217342443932204,3.91612485717304e-23
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0181411635816088,0.0018305890526292,0.0145532090384556,0.0217291181247621,4.15507258244704e-23
NMR metabolomics,X23408.Triglycerides in VLDL,ULBP2,UL16-binding protein 2,29218,0.0266827128278701,0.00269592788838671,0.0213986941666322,0.0319667314891081,4.64441303601887e-23
NMR metabolomics,X23408.Triglycerides in VLDL,AGER,Advanced glycosylation end product-specific receptor,29378,0.0284164507872659,0.00287604086590353,0.022779410690095,0.0340534908844369,5.49874371819075e-23
NMR metabolomics,X23408.Triglycerides in VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.0405397960987455,0.00410316417025651,0.0324975943250427,0.0485819978724482,5.51254215950683e-23
NMR metabolomics,X23408.Triglycerides in VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,0.0352908528233432,0.00357316803008546,0.0282874434843757,0.0422942621623107,5.71872528484863e-23
NMR metabolomics,X23408.Triglycerides in VLDL,SPTLC1,Serine palmitoyltransferase 1,24845,0.0259174501504019,0.00262528112843731,0.0207718991386648,0.031063001162139,6.05286404390121e-23
NMR metabolomics,X23408.Triglycerides in VLDL,KLK6,Kallikrein-6,29519,0.0213287324120123,0.00216186757111212,0.0170914719726325,0.025565992851392,6.3501402300788e-23
NMR metabolomics,X23408.Triglycerides in VLDL,CDH15,Cadherin-15,29639,0.0402327069011494,0.00408161351478842,0.0322327444121641,0.0482326693901347,6.92923365732846e-23
NMR metabolomics,X23408.Triglycerides in VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.0415134260586979,0.00421810944702425,0.0332459315425304,0.0497809205748654,8.21439082591818e-23
NMR metabolomics,X23408.Triglycerides in VLDL,CFHR2,Complement factor H-related protein 2,24789,0.039572203926968,0.00403338167164888,0.0316667758505362,0.0474776320033998,1.10855858943449e-22
NMR metabolomics,X23408.Triglycerides in VLDL,COPB2,Coatomer subunit beta',24111,0.0298518296018943,0.00304463609883889,0.02388434284817,0.0358193163556185,1.18450870880861e-22
NMR metabolomics,X23408.Triglycerides in VLDL,OMD,Osteomodulin,29581,-0.029848327488503,0.00304540167185769,-0.035817314765344,-0.0238793402116619,1.20561542936435e-22
NMR metabolomics,X23408.Triglycerides in VLDL,BAX,Apoptosis regulator BAX,28722,0.0624674569308672,0.00637881551284972,0.0499649785256817,0.0749699353360527,1.30974642357944e-22
NMR metabolomics,X23408.Triglycerides in VLDL,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0177844966749911,0.00181658940749663,0.0142239814362978,0.0213450119136845,1.34503053312237e-22
NMR metabolomics,X23408.Triglycerides in VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,0.0289343649772078,0.0029593930456393,0.0231339546077548,0.0347347753466608,1.54967542980286e-22
NMR metabolomics,X23408.Triglycerides in VLDL,RHOC,Rho-related GTP-binding protein RhoC,29089,0.0801720080876396,0.00822824288212374,0.064044652038677,0.0962993641366021,2.12786099935982e-22
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE6,Ribonuclease K6,24828,0.0211716416527109,0.00217327253291427,0.0169120274881989,0.0254312558172229,2.19286225701892e-22
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL2,Fc receptor-like protein 2,29645,0.0338809439129983,0.00348041291694067,0.0270593345957946,0.0407025532302021,2.31549951768754e-22
NMR metabolomics,X23408.Triglycerides in VLDL,RALY,RNA-binding protein Raly,24793,0.0330945662735717,0.00340433620491236,0.0264220673119435,0.0397670652352,2.68156790525715e-22
NMR metabolomics,X23408.Triglycerides in VLDL,NPHS1,Nephrin,24229,0.0234053605734038,0.0024121433824819,0.0186775595437393,0.0281331616030683,3.20927417104282e-22
NMR metabolomics,X23408.Triglycerides in VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,0.0250590500671139,0.00258362516633705,0.0199951447410932,0.0301229553931345,3.33719550397934e-22
NMR metabolomics,X23408.Triglycerides in VLDL,LAG3,Lymphocyte activation gene 3 protein,29349,-0.0279472552892401,0.00288318248854582,-0.0335982929667899,-0.0222962176116903,3.47959780589965e-22
NMR metabolomics,X23408.Triglycerides in VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.0576484485488309,0.00594911503537206,0.0459881830795017,0.0693087140181602,3.58640301637463e-22
NMR metabolomics,X23408.Triglycerides in VLDL,SAA4,Serum amyloid A-4 protein,24966,0.0224177313977727,0.0023155307296776,0.0178792911676046,0.0269561716279408,3.95408452057422e-22
NMR metabolomics,X23408.Triglycerides in VLDL,NAGA,Alpha-N-acetylgalactosaminidase,24177,0.0400032331679567,0.00413910663671655,0.0318905841599922,0.0481158821759211,4.66874286719394e-22
NMR metabolomics,X23408.Triglycerides in VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,0.0319710440062997,0.00331768514320533,0.0254683811256173,0.0384737068869822,6.04971768130608e-22
NMR metabolomics,X23408.Triglycerides in VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,0.026089579231178,0.00273073527671719,0.0207373380888124,0.0314418203735437,1.36153038738017e-21
NMR metabolomics,X23408.Triglycerides in VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,29581,0.0178323116164769,0.00186750835277071,0.0141719952450463,0.0214926279879075,1.41068390486682e-21
NMR metabolomics,X23408.Triglycerides in VLDL,LMNB2,Lamin-B2,24845,0.0188940645773847,0.00198088265747153,0.0150115345687405,0.0227765945860289,1.58210768580213e-21
NMR metabolomics,X23408.Triglycerides in VLDL,PVALB,Parvalbumin alpha,29599,0.0754868204291,0.00792414732040948,0.0599554916810975,0.0910181491771026,1.75186204438664e-21
NMR metabolomics,X23408.Triglycerides in VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.0106377358296788,0.00111915464045753,0.00844419273438208,0.0128312789249756,2.14202706368026e-21
NMR metabolomics,X23408.Triglycerides in VLDL,ALCAM,CD166 antigen,29820,0.0130985979277496,0.00138148766934385,0.0103908820958356,0.0158063137596635,2.6855739268469e-21
NMR metabolomics,X23408.Triglycerides in VLDL,AFAP1,Actin filament-associated protein 1,24381,0.0563095483334374,0.00595064614669674,0.0446462818859118,0.067972814780963,3.26158914140806e-21
NMR metabolomics,X23408.Triglycerides in VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.0527996717931706,0.00560521478677636,0.041813450811089,0.0637858927752523,4.84881432442173e-21
NMR metabolomics,X23408.Triglycerides in VLDL,SEZ6L2,Seizure 6-like protein 2,29349,-0.0158687947487439,0.00169239588506333,-0.019185890683468,-0.0125516988140198,7.29235944312794e-21
NMR metabolomics,X23408.Triglycerides in VLDL,ITGA11,Integrin alpha-11,29434,-0.0226903820901511,0.00242048306331456,-0.0274345288942476,-0.0179462352860545,7.44460935524711e-21
NMR metabolomics,X23408.Triglycerides in VLDL,CD300LF,CMRF35-like molecule 1,29725,0.0397948252334831,0.00425925741980723,0.0314466806906609,0.0481429697763053,9.9847518398105e-21
NMR metabolomics,X23408.Triglycerides in VLDL,S100A13,Protein S100-A13,24229,0.0231904983714969,0.00248921662522907,0.0183116337860479,0.0280693629569459,1.30315984116341e-20
NMR metabolomics,X23408.Triglycerides in VLDL,MPO,Myeloperoxidase,29443,0.0301810253708615,0.00324187808617194,0.0238269443219645,0.0365351064197585,1.36779118935386e-20
NMR metabolomics,X23408.Triglycerides in VLDL,INSR,Insulin receptor,24229,0.0111846627110303,0.00120189204144131,0.00882895430980537,0.0135403711122553,1.43814108859378e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0191915820624987,0.00206336233870826,-0.0232357722463669,-0.0151473918786305,1.48309232805849e-20
NMR metabolomics,X23408.Triglycerides in VLDL,MDM1,Nuclear protein MDM1,24195,0.0206047840238463,0.00221679663036296,0.0162598626283348,0.0249497054193577,1.59498869191795e-20
NMR metabolomics,X23408.Triglycerides in VLDL,PRKD2,Serine/threonine-protein kinase D2,24111,0.0300319948590422,0.00323535961505443,0.0236906900135355,0.0363732997045489,1.7920763248496e-20
NMR metabolomics,X23408.Triglycerides in VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,0.0332060062679499,0.00358255734626363,0.0261841938692732,0.0402278186666266,2.00699900754666e-20
NMR metabolomics,X23408.Triglycerides in VLDL,MMP12,Macrophage metalloelastase,29466,0.0347136697365737,0.00374839307232613,0.0273668193148145,0.0420605201583329,2.15967783020296e-20
NMR metabolomics,X23408.Triglycerides in VLDL,IL7R,Interleukin-7 receptor subunit alpha,29443,-0.0342729282315381,0.0037036478810617,-0.041532078078419,-0.0270137783846572,2.30816167516945e-20
NMR metabolomics,X23408.Triglycerides in VLDL,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.0259074943495374,0.0027998234798074,0.0204198403291149,0.03139514836996,2.35311328501941e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CABP2,Calcium-binding protein 2,24195,0.042717540142736,0.00462333322178791,0.0336558070280317,0.0517792732574403,2.6731719935976e-20
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.0370116955694231,0.00401038239076405,0.0291513460835256,0.0448720450553207,2.91060268315056e-20
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,0.0472718039717569,0.00512231954969223,0.0372320576543601,0.0573115502891537,2.95796962681317e-20
NMR metabolomics,X23408.Triglycerides in VLDL,XG,Glycoprotein Xg,29693,0.0209533354946975,0.0022735384549245,0.0164972001230455,0.0254094708663496,3.27595947691195e-20
NMR metabolomics,X23408.Triglycerides in VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.0238734702318728,0.00259355071482772,0.0187901108308104,0.0289568296329351,3.63588624860758e-20
NMR metabolomics,X23408.Triglycerides in VLDL,MYOM3,Myomesin-3,24381,-0.0608156576639831,0.00660799570173506,-0.0737673292393838,-0.0478639860885824,3.74065017896594e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CD300C,CMRF35-like molecule 6,29694,0.0224510219404267,0.00244168948013719,0.0176653105593578,0.0272367333214956,3.99259832949446e-20
NMR metabolomics,X23408.Triglycerides in VLDL,PKD1,Polycystin-1,24922,0.0172677334579672,0.00188078523240314,0.013581394402457,0.0209540725134773,4.5882207540826e-20
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE3,Eosinophil cationic protein,29343,0.0703593907469735,0.00766764050398587,0.0553308153591612,0.0853879661347858,4.75251976632212e-20
NMR metabolomics,X23408.Triglycerides in VLDL,AZU1,Azurocidin,28534,0.0496195462116665,0.00540844071195147,0.0390190024162417,0.0602200900070914,4.83552046373053e-20
NMR metabolomics,X23408.Triglycerides in VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.0289498350600874,0.00315746231261667,0.0227612089273588,0.0351384611928161,5.15779486209226e-20
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.0165657059156354,0.00180695704225864,-0.0201073417184623,-0.0130240701128085,5.20168103413264e-20
NMR metabolomics,X23408.Triglycerides in VLDL,NFYA,Nuclear transcription factor Y subunit alpha,24111,0.024915027082679,0.00271889116135872,0.0195860004064159,0.0302440537589421,5.40521537746966e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,0.0277501032442081,0.00302992477450355,0.0218114506861811,0.033688755802235,5.58285773074768e-20
NMR metabolomics,X23408.Triglycerides in VLDL,NFIC,Nuclear factor 1 C-type,24867,0.0288425744704068,0.0031499930743495,0.0226685880446817,0.0350165608961318,5.76798785251825e-20
NMR metabolomics,X23408.Triglycerides in VLDL,ENSA,Alpha-endosulfine,24793,0.0341390748268752,0.00373693438597832,0.0268146834303576,0.0414634662233927,6.98972207783416e-20
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN8,Tetraspanin-8,24805,0.0647135077662364,0.00708632295417044,0.0508243147760623,0.0786027007564105,7.2126644026154e-20
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFD,Vascular endothelial growth factor D,29732,-0.0230680309364305,0.00252774472574132,-0.0280224105988835,-0.0181136512739775,7.54904827773327e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL9,C-X-C motif chemokine 9,29581,0.0427773457451776,0.00469246667759256,0.0335801110570962,0.051974580433259,8.26088577827595e-20
NMR metabolomics,X23408.Triglycerides in VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,0.0362485867551035,0.00397716648666018,0.0284533404412495,0.0440438330689574,8.52870537411102e-20
NMR metabolomics,X23408.Triglycerides in VLDL,ITGBL1,Integrin beta-like protein 1,24938,0.024030575891606,0.00263678492666978,0.0188624774353332,0.0291986743478788,8.55387962337675e-20
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4D,C-type lectin domain family 4 member D,29434,0.0395598241606895,0.00434224950345257,0.0310490151339224,0.0480706331874565,8.71036337448772e-20
NMR metabolomics,X23408.Triglycerides in VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,0.0277673816372851,0.00304938825542129,0.0217905806566594,0.0337441826179108,9.0924420669804e-20
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.0192633942226658,0.00211586167579266,0.0151163053381122,0.0234104831072194,9.21352552676851e-20
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,0.0381970986946871,0.00421001324318497,0.0299454727380445,0.0464487246513296,1.24257984235018e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CA1,Carbonic anhydrase 1,28867,0.0382143334509618,0.00421716733432291,0.0299486854756889,0.0464799814262347,1.36447452985613e-19
NMR metabolomics,X23408.Triglycerides in VLDL,S100A11,Protein S100-A11,29208,0.0290013247540835,0.00321286007606983,0.0227041190049866,0.0352985305031803,1.87622986772099e-19
NMR metabolomics,X23408.Triglycerides in VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,0.0215194665864582,0.00238832184926767,0.0168383557618936,0.0262005774110228,2.20321551893305e-19
NMR metabolomics,X23408.Triglycerides in VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,0.0179187740732159,0.00199208445070533,0.0140142885498335,0.0218232595965984,2.53153301633071e-19
NMR metabolomics,X23408.Triglycerides in VLDL,PPM1A,Protein phosphatase 1A,28797,0.0197542350410114,0.00220074810087234,0.0154407687633016,0.0240677013187212,2.97065694057987e-19
NMR metabolomics,X23408.Triglycerides in VLDL,LYZL2,Lysozyme-like protein 2,24016,0.022878370043861,0.00255144254160024,0.0178775426623245,0.0278791974253974,3.26899940445679e-19
NMR metabolomics,X23408.Triglycerides in VLDL,KIF1C,Kinesin-like protein KIF1C,24111,0.0229827959852395,0.00257074447495134,0.0179441368143349,0.0280214551561441,4.15962280474988e-19
NMR metabolomics,X23408.Triglycerides in VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,28797,0.0326149744966605,0.00364886711456169,0.0254631949521196,0.0397667540412014,4.17949079861956e-19
NMR metabolomics,X23408.Triglycerides in VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.0649289878173765,0.00726712818799414,0.0506854165689079,0.079172559065845,4.36356981291088e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CD59,CD59 glycoprotein,28277,0.0145474680116055,0.00162840296865385,0.0113557981930439,0.017739137830167,4.3691155246592e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CCL21,C-C motif chemokine 21,29581,0.0255556824925805,0.00286689334469726,0.0199365715369739,0.0311747934481872,5.19555852410966e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CD14,Monocyte differentiation antigen CD14,28954,0.0259651941528821,0.0029243874158757,0.0202333948177657,0.0316969934879985,7.13712665149804e-19
NMR metabolomics,X23408.Triglycerides in VLDL,CA12,Carbonic anhydrase 12,29349,-0.0204054884117468,0.00230127998935268,-0.024915997190878,-0.0158949796326155,7.92937647583541e-19
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH1,Protocadherin-1,29713,0.0132919922925361,0.00149934019578693,0.0103532855087937,0.0162306990762784,8.05208956866903e-19
NMR metabolomics,X23408.Triglycerides in VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,28774,0.0257560394111134,0.00290959348261882,0.0200532361851805,0.0314588426370463,9.07028147634517e-19
NMR metabolomics,X23408.Triglycerides in VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,0.039180273456559,0.00445569205173038,0.0304471170351675,0.0479134298779506,1.54448507336163e-18
NMR metabolomics,X23408.Triglycerides in VLDL,DGCR6,Protein DGCR6,24101,0.0272252880049764,0.00310075972650232,0.0211477989410318,0.033302777068921,1.73821407835723e-18
NMR metabolomics,X23408.Triglycerides in VLDL,HSPA2,Heat shock-related 70 kDa protein 2,24793,0.0211538534539788,0.00241071729458024,0.0164288475566015,0.0258788593513561,1.81824273997365e-18
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,24111,0.0616244426566319,0.00703996778036724,0.0478261058071121,0.0754227795061517,2.20121723167663e-18
NMR metabolomics,X23408.Triglycerides in VLDL,PSPN,Persephin,29434,0.0579868480929732,0.00663945296596078,0.0449735202796901,0.0710001759062564,2.59327014104225e-18
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,0.0178719322134916,0.00204812320146975,0.0138576107386109,0.0218862536883723,2.77387442937871e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CRLF1,Cytokine receptor-like factor 1,29581,0.0158671286684823,0.00182240055890182,0.0122952235730347,0.0194390337639299,3.28763908387509e-18
NMR metabolomics,X23408.Triglycerides in VLDL,RAB6A,Ras-related protein Rab-6A,29434,0.0283725539997488,0.00327102602271894,0.0219613429952197,0.0347837650042779,4.38662367945228e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CLU,Clusterin,24966,0.0194758341702707,0.00224609951502069,0.0150734791208302,0.0238781892197113,4.54096990817574e-18
NMR metabolomics,X23408.Triglycerides in VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,0.0219933029503632,0.00253761471374856,0.017019578111416,0.0269670277893103,4.71403943834226e-18
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN8,Septin-8,24801,0.0196476884365255,0.00227693256688234,0.0151849006054361,0.0241104762676148,6.55310885244847e-18
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL3,Fc receptor-like protein 3,28931,0.0329606904410224,0.00382653013731399,0.025460691371887,0.0404606895101579,7.42580791310838e-18
NMR metabolomics,X23408.Triglycerides in VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,0.0406766239522825,0.0047271822257274,0.0314113467898568,0.0499419011147082,8.10321877211756e-18
NMR metabolomics,X23408.Triglycerides in VLDL,IL18BP,Interleukin-18-binding protein,29594,0.018729300625531,0.00217994617047362,0.0144566061314027,0.0230019951196593,8.98860252768904e-18
NMR metabolomics,X23408.Triglycerides in VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,0.0273526120766711,0.00318492088359527,0.0211101671448244,0.0335950570085179,9.34864553872698e-18
NMR metabolomics,X23408.Triglycerides in VLDL,LUZP2,Leucine zipper protein 2,24793,0.0272022996429402,0.00316975724107526,0.0209895754504327,0.0334150238354477,9.87676088874509e-18
NMR metabolomics,X23408.Triglycerides in VLDL,GLYR1,Putative oxidoreductase GLYR1,24793,0.035937753591759,0.00419879940800596,0.0277081067520673,0.0441674004314506,1.20291711819146e-17
NMR metabolomics,X23408.Triglycerides in VLDL,LTB,Lymphotoxin-beta,24793,0.0210998415837672,0.00247204329789241,0.0162546367198981,0.0259450464476364,1.47573110200569e-17
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.0155645556442225,0.00182847267816367,0.0119807491950217,0.0191483620934233,1.78381776848272e-17
NMR metabolomics,X23408.Triglycerides in VLDL,HMBS,Porphobilinogen deaminase,29725,0.0258518549888928,0.00304255541356554,0.0198884463783044,0.0318152635994813,2.03932353540777e-17
NMR metabolomics,X23408.Triglycerides in VLDL,EBI3_IL27,Interleukin-27,29674,-0.0185600600230202,0.00218441613409962,-0.0228415156458555,-0.014278604400185,2.0426416177732e-17
NMR metabolomics,X23408.Triglycerides in VLDL,AMPD3,AMP deaminase 3,24845,0.0426119864156943,0.00501596882732036,0.0327806875141464,0.0524432853172422,2.08392370453332e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,24229,0.0185211304756969,0.00218219126911867,0.0142440355882243,0.0227982253631695,2.23246338041638e-17
NMR metabolomics,X23408.Triglycerides in VLDL,BRK1,Protein BRICK1,28774,0.0268351288526259,0.00316270262244093,0.0206362317126417,0.0330340259926101,2.26171148485551e-17
NMR metabolomics,X23408.Triglycerides in VLDL,TPM3,Tropomyosin alpha-3 chain,24111,-0.0265199722405741,0.00312606131936656,-0.0326470524265326,-0.0203928920546157,2.30880749635947e-17
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2,Apoptosis regulator Bcl-2,24805,0.0322185106981317,0.00379900919043509,0.024772452684879,0.0396645687113845,2.36010547883369e-17
NMR metabolomics,X23408.Triglycerides in VLDL,TNC,Tenascin,29594,-0.0285545667102779,0.00336856326289974,-0.0351569507055614,-0.0219521827149944,2.42115029382223e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CD300E,CMRF35-like molecule 2,29642,0.0243681983789881,0.00287662209915904,0.0187300190646364,0.0300063776933399,2.54135090559944e-17
NMR metabolomics,X23408.Triglycerides in VLDL,PRTG,Protogenin,29725,0.0148976735972041,0.00176029135917224,0.0114475025332265,0.0183478446611817,2.71952941349886e-17
NMR metabolomics,X23408.Triglycerides in VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,0.016482663752612,0.00194775051575798,0.0126650727417264,0.0203002547634977,2.73823953196285e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.0325848820878923,0.00385760188684346,0.0250239823896791,0.0401457817861054,3.15662097261315e-17
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.0169777295133983,0.00201155171837141,-0.0209203708814062,-0.0130350881453903,3.31345846179914e-17
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0195213877022026,0.00231742490657627,0.0149792348853131,0.0240635405190921,3.84057315438262e-17
NMR metabolomics,X23408.Triglycerides in VLDL,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.0330954807358298,0.00393202664959674,0.0253887085026201,0.0408022529690394,4.07179266415227e-17
NMR metabolomics,X23408.Triglycerides in VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.0196724319717271,0.00233867608597636,0.0150886268432134,0.0242562371002407,4.25816837334428e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CD209,CD209 antigen,29527,-0.0231014465585007,0.0027480918040811,-0.0284877064944997,-0.0177151866225018,4.41704318080111e-17
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,0.0163416389847264,0.00194419559928284,0.0125310156101321,0.0201522623593208,4.45352656514173e-17
NMR metabolomics,X23408.Triglycerides in VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,-0.0182018880139261,0.00216690510640645,-0.0224490220224827,-0.0139547540053695,4.71093198576728e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,0.0235944260733268,0.00280921400157038,0.0180883666302489,0.0291004855164048,4.74327128097217e-17
NMR metabolomics,X23408.Triglycerides in VLDL,GSTT2B,Glutathione S-transferase theta-2B,24845,0.142323558124614,0.0169489279520791,0.109103659338539,0.175543456910689,4.81350371071479e-17
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA7,Thyroxine-binding globulin,24966,0.0109875849696936,0.00131038048216761,0.00841923922464505,0.0135559307147421,5.33555340504533e-17
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,0.0159419917741669,0.00190236720212634,0.0122133520579993,0.0196706314903345,5.5204695134619e-17
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD1,Programmed cell death protein 1,29661,0.0253929222929297,0.00303030422721356,0.0194535260075912,0.0313323185782683,5.5395286953412e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CTSH,Pro-cathepsin H,28852,0.0433778730147134,0.00517893707064517,0.0332271563562489,0.053528589673178,5.72936682433355e-17
NMR metabolomics,X23408.Triglycerides in VLDL,TSHB,Thyrotropin subunit beta,29478,0.0454851594439487,0.00543132380685508,0.0348397647825128,0.0561305541053847,5.78382203708935e-17
NMR metabolomics,X23408.Triglycerides in VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,-0.0199519668353083,0.00238247699454661,-0.0246216217446196,-0.0152823119259969,5.79030517584985e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CCN3,CCN family member 3,29795,0.0200054842949171,0.00239084451988738,0.0153194290359378,0.0246915395538964,6.13734159425316e-17
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.0240961902233869,0.00288757318565431,0.0184365467795044,0.0297558336672693,7.44940951565031e-17
NMR metabolomics,X23408.Triglycerides in VLDL,LYAR,Cell growth-regulating nucleolar protein,28797,0.031102143425995,0.00373583147873549,0.0237799137276734,0.0384243731243165,8.77537977793807e-17
NMR metabolomics,X23408.Triglycerides in VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.0411445755895325,0.00494535551663689,0.0314516787769242,0.0508374724021408,9.26679230013919e-17
NMR metabolomics,X23408.Triglycerides in VLDL,CHRDL1,Chordin-like protein 1,29536,0.018487662424154,0.0022255353019618,0.0141256132323089,0.0228497116159992,1.02248617441644e-16
NMR metabolomics,X23408.Triglycerides in VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.0452371256134175,0.00545256574237565,0.0345500967583612,0.0559241544684738,1.12769994888839e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PRL,Prolactin,29694,-0.0443617385050477,0.00535323631516887,-0.0548540816827787,-0.0338693953273167,1.21079253428937e-16
NMR metabolomics,X23408.Triglycerides in VLDL,INSL3,Insulin-like 3,24845,0.0442386790461846,0.00534432228255327,0.0337638073723802,0.054713550719989,1.31828172013131e-16
NMR metabolomics,X23408.Triglycerides in VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,0.0211545269933004,0.00255868682080677,0.0161395008245192,0.0261695531620817,1.43471409656412e-16
NMR metabolomics,X23408.Triglycerides in VLDL,PZP,Pregnancy zone protein,24966,0.0311017385878388,0.0037746292459184,0.0237034652658388,0.0385000119098389,1.81061745924691e-16
NMR metabolomics,X23408.Triglycerides in VLDL,APOBR,Apolipoprotein B receptor,24240,-0.0246898646509115,0.00301779483587437,-0.0306047425292253,-0.0187749867725978,2.94156300725244e-16
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAM,Integrin alpha-M,29443,-0.0182798214512391,0.00223547616140999,-0.0226613547276027,-0.0138982881748756,3.02213084979594e-16
NMR metabolomics,X23408.Triglycerides in VLDL,IL1B,Interleukin-1 beta,28745,0.03247887352669,0.003978721110693,0.0246805801497317,0.0402771669036483,3.39644164233172e-16
NMR metabolomics,X23408.Triglycerides in VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,28916,0.0307239003912836,0.00376782617455256,0.0233389610891606,0.0381088396934066,3.6536268437268e-16
NMR metabolomics,X23408.Triglycerides in VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,0.0242922315165835,0.0029912415957449,0.0184293979889235,0.0301550650442435,4.83158833875473e-16
NMR metabolomics,X23408.Triglycerides in VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.0443966905820271,0.00547070857795576,0.0336741017692338,0.0551192793948204,5.07221078058514e-16
NMR metabolomics,X23408.Triglycerides in VLDL,DPP7,Dipeptidyl peptidase 2,29279,0.0344099703813474,0.00425000630399795,0.0260799580255115,0.0427399827371834,5.8763297582916e-16
NMR metabolomics,X23408.Triglycerides in VLDL,RAB37,Ras-related protein Rab-37,28931,0.0468858674479904,0.00581349848690209,0.0354914104136623,0.0582803244823185,7.60445914025364e-16
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.0204793468493274,0.00254065278829179,0.0154996673842755,0.0254590263143793,7.87342954854891e-16
NMR metabolomics,X23408.Triglycerides in VLDL,BCAM,Basal cell adhesion molecule,29443,-0.0136737127321467,0.00170113992174496,-0.0170079469787668,-0.0103394784855265,9.47337760167548e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CGA,Glycoprotein hormones alpha chain,29443,0.0455204697421776,0.0056666731801951,0.0344137903089952,0.05662714917536,9.8632742257723e-16
NMR metabolomics,X23408.Triglycerides in VLDL,CA7,Carbonic anhydrase 7,24445,-0.0195677605942258,0.00243565311183771,-0.0243416406934277,-0.0147938804950239,9.86669382706472e-16
NMR metabolomics,X23408.Triglycerides in VLDL,ICOSLG,ICOS ligand,29349,0.0108207242714372,0.00134870517548711,0.00817726212748247,0.0134641864153919,1.06972736357099e-15
NMR metabolomics,X23408.Triglycerides in VLDL,GBP4,Guanylate-binding protein 4,28774,0.0278408780924017,0.00347163520280347,0.0210364730949069,0.0346452830898965,1.10153908421942e-15
NMR metabolomics,X23408.Triglycerides in VLDL,SRPX,Sushi repeat-containing protein SRPX,24922,-0.0201330831074204,0.00251127987346951,-0.0250551916594206,-0.0152109745554202,1.13027223427997e-15
NMR metabolomics,X23408.Triglycerides in VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.0190925415976791,0.00238908328773753,0.0144099383537135,0.0237751448416446,1.38958162078389e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4M,C-type lectin domain family 4 member M,24888,-0.0276971324880222,0.00346714266452836,-0.0344927321104978,-0.0209015328655466,1.42513921606148e-15
NMR metabolomics,X23408.Triglycerides in VLDL,SCARF2,Scavenger receptor class F member 2,29694,-0.0164534004035289,0.00206060466089682,-0.0204921855388867,-0.0124146152681712,1.45867409927722e-15
NMR metabolomics,X23408.Triglycerides in VLDL,YAP1,Transcriptional coactivator YAP1,24845,0.0152587439003905,0.00191411690252076,0.0115070747714498,0.0190104130293312,1.63211474157085e-15
NMR metabolomics,X23408.Triglycerides in VLDL,IFNG,Interferon gamma,28931,0.0640594271062878,0.00804072054103559,0.0482996148458581,0.0798192393667176,1.68677905251159e-15
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,0.0188870095364686,0.00237518117617943,0.014231654431157,0.0235423646417803,1.90273576569934e-15
NMR metabolomics,X23408.Triglycerides in VLDL,TBC1D17,TBC1 domain family member 17,28774,0.0250567513544283,0.00315380793347301,0.0188752878048212,0.0312382149040354,2.01373185568703e-15
NMR metabolomics,X23408.Triglycerides in VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,-0.014013905483968,0.00176757156511856,-0.0174783457516003,-0.0105494652163356,2.31621997980356e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CRISP3,Cysteine-rich secretory protein 3,24738,-0.015196278709733,0.00191856037575621,-0.0189566570462152,-0.0114359003732509,2.4612354883281e-15
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS11D,Transmembrane protease serine 11D,24801,0.0214452150490079,0.00272066747306427,0.016112706801802,0.0267777232962139,3.34467506047248e-15
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,0.0236869993999762,0.00301097240767118,0.0177854934809407,0.0295885053190117,3.76177043287067e-15
NMR metabolomics,X23408.Triglycerides in VLDL,THBS4,Thrombospondin-4,29518,0.0249652358696362,0.00319390579708289,0.0187051805073537,0.0312252912319187,5.61029452962456e-15
NMR metabolomics,X23408.Triglycerides in VLDL,CPE,Carboxypeptidase E,29468,-0.021314223477367,0.00272798809920111,-0.0266610801518012,-0.0159673668029328,5.76179947680336e-15
NMR metabolomics,X23408.Triglycerides in VLDL,NXPH1,Neurexophilin-1,28774,0.0210957861602594,0.00270097527366323,0.0158018746238794,0.0263896976966393,5.89248776945933e-15
NMR metabolomics,X23408.Triglycerides in VLDL,OBP2B,Odorant-binding protein 2b,29137,-0.0344006575230472,0.00442532320444048,-0.0430742910037506,-0.0257270240423439,7.8798101451191e-15
NMR metabolomics,X23408.Triglycerides in VLDL,FSTL3,Follistatin-related protein 3,29351,0.0175192113039174,0.00225376626947129,0.0131018294157537,0.0219365931920812,7.8958380198491e-15
NMR metabolomics,X23408.Triglycerides in VLDL,IGSF21,Immunoglobulin superfamily member 21,24240,0.0218738506144671,0.00281507622243036,0.0163563012185036,0.0273914000104306,8.14286020490396e-15
NMR metabolomics,X23408.Triglycerides in VLDL,LCP1,Plastin-2,24938,0.0260811664305984,0.00335890569214179,0.0194977112740005,0.0326646215871963,8.49204664774766e-15
NMR metabolomics,X23408.Triglycerides in VLDL,EPCAM,Epithelial cell adhesion molecule,29457,-0.0530953085270245,0.00684762218333813,-0.0665166480063672,-0.0396739690476817,9.20288505885737e-15
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,0.0163525470267812,0.00210940854583138,0.0122181062769517,0.0204869877766107,9.32217240815844e-15
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA1,Annexin A1,24281,0.0234498334352756,0.00302935802722365,0.0175122917019173,0.029387375168634,1.02587630761026e-14
NMR metabolomics,X23408.Triglycerides in VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,0.0245150350752032,0.00317170577662965,0.0182984917530091,0.0307315783973974,1.11595760177282e-14
NMR metabolomics,X23408.Triglycerides in VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.0126984456098881,0.00164700177236828,0.00947032213604629,0.01592656908373,1.29704358198499e-14
NMR metabolomics,X23408.Triglycerides in VLDL,GGT5,Glutathione hydrolase 5 proenzyme,29218,0.0126700257497761,0.00164672638401222,0.00944244203711211,0.01589760946244,1.47010954508608e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,0.0264220437315135,0.00343831742918036,0.01968294157032,0.033161145892707,1.58347713741839e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CHL1,Neural cell adhesion molecule L1-like protein,29542,-0.0167410072815986,0.00218411755810137,-0.0210218776954773,-0.01246013686772,1.84475865902605e-14
NMR metabolomics,X23408.Triglycerides in VLDL,LGALS4,Galectin-4,29454,0.0295246871526908,0.00385355983534624,0.0219717098754121,0.0370776644299694,1.89166349956453e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CCN5,CCN family member 5,29443,0.0210545164224808,0.00274896281249117,0.0156665493099981,0.0264424835349635,1.93013384948095e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CR2,Complement receptor type 2,29594,0.0250262933590184,0.00328965704699115,0.0185785655469158,0.0314740211711211,2.8758704343288e-14
NMR metabolomics,X23408.Triglycerides in VLDL,B2M,Beta-2-microglobulin,24966,0.0167303704402124,0.00220115700661218,0.0124161027072525,0.0210446381731723,3.04843610547295e-14
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF7,SLAM family member 7,29434,-0.0314062914274002,0.00414122449234099,-0.0395230914323886,-0.0232894914224119,3.45419949366919e-14
NMR metabolomics,X23408.Triglycerides in VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,0.0139946383358378,0.00184610849447893,0.0103762656866591,0.0176130109850165,3.54093387720114e-14
NMR metabolomics,X23408.Triglycerides in VLDL,VEGFB,Vascular endothelial growth factor B,24229,0.0155194090869329,0.00204921581017333,0.0115029460989932,0.0195358720748726,3.76735181648611e-14
NMR metabolomics,X23408.Triglycerides in VLDL,PRUNE2,Protein prune homolog 2,24445,0.0156655996737341,0.00207084128968352,0.0116067507459544,0.0197244486015138,4.01997502513803e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IL6ST,Interleukin-6 receptor subunit beta,29478,0.00940471473375527,0.00124490311463874,0.00696470462906334,0.0118447248384472,4.3240303098771e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,-0.0141111482123093,0.00187408417191543,-0.0177843531892636,-0.0104379432353551,5.26109506369807e-14
NMR metabolomics,X23408.Triglycerides in VLDL,GNLY,Granulysin,29443,0.0276978470904196,0.00368789516804448,0.0204695725610524,0.0349261216197868,6.05824116194364e-14
NMR metabolomics,X23408.Triglycerides in VLDL,CLGN,Calmegin,24195,0.0238471240311517,0.00318347011547225,0.0176075226048261,0.0300867254574773,7.07326429848176e-14
NMR metabolomics,X23408.Triglycerides in VLDL,GZMB,Granzyme B,29434,0.034478520593527,0.00460914562856727,0.0254445951615352,0.0435124460255189,7.61303058705615e-14
NMR metabolomics,X23408.Triglycerides in VLDL,PADI4,Protein-arginine deiminase type-4,28722,0.0375182926103191,0.00502230137708315,0.0276745819112361,0.0473620033094021,8.2263982749711e-14
NMR metabolomics,X23408.Triglycerides in VLDL,IL34,Interleukin-34,28722,0.0190862759708357,0.00255551138435185,0.0140774736575061,0.0240950782841653,8.33105708914535e-14
NMR metabolomics,X23408.Triglycerides in VLDL,HMOX1,Heme oxygenase 1,29165,-0.0253233447321778,0.00339498951112419,-0.0319775241739812,-0.0186691652903744,8.95850951631242e-14
NMR metabolomics,X23408.Triglycerides in VLDL,SATB1,DNA-binding protein SATB1,24867,0.0156715537149086,0.00210261029549914,0.0115504375357303,0.019792669894087,9.39469664472638e-14
NMR metabolomics,X23408.Triglycerides in VLDL,APOB,Apolipoprotein B-100,24951,0.0118686345445033,0.00159325202802352,0.00874586056957717,0.0149914085194294,9.68709637644211e-14
NMR metabolomics,X23408.Triglycerides in VLDL,APOA4,Apolipoprotein A-IV,24966,0.0188504112834267,0.00253076698391674,0.0138901079949499,0.0238107145719035,9.74690887953721e-14
NMR metabolomics,X23408.Triglycerides in VLDL,UROS,Uroporphyrinogen-III synthase,24195,0.0359982207224483,0.00483570576619268,0.0265202374207106,0.0454762040241859,1.00748566672133e-13
NMR metabolomics,X23408.Triglycerides in VLDL,KLK14,Kallikrein-14,29725,-0.0241708951784965,0.00325784503559652,-0.0305562714482657,-0.0177855189087274,1.20898274928423e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.0183372711958252,0.00247173797631925,0.0134926647622395,0.023181877629411,1.21360051133063e-13
NMR metabolomics,X23408.Triglycerides in VLDL,DSG3,Desmoglein-3,29589,0.0179143435831102,0.00241591091553041,0.0131791581886706,0.0226495289775498,1.24742235311372e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN1,Contactin-1,29820,-0.0142664084845997,0.00192599612875236,-0.0180413608969543,-0.010491456072245,1.32321107853945e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CLC,Galectin-10,29426,-0.0346917183206203,0.00468444199536552,-0.0438732246315367,-0.0255102120097039,1.33926975713366e-13
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC38,Leucine-rich repeat-containing protein 38,24195,0.0253299375337456,0.00342411463825663,0.0186186728427626,0.0320412022247286,1.43274210756217e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA5,Protein disulfide-isomerase A5,24016,0.0321348935465139,0.0043484598091924,0.0236119123204968,0.040657874772531,1.51684065767144e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CST1,Cystatin-SN,21656,0.0549039857137301,0.00744348331898441,0.0403147584085207,0.0694932130189396,1.6884549249119e-13
NMR metabolomics,X23408.Triglycerides in VLDL,MST1,Hepatocyte growth factor-like protein,24615,0.033463381209978,0.00454617882064024,0.0245528707215231,0.0423738916984329,1.88585407260974e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,-0.0111255659527663,0.0015157718496204,-0.0140964787780223,-0.00815465312751033,2.19435223016332e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PGA4,Pepsin A-4,24951,0.0366839962776955,0.00503472015101599,0.0268159447817041,0.0465520477736868,3.28280473979967e-13
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINI1,Neuroserpin,24329,0.0157785241530502,0.00216676927971633,0.0115316563648062,0.0200253919412942,3.38779173994774e-13
NMR metabolomics,X23408.Triglycerides in VLDL,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.0201101803228062,0.00276212472952857,0.0146964158529302,0.0255239447926822,3.42257876339228e-13
NMR metabolomics,X23408.Triglycerides in VLDL,LXN,Latexin,29117,-0.0345750561767548,0.00475422150396144,-0.0438933303245192,-0.0252567820289904,3.61803197684409e-13
NMR metabolomics,X23408.Triglycerides in VLDL,OSM,Oncostatin-M,29293,0.036488354883682,0.00502013758532235,0.0266488852164502,0.0463278245509138,3.72873075632004e-13
NMR metabolomics,X23408.Triglycerides in VLDL,HGFAC,Hepatocyte growth factor activator,24720,0.0144454412459287,0.00198785632185704,0.0105492428550889,0.0183416396367685,3.78901388708082e-13
NMR metabolomics,X23408.Triglycerides in VLDL,OLFM4,Olfactomedin-4,23498,0.0634439437794366,0.00873249437709133,0.0463282548003376,0.0805596327585356,3.83907119652635e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ALPP,"Alkaline phosphatase, placental type",29349,0.0530848172377898,0.00730841938342149,0.0387603152462837,0.0674093192292959,3.86544268833036e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PODXL,Podocalyxin,29349,0.00776218245875638,0.00107031269280265,0.00566436958086318,0.00985999533664958,4.20022740704399e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD6,Programmed cell death protein 6,29478,-0.0358572895562579,0.00494779757295106,-0.0455549727992419,-0.0261596063132738,4.36176955806196e-13
NMR metabolomics,X23408.Triglycerides in VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,0.019879213368616,0.00274634262990878,0.0144963818139948,0.0252620449232372,4.65045772268909e-13
NMR metabolomics,X23408.Triglycerides in VLDL,PON1,Serum paraoxonase/arylesterase 1,24951,-0.0135466895493748,0.00187190504691065,-0.0172156234413197,-0.00987775565742996,4.72513544627071e-13
NMR metabolomics,X23408.Triglycerides in VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,0.0438559768741326,0.00606259453164908,0.0319732915921004,0.0557386621561648,4.83473883143934e-13
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RAP,Interleukin-1 receptor accessory protein,29443,-0.0223900396634433,0.00309825181036663,-0.0284626132117619,-0.0163174661151247,5.07019467370915e-13
NMR metabolomics,X23408.Triglycerides in VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,24229,0.0191458503657558,0.00265344896821626,0.0139450903880519,0.0243466103434597,5.53347787241346e-13
NMR metabolomics,X23408.Triglycerides in VLDL,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.0128180593846711,0.00178123305435907,0.00932684259812737,0.0163092761712149,6.34064460708572e-13
NMR metabolomics,X23408.Triglycerides in VLDL,FGF16,Fibroblast growth factor 16,24229,0.0243952684514599,0.0033932310556584,0.0177445355823695,0.0310460013205504,6.69686069314671e-13
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.0178686397727356,0.00248994154385576,0.0129883543467783,0.0227489251986928,7.36231368713869e-13
NMR metabolomics,X23408.Triglycerides in VLDL,EPO,Erythropoietin,29434,0.0384659231018705,0.00536380573401734,0.0279528638631965,0.0489789823405445,7.59933815515178e-13
NMR metabolomics,X23408.Triglycerides in VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.0265963933050131,0.0037188161710747,0.0193075136097067,0.0338852730003195,8.76624433976402e-13
NMR metabolomics,X23408.Triglycerides in VLDL,NRCAM,Neuronal cell adhesion molecule,29478,0.0143131606853782,0.0020013946437325,0.0103904271836625,0.0182358941870939,8.77746388885779e-13
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.0155597258501266,0.00217803980529701,-0.0198286838685088,-0.0112907678317445,9.28567598384465e-13
NMR metabolomics,X23408.Triglycerides in VLDL,KLRK1,NKG2-D type II integral membrane protein,24845,0.0235120336069308,0.00329111268313109,0.0170614527479938,0.0299626144658677,9.30869329052591e-13
NMR metabolomics,X23408.Triglycerides in VLDL,SIL1,Nucleotide exchange factor SIL1,24240,0.0163281735137586,0.00229035046874324,0.0118390865950218,0.0208172604324953,1.03848688089379e-12
NMR metabolomics,X23408.Triglycerides in VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,24867,0.0193793551506338,0.00272587733781661,0.0140366355685132,0.0247220747327543,1.19697786333248e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.0447356592238523,0.0062942723589045,0.0323988854003995,0.0570724330473052,1.20966934806758e-12
NMR metabolomics,X23408.Triglycerides in VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,0.0243141493767147,0.00342279128401088,0.0176054784600534,0.031022820293376,1.24924569491403e-12
NMR metabolomics,X23408.Triglycerides in VLDL,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.0195344819653029,0.00275540633975131,0.0141338855393903,0.0249350783912154,1.37629541182657e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.0151404936191069,0.00213598076323338,0.0109539713231695,0.0193270159150444,1.38888345264571e-12
NMR metabolomics,X23408.Triglycerides in VLDL,BLVRB,Flavin reductase,29443,0.0325478822533248,0.00460018880015084,0.0235315122050292,0.0415642523016205,1.52419492308587e-12
NMR metabolomics,X23408.Triglycerides in VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.0182088855135594,0.00257556309588315,0.0131607818456284,0.0232569891814903,1.58601417195252e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PEPD,Xaa-Pro dipeptidase,24951,0.0130971183282491,0.00185354004172291,0.0094641798464722,0.016730056810026,1.63652784913895e-12
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,0.0137785520741338,0.00195432102513139,0.0099480828648763,0.0176090212833914,1.82558313068268e-12
NMR metabolomics,X23408.Triglycerides in VLDL,TFPI2,Tissue factor pathway inhibitor 2,29473,0.0194465939186154,0.00275863939853224,0.0140396606974922,0.0248535271397386,1.83721274269887e-12
NMR metabolomics,X23408.Triglycerides in VLDL,FABP3,"Fatty acid-binding protein, heart",24922,0.0252200509064831,0.00358832980081062,0.0181869244968943,0.0322531773160719,2.14369665309622e-12
NMR metabolomics,X23408.Triglycerides in VLDL,ECM1,Extracellular matrix protein 1,24349,0.0182809165081312,0.00260384521960709,0.0131773798777013,0.0233844531385611,2.26495821415875e-12
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0183565230097041,0.00261565822702947,0.0132298328847264,0.0234832131346819,2.31101297039979e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CHAD,Chondroadherin,24381,0.0257362396727626,0.00367001962953618,0.0185430011988717,0.0329294781466536,2.40103389438068e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PFDN2,Prefoldin subunit 2,28774,0.027524315120709,0.00393307923854134,0.019815479813168,0.03523315042825,2.65028119525723e-12
NMR metabolomics,X23408.Triglycerides in VLDL,LEO1,RNA polymerase-associated protein LEO1,24867,0.0148897822663456,0.00213192778405551,0.0107112038095968,0.0190683607230944,2.93726601173678e-12
NMR metabolomics,X23408.Triglycerides in VLDL,BCL2L15,Bcl-2-like protein 15,24229,0.0279151511981772,0.00399741716166346,0.0200802135613169,0.0357500888350376,2.95783970698971e-12
NMR metabolomics,X23408.Triglycerides in VLDL,GZMH,Granzyme H,28916,0.037645434344438,0.0054021924638622,0.0270571371152681,0.0482337315736079,3.27093640640352e-12
NMR metabolomics,X23408.Triglycerides in VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0125553015190737,0.00180273491593862,0.00902194108383404,0.0160886619543134,3.36302809152778e-12
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,0.0187163267615311,0.00268994320609412,0.0134440380775866,0.0239886154454755,3.52556502379823e-12
NMR metabolomics,X23408.Triglycerides in VLDL,PRELP,Prolargin,29454,0.0114338051762544,0.00164418628293871,0.00821120006169452,0.0146564102908143,3.6227126696213e-12
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM5,Intercellular adhesion molecule 5,29478,0.0220969703933253,0.00317779867742236,0.0158684849855775,0.0283254558010731,3.63640099293665e-12
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN10,Ataxin-10,28774,0.0357519060856993,0.00514297546364577,0.0256716741769536,0.045832137994445,3.68872237236204e-12
NMR metabolomics,X23408.Triglycerides in VLDL,GPC1,Glypican-1,29725,0.0144624170687011,0.0020809869354539,0.0103836826752115,0.0185411514621908,3.73381389056381e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,24445,0.0341998886675241,0.00493022753720022,0.0245366426946117,0.0438631346404365,4.11152471757398e-12
NMR metabolomics,X23408.Triglycerides in VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,0.0169265796762135,0.00244129275316492,0.0121416458800102,0.0217115134724167,4.19200822188356e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC10A,C-type lectin domain family 10 member A,29218,-0.0177442879558844,0.0025597040726346,-0.0227613079382482,-0.0127272679735206,4.23061585793085e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CRTAP,Cartilage-associated protein,24195,0.0239115049795316,0.0034554966314335,0.0171387315819219,0.0306842783771413,4.6342026018256e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SNU13,NHP2-like protein 1,24111,0.0306660764790743,0.0044321078571623,0.0219791450790362,0.0393530078791124,4.65992039139542e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,0.0196147715203649,0.00283665979209524,0.0140549183278582,0.0251746247128715,4.80022568127523e-12
NMR metabolomics,X23408.Triglycerides in VLDL,EGFLAM,Pikachurin,24805,0.0150170101815563,0.00218140694974862,0.010741452560049,0.0192925678030636,5.95432938318053e-12
NMR metabolomics,X23408.Triglycerides in VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,0.0134140401035763,0.00194964939453649,0.00959272729028477,0.0172353529168678,6.11701506609925e-12
NMR metabolomics,X23408.Triglycerides in VLDL,FUCA1,Tissue alpha-L-fucosidase,29623,0.0398627599167305,0.00581089130453194,0.0284734129598479,0.0512521068736131,7.02102575468763e-12
NMR metabolomics,X23408.Triglycerides in VLDL,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.0330410315939588,0.00482177640423742,-0.0424917133462642,-0.0235903498416535,7.42873927751661e-12
NMR metabolomics,X23408.Triglycerides in VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,0.0129718812683227,0.00190476335917498,0.00923854508433974,0.0167052174523057,9.93057655634958e-12
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB2A2,Mammaglobin-A,24111,-0.0152200724513506,0.00223793063873548,-0.0196064165032722,-0.0108337283994291,1.06356069069792e-11
NMR metabolomics,X23408.Triglycerides in VLDL,MYOM2,Myomesin-2,24111,-0.0245470471616453,0.00361556098384389,-0.0316335466899793,-0.0174605476333112,1.15314052012508e-11
NMR metabolomics,X23408.Triglycerides in VLDL,SHISA5,Protein shisa-5,24938,0.0121652042069118,0.00179342314440612,0.00865009484387581,0.0156803135699478,1.20146017412448e-11
NMR metabolomics,X23408.Triglycerides in VLDL,MTPN,Myotrophin,28916,0.015704175451107,0.00231731208253972,0.0111622437693292,0.0202461071328849,1.2514472238534e-11
NMR metabolomics,X23408.Triglycerides in VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,0.0143742936386052,0.00212197718611216,0.0102152183538253,0.018533368923385,1.2767163079516e-11
NMR metabolomics,X23408.Triglycerides in VLDL,FGA,Fibrinogen alpha chain,24407,0.014831092098441,0.00218969848044063,0.0105392830767773,0.0191229011201046,1.28898105875059e-11
NMR metabolomics,X23408.Triglycerides in VLDL,EDN1,Endothelin-1,24240,0.014005972468988,0.00206926634421511,0.00995021043432641,0.0180617345036496,1.33030778837418e-11
NMR metabolomics,X23408.Triglycerides in VLDL,LIF,Leukemia inhibitory factor,28774,0.0245676510198028,0.0036345867289671,0.0174438610310273,0.0316914410085784,1.41203174257555e-11
NMR metabolomics,X23408.Triglycerides in VLDL,RAB44,Ras-related protein Rab-44,24793,0.020154459944659,0.00298333912082964,0.0143071152678329,0.0260018046214851,1.45323022930221e-11
NMR metabolomics,X23408.Triglycerides in VLDL,ACTN2,Alpha-actinin-2,24111,-0.0283394483821776,0.00419829549910578,-0.036568107560425,-0.0201107892039303,1.5096508084889e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CA9,Carbonic anhydrase 9,29725,-0.0217469043858743,0.00323161890309716,-0.0280808774359447,-0.0154129313358039,1.73439390787523e-11
NMR metabolomics,X23408.Triglycerides in VLDL,REG3G,Regenerating islet-derived protein 3-gamma,24793,0.0190460699144105,0.00283152998671962,0.0134962711404401,0.024595868688381,1.77668626379504e-11
NMR metabolomics,X23408.Triglycerides in VLDL,KLK8,Kallikrein-8,28443,0.0170696892980756,0.00254519169754058,0.012081113570896,0.0220582650252551,2.02884013418167e-11
NMR metabolomics,X23408.Triglycerides in VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,0.016733739100337,0.00249558839545806,0.0118423858452392,0.0216250923554348,2.0465286826283e-11
NMR metabolomics,X23408.Triglycerides in VLDL,QPCT,Glutaminyl-peptide cyclotransferase,29517,0.012731648090664,0.0019015821123358,0.00900454715048582,0.0164587490308422,2.19098267417132e-11
NMR metabolomics,X23408.Triglycerides in VLDL,SPARCL1,SPARC-like protein 1,29489,-0.0129776763183523,0.00194115335738006,-0.0167823368988172,-0.00917301573788735,2.34163355781845e-11
NMR metabolomics,X23408.Triglycerides in VLDL,SSH3,Protein phosphatase Slingshot homolog 3,24016,0.013902920220157,0.0020798717366976,0.00982637161622968,0.0179794688240843,2.36781724237748e-11
NMR metabolomics,X23408.Triglycerides in VLDL,DSC2,Desmocollin-2,29135,-0.0162243753232987,0.002430098741842,-0.020987368857309,-0.0114613817892883,2.49235484345098e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,0.0156815474287851,0.00235305229871265,0.0110695649233083,0.0202935299342619,2.70595318893328e-11
NMR metabolomics,X23408.Triglycerides in VLDL,DUSP3,Dual specificity protein phosphatase 3,28774,0.0400139462454109,0.00602308770079616,0.0282086943518504,0.0518191981389714,3.11936222543575e-11
NMR metabolomics,X23408.Triglycerides in VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.0192109958413045,0.0028928169418093,0.0135410746353582,0.0248809170472507,3.18159131487226e-11
NMR metabolomics,X23408.Triglycerides in VLDL,EPHX2,Bifunctional epoxide hydrolase 2,28916,0.0289302844515688,0.00436813485495436,0.0203687401358583,0.0374918287672794,3.58080360622225e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PROCR,Endothelial protein C receptor,24111,-0.0168168791882347,0.00254038688743199,-0.0217960374876014,-0.011837720888868,3.67219031942489e-11
NMR metabolomics,X23408.Triglycerides in VLDL,DNPEP,Aspartyl aminopeptidase,24845,0.0272741272220837,0.00412784411474956,0.0191835527571746,0.0353647016869929,3.9916812536644e-11
NMR metabolomics,X23408.Triglycerides in VLDL,GIMAP7,GTPase IMAP family member 7,24381,-0.0151113360264783,0.00228908311220153,-0.0195979389263933,-0.0106247331265633,4.15441059879943e-11
NMR metabolomics,X23408.Triglycerides in VLDL,BOC,Brother of CDO,28916,-0.0108983184154539,0.00165646496393943,-0.0141449897447752,-0.00765164708613264,4.80859924200491e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PMS1,PMS1 protein homolog 1,24195,0.0236654017130656,0.00359832845882972,0.0166126779337593,0.0307181254923718,4.9056915080267e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.0176251188221243,0.0026803292817112,-0.0228785642142783,-0.0123716734299704,4.9375991013848e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,0.0292320138531109,0.00444896829906773,0.0205120359869381,0.0379519917192836,5.11591001533294e-11
NMR metabolomics,X23408.Triglycerides in VLDL,CSF1,Macrophage colony-stimulating factor 1,29581,0.0125140282971298,0.00190852355172643,0.00877332213574604,0.0162547344585136,5.583658159158e-11
NMR metabolomics,X23408.Triglycerides in VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,0.0235137596739615,0.00358902836442287,0.0164792640796926,0.0305482552682303,5.80526217066697e-11
NMR metabolomics,X23408.Triglycerides in VLDL,BRD1,Bromodomain-containing protein 1,24445,-0.014178849138241,0.00217515687911783,-0.0184421566213119,-0.00991554165517001,7.23791238077237e-11
NMR metabolomics,X23408.Triglycerides in VLDL,PREB,Prolactin regulatory element-binding protein,28931,0.0133474613415269,0.00205197808078172,0.00932558430319477,0.0173693383798591,7.91292621042559e-11
NMR metabolomics,X23408.Triglycerides in VLDL,TK1,"Thymidine kinase, cytosolic",24445,0.0210843285380827,0.00324476177098207,0.0147245954669579,0.0274440616092076,8.29851762206431e-11
NMR metabolomics,X23408.Triglycerides in VLDL,COL1A1,Collagen alpha-1(I) chain,29820,-0.011478822994855,0.0017671908201385,-0.0149425170023265,-0.00801512898738359,8.40496211262773e-11
NMR metabolomics,X23408.Triglycerides in VLDL,RSPO3,R-spondin-3,29725,0.0129868788176676,0.00200405419555991,0.00905893259437014,0.016914825040965,9.29706263458975e-11
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE1,Ribonuclease pancreatic,24951,0.0111671019676546,0.0017263119347435,0.00778353057555737,0.0145506733597519,1.00640063543552e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MILR1,Allergin-1,28931,-0.0230628721244566,0.00356839251382659,-0.0300569214515567,-0.0160688227973565,1.04212600499288e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SPP1,Osteopontin,29757,-0.0210091983143164,0.00325818355702871,-0.0273952380860927,-0.0146231585425401,1.14972327989485e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CLASP1,CLIP-associating protein 1,24016,0.0333167471405694,0.00517331076689912,0.0231770580374471,0.0434564362436917,1.2163790635038e-10
NMR metabolomics,X23408.Triglycerides in VLDL,LMOD1,Leiomodin-1,24867,-0.0161877491666391,0.00251376328634301,-0.0211147252078713,-0.0112607731254068,1.21939166236582e-10
NMR metabolomics,X23408.Triglycerides in VLDL,DSG4,Desmoglein-4,29242,0.0225363804442043,0.00350150343164369,0.0156734337181827,0.0293993271702259,1.24397405285917e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA1,Alpha-1-antitrypsin,24548,-0.00370318628538439,0.000576342686116619,-0.00483281795017296,-0.00257355462059581,1.3400657244101e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,0.0200256957752389,0.0031167993897535,0.013916768971322,0.0261346225791557,1.34247147674483e-10
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,0.0189588549830958,0.00295326458689593,0.0131704563927798,0.0247472535734119,1.38704844811094e-10
NMR metabolomics,X23408.Triglycerides in VLDL,FABP1,"Fatty acid-binding protein, liver",29454,0.0426124320649754,0.0066425927215481,0.0295929503307411,0.0556319137992096,1.42931373802842e-10
NMR metabolomics,X23408.Triglycerides in VLDL,FOSB,Protein fosB,28774,0.0175724560985904,0.00274037101347595,0.0122013289121776,0.0229435832850033,1.45432908753997e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,0.0153807687538958,0.00240224027133383,0.0106723778220815,0.0200891596857102,1.54976516729634e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA7A,Semaphorin-7A,29736,0.012499657272984,0.001953999751892,0.00866981775927572,0.0163294967866924,1.60857046049832e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.0315138562123205,0.0049367087378059,0.0218379070862209,0.04118980533842,1.75595091188601e-10
NMR metabolomics,X23408.Triglycerides in VLDL,HSBP1,Heat shock factor-binding protein 1,24240,0.0431902011842202,0.00678213757045205,0.0298972115461342,0.0564831908223063,1.94654518871934e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CREBZF,CREB/ATF bZIP transcription factor,24016,-0.0118162487375348,0.00185808209737284,-0.0154580896483856,-0.00817440782668406,2.06218909665959e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CHGA,Chromogranin-A,24938,-0.0395072558214192,0.00622071563031441,-0.0516998584568355,-0.027314653186003,2.17725147142449e-10
NMR metabolomics,X23408.Triglycerides in VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.0466148746689735,0.00734152165347009,0.0322254922281721,0.0610042571097749,2.19876371015069e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,0.0140285921919526,0.00221183889467743,0.00969338795838485,0.0183637964255204,2.30056747755286e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MBL2,Mannose-binding protein C,24610,-0.0485552499839494,0.00765658462596499,-0.0635621558508408,-0.033548344117058,2.31293295410844e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,24938,0.0273645528691961,0.00434568425871402,0.0188470117221166,0.0358820940162756,3.08623479258188e-10
NMR metabolomics,X23408.Triglycerides in VLDL,TGFB2,Transforming growth factor beta-2 proprotein,24793,0.023370654684692,0.00371382276434351,0.0160915620665787,0.0306497473028053,3.16836353629836e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SDK2,Protein sidekick-2,24381,0.0172626695525548,0.00274511392634132,0.0118822462569258,0.0226430928481838,3.25972611614105e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CLSTN2,Calsyntenin-2,29786,-0.0175646989683272,0.00279773705314449,-0.0230482635924904,-0.0120811343441639,3.47278923317113e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,0.0166071755732324,0.00264536071878299,0.0114222685644178,0.0217920825820471,3.48977433557158e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CLIC5,Chloride intracellular channel protein 5,24195,-0.0141744424756994,0.0022595068791154,-0.0186030759587656,-0.00974580899263324,3.59587744790964e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ATXN2,Ataxin-2,24101,0.0490622462745251,0.00786100499798285,0.0336546764784787,0.0644698160705715,4.41413393036855e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CD7,T-cell antigen CD7,24177,0.0192620172060817,0.00309460107768657,0.0131965990938161,0.0253274353183474,4.91367354212682e-10
NMR metabolomics,X23408.Triglycerides in VLDL,FCRLB,Fc receptor-like B,28797,0.0268783169164581,0.00433120651245733,0.0183891521520417,0.0353674816808745,5.51837849422436e-10
NMR metabolomics,X23408.Triglycerides in VLDL,CDHR1,Cadherin-related family member 1,28774,0.018767003820466,0.00302516880826103,0.0128376729562744,0.0246963346846576,5.59295508400536e-10
NMR metabolomics,X23408.Triglycerides in VLDL,NECTIN1,Nectin-1,24229,0.0142280734918396,0.00229402920697165,0.00973177624617521,0.0187243707375041,5.6572761561424e-10
NMR metabolomics,X23408.Triglycerides in VLDL,NEO1,Neogenin,24867,0.00962457228439386,0.00155342055764278,0.00657986799141401,0.0126692765773737,5.89264290740617e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MATN3,Matrilin-3,29169,-0.0140460563174076,0.00227297758039046,-0.0185010923749729,-0.00959102025984226,6.51208024247829e-10
NMR metabolomics,X23408.Triglycerides in VLDL,ANPEP,Aminopeptidase N,29531,0.0122515064941528,0.00198308818232236,0.00836465365680103,0.0161383593315047,6.57685707026008e-10
NMR metabolomics,X23408.Triglycerides in VLDL,GPNMB,Transmembrane glycoprotein NMB,28733,0.0124580220249273,0.0020263749983872,0.00848632702808841,0.0164297170217662,7.9531288051741e-10
NMR metabolomics,X23408.Triglycerides in VLDL,SCGB1A1,Uteroglobin,29523,0.0240057538116987,0.00390753152974928,0.0163469920133901,0.0316645156100073,8.17754570597813e-10
NMR metabolomics,X23408.Triglycerides in VLDL,EPHB4,Ephrin type-B receptor 4,29820,-0.0108258511001906,0.00176318726723295,-0.0142816981439672,-0.007370004056414,8.35978627300499e-10
NMR metabolomics,X23408.Triglycerides in VLDL,STX3,Syntaxin-3,24845,0.0166713830695597,0.00271866100133704,0.0113428075069391,0.0219999586321803,8.79773036112082e-10
NMR metabolomics,X23408.Triglycerides in VLDL,EFNA1,Ephrin-A1,29390,0.0122300009927133,0.00199772678195402,0.00831445650008336,0.0161455454853431,9.36015423520733e-10
NMR metabolomics,X23408.Triglycerides in VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,28797,0.0172216561571783,0.00281817827004474,0.0116980267478906,0.022745285566466,1.00330094215628e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ACAN,Aggrecan core protein,29192,0.0122119527454948,0.001998832715911,0.00829424062230922,0.0161296648686803,1.01180202983106e-09
NMR metabolomics,X23408.Triglycerides in VLDL,MUC16,Mucin-16,29349,0.0814398915006996,0.013349710423912,0.055274459069832,0.107605323931567,1.07059538407933e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ITM2A,Integral membrane protein 2A,29434,-0.0259703338391619,0.00426854634007422,-0.0343366846657074,-0.0176039830126165,1.18579700205907e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH12,Protocadherin-12,24867,0.0109800972251109,0.00181005268349288,0.0074323939654649,0.014527800484757,1.32883886274961e-09
NMR metabolomics,X23408.Triglycerides in VLDL,EFHD1,EF-hand domain-containing protein D1,24867,0.015124483970745,0.00249783644659423,0.0102287245354203,0.0200202434060697,1.42401252024319e-09
NMR metabolomics,X23408.Triglycerides in VLDL,AHNAK2,Protein AHNAK2,24240,0.0127689040058567,0.00210937697209869,0.00863452514054325,0.0169032828711701,1.43903819961866e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CALB1,Calbindin,29349,0.0186414872087398,0.00308454493401338,0.0125957791380736,0.024687195279406,1.52610814749439e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ODAM,Odontogenic ameloblast-associated protein,28722,0.0228796044592101,0.00379445148106342,0.0154424795563258,0.0303167293620944,1.6621426030632e-09
NMR metabolomics,X23408.Triglycerides in VLDL,EIF5,Eukaryotic translation initiation factor 5,24111,0.0188265609438996,0.00312309885974993,0.0127052871787898,0.0249478347090095,1.68240290998829e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CST7,Cystatin-F,29498,0.0396210048717536,0.00657348987807106,0.0267369647107343,0.0525050450327729,1.68602060789884e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.0245653439362483,0.00408640853538812,0.0165559832068876,0.032574704665609,1.86053339938908e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CASP1,Caspase-1,28774,0.0288613311127876,0.0048031952877377,0.0194470683488217,0.0382755938767535,1.8917336372528e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,0.0179442079545031,0.00298920715935192,0.0120853619221733,0.0238030539868329,1.95971127309042e-09
NMR metabolomics,X23408.Triglycerides in VLDL,KEL,Kell blood group glycoprotein,28774,0.0152310833872342,0.00253882486785176,0.0102549866462447,0.0202071801282236,2.00579146981342e-09
NMR metabolomics,X23408.Triglycerides in VLDL,FABP9,Fatty acid-binding protein 9,29434,0.02368009148179,0.00396000547478655,0.0159184807512084,0.0314417022123717,2.25968338276444e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP5,Rho GTPase-activating protein 5,24016,0.0323267395206578,0.00543329835385893,0.0216774747470943,0.0429760042942213,2.72283695865558e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,29443,0.0179329756222635,0.00302403453324928,0.0120058679370949,0.0238600833074321,3.06034193781912e-09
NMR metabolomics,X23408.Triglycerides in VLDL,DDI2,Protein DDI1 homolog 2,24381,0.0321392658997441,0.00542883311576171,0.0214987529928511,0.042779778806637,3.26042647484148e-09
NMR metabolomics,X23408.Triglycerides in VLDL,SNX18,Sorting nexin-18,24805,0.0186272724658035,0.00316075321455062,0.0124321961652843,0.0248223487663228,3.83447925702226e-09
NMR metabolomics,X23408.Triglycerides in VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,28862,0.0217775185746528,0.00370929003585932,0.0145073101043685,0.029047727044937,4.37715197562003e-09
NMR metabolomics,X23408.Triglycerides in VLDL,DLL4,Delta-like protein 4,24240,0.03572284504814,0.00609428087739787,0.0237780545284402,0.0476676355678398,4.64088078828097e-09
NMR metabolomics,X23408.Triglycerides in VLDL,IL15,Interleukin-15,29434,0.0135670931784476,0.0023190854551465,0.00902168568636049,0.0181125006705348,4.9620124433767e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PRSS53,Serine protease 53,24845,0.0154283350727282,0.00264660111761542,0.0102409968822019,0.0206156732632544,5.62846086247186e-09
NMR metabolomics,X23408.Triglycerides in VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,24101,-0.0137168896671979,0.00235353944288612,-0.0183298269752547,-0.00910395235914105,5.67435511608624e-09
NMR metabolomics,X23408.Triglycerides in VLDL,C8B,Complement component C8 beta chain,24966,0.0124991931261112,0.00215308031661716,0.00827915570554153,0.0167192305466808,6.50440044847804e-09
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.0163061124193025,0.0028135494327502,-0.0218206693074929,-0.0107915555311121,6.89110477054204e-09
NMR metabolomics,X23408.Triglycerides in VLDL,DPEP1,Dipeptidase 1,29163,-0.0198132245540624,0.00343348708727735,-0.026542859245126,-0.0130835898629988,7.97967117676848e-09
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA1549L,UPF0606 protein KIAA1549L,24445,-0.0115487432348321,0.0020023075241889,-0.0154732659822423,-0.00762422048742181,8.13214873306364e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ARG1,Arginase-1,29216,0.0211063935500483,0.00366125792921444,0.013930328008788,0.0282824590913086,8.25806765154881e-09
NMR metabolomics,X23408.Triglycerides in VLDL,ACHE,Acetylcholinesterase,24381,0.0134843961091136,0.00234083263325853,0.0088963641479269,0.0180724280703003,8.48677474999338e-09
NMR metabolomics,X23408.Triglycerides in VLDL,TPSAB1,Tryptase alpha/beta-1,29753,0.0213007205183508,0.00370140264889298,0.0140459713265206,0.0285554697101811,8.76110576228628e-09
NMR metabolomics,X23408.Triglycerides in VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,0.0425365934623333,0.00739280085850296,0.0280467037796675,0.0570264831449991,8.81379629813372e-09
NMR metabolomics,X23408.Triglycerides in VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,24445,0.0178977804035359,0.00311167570904925,0.0117988960137994,0.0239966647932724,8.93440363807365e-09
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G2A,"Phospholipase A2, membrane associated",29402,-0.0226083018547894,0.00393342958586308,-0.0303178238430811,-0.0148987798664978,9.13417845053926e-09
NMR metabolomics,X23408.Triglycerides in VLDL,GIPC2,PDZ domain-containing protein GIPC2,24845,0.0121043014643142,0.00210921124811219,0.00797024741801433,0.0162383555106141,9.64696772176412e-09
NMR metabolomics,X23408.Triglycerides in VLDL,RPS10,40S ribosomal protein S10,24111,-0.017025719518002,0.00297370220484917,-0.0228541758395063,-0.0111972631964976,1.04398613697828e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.00899234998376056,0.00157405182689858,0.00590720840303934,0.0120774915644818,1.12159020837208e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,-0.0127382082202164,0.00223503662354118,-0.0171188800023571,-0.00835753643807567,1.21683758702328e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CKAP4,Cytoskeleton-associated protein 4,29678,0.0109361222673895,0.00192095662219877,0.00717104728787986,0.0147011972468991,1.25958849575523e-08
NMR metabolomics,X23408.Triglycerides in VLDL,NPTX2,Neuronal pentraxin-2,24938,-0.0133948277212366,0.00236316541735044,-0.0180266319392435,-0.00876302350322976,1.45922754332492e-08
NMR metabolomics,X23408.Triglycerides in VLDL,NPR1,Atrial natriuretic peptide receptor 1,24111,-0.0165899690376659,0.00292786468333701,-0.0223285838170065,-0.0108513542583254,1.47634446733523e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SAFB2,Scaffold attachment factor B2,24867,0.0110135678667776,0.001944256128901,0.0072028258541316,0.0148243098794235,1.48935642151743e-08
NMR metabolomics,X23408.Triglycerides in VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,0.0155837996494247,0.0027520275609963,0.0101898256298719,0.0209777736689774,1.5043020455502e-08
NMR metabolomics,X23408.Triglycerides in VLDL,RPA2,Replication protein A 32 kDa subunit,24229,0.0127372583437458,0.00225556602228584,0.00831634894006552,0.017158167747426,1.650679604422e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SIRPB1,Signal-regulatory protein beta-1,29409,0.0183817638687411,0.0032632057046206,0.0119858806876847,0.0247776470497974,1.78678534650427e-08
NMR metabolomics,X23408.Triglycerides in VLDL,GM2A,Ganglioside GM2 activator,24421,0.0153320987085647,0.00272170763756941,0.00999755173892861,0.0206666456782007,1.78776530581662e-08
NMR metabolomics,X23408.Triglycerides in VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,0.0266643750177324,0.00473703918650895,0.0173797782121748,0.0359489718232899,1.83310474416388e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ALPI,Intestinal-type alkaline phosphatase,24229,0.0490522369895766,0.00871829354354629,0.0319643816442259,0.0661400923349274,1.86087000312908e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CFHR4,Complement factor H-related protein 4,24892,0.0291387181520232,0.00518582852804329,0.0189744942370584,0.039302942066988,1.94217311050453e-08
NMR metabolomics,X23408.Triglycerides in VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,-0.0280480528527475,0.00499328935047883,-0.037834899979686,-0.018261205725809,1.96213738889515e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CNPY2,Protein canopy homolog 2,28916,0.0241070539056131,0.0043065489658396,0.0156662179325675,0.0325478898786587,2.19099215277187e-08
NMR metabolomics,X23408.Triglycerides in VLDL,LHB,Lutropin subunit beta,28797,0.0343718622799214,0.0061514264064101,0.0223150665233576,0.0464286580364852,2.32276547377112e-08
NMR metabolomics,X23408.Triglycerides in VLDL,EXTL1,Exostosin-like 1,24111,0.01884986897817,0.00337400796840721,0.0122368133600918,0.0254629245962481,2.3380412297762e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA6,Corticosteroid-binding globulin,24966,0.00666174419705545,0.00119316405363773,0.00432314265192551,0.00900034574218539,2.38506989602007e-08
NMR metabolomics,X23408.Triglycerides in VLDL,PLIN3,Perilipin-3,29478,0.0167486978666556,0.00300708540718808,0.0108548104685669,0.0226425852647442,2.57336783763353e-08
NMR metabolomics,X23408.Triglycerides in VLDL,VCAN,Versican core protein,29694,-0.0118298738997976,0.00212426027825045,-0.0159934240451685,-0.00766632375442675,2.58513172228934e-08
NMR metabolomics,X23408.Triglycerides in VLDL,COL9A2,Collagen alpha-2(IX) chain,24445,0.0179181509078576,0.00322606939189922,0.0115950548997352,0.0242412469159801,2.8183013449406e-08
NMR metabolomics,X23408.Triglycerides in VLDL,GBA,Lysosomal acid glucosylceramidase,24195,0.0211803926023056,0.00382300538488227,0.0136873020479363,0.0286734831566748,3.05190968683222e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.0147251530569878,0.00266012185158176,0.00951131422788759,0.0199389918860881,3.12953381932291e-08
NMR metabolomics,X23408.Triglycerides in VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.0105695985883836,0.00190957396185336,0.006826833623151,0.0143123635536162,3.14269225028894e-08
NMR metabolomics,X23408.Triglycerides in VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,0.02011865759354,0.00365812436092877,0.0129487338461196,0.0272885813409604,3.83627510435836e-08
NMR metabolomics,X23408.Triglycerides in VLDL,ERC2,ERC protein 2,24195,0.0293909497760742,0.00534510073623503,0.0189145523330536,0.0398673472190949,3.86533701108631e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,28774,0.0562832795094296,0.0102629518932682,0.0361678937986239,0.0763986652202352,4.19021990911643e-08
NMR metabolomics,X23408.Triglycerides in VLDL,RCC1,Regulator of chromosome condensation,24793,0.0198730334631076,0.00364806467522155,0.0127228266996733,0.0270232402265418,5.15527131505587e-08
NMR metabolomics,X23408.Triglycerides in VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,24445,0.0223944365923224,0.00412771403712057,0.014304117079566,0.0304847561050787,5.83790936247304e-08
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL5,Fc receptor-like protein 5,29443,-0.0220326555750759,0.00406660961231369,-0.0300032104152107,-0.014062100734941,6.07614252590701e-08
NMR metabolomics,X23408.Triglycerides in VLDL,WFDC2,WAP four-disulfide core domain protein 2,27939,0.0153338446124266,0.00283046848684832,0.00978612637820389,0.0208815628466493,6.09635346780598e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,0.0169641307381725,0.00313814390832042,0.0108133686778645,0.0231148927984806,6.51294830504424e-08
NMR metabolomics,X23408.Triglycerides in VLDL,VIM,Vimentin,28916,0.0444162551251369,0.00824493531004876,0.0282561819174414,0.0605763283328325,7.2164247954961e-08
NMR metabolomics,X23408.Triglycerides in VLDL,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.00923566362822264,0.00171524343008753,0.00587378650525107,0.0125975407511942,7.32146054816841e-08
NMR metabolomics,X23408.Triglycerides in VLDL,VWF,von Willebrand factor,29820,-0.0275354752285992,0.00512733313220951,-0.0375850481677298,-0.0174859022894685,7.91799518616191e-08
NMR metabolomics,X23408.Triglycerides in VLDL,DDX25,ATP-dependent RNA helicase DDX25,24195,-0.0142892567598811,0.00267142261215481,-0.0195252450797045,-0.00905326844005767,8.92783958549353e-08
NMR metabolomics,X23408.Triglycerides in VLDL,TRIM26,Tripartite motif-containing protein 26,24016,0.0212380857649638,0.00397198921319392,0.0134529869071037,0.0290231846228239,9.02585960798257e-08
NMR metabolomics,X23408.Triglycerides in VLDL,SPON1,Spondin-1,29497,0.0123936480996663,0.00232179062843889,0.00784293846792612,0.0169443577314066,9.46871517347038e-08
NMR metabolomics,X23408.Triglycerides in VLDL,DCTPP1,dCTP pyrophosphatase 1,29478,0.0119538654315065,0.00224536800226411,0.00755294414706883,0.0163547867159441,1.02370938568522e-07
NMR metabolomics,X23408.Triglycerides in VLDL,IL1R1,Interleukin-1 receptor type 1,29390,-0.00866044357251523,0.00162737833333057,-0.0118501051058431,-0.00547078203918731,1.0354635458546e-07
NMR metabolomics,X23408.Triglycerides in VLDL,RBPMS,RNA-binding protein with multiple splicing,24229,0.0243087022224453,0.00456835293244261,0.0153547304748578,0.0332626739700328,1.0405325338835e-07
NMR metabolomics,X23408.Triglycerides in VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.0147126213968248,0.00277298504172222,0.00927757071504925,0.0201476720786003,1.13072483876023e-07
NMR metabolomics,X23408.Triglycerides in VLDL,FAM3D,Protein FAM3D,24805,0.0317745517284982,0.00598984720907321,0.0200344511987147,0.0435146522582817,1.13804457491035e-07
NMR metabolomics,X23408.Triglycerides in VLDL,FGFR4,Fibroblast growth factor receptor 4,24381,0.0198954383140668,0.00375111379939981,0.0125432552672432,0.0272476213608904,1.14358569379509e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MRC1,Macrophage mannose receptor 1,24951,0.0106151617339893,0.00200583184411676,0.00668373131952044,0.0145465921484581,1.21908186567796e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.0128554737370623,0.00243051016940293,0.00809167380503254,0.017619273669092,1.23727150703246e-07
NMR metabolomics,X23408.Triglycerides in VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.0142950015824251,0.00271359768932325,-0.0196136530534986,-0.00897635011135148,1.38942485613078e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CYTL1,Cytokine-like protein 1,24938,0.00898690005123051,0.00171104313052738,0.00563325551539683,0.0123405445870642,1.51449928487799e-07
NMR metabolomics,X23408.Triglycerides in VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,0.0240802445102768,0.00459880641431201,0.0150665839382252,0.0330939050823283,1.65277496474597e-07
NMR metabolomics,X23408.Triglycerides in VLDL,FMR1,Synaptic functional regulator FMR1,28797,0.0131608395885876,0.00251390329831177,0.00823358912389655,0.0180880900532787,1.6594329736543e-07
NMR metabolomics,X23408.Triglycerides in VLDL,NPTX1,Neuronal pentraxin-1,29443,0.0150491527744455,0.0028753073801226,0.00941355030940524,0.0206847552394858,1.67082033772893e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LY9,T-lymphocyte surface antigen Ly-9,29116,0.0108256931623422,0.00208307613311935,0.00674286394142831,0.0149085223832562,2.03924062755621e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GBP2,Guanylate-binding protein 2,28931,0.0220348566026071,0.0042406518016994,0.0137231790712763,0.0303465341339379,2.04891377872177e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GLP1R,Glucagon-like peptide 1 receptor,24101,-0.0139125541799067,0.002689273354945,-0.0191835299555989,-0.00864157840421445,2.31774184344828e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MYL3,Myosin light chain 3,24240,-0.0266881170752267,0.00518570368787641,-0.0368520963034644,-0.0165241378469889,2.67491657986531e-07
NMR metabolomics,X23408.Triglycerides in VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,0.0199761112082397,0.00389041913102558,0.0123508897114296,0.0276013327050499,2.84735845305617e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CDH3,Cadherin-3,29694,0.0131128348737744,0.00255941978150003,0.00809637210203436,0.0181292976455145,3.02012229022649e-07
NMR metabolomics,X23408.Triglycerides in VLDL,NAPRT,Nicotinate phosphoribosyltransferase,24845,0.0120525580447164,0.0023555338849561,0.00743571163020248,0.0166694044592304,3.13243284879596e-07
NMR metabolomics,X23408.Triglycerides in VLDL,KLK11,Kallikrein-11,29296,0.0111581573749189,0.00218169548055021,0.00688203423304047,0.0154342805167973,3.16649660407969e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PLA2G1B,Phospholipase A2,29787,-0.0155323872934646,0.00304644976473091,-0.0215034288323372,-0.00956134575459204,3.44412813011512e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MUC2,Mucin-2,24938,0.0330363145957836,0.00648506920689617,0.0203255789502671,0.0457470502413001,3.52748281299462e-07
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,0.0256523069542271,0.00505279226505059,0.0157488341147279,0.0355557797937262,3.86496564953183e-07
NMR metabolomics,X23408.Triglycerides in VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.0102192865587883,0.00202053024989985,-0.014179525848592,-0.00625904726898463,4.268535133853e-07
NMR metabolomics,X23408.Triglycerides in VLDL,STX5,Syntaxin-5,24229,0.0145898676214711,0.00289693682887965,0.00891187143686698,0.0202678638060752,4.78002408534407e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,0.0204518266628785,0.00406277638808861,0.0124887849422248,0.0284148683835321,4.83294832704253e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CHRM1,Muscarinic acetylcholine receptor M1,24195,-0.0131693566915223,0.00261904815302987,-0.0183026910714609,-0.00803602231158379,4.98385928422937e-07
NMR metabolomics,X23408.Triglycerides in VLDL,NTF3,Neurotrophin-3,29434,0.0123414631253248,0.0024548356274571,0.0075299852955089,0.0171529409551407,5.00066840379035e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CPA4,Carboxypeptidase A4,23902,0.015599103183435,0.00311014189397509,0.00950322507124386,0.0216949812956262,5.32579468576773e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SDC1,Syndecan-1,29478,0.0142297452050768,0.00284116502415784,0.00866106175772746,0.0197984286524262,5.51956664304004e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN4,Contactin-4,29443,-0.00852382939040467,0.00170216664573505,-0.0118600760160454,-0.00518758276476398,5.54210966920455e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GSTP1,Glutathione S-transferase P,28604,-0.0247100724097886,0.00493480195760983,-0.0343822842467039,-0.0150378605728734,5.55246682073046e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CDK1,Cyclin-dependent kinase 1,24016,0.0129553283360132,0.00258773840878936,0.00788336105478601,0.0180272956172403,5.58415896363717e-07
NMR metabolomics,X23408.Triglycerides in VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.0302405978691958,0.00604831265988224,-0.042095290682565,-0.0183859050558266,5.77181115195765e-07
NMR metabolomics,X23408.Triglycerides in VLDL,IL6,Interleukin-6,29349,0.0260074577380578,0.0052095164707338,0.0157968054554195,0.036218110020696,6.00067505481233e-07
NMR metabolomics,X23408.Triglycerides in VLDL,SLC13A1,Solute carrier family 13 member 1,24793,0.0214445786251972,0.00432768714525711,0.0129623118204932,0.0299268454299011,7.27299383143934e-07
NMR metabolomics,X23408.Triglycerides in VLDL,EPHB6,Ephrin type-B receptor 6,29163,0.0111737277551466,0.00225568828073273,0.00675257872491043,0.0155948767853827,7.32685158149578e-07
NMR metabolomics,X23408.Triglycerides in VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.00681103701536466,0.0013771655021683,-0.00951028139961453,-0.00411179263111479,7.63663822988018e-07
NMR metabolomics,X23408.Triglycerides in VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,0.010022683591281,0.00202813947567703,0.00604753021895402,0.013997836963608,7.79045188607695e-07
NMR metabolomics,X23408.Triglycerides in VLDL,CLPS,Colipase,29400,0.0247573085353912,0.00501497522286224,0.0149279570985812,0.0345866599722012,7.99001897138669e-07
NMR metabolomics,X23408.Triglycerides in VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,0.0170502944736282,0.00345846786870113,0.010271697450974,0.0238288914962824,8.27533328680004e-07
NMR metabolomics,X23408.Triglycerides in VLDL,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.0214787074052817,0.0043775520340351,-0.0300587093919905,-0.0128987054185729,9.31776443234694e-07
NMR metabolomics,X23408.Triglycerides in VLDL,IL10RA,Interleukin-10 receptor subunit alpha,28931,0.0201596882298971,0.00412115382655378,0.0120822267298517,0.0282371497299425,1.00475749309585e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CHRDL2,Chordin-like protein 2,29478,0.0184219253749512,0.00377360709703825,0.0110256554647563,0.0258181952851462,1.05681330702587e-06
NMR metabolomics,X23408.Triglycerides in VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.0155000560187524,0.00318348633952586,0.00926042279328172,0.0217396892442231,1.12915686523886e-06
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.0101467942141855,0.00208943735161669,0.0060514970050168,0.0142420914233542,1.20253479377577e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.0176591291419408,0.00364446092566027,0.0105159857276467,0.0248022725562349,1.27096634152428e-06
NMR metabolomics,X23408.Triglycerides in VLDL,QSOX1,Sulfhydryl oxidase 1,24502,0.0146235058916927,0.00302114444155591,0.00870206278624308,0.0205449489971423,1.30376171832636e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.0117581968778775,0.00243282223292056,-0.0165265284544018,-0.00698986530135322,1.35062185243623e-06
NMR metabolomics,X23408.Triglycerides in VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,0.0139383808369469,0.0028844360329592,0.00828488621234687,0.0195918754615469,1.35808884891873e-06
NMR metabolomics,X23408.Triglycerides in VLDL,LMNB1,Lamin-B1,24756,0.0201100715170188,0.00416668469822152,0.0119433695085046,0.028276773525533,1.39854342668433e-06
NMR metabolomics,X23408.Triglycerides in VLDL,C1QL2,Complement C1q-like protein 2,24229,0.0146677225586097,0.00304485903949623,0.0086997988411971,0.0206356462760223,1.46460233363871e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NEDD9,Enhancer of filamentation 1,24229,0.011372126854818,0.00236416262970457,0.006738368100597,0.0160058856090389,1.51675588431124e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PI3,Elafin,29014,0.0186874351638822,0.00389476364864673,0.0110536984125346,0.0263211719152298,1.60980021148694e-06
NMR metabolomics,X23408.Triglycerides in VLDL,JCHAIN,Immunoglobulin J chain,28931,-0.0208508272461094,0.00435889194791325,-0.0293942554640194,-0.0123073990281995,1.7310402983491e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PDRG1,p53 and DNA damage-regulated protein 1,24195,0.0177229023251999,0.003706851866575,0.010457472666713,0.0249883319836869,1.75346747036499e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,0.0119043503127827,0.00249150635124474,0.00702099786434297,0.0167877027612224,1.78108324086378e-06
NMR metabolomics,X23408.Triglycerides in VLDL,KRT8,"Keratin, type II cytoskeletal 8",24101,0.0245916004408117,0.00515876945903126,0.0144804123011105,0.034702788580513,1.88126618822616e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CD55,Complement decay-accelerating factor,28490,0.00885774306161699,0.00185904476922309,0.00521401531393973,0.0125014708092943,1.90090707626871e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NXPH3,Neurexophilin-3,24229,0.0102176385652817,0.00214518279903979,0.00601308027916367,0.0144221968513996,1.91780861922883e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ROBO4,Roundabout homolog 4,24240,-0.00606135549932745,0.0012771533833033,-0.00856457613060192,-0.00355813486805299,2.08674183075394e-06
NMR metabolomics,X23408.Triglycerides in VLDL,COMMD9,COMM domain-containing protein 9,24793,0.0132343663008367,0.00279664303030403,0.00775294596144078,0.0187157866402326,2.23288263443044e-06
NMR metabolomics,X23408.Triglycerides in VLDL,EP300,Histone acetyltransferase p300,24229,0.0100969596822987,0.00214175418469876,0.0058991214802891,0.0142947978843083,2.43843222528633e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CD48,CD48 antigen,29536,0.0099728656396043,0.00211827968942318,0.00582103744833486,0.0141246938308737,2.51291422802879e-06
NMR metabolomics,X23408.Triglycerides in VLDL,HEPACAM2,HEPACAM family member 2,24845,-0.0139615340452171,0.00297728038343818,-0.0197970035967559,-0.00812606449367823,2.75519983046782e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,0.0288558775197342,0.00616663296364317,0.0167692769109936,0.0409424781284748,2.89331591995135e-06
NMR metabolomics,X23408.Triglycerides in VLDL,RAB39B,Ras-related protein Rab-39B,24111,0.0299157534649553,0.00640531186503275,0.0173613422094911,0.0424701647204195,3.02146546678969e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.0611194554465241,0.0131009696214758,0.0354415549884315,0.0867973559046167,3.09583339337336e-06
NMR metabolomics,X23408.Triglycerides in VLDL,DCN,Decorin,28916,-0.00754469443111824,0.00161872566918706,-0.0107173967427249,-0.0043719921195116,3.16256435865722e-06
NMR metabolomics,X23408.Triglycerides in VLDL,S100G,Protein S100-G,24867,-0.0153290431917619,0.00329223921937827,-0.0217818320617434,-0.00887625432178053,3.23897539720025e-06
NMR metabolomics,X23408.Triglycerides in VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,-0.00873372466409699,0.00187667690430826,-0.0124120113965412,-0.0050554379316528,3.27257628511539e-06
NMR metabolomics,X23408.Triglycerides in VLDL,IL17RA,Interleukin-17 receptor A,29443,0.0144906817355493,0.00311619536383335,0.00838293882243591,0.0205984246486626,3.33182260685079e-06
NMR metabolomics,X23408.Triglycerides in VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.0182512342893961,0.00393243558923519,0.0105436605344951,0.025958808044297,3.47911626377159e-06
NMR metabolomics,X23408.Triglycerides in VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,28774,0.0161765956361123,0.00348912145235496,0.00933791758949658,0.023015273682728,3.56267612286803e-06
NMR metabolomics,X23408.Triglycerides in VLDL,TFF2,Trefoil factor 2,29536,0.0188563424133951,0.00407731482779027,0.0108648053509262,0.026847879475864,3.76737241784444e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CD200,OX-2 membrane glycoprotein,29434,-0.00861445200480749,0.00187647477457405,-0.0122923425629726,-0.00493656144664235,4.43452634465926e-06
NMR metabolomics,X23408.Triglycerides in VLDL,MSLN,Mesothelin,29293,0.018159475727389,0.00395672902948904,0.0104042868295904,0.0259146646251875,4.46115593410937e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PRDX2,Peroxiredoxin-2,24556,0.0200396988820037,0.00436699431086712,0.0114803900327041,0.0285990077313033,4.47793340753102e-06
NMR metabolomics,X23408.Triglycerides in VLDL,FAM171B,Protein FAM171B,24793,0.0088229956227715,0.00192412347944186,0.00505171360306545,0.0125942776424776,4.55196692874568e-06
NMR metabolomics,X23408.Triglycerides in VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.0104215908238145,0.00227616426702769,-0.0148828727871888,-0.00596030886044023,4.70109988778183e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CD86,T-lymphocyte activation antigen CD86,24805,0.0096781893178137,0.00212149902707276,0.00552005122475109,0.0138363274108763,5.0921502845247e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CSF3,Granulocyte colony-stimulating factor,28931,0.0155991339006001,0.00342543916292217,0.00888527314127266,0.0223129946599276,5.28731412479787e-06
NMR metabolomics,X23408.Triglycerides in VLDL,BRD3,Bromodomain-containing protein 3,24111,0.0154166013207157,0.00339586494634302,0.00876070602588338,0.022072496615548,5.65756809634742e-06
NMR metabolomics,X23408.Triglycerides in VLDL,NDRG1,Protein NDRG1,28774,0.021663837150473,0.00477217481610918,0.012310374510899,0.0310172997900469,5.658524206326e-06
NMR metabolomics,X23408.Triglycerides in VLDL,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.0110550288745785,0.00245784814957829,0.0062376465014051,0.015872411247752,6.89034538800569e-06
NMR metabolomics,X23408.Triglycerides in VLDL,RLN1,Prorelaxin H1,24867,-0.0218654968958508,0.00488189206589331,-0.0314340053450017,-0.0122969884466999,7.53633851005741e-06
NMR metabolomics,X23408.Triglycerides in VLDL,IFNGR1,Interferon gamma receptor 1,29581,0.0066492044501741,0.00148736593948902,0.00373396720877563,0.00956444169157258,7.83427981228632e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.0187869634185192,0.00421041105566898,0.010534557749408,0.0270393690876304,8.15573073791433e-06
NMR metabolomics,X23408.Triglycerides in VLDL,FOLH1,Glutamate carboxypeptidase 2,24229,0.0335519168729076,0.0075228099824762,0.0188072093072542,0.0482966244385609,8.23187480985736e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.0201730998761276,0.004524009586201,0.0113060410871736,0.0290401586650815,8.26123946170109e-06
NMR metabolomics,X23408.Triglycerides in VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,-0.0118743624061741,0.00267038422064422,-0.0171083154786368,-0.00664040933371147,8.75943373766295e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,-0.0108010916778586,0.00243424528453524,-0.0155722124355477,-0.0060299709201695,9.15652392633385e-06
NMR metabolomics,X23408.Triglycerides in VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.0223130986145964,0.00503094433183615,0.0124524477241975,0.0321737495049952,9.23294523636156e-06
NMR metabolomics,X23408.Triglycerides in VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,0.0169126300528484,0.00381505362487096,0.00943512494810127,0.0243901351575954,9.32181249108955e-06
NMR metabolomics,X23408.Triglycerides in VLDL,CENPJ,Centromere protein J,24445,0.0224998660979347,0.00509377968062495,0.0125160579239098,0.0324836742719596,1.0045152784304e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.0152812643853036,0.0034821601670416,-0.0221062983127051,-0.00845623045790202,1.14560319169927e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,0.00665945750059507,0.00151972037078644,0.00368080557385366,0.00963810942733649,1.18062241768175e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,29349,0.00961047164128326,0.00221070391029666,0.00527749197710181,0.0139434513054647,1.38321945517633e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,29434,0.0201250874762975,0.00463462453366685,0.0110412233903105,0.0292089515622845,1.41447887394398e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,0.0159718175582182,0.00367914308454494,0.00876069711251015,0.0231829380039263,1.42281967836907e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SYT1,Synaptotagmin-1,24845,0.0121442412705475,0.00280134838750832,0.0066535984310312,0.0176348841100638,1.46239413295652e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NELL2,Protein kinase C-binding protein NELL2,29581,0.00874169331429048,0.00201997347315651,0.00478254530690372,0.0127008413216772,1.5121836909947e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SOD3,Extracellular superoxide dismutase,24951,-0.0183186595526185,0.00424357023653647,-0.0266360572162299,-0.010001261889007,1.58914881302818e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PCDHB15,Protocadherin beta-15,24793,-0.0122007531416055,0.00283711532800462,-0.0177614991844945,-0.00664000709871644,1.71135649682815e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NRTN,Neurturin,28931,0.0150107268057708,0.00349911292681037,0.00815246546922245,0.0218689881423191,1.7936065043984e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.0187679002742922,0.00438025763860139,0.0101825953026335,0.0273532052459509,1.83731235279345e-05
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA2,Ephrin type-A receptor 2,28347,0.00949431321208034,0.00222518139494937,0.00513295767797958,0.0138556687461811,1.98976319167311e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM3,Intercellular adhesion molecule 3,29820,-0.00785611902351131,0.00184428028040279,-0.0114709083731008,-0.00424132967392184,2.05309523790226e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NTF4,Neurotrophin-4,28797,0.0118842448463408,0.00279264088215489,0.00641066871731721,0.0173578209753644,2.09187569147631e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NCR1,Natural cytotoxicity triggering receptor 1,29375,0.0111266735055135,0.00261984549084235,0.00599177634346247,0.0162615706675645,2.17247992451141e-05
NMR metabolomics,X23408.Triglycerides in VLDL,F3,Tissue factor,29541,-0.00820074133437748,0.00193217934159391,-0.0119878128439015,-0.00441366982485342,2.19949454167807e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MAPK13,Mitogen-activated protein kinase 13,24016,0.0127138862046617,0.00299853833978327,0.00683675105868644,0.0185910213506369,2.24327632594655e-05
NMR metabolomics,X23408.Triglycerides in VLDL,COMP,Cartilage oligomeric matrix protein,29214,0.0100687363113099,0.00237878055595303,0.00540632642164197,0.0147311462009778,2.31576132630608e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC14A,C-type lectin domain family 14 member A,29443,-0.00946502595751575,0.0022451452201708,-0.0138655105890505,-0.00506454132598098,2.49664881081066e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC6A,C-type lectin domain family 6 member A,28797,0.0140233727758275,0.00332881506832472,0.00749889524191103,0.0205478503097439,2.5307879935268e-05
NMR metabolomics,X23408.Triglycerides in VLDL,HYAL1,Hyaluronidase-1,29265,0.00684337698215599,0.00162697216625517,0.00365451153629586,0.0100322424280161,2.60468339942844e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CCL28,C-C motif chemokine 28,29327,0.0176287087538655,0.00419189008225374,0.00941260419264813,0.0258448133150828,2.6135698565785e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TXNL1,Thioredoxin-like protein 1,24069,0.0290944292723739,0.0069632326315396,0.0154464933145563,0.0427423652301915,2.94740739178865e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTSL5,ADAMTS-like protein 5,24922,-0.0116589672008223,0.00279429649297356,-0.0171357883270505,-0.00618214607459415,3.02408155604189e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TYMP,Thymidine phosphorylase,29301,0.0194293364605069,0.00470113510160135,0.0102151116613682,0.0286435612596455,3.59205085506106e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.00827821704650746,0.00200456079482431,0.00434927788865181,0.0122071562043631,3.64251323899885e-05
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA4,Ephrin type-A receptor 4,24381,0.00837635618464394,0.00202862178837178,0.00440025747943526,0.0123524548898526,3.65418865705354e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CLMP,CXADR-like membrane protein,29725,0.0061763077110413,0.00149737508253818,0.00324145254926647,0.00911116287281612,3.72136161845588e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CDH6,Cadherin-6,29478,-0.011178794860208,0.00271190435345621,-0.0164941273929822,-0.00586346232743381,3.76428514710627e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,0.00933183059419752,0.00226652458390052,0.00488944240975249,0.0137742187786425,3.84478748667075e-05
NMR metabolomics,X23408.Triglycerides in VLDL,BABAM1,BRISC and BRCA1-A complex member 1,24229,0.0085792878278013,0.00208684195940313,0.00448907758737117,0.0126694980682314,3.95017244669342e-05
NMR metabolomics,X23408.Triglycerides in VLDL,OPTC,Opticin,29349,-0.0131131612747725,0.00319085995804256,-0.0193672467925359,-0.00685907575700911,3.97419656863345e-05
NMR metabolomics,X23408.Triglycerides in VLDL,GUK1,Guanylate kinase,24111,-0.011682611898179,0.00284490142027748,-0.0172586186819228,-0.00610660511443514,4.03009093699583e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SCG3,Secretogranin-3,29497,-0.0096381623666383,0.00235264296651335,-0.0142493425810045,-0.00502698215227212,4.20131030569509e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NMRK2,Nicotinamide riboside kinase 2,24016,-0.0120450057493023,0.00294742311257134,-0.0178219550499422,-0.00626805644866252,4.39120754084459e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TERF1,Telomeric repeat-binding factor 1,24229,-0.00848334594443706,0.00208280759913565,-0.0125656488387429,-0.00440104305013119,4.65522657838914e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MELTF,Melanotransferrin,24922,0.00854788655621591,0.00209986407894734,0.00443215296147912,0.0126636201509527,4.70195928415208e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CD109,CD109 antigen,29443,-0.00970389217158205,0.00238672274730314,-0.0143818687562962,-0.00502591558686789,4.79962768539537e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ATP6V1D,V-type proton ATPase subunit D,29349,0.00749184344448262,0.00184423845211894,0.00387713607832951,0.0111065508106357,4.87185821417349e-05
NMR metabolomics,X23408.Triglycerides in VLDL,FSTL1,Follistatin-related protein 1,24240,-0.00657987909512813,0.0016204755028508,-0.00975601108071569,-0.00340374710954056,4.91296097526818e-05
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA1549,UPF0606 protein KIAA1549,24445,0.0200464328447509,0.00494008864627158,0.0103638590980586,0.0297290065914432,4.96678428316824e-05
NMR metabolomics,X23408.Triglycerides in VLDL,GFRA2,GDNF family receptor alpha-2,29349,0.00602556485644624,0.00148721231273044,0.00311062872349459,0.0089405009893979,5.10030562522415e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN2,Contactin-2,29725,0.0127735948272271,0.00315537007054566,0.00658906948895763,0.0189581201654966,5.17419344933e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CEP152,Centrosomal protein of 152 kDa,24016,0.0119735360249053,0.00295872231815778,0.00617444028131602,0.0177726317684945,5.20717354331664e-05
NMR metabolomics,X23408.Triglycerides in VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,24229,0.0104969869660743,0.00259426853431053,0.00541222063882564,0.0155817532933229,5.22122837608221e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ELAVL4,ELAV-like protein 4,24101,0.024301530387229,0.00600736242922901,0.0125271000259401,0.0360759607485178,5.24209453576591e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CEP290,Centrosomal protein of 290 kDa,24445,0.0152247806991438,0.00376532378762868,0.00784474607539161,0.022604815322896,5.28389522521377e-05
NMR metabolomics,X23408.Triglycerides in VLDL,LEG1,Protein LEG1 homolog,23603,-0.0200563056146946,0.00496494513731981,-0.0297875980838415,-0.0103250131455478,5.37158761823462e-05
NMR metabolomics,X23408.Triglycerides in VLDL,AOC3,Membrane primary amine oxidase,29594,-0.0086161137401558,0.00213425818461377,-0.0127992597819988,-0.00443296769831281,5.42630484409882e-05
NMR metabolomics,X23408.Triglycerides in VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,24195,0.0178240140724741,0.00442866286040487,0.00914383486608057,0.0265041932788676,5.72230427351106e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PTK7,Inactive tyrosine-protein kinase 7,28774,0.0109208388178579,0.00271800079143394,0.00559355726664742,0.0162481203690684,5.88515612814185e-05
NMR metabolomics,X23408.Triglycerides in VLDL,IL15RA,Interleukin-15 receptor subunit alpha,28931,0.0099901653548311,0.00248926315143964,0.0051112095780094,0.0148691211316528,6.00259280003077e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PRKCQ,Protein kinase C theta type,28931,0.0123430644225606,0.00308375479513876,0.0062989050240886,0.0183872238210326,6.28039648673846e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SLC12A2,Solute carrier family 12 member 2,24111,-0.00780759587384715,0.00195559302858698,-0.0116405582098776,-0.00397463353781666,6.55895126349625e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.0157798519939852,0.00395450889353402,0.00802901456265847,0.0235306894253118,6.61698797885712e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ARTN,Artemin,28931,0.0126214272786512,0.00316829523447691,0.00641156861907644,0.0188312859382259,6.8026608328516e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CEP164,Centrosomal protein of 164 kDa,28931,0.0177685036805338,0.00446407178132676,0.00901892298913338,0.0265180843719343,6.89859978103589e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.013830936150012,0.00347647984867474,-0.0206448366534144,-0.00701703564660947,6.95370852692795e-05
NMR metabolomics,X23408.Triglycerides in VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,-0.00592336267981218,0.00148983988599368,-0.00884344885635979,-0.00300327650326457,7.0335179843669e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,0.0174475987902757,0.00439384106629634,0.00883567030033489,0.0260595272802166,7.18019312617101e-05
NMR metabolomics,X23408.Triglycerides in VLDL,IDS,Iduronate 2-sulfatase,29786,0.00249349738687279,0.000628465674208113,0.00126170466542489,0.00372529010832069,7.27715249580638e-05
NMR metabolomics,X23408.Triglycerides in VLDL,FCAR,Immunoglobulin alpha Fc receptor,29434,0.013372413608394,0.00337668541049925,0.00675411020381546,0.0199907170129725,7.50572704598149e-05
NMR metabolomics,X23408.Triglycerides in VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.0114604610019211,0.00289403006380678,-0.0171327599269824,-0.00578816207685978,7.51539980201359e-05
NMR metabolomics,X23408.Triglycerides in VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.0101631567832992,0.00256914122470826,0.005127639982871,0.0151986735837274,7.64715523947482e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.00521920625607665,0.00132332919994597,0.00262548102418254,0.00781293148797076,8.03536284216344e-05
NMR metabolomics,X23408.Triglycerides in VLDL,CALCB,Calcitonin gene-related peptide 2,24845,0.0112119521413942,0.00284683580170199,0.00563215397005834,0.0167917503127302,8.22538815282669e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NEFL,Neurofilament light polypeptide,28674,0.0124865882985527,0.00317158939241699,0.00627027308941542,0.01870290350769,8.26970824675612e-05
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB1,Integrin beta-1,29474,0.0060409880376499,0.00153557091877468,0.00303126903685152,0.00905070703844828,8.37234212841771e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SCP2,Non-specific lipid-transfer protein,28797,0.0211840940048461,0.00539145651408834,0.010616839237233,0.0317513487724592,8.54290307342917e-05
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA11,Serpin A11,29820,-0.0113600866455776,0.00289517630784547,-0.0170346322089547,-0.00568554108220047,8.73593646224994e-05
NMR metabolomics,X23408.Triglycerides in VLDL,NUP50,Nuclear pore complex protein Nup50,24111,-0.00938923799439911,0.00239705400276765,-0.0140874638398237,-0.00469101214897451,8.9908396275812e-05
NMR metabolomics,X23408.Triglycerides in VLDL,DRAXIN,Draxin,29218,0.0118785395091218,0.00303442615221488,0.00593106425078064,0.017826014767463,9.07627665806687e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,29454,0.0815219821076363,0.0208803790720359,0.0405964391264459,0.122447525088827,9.47331069500763e-05
NMR metabolomics,X23408.Triglycerides in VLDL,COL9A1,Collagen alpha-1(IX) chain,29434,0.0128873936990057,0.0033119649242737,0.00639594244742921,0.0193788449505821,9.99847365502897e-05
NMR metabolomics,X23408.Triglycerides in VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,0.00761375651311693,0.00195767031612789,0.00377672269350627,0.0114507903327276,0.000100799306624575
NMR metabolomics,X23408.Triglycerides in VLDL,CDKL5,Cyclin-dependent kinase-like 5,24101,-0.0146524584966207,0.00378007638503223,-0.0220614082112838,-0.00724350878195749,0.000106367120139594
NMR metabolomics,X23408.Triglycerides in VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,0.0193699883470357,0.00499739381812248,0.00957509646351568,0.0291648802305558,0.000106457271568283
NMR metabolomics,X23408.Triglycerides in VLDL,METAP1,Methionine aminopeptidase 1,28774,0.00817842592098704,0.00211661849534302,0.00402985367011472,0.0123269981718593,0.0001118305310568
NMR metabolomics,X23408.Triglycerides in VLDL,DCC,Netrin receptor DCC,24195,0.00626144939795339,0.00162255410990955,0.00308124334253068,0.0094416554533761,0.000114143780132899
NMR metabolomics,X23408.Triglycerides in VLDL,TMOD4,Tropomodulin-4,24016,-0.0112029388608605,0.00290808490333516,-0.0169027852713974,-0.00550309245032362,0.000117297303000219
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF8,SLAM family member 8,28797,0.0145689628039652,0.00379210326352275,0.00713644040746058,0.0220014852004697,0.000122336738455368
NMR metabolomics,X23408.Triglycerides in VLDL,FOLR1,Folate receptor alpha,29383,0.00782795759959586,0.00204206698013152,0.00382550631853808,0.0118304088806536,0.00012667333737684
NMR metabolomics,X23408.Triglycerides in VLDL,NLGN2,Neuroligin-2,24101,-0.0129240903375304,0.00337245662505496,-0.0195341053226381,-0.00631407535242265,0.000127300011724472
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,29443,-0.00918648559303437,0.00239816701200644,-0.013886892936567,-0.00448607824950175,0.000128081800777223
NMR metabolomics,X23408.Triglycerides in VLDL,MKI67,Proliferation marker protein Ki-67,24229,0.0105895673782581,0.00276783489573527,0.00516461098261698,0.0160145237738992,0.000130601548951432
NMR metabolomics,X23408.Triglycerides in VLDL,GSAP,Gamma-secretase-activating protein,28797,0.0233943768060369,0.00615166298645466,0.0113371173525858,0.035451636259488,0.000143286779805753
NMR metabolomics,X23408.Triglycerides in VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,0.0102480620012736,0.00269887284880849,0.00495827121760897,0.0155378527849382,0.000146718696406796
NMR metabolomics,X23408.Triglycerides in VLDL,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.0128889136846208,0.00341409699673215,-0.0195805437982158,-0.00619728357102578,0.000160190620555341
NMR metabolomics,X23408.Triglycerides in VLDL,NINJ1,Ninjurin-1,28797,0.0147712898753573,0.0039166049687955,0.00709474413651817,0.0224478356141965,0.000162624649562862
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,0.0197238699142877,0.00523783843928441,0.00945770657329022,0.0299900332552851,0.00016649768769277
NMR metabolomics,X23408.Triglycerides in VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,0.012235124428557,0.00324934909885662,0.00586640019479807,0.018603848662316,0.000166672410234142
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.0185767776147244,0.00495087846296276,0.00887305582731738,0.0282804994021314,0.000175608717410019
NMR metabolomics,X23408.Triglycerides in VLDL,AMBN,Ameloblastin,28931,-0.00757636157152937,0.0020236141935111,-0.0115426453908111,-0.00361007775224761,0.000181482301256447
NMR metabolomics,X23408.Triglycerides in VLDL,NME1,Nucleoside diphosphate kinase A,24229,-0.00581016925329003,0.00155369138605432,-0.0088554043699565,-0.00276493413662357,0.000184744937582142
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.00783300675736367,0.00210896329602281,0.00369943869715896,0.0119665748175684,0.000204345887258608
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBR3,Transforming growth factor beta receptor type 3,29820,-0.00831308829790513,0.00223884400955163,-0.0127012225566263,-0.00392495403918394,0.000205095623595766
NMR metabolomics,X23408.Triglycerides in VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,0.014698800419864,0.00396932351141894,0.00691892633748287,0.0224786745022451,0.000213442229947555
NMR metabolomics,X23408.Triglycerides in VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,0.00713136646065549,0.001929318648261,0.00334990191006393,0.010912831011247,0.000219156866323253
NMR metabolomics,X23408.Triglycerides in VLDL,GFRAL,GDNF family receptor alpha-like,24025,-0.016326080471688,0.00444393545294963,-0.0250361939594692,-0.00761596698390667,0.000239499516803534
NMR metabolomics,X23408.Triglycerides in VLDL,SCN2B,Sodium channel subunit beta-2,24195,-0.00750658619737807,0.00205469745595869,-0.0115337932110571,-0.00347937918369905,0.000259359778245272
NMR metabolomics,X23408.Triglycerides in VLDL,MYOM1,Myomesin-1,24101,0.012357640022395,0.00338545897138573,0.00572214043847895,0.018993139606311,0.000262578835901158
NMR metabolomics,X23408.Triglycerides in VLDL,SH3GL3,Endophilin-A3,24307,0.0216193767219168,0.00594507055606415,0.00996703843203106,0.0332717150118025,0.000276915825855995
NMR metabolomics,X23408.Triglycerides in VLDL,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00583331574511183,0.00160775646647774,0.00268211307081546,0.00898451841940819,0.000285843801782102
NMR metabolomics,X23408.Triglycerides in VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,0.0156169860434606,0.00431079545997321,0.00716782694191314,0.0240661451450081,0.000291968009776998
NMR metabolomics,X23408.Triglycerides in VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,-0.0150497768472702,0.00415937437624806,-0.0232021506247164,-0.00689740306982396,0.000297175082588629
NMR metabolomics,X23408.Triglycerides in VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,-0.015736231627016,0.00435600495349964,-0.0242740013358753,-0.00719846191815673,0.000303831766225037
NMR metabolomics,X23408.Triglycerides in VLDL,KRT19,"Keratin, type I cytoskeletal 19",29378,0.0172245858603992,0.00479592051400213,0.00782458165295502,0.0266245900678434,0.000329306875653307
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC12A,C-type lectin domain family 12 member A,24229,0.00517779532249267,0.00144637876402301,0.00234289294500756,0.00801269769997777,0.000344485259313352
NMR metabolomics,X23408.Triglycerides in VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,0.00712134901821545,0.00199057283012255,0.00321982627117525,0.0110228717652557,0.000347503680069413
NMR metabolomics,X23408.Triglycerides in VLDL,ASPN,Asporin,24922,0.00697917438287079,0.00195196712459913,0.0031533188186565,0.0108050299470851,0.000350278223673045
NMR metabolomics,X23408.Triglycerides in VLDL,PRR4,Proline-rich protein 4,24203,-0.017654303626008,0.00494674482336394,-0.0273499234798013,-0.00795868377221463,0.000359213981711974
NMR metabolomics,X23408.Triglycerides in VLDL,RAD51,DNA repair protein RAD51 homolog 1,24445,0.0134763685078078,0.00378924100389611,0.00604945614017144,0.0209032808754442,0.000376564549949366
NMR metabolomics,X23408.Triglycerides in VLDL,REN,Renin,29478,-0.0191084706758774,0.0053739339036038,-0.0296413811269409,-0.00857556022481398,0.00037746471341195
NMR metabolomics,X23408.Triglycerides in VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.0128769955633829,0.00362773305563904,-0.0199873523524355,-0.00576663877433041,0.000386418424283373
NMR metabolomics,X23408.Triglycerides in VLDL,TIMP2,Metalloproteinase inhibitor 2,24922,-0.00668893136024899,0.00188460869817188,-0.0103827644086659,-0.00299509831183211,0.000387053750319
NMR metabolomics,X23408.Triglycerides in VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,0.0220546609888044,0.00622557645730055,0.00985253113249532,0.0342567908451135,0.000396972155977787
NMR metabolomics,X23408.Triglycerides in VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,-0.00795080010050295,0.00225107073698046,-0.0123628987449847,-0.00353870145602125,0.000413184577877671
NMR metabolomics,X23408.Triglycerides in VLDL,GPR101,Probable G-protein coupled receptor 101,24101,-0.0153575695140931,0.00437427354853059,-0.023931145669213,-0.00678399335897312,0.000447434586802135
NMR metabolomics,X23408.Triglycerides in VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,0.0371123027937707,0.0106099582994176,0.0163167845269122,0.0579078210606292,0.000469673796611414
NMR metabolomics,X23408.Triglycerides in VLDL,COL5A1,Collagen alpha-1(V) chain,24381,0.0100000159450234,0.0028631833054562,0.00438817666632928,0.0156118552237176,0.000479151222484278
NMR metabolomics,X23408.Triglycerides in VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.00825458419602108,0.00236952629997032,-0.0128988557439629,-0.00361031264807926,0.00049535941623642
NMR metabolomics,X23408.Triglycerides in VLDL,GAL,Galanin peptides,29581,-0.015872945455411,0.00456030819013464,-0.0248111495080749,-0.00693474140274709,0.000500875143549867
NMR metabolomics,X23408.Triglycerides in VLDL,CAPS,Calcyphosin,24845,0.0233780905488405,0.00671740100870814,0.0102119845717726,0.0365441965259085,0.000501845905319251
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,-0.0099096093286028,0.00284749637099278,-0.0154907022157487,-0.00432851644145696,0.000502088317858588
NMR metabolomics,X23408.Triglycerides in VLDL,SAG,S-arrestin,24101,-0.012989064617668,0.00374716220397362,-0.0203335025374563,-0.00564462669787973,0.000528448835662064
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN3,Neuronal-specific septin-3,24867,-0.0185660307678301,0.00536832621496586,-0.0290879501491632,-0.00804411138649702,0.000544224416574274
NMR metabolomics,X23408.Triglycerides in VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,-0.00501211196446956,0.00144936951690824,-0.00785287621760972,-0.0021713477113294,0.000544872819166722
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.00783183189048524,0.00228243137758311,-0.0123053973905481,-0.00335826639042235,0.000601570765959188
NMR metabolomics,X23408.Triglycerides in VLDL,FDX1,"Adrenodoxin, mitochondrial",24111,0.0152790134958669,0.00445341272787717,0.00655032454922763,0.0240077024425061,0.000602690765186182
NMR metabolomics,X23408.Triglycerides in VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.00635018980114356,0.00185518267210284,-0.00998634783846511,-0.002714031763822,0.000620488369032621
NMR metabolomics,X23408.Triglycerides in VLDL,NPTXR,Neuronal pentraxin receptor,29478,0.0082231074760904,0.0024068551531509,0.00350567137591463,0.0129405435762662,0.000635088688795625
NMR metabolomics,X23408.Triglycerides in VLDL,CLSTN1,Calsyntenin-1,28774,0.0124825589237918,0.0036559971278003,0.00531680455330324,0.0196483132942804,0.000640415399935968
NMR metabolomics,X23408.Triglycerides in VLDL,SPESP1,Sperm equatorial segment protein 1,24922,0.00734154026226647,0.00215308214585839,0.00312149925638402,0.0115615812681489,0.000651179363978431
NMR metabolomics,X23408.Triglycerides in VLDL,PADI2,Protein-arginine deiminase type-2,28931,0.01358827237416,0.00399354561128823,0.00576092297603506,0.0214156217722849,0.000668485016649481
NMR metabolomics,X23408.Triglycerides in VLDL,TNN,Tenascin-N,24938,0.0103998913423382,0.00308319033782219,0.00435683828020668,0.0164429444044696,0.000744416339263694
NMR metabolomics,X23408.Triglycerides in VLDL,KIRREL2,Kin of IRRE-like protein 2,28774,0.00952897223892569,0.0028289197846369,0.00398428946103736,0.015073655016814,0.000757012338150632
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC1,Sialoadhesin,29581,0.0101128215328643,0.00300253026386721,0.00422786221568456,0.015997780850044,0.000757847460515741
NMR metabolomics,X23408.Triglycerides in VLDL,TSC1,Hamartin,24229,0.0178854687659551,0.00532529574915256,0.00744788909761608,0.0283230484342941,0.000784628304102675
NMR metabolomics,X23408.Triglycerides in VLDL,MYH7B,Myosin-7B,24016,-0.0105529329261479,0.00314822192593082,-0.0167234479009723,-0.00438241795132352,0.000803453065212054
NMR metabolomics,X23408.Triglycerides in VLDL,GPA33,Cell surface A33 antigen,29349,0.0318573367959318,0.00953793466115022,0.0131629848600774,0.0505516887317862,0.00083862707350815
NMR metabolomics,X23408.Triglycerides in VLDL,SOX9,Transcription factor SOX-9,24195,0.00647222575290237,0.00193816764830007,0.00267341716223423,0.0102710343435705,0.000841007001506321
NMR metabolomics,X23408.Triglycerides in VLDL,MMP8,Neutrophil collagenase,29640,0.0170848868020631,0.00512008400220198,0.0070495221577472,0.0271202514463789,0.000848417741895172
NMR metabolomics,X23408.Triglycerides in VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,0.0204752225565797,0.00613723663565169,0.0084462387507024,0.032504206362457,0.000850522249239219
NMR metabolomics,X23408.Triglycerides in VLDL,C9orf40,Uncharacterized protein C9orf40,24805,0.0188810152421568,0.00568503957958388,0.00773833766617243,0.0300236928181413,0.000897685590339537
NMR metabolomics,X23408.Triglycerides in VLDL,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.0109066840615451,0.00328760505420612,-0.0173503899677891,-0.0044629781553011,0.00090930505286496
NMR metabolomics,X23408.Triglycerides in VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.00685777434390311,0.0020679863400927,0.00280452111732143,0.0109110275704848,0.000913976385576643
NMR metabolomics,X23408.Triglycerides in VLDL,PSMG4,Proteasome assembly chaperone 4,24229,0.013169440876718,0.00398026954921308,0.00536811256026033,0.0209707691931756,0.000938733723831909
NMR metabolomics,X23408.Triglycerides in VLDL,RBP7,Retinoid-binding protein 7,24805,0.0141073767563599,0.00426617243966943,0.00574567877460781,0.022469074738112,0.000945025461878325
NMR metabolomics,X23408.Triglycerides in VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.0122168869114538,0.00370872570391132,0.00494778453178763,0.01948598929112,0.000988802594472559
NMR metabolomics,X23408.Triglycerides in VLDL,RYR1,Ryanodine receptor 1,24111,-0.00794171492868745,0.00242047726748584,-0.0126858503729597,-0.0031975794844152,0.00103567111122501
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.00987201333157224,0.00301171595606718,0.00396905005768057,0.0157749766054639,0.00104714207989187
NMR metabolomics,X23408.Triglycerides in VLDL,HCG22,Protein PBMUCL2,24111,-0.012891391967567,0.00393354159210876,-0.0206011334881002,-0.00518165044703382,0.00104953568115744
NMR metabolomics,X23408.Triglycerides in VLDL,CFD,Complement factor D,24966,0.00453959601422557,0.00138582246134056,0.00182338398999807,0.00725580803845307,0.00105528715125397
NMR metabolomics,X23408.Triglycerides in VLDL,MYH4,Myosin-4,24111,-0.0108418918866546,0.00331265900865664,-0.0173347035436217,-0.00434908022968763,0.00106612457018653
NMR metabolomics,X23408.Triglycerides in VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,0.0157188408634538,0.0048192158944035,0.00627317771042299,0.0251645040164847,0.0011087487506953
NMR metabolomics,X23408.Triglycerides in VLDL,REXO2,"Oligoribonuclease, mitochondrial",24111,-0.0109901763787334,0.00339267375983985,-0.0176398169480195,-0.00434053580944728,0.00119950085925681
NMR metabolomics,X23408.Triglycerides in VLDL,GFAP,Glial fibrillary acidic protein,28753,0.0105918195395199,0.00327248631447411,0.00417774636315066,0.0170058927158892,0.00121088113031779
NMR metabolomics,X23408.Triglycerides in VLDL,SULT1A1,Sulfotransferase 1A1,29694,-0.0293581209041048,0.00907607281051271,-0.0471472236127097,-0.0115690181954999,0.00121915681476067
NMR metabolomics,X23408.Triglycerides in VLDL,NRXN3,Neurexin-3,24195,0.00809679070445693,0.00250399226175484,0.00318896587141743,0.0130046155374964,0.00122424808694176
NMR metabolomics,X23408.Triglycerides in VLDL,CD160,CD160 antigen,29786,0.0107069534961248,0.0033159151389638,0.0042077598237557,0.0172061471684938,0.00124376410471908
NMR metabolomics,X23408.Triglycerides in VLDL,MYO6,Unconventional myosin-VI,24867,0.00854089975590826,0.00264916784415372,0.00334853078136697,0.0137332687304495,0.0012657948063883
NMR metabolomics,X23408.Triglycerides in VLDL,RBM19,Probable RNA-binding protein 19,24111,-0.0109157654095994,0.00339456259980601,-0.0175691081052192,-0.00426242271397962,0.00130315713729583
NMR metabolomics,X23408.Triglycerides in VLDL,CD99,CD99 antigen,29443,-0.0044692789997201,0.00139138182815815,-0.00719638738291007,-0.00174217061653012,0.00131903123989275
NMR metabolomics,X23408.Triglycerides in VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.0126485592884693,0.00394105644492397,0.0049240886564183,0.0203730299205203,0.00133141825632928
NMR metabolomics,X23408.Triglycerides in VLDL,BMP4,Bone morphogenetic protein 4,29169,-0.0104515418527973,0.00327092383981332,-0.0168625525788314,-0.00404053112676318,0.00139840359955052
NMR metabolomics,X23408.Triglycerides in VLDL,ID4,DNA-binding protein inhibitor ID-4,24445,-0.00994503275936037,0.00311330711550327,-0.0160471147057468,-0.00384295081297396,0.00140317695032884
NMR metabolomics,X23408.Triglycerides in VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,0.0111592257858342,0.0034993525822542,0.00430049472461597,0.0180179568470524,0.00142973036512785
NMR metabolomics,X23408.Triglycerides in VLDL,DPP10,Inactive dipeptidyl peptidase 10,29434,0.00794452613531375,0.00249487713854251,0.00305456694377042,0.0128344853268571,0.00145237835378776
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD5,Sushi domain-containing protein 5,24273,-0.00774349948932304,0.00243273374300946,-0.0125116576256216,-0.00297534135302449,0.00145919129724768
NMR metabolomics,X23408.Triglycerides in VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.0112383904280154,0.00354473348442033,0.0042907127985516,0.0181860680574793,0.00152364092038274
NMR metabolomics,X23408.Triglycerides in VLDL,GPR158,Probable G-protein coupled receptor 158,24867,0.00803855286797698,0.00254273213968337,0.00305479787419757,0.0130223078617564,0.00157209871883896
NMR metabolomics,X23408.Triglycerides in VLDL,EPN1,Epsin-1,24445,0.009799929019735,0.00310106632728892,0.00372183901824872,0.0158780190212213,0.0015786382557899
NMR metabolomics,X23408.Triglycerides in VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.00575194817123162,0.00182200337488385,-0.00932307478600398,-0.00218082155645927,0.00159626938222166
NMR metabolomics,X23408.Triglycerides in VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.00962919331319564,0.00305768940470136,0.00363612207998097,0.0156222645464103,0.00163926350482311
NMR metabolomics,X23408.Triglycerides in VLDL,RALB,Ras-related protein Ral-B,24229,0.00660391460035003,0.00209745698037526,0.00249289891881451,0.0107149302818855,0.00164290874547553
NMR metabolomics,X23408.Triglycerides in VLDL,IL17C,Interleukin-17C,28931,-0.015615037339098,0.00498399551884191,-0.0253836685560281,-0.00584640612216783,0.00173180960799206
NMR metabolomics,X23408.Triglycerides in VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,0.0151334652656929,0.00483395534025363,0.00565891279879581,0.02460801773259,0.00174616677693411
NMR metabolomics,X23408.Triglycerides in VLDL,PRG3,Proteoglycan 3,24938,-0.0110245251308614,0.00353900479494532,-0.0179609745289542,-0.00408807573276856,0.00184060932650799
NMR metabolomics,X23408.Triglycerides in VLDL,ENO1,Alpha-enolase,29392,0.0173664597972692,0.0055768651956697,0.00643580401375663,0.0282971155807819,0.00184735458596322
NMR metabolomics,X23408.Triglycerides in VLDL,SAT1,Diamine acetyltransferase 1,24111,-0.0110832811711267,0.00357707951223143,-0.0180943570151003,-0.00407220532715309,0.00194781770677053
NMR metabolomics,X23408.Triglycerides in VLDL,RGMA,Repulsive guidance molecule A,29694,-0.0068880044497094,0.00222547607361988,-0.0112499375540044,-0.00252607134541443,0.00196949412101948
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B4,Protein ATP1B4,24016,-0.00922617885346407,0.0029836662465568,-0.0150741646967154,-0.00337819301021274,0.00198887374227113
NMR metabolomics,X23408.Triglycerides in VLDL,PCDH17,Protocadherin-17,29478,0.00787004128319685,0.00254790043622513,0.00287615642819559,0.0128639261381981,0.00201130631180177
NMR metabolomics,X23408.Triglycerides in VLDL,FLT1,Vascular endothelial growth factor receptor 1,29288,0.00490517698890546,0.00158894796922678,0.00179083896922097,0.00801951500858994,0.00202335936540214
NMR metabolomics,X23408.Triglycerides in VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,-0.0107082487054597,0.00348191617602029,-0.0175328044104595,-0.00388369300045993,0.00210419990176719
NMR metabolomics,X23408.Triglycerides in VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,0.00699684933501506,0.00227980886108469,0.00252842396728907,0.0114652747027411,0.00214978669773742
NMR metabolomics,X23408.Triglycerides in VLDL,CDH23,Cadherin-23,24845,-0.00576582003204744,0.00188097474776686,-0.00945253053767048,-0.0020791095264244,0.00217658761610923
NMR metabolomics,X23408.Triglycerides in VLDL,LY6D,Lymphocyte antigen 6D,29283,0.00832267220655658,0.00271693250023539,0.00299748450609521,0.0136478599070179,0.00219138162486382
NMR metabolomics,X23408.Triglycerides in VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,-0.00626939620239729,0.0020498248165954,-0.0102870528429243,-0.00225173956187031,0.00222689645737612
NMR metabolomics,X23408.Triglycerides in VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.0102816438869455,0.00336196951464827,0.00369218363823485,0.0168711041356561,0.0022286027452779
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.00982075558051273,0.00321913393207893,-0.0161302580873874,-0.00351125307363802,0.00228476032795648
NMR metabolomics,X23408.Triglycerides in VLDL,KLK15,Kallikrein-15,24754,0.0111791566291099,0.00366913912463173,0.00398764394483173,0.0183706693133881,0.00231530271215507
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,0.00851361570583868,0.00279442355573682,0.00303654553659451,0.0139906858750829,0.00231661320265085
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA6C,Semaphorin-6C,24229,0.00564817735411316,0.00185847818999444,0.00200556010172405,0.00929079460650226,0.00237506771567565
NMR metabolomics,X23408.Triglycerides in VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.0137738440674608,0.00454389921373091,-0.0226798865263734,-0.00486780160854827,0.0024377260787399
NMR metabolomics,X23408.Triglycerides in VLDL,FDX2,"Ferredoxin-2, mitochondrial",24111,0.0121223182105213,0.00399946320066178,0.0042833703372242,0.0199612660838184,0.00244014978251388
NMR metabolomics,X23408.Triglycerides in VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.0109725142145337,0.00362546263228206,0.00386660745526091,0.0180784209738066,0.00247653340335637
NMR metabolomics,X23408.Triglycerides in VLDL,PGLYRP1,Peptidoglycan recognition protein 1,29673,0.00905511365311485,0.0029965410497539,0.00318189319559721,0.0149283341106325,0.00251444781483719
NMR metabolomics,X23408.Triglycerides in VLDL,TJP3,Tight junction protein ZO-3,24101,-0.00916330980344411,0.00303997201940355,-0.0151216549614751,-0.00320496464541314,0.00257862724918009
NMR metabolomics,X23408.Triglycerides in VLDL,DDA1,DET1- and DDB1-associated protein 1,24111,0.0085340496897033,0.00283422606969425,0.00297896659310256,0.014089132786304,0.00260599549932676
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,-0.0108338578267155,0.00360407399168421,-0.0178978428504165,-0.00376987280301443,0.00264978784913215
NMR metabolomics,X23408.Triglycerides in VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.0106528355013218,0.00354823224481742,-0.0176073707011639,-0.00369830030147963,0.0026822823343427
NMR metabolomics,X23408.Triglycerides in VLDL,TUBB3,Tubulin beta-3 chain,24101,-0.00599103814784252,0.00199636827758862,-0.0099039199719162,-0.00207815632376883,0.00269397990630874
NMR metabolomics,X23408.Triglycerides in VLDL,GKN1,Gastrokine-1,28114,0.00594920583301624,0.00198946212325934,0.00204986007142794,0.00984855159460454,0.00278891180220388
NMR metabolomics,X23408.Triglycerides in VLDL,CEP112,Centrosomal protein of 112 kDa,24111,0.00963892302171783,0.00325323448454658,0.00326258343200654,0.0160152626114291,0.00305079249514237
NMR metabolomics,X23408.Triglycerides in VLDL,MANSC4,MANSC domain-containing protein 4,24111,0.0139830469951932,0.00472359495679477,0.00472480087987549,0.023241293110511,0.00307683470842565
NMR metabolomics,X23408.Triglycerides in VLDL,CST6,Cystatin-M,28830,0.0102051363822196,0.00345543894808194,0.00343247604397896,0.0169777967204602,0.00314594435051833
NMR metabolomics,X23408.Triglycerides in VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,0.0246309996715265,0.0083519839540258,0.00826111112163594,0.0410008882214171,0.00318935625131495
NMR metabolomics,X23408.Triglycerides in VLDL,TFF1,Trefoil factor 1,29319,0.0164635701560636,0.00558360208105898,0.00551971007718802,0.0274074302349392,0.00319512965427802
NMR metabolomics,X23408.Triglycerides in VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,0.00988840755403689,0.0033626945648168,0.00329752620699596,0.0164792889010778,0.003278585928366
NMR metabolomics,X23408.Triglycerides in VLDL,GSN,Gelsolin,24845,-0.00396385207737916,0.0013504206991089,-0.0066106766476326,-0.00131702750712573,0.00333560707801427
NMR metabolomics,X23408.Triglycerides in VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,0.00704040698697633,0.00240281912333681,0.00233088150523618,0.0117499324687165,0.003391550778585
NMR metabolomics,X23408.Triglycerides in VLDL,JUN,Transcription factor AP-1,28931,0.0103921970438643,0.00354930491533776,0.00343555940980227,0.0173488346779263,0.00341467879860757
NMR metabolomics,X23408.Triglycerides in VLDL,TG,Thyroglobulin,24793,-0.0231235767091299,0.00791752412947348,-0.0386419240028979,-0.00760522941536186,0.00349721768612466
NMR metabolomics,X23408.Triglycerides in VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.0140590145650496,0.00481551494717085,0.00462060526859472,0.0234974238615044,0.00350837574619475
NMR metabolomics,X23408.Triglycerides in VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,24229,-0.0125651329272315,0.00430954798873302,-0.0210118469851483,-0.00411841886931482,0.00355274023822635
NMR metabolomics,X23408.Triglycerides in VLDL,IL3RA,Interleukin-3 receptor subunit alpha,28931,0.0065186685280552,0.0022383415179037,0.00213151915296395,0.0109058179031464,0.00359079609114982
NMR metabolomics,X23408.Triglycerides in VLDL,HLA_DRA,,29322,-0.00742630184312914,0.00255680211345384,-0.0124376339854987,-0.00241496970075961,0.00368082735936427
NMR metabolomics,X23408.Triglycerides in VLDL,SEZ6,Seizure protein 6 homolog,24195,-0.00642280851856218,0.00221634970126046,-0.0107668539330327,-0.00207876310409168,0.00375981333960039
NMR metabolomics,X23408.Triglycerides in VLDL,CCND2,G1/S-specific cyclin-D2,24445,0.00755075089965884,0.00261451993242088,0.00242629183211391,0.0126752099672038,0.0038803200847757
NMR metabolomics,X23408.Triglycerides in VLDL,POF1B,Protein POF1B,24229,0.0093813911968493,0.00325533492204711,0.00300093474963696,0.0157618476440616,0.00395693674361118
NMR metabolomics,X23408.Triglycerides in VLDL,CYB5A,Cytochrome b5,24016,0.0147649455835142,0.00512856532413064,0.00471295754821815,0.0248169336188103,0.00399338634563504
NMR metabolomics,X23408.Triglycerides in VLDL,CTNNA1,Catenin alpha-1,24101,-0.00715721081055376,0.00249321479174543,-0.0120439118023748,-0.00227050981873271,0.00409952456196029
NMR metabolomics,X23408.Triglycerides in VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,0.00674842414833636,0.00235265504771146,0.0021372202548219,0.0113596280418508,0.00412871938783901
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.00555182923579446,0.00194023173147272,0.00174897504210793,0.00935468342948099,0.00422033564484295
NMR metabolomics,X23408.Triglycerides in VLDL,PNMA2,Paraneoplastic antigen Ma2,24101,0.00880908873626459,0.00311170700786384,0.00271014300085147,0.0149080344716777,0.00464483310818276
NMR metabolomics,X23408.Triglycerides in VLDL,PPM1B,Protein phosphatase 1B,24229,0.0125391427230364,0.00443476954523265,0.00384699441438037,0.0212312910316923,0.00469570544843809
NMR metabolomics,X23408.Triglycerides in VLDL,TNXB,Tenascin-X,29443,-0.00515924975634155,0.00182630319944834,-0.00873880402726028,-0.00157969548542281,0.0047317013413613
NMR metabolomics,X23408.Triglycerides in VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,-0.0126232471975824,0.00447227835764054,-0.0213889127785579,-0.00385758161660699,0.00476816836054889
NMR metabolomics,X23408.Triglycerides in VLDL,FBLN2,Fibulin-2,24938,-0.00628470095719139,0.00222663656669762,-0.0106489086279187,-0.00192049328646405,0.00476872678105882
NMR metabolomics,X23408.Triglycerides in VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,29820,0.0060518379809341,0.00214655224738333,0.00184459557606277,0.0102590803858054,0.00481558304006846
NMR metabolomics,X23408.Triglycerides in VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,0.0114352063896282,0.00406749583828651,0.00346291454658669,0.0194074982326698,0.00493721167510925
NMR metabolomics,X23408.Triglycerides in VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",24016,0.0183845472150533,0.00656643959762076,0.00551432560371657,0.03125476882639,0.0051179225589478
NMR metabolomics,X23408.Triglycerides in VLDL,TNR,Tenascin-R,29218,-0.00835609934860277,0.00298488250215838,-0.0142064690528332,-0.00250572964437234,0.00512196051241535
NMR metabolomics,X23408.Triglycerides in VLDL,CLSPN,Claspin,28719,0.00685469099374833,0.00245872685212211,0.002035586363589,0.0116737956239077,0.0053085374722833
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL14,C-X-C motif chemokine 14,28931,0.0116581741507864,0.00421349307539173,0.00339972772301861,0.0199166205785542,0.00566338223275458
NMR metabolomics,X23408.Triglycerides in VLDL,AIDA,"Axin interactor, dorsalization-associated protein",24195,0.0165458009795181,0.00598839978105077,0.00480853740865857,0.0282830645503776,0.0057320379628718
NMR metabolomics,X23408.Triglycerides in VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,29628,-0.00393337472855959,0.00143116956661547,-0.00673846707912591,-0.00112828237799327,0.00599297610186668
NMR metabolomics,X23408.Triglycerides in VLDL,DIPK2B,Divergent protein kinase domain 2B,24381,0.00548583619726113,0.00199733911468956,0.0015710515324696,0.00940062086205266,0.00602658272249761
NMR metabolomics,X23408.Triglycerides in VLDL,LIFR,Leukemia inhibitory factor receptor,29434,-0.00472226828404224,0.00171947941994488,-0.0080924479471342,-0.00135208862095029,0.00603016316044096
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS5,Transmembrane protease serine 5,29079,-0.00739270362007839,0.00269488328988042,-0.012674674868244,-0.00211073237191276,0.00608740315933239
NMR metabolomics,X23408.Triglycerides in VLDL,IFNW1,Interferon omega-1,24111,-0.00700907175804405,0.00255757436973418,-0.012021917522723,-0.00199622599336505,0.00613880968616937
NMR metabolomics,X23408.Triglycerides in VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,0.00716246334292049,0.00262201693427208,0.00202331015174721,0.0123016165340938,0.00630603169673734
NMR metabolomics,X23408.Triglycerides in VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.00757303671264433,0.00277565206299001,0.00213275866918391,0.0130133147561048,0.00636907909958357
NMR metabolomics,X23408.Triglycerides in VLDL,TLR4,Toll-like receptor 4,24229,0.0054713270901241,0.00201192935518159,0.00152794555396819,0.00941470862628001,0.00654385876591223
NMR metabolomics,X23408.Triglycerides in VLDL,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.00829675806676808,0.00305122995713382,-0.0142771687827504,-0.00231634735078579,0.00654964059621978
NMR metabolomics,X23408.Triglycerides in VLDL,FCRL6,Fc receptor-like protein 6,29434,0.0130610626502542,0.00480542830440798,0.00364242317361457,0.0224797021268939,0.00657200773193746
NMR metabolomics,X23408.Triglycerides in VLDL,GBP6,Guanylate-binding protein 6,24111,-0.00889546820940887,0.00327374160290315,-0.015312001751099,-0.00247893466771869,0.00658803334927298
NMR metabolomics,X23408.Triglycerides in VLDL,UNG,Uracil-DNA glycosylase,24793,0.00660722487264831,0.00244122738685463,0.00182241919441325,0.0113920305508834,0.00680395397878487
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJA4,DnaJ homolog subfamily A member 4,24845,0.0134466762878933,0.00497412099625001,0.00369739913524323,0.0231959534405433,0.00686958576113101
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB5,Integrin beta-5,29566,0.00716518345481747,0.00266536980503092,0.00194105863695687,0.0123893082726781,0.0071867601646359
NMR metabolomics,X23408.Triglycerides in VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.00444324240012667,0.00165590765845617,0.00119766338955257,0.00768882141070076,0.00729562873885912
NMR metabolomics,X23408.Triglycerides in VLDL,IL36G,Interleukin-36 gamma,24149,0.0129308208710877,0.00482875944599492,0.0034664523569377,0.0223951893852378,0.00741406989391029
NMR metabolomics,X23408.Triglycerides in VLDL,MAMDC2,MAM domain-containing protein 2,24922,-0.00655247213563925,0.00245721911102837,-0.0113686215932548,-0.00173632267802365,0.00766675064148062
NMR metabolomics,X23408.Triglycerides in VLDL,AIF1L,Allograft inflammatory factor 1-like,24240,0.0108304089812433,0.00406665200606588,0.00285977104935413,0.0188010469131324,0.00774468287133709
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,-0.00920236270543368,0.00345838974509989,-0.0159808066058295,-0.0024239188050379,0.00779877433310646
NMR metabolomics,X23408.Triglycerides in VLDL,PTTG1,Securin,24445,0.00777778874762126,0.00293624695080643,0.00202274472404065,0.0135328327712019,0.00808090656308208
NMR metabolomics,X23408.Triglycerides in VLDL,CPVL,Probable serine carboxypeptidase CPVL,29662,0.00762124375293631,0.0028800961490618,0.00197625530077519,0.0132662322050974,0.00814502223148494
NMR metabolomics,X23408.Triglycerides in VLDL,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.00747517221455444,0.00282507276309734,-0.0130123148302252,-0.00193802959888365,0.00815001804570419
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.00767583823321576,0.00290390401113638,-0.0133674900950431,-0.00198418637138846,0.00821590705920625
NMR metabolomics,X23408.Triglycerides in VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.00705661253351134,0.0026712076494232,0.00182104554064186,0.0122921795263808,0.00825288627758519
NMR metabolomics,X23408.Triglycerides in VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,-0.00979993403891531,0.00371773617510188,-0.017086696942115,-0.00251317113571564,0.00839450275816867
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,24805,0.0102391397779693,0.00388543530756427,0.00262368657514333,0.0178545929807953,0.0084124681318845
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,29349,0.0128002458177732,0.0048793307582479,0.00323675753160728,0.022363734103939,0.00871120175142111
NMR metabolomics,X23408.Triglycerides in VLDL,PSMC3,26S proteasome regulatory subunit 6A,24016,-0.00561690972304055,0.00214691010046604,-0.00982485351995399,-0.00140896592612711,0.00889502955632591
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,0.00596388212895516,0.00227998431244745,0.00149511287655815,0.0104326513813522,0.00890840187383736
NMR metabolomics,X23408.Triglycerides in VLDL,KLK3,Prostate-specific antigen,24938,-0.0164756699199209,0.00630567982930587,-0.0288348023853604,-0.00411653745448137,0.00898498338710983
NMR metabolomics,X23408.Triglycerides in VLDL,COL3A1,Collagen alpha-1(III) chain,24938,0.00428616470811296,0.00165229213774705,0.00104767211812873,0.00752465729809718,0.00949021210033644
NMR metabolomics,X23408.Triglycerides in VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,-0.00880579090873924,0.0033971021967298,-0.0154641112143297,-0.00214747060314882,0.00954363547971076
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.00750594421358514,0.00290178198404542,-0.0131934369023142,-0.00181845152485612,0.00969567528488852
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.0102693721544128,0.00399447566135463,0.00244019985815775,0.0180985444506679,0.0101495946546492
NMR metabolomics,X23408.Triglycerides in VLDL,CD70,CD70 antigen,29434,-0.00776526820812317,0.00302364684118813,-0.0136916160168519,-0.00183892039939443,0.0102283059709744
NMR metabolomics,X23408.Triglycerides in VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,0.00515236422488389,0.00200835396307537,0.00121599045725616,0.00908873799251162,0.0103095519199082
NMR metabolomics,X23408.Triglycerides in VLDL,ACE,Angiotensin-converting enzyme,24951,-0.00474705784790641,0.00185606483073297,-0.00838494491614303,-0.0011091707796698,0.0105458069585266
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA3G,Semaphorin-3G,24381,0.00799430964552019,0.00313682106849842,0.00184614035126329,0.0141424789397771,0.0108236094775376
NMR metabolomics,X23408.Triglycerides in VLDL,TTN,Titin,24111,-0.0121318491451048,0.00476446584868672,-0.0214702022085307,-0.00279349608167882,0.0108927372266279
NMR metabolomics,X23408.Triglycerides in VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,29216,0.0104780604709734,0.00412728608442092,0.0023885797455084,0.0185675411964384,0.0111307454020183
NMR metabolomics,X23408.Triglycerides in VLDL,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.0126838446280362,0.00501588793800959,-0.022514984986535,-0.00285270426953744,0.0114538136786875
NMR metabolomics,X23408.Triglycerides in VLDL,SSB,Lupus La protein,28774,0.010668714461778,0.0042199542205334,0.0023976041895325,0.0189398247340234,0.0114715530317171
NMR metabolomics,X23408.Triglycerides in VLDL,IL2RG,Cytokine receptor common subunit gamma,24793,0.00666022236269997,0.00263946510213475,0.00148687076251586,0.0118335739628841,0.0116313663026124
NMR metabolomics,X23408.Triglycerides in VLDL,PALM3,Paralemmin-3,24111,0.0132091451662208,0.00523905735477025,0.00294059275087106,0.0234776975815705,0.0116991797796804
NMR metabolomics,X23408.Triglycerides in VLDL,STX1B,Syntaxin-1B,24195,0.00744795622825284,0.00295492917296058,0.00165629504925011,0.0132396174072556,0.0117245594183827
NMR metabolomics,X23408.Triglycerides in VLDL,TEF,Thyrotroph embryonic factor,24111,0.00765869381847181,0.00304031614032605,0.00169967418343275,0.0136177134535109,0.0117737710579781
NMR metabolomics,X23408.Triglycerides in VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,-0.00512032149197149,0.0020413035050842,-0.00912127636193652,-0.00111936662200645,0.0121346126089835
NMR metabolomics,X23408.Triglycerides in VLDL,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.0108322576338235,0.00432111271932856,0.00236287670393951,0.0193016385637075,0.0121876703455236
NMR metabolomics,X23408.Triglycerides in VLDL,MN1,Transcriptional activator MN1,24195,-0.0105071225799483,0.00420267977993259,-0.0187443749486162,-0.00226987021128047,0.0124223705079566
NMR metabolomics,X23408.Triglycerides in VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.00748275642729766,0.00300088099704036,0.00160102967309856,0.0133644831814968,0.0126539243967747
NMR metabolomics,X23408.Triglycerides in VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.0102024944612503,0.00410339587679869,0.00215983854272484,0.0182451503797757,0.0129126767751614
NMR metabolomics,X23408.Triglycerides in VLDL,TMEM25,Transmembrane protein 25,24867,-0.00795286839804697,0.00320447808300821,-0.0142336454407431,-0.00167209135535087,0.0130786798995721
NMR metabolomics,X23408.Triglycerides in VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,0.0128964869304674,0.00520646084219893,0.00269182367975753,0.0231011501811773,0.0132541724480654
NMR metabolomics,X23408.Triglycerides in VLDL,CALY,Neuron-specific vesicular protein calcyon,24111,-0.00674092221252411,0.00272759665395667,-0.0120870116542792,-0.00139483277076904,0.0134662092765524
NMR metabolomics,X23408.Triglycerides in VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.00492500772064392,0.00199294338943463,0.00101883867735205,0.00883117676393579,0.0134720073897521
NMR metabolomics,X23408.Triglycerides in VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,-0.00704356671399096,0.00285685434021567,-0.0126430012208137,-0.00144413220716824,0.013689198977701
NMR metabolomics,X23408.Triglycerides in VLDL,THBS2,Thrombospondin-2,29443,0.00649752631407489,0.00264639958844467,0.00131058312072335,0.0116844695074264,0.0140850910640274
NMR metabolomics,X23408.Triglycerides in VLDL,MSLNL,Mesothelin-like protein,24195,-0.00651554573401567,0.00267411864221965,-0.0117568182727662,-0.00127427319526516,0.0148364813189442
NMR metabolomics,X23408.Triglycerides in VLDL,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.00775311884885596,0.00320700082010676,0.00146739724144671,0.0140388404562652,0.0156310741855128
NMR metabolomics,X23408.Triglycerides in VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,-0.00742978227881848,0.00307601652515907,-0.0134587746681303,-0.00140078988950671,0.0157257231962623
NMR metabolomics,X23408.Triglycerides in VLDL,CADPS,Calcium-dependent secretion activator 1,24195,-0.00738792961486264,0.00305899613866799,-0.0133835620466519,-0.00139229718307338,0.015736168713145
NMR metabolomics,X23408.Triglycerides in VLDL,SUMF1,Formylglycine-generating enzyme,24229,0.0112676306651583,0.00471742191813001,0.00202148370562352,0.0205137776246931,0.0169242532094405
NMR metabolomics,X23408.Triglycerides in VLDL,LTO1,Protein LTO1 homolog,28931,0.00695356068127713,0.00291367665409469,0.00124275443925155,0.0126643669233027,0.01701486525037
NMR metabolomics,X23408.Triglycerides in VLDL,CTRC,Chymotrypsin-C,29456,0.0107731846948693,0.00451716919545271,0.00191953307178195,0.0196268363179566,0.0170881222430682
NMR metabolomics,X23408.Triglycerides in VLDL,OTOA,Otoancorin,24101,-0.00907795546848246,0.00381220485964037,-0.0165498769933776,-0.00160603394358734,0.0172599677651515
NMR metabolomics,X23408.Triglycerides in VLDL,CD33,Myeloid cell surface antigen CD33,29566,0.013327731508323,0.00560702955315984,0.00233795358412974,0.0243175094325163,0.0174619164337202
NMR metabolomics,X23408.Triglycerides in VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,0.00446788270914542,0.00188247119236186,0.000778239172116177,0.00815752624617467,0.0176323425014958
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,29673,0.00509694842193323,0.00215272764289962,0.000877602241849978,0.00931629460201648,0.0179068777921803
NMR metabolomics,X23408.Triglycerides in VLDL,RTKN2,Rhotekin-2,24111,-0.00869772402254106,0.00367401154653832,-0.0158987866537562,-0.00149666139132595,0.0179231387920756
NMR metabolomics,X23408.Triglycerides in VLDL,GUCA2A,Guanylin,29333,-0.005722937442551,0.00242298634342392,-0.0104719906756619,-0.000973884209440116,0.0181863029683857
NMR metabolomics,X23408.Triglycerides in VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,-0.00562511073404502,0.00238878194967429,-0.0103071233554066,-0.000943098112683414,0.0185405059858957
NMR metabolomics,X23408.Triglycerides in VLDL,PLXDC1,Plexin domain-containing protein 1,28797,0.0055244577803122,0.0023484526974167,0.000921490493375462,0.0101274250672489,0.018660304660847
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00429987379336404,0.00183282143347795,0.000707543783747258,0.00789220380298082,0.0189821373208196
NMR metabolomics,X23408.Triglycerides in VLDL,HBQ1,Hemoglobin subunit theta-1,29725,-0.00997903297740047,0.00425380226529394,-0.0183164854173766,-0.00164158053742436,0.0189872789119057
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC7A,C-type lectin domain family 7 member A,29786,0.00976682860532355,0.00416562987518742,0.0016021940499562,0.0179314631606909,0.0190528981354686
NMR metabolomics,X23408.Triglycerides in VLDL,SHPK,Sedoheptulokinase,24445,-0.00690447770109682,0.00294517293972347,-0.0126770166629548,-0.00113193873923883,0.0190689087878033
NMR metabolomics,X23408.Triglycerides in VLDL,KIF20B,Kinesin-like protein KIF20B,24101,0.0127100350826652,0.00542943317909102,0.00206834605164682,0.0233517241136836,0.0192428216885217
NMR metabolomics,X23408.Triglycerides in VLDL,NOP56,Nucleolar protein 56,24111,0.0184331925379464,0.00787639817463337,0.00299545211566497,0.0338709329602278,0.0192759908484739
NMR metabolomics,X23408.Triglycerides in VLDL,DDX1,ATP-dependent RNA helicase DDX1,24805,0.00829542037975552,0.00354968814804252,0.00133803160959218,0.0152528091499189,0.0194500450589039
NMR metabolomics,X23408.Triglycerides in VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,0.0160566543093151,0.00688881739910843,0.0025545722070626,0.0295587364115676,0.0197703667771265
NMR metabolomics,X23408.Triglycerides in VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.00567522775669243,0.00244498002755209,0.000883066902690341,0.0104673886106945,0.0202841164570061
NMR metabolomics,X23408.Triglycerides in VLDL,ART5,Ecto-ADP-ribosyltransferase 5,24101,-0.010322647292482,0.00445834709818128,-0.0190610076049174,-0.00158428698004673,0.02060198103162
NMR metabolomics,X23408.Triglycerides in VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,-0.00886162822719782,0.00385705248804973,-0.0164214511037753,-0.00130180535062036,0.0215980537247874
NMR metabolomics,X23408.Triglycerides in VLDL,MMP13,Collagenase 3,28774,-0.00531865228258813,0.00231785944350409,-0.00986165679185615,-0.000775647773320108,0.021760949773344
NMR metabolomics,X23408.Triglycerides in VLDL,LAMA1,Laminin subunit alpha-1,24111,-0.00878748948992477,0.00383540389003375,-0.0163048811143909,-0.00127009786545862,0.0219632704148209
NMR metabolomics,X23408.Triglycerides in VLDL,IL19,Interleukin-19,28654,0.0113737818362815,0.00497875421108638,0.00161542358255221,0.0211321400900108,0.0223515911944723
NMR metabolomics,X23408.Triglycerides in VLDL,KLK1,Kallikrein-1,29199,-0.0204086842378506,0.00901661408029899,-0.0380812478352367,-0.00273612064046462,0.0236150761353647
NMR metabolomics,X23408.Triglycerides in VLDL,PSAPL1,Proactivator polypeptide-like 1,24805,-0.00805924544156299,0.00357027488702627,-0.0150569842201345,-0.0010615066629915,0.0239968815201864
NMR metabolomics,X23408.Triglycerides in VLDL,PKLR,Pyruvate kinase PKLR,29491,0.010287018995578,0.00456464609900382,0.00134031264153051,0.0192337253496255,0.0242268307910769
NMR metabolomics,X23408.Triglycerides in VLDL,REG1A,Lithostathine-1-alpha,29353,-0.00783107297879225,0.00348089533852865,-0.0146536278423084,-0.00100851811527609,0.0244735016058671
NMR metabolomics,X23408.Triglycerides in VLDL,IL11,Interleukin-11,28931,0.00990306216142277,0.00441905598538059,0.00124171243007681,0.0185644118927687,0.0250342530807539
NMR metabolomics,X23408.Triglycerides in VLDL,GLI2,Zinc finger protein GLI2,24229,-0.0053019188213549,0.00236811117325141,-0.00994341672092767,-0.000660420921782129,0.0251727136878321
NMR metabolomics,X23408.Triglycerides in VLDL,FGF5,Fibroblast growth factor 5,28931,-0.00523432903976489,0.00234339529808186,-0.00982738382400533,-0.000641274255524444,0.0255136113625517
NMR metabolomics,X23408.Triglycerides in VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.019464694509852,0.00873204292176143,0.0023498903831996,0.0365794986365044,0.0258141959141676
NMR metabolomics,X23408.Triglycerides in VLDL,REST,RE1-silencing transcription factor,24016,-0.00554423925869031,0.00248904726710793,-0.0104227719022219,-0.000665706615158769,0.0259261558659285
NMR metabolomics,X23408.Triglycerides in VLDL,NMI,N-myc-interactor,24706,0.0113207509353216,0.00510930586948502,0.001306511431131,0.0213349904395123,0.0267203096960996
NMR metabolomics,X23408.Triglycerides in VLDL,PLXDC2,Plexin domain-containing protein 2,24845,0.0042449935849157,0.00191831669688611,0.000485092859018919,0.00800489431081247,0.0269153782155156
NMR metabolomics,X23408.Triglycerides in VLDL,MMP9,Matrix metalloproteinase-9,29411,0.00945508201876157,0.00427991686699623,0.00106644495944897,0.0178437190780742,0.0271702067950594
NMR metabolomics,X23408.Triglycerides in VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,-0.00740768076022478,0.00336007638149129,-0.0139934304679477,-0.000821931052501851,0.0274903790293588
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA10,Annexin A10,28774,0.0127781080236841,0.00581011991106941,0.00139027299798801,0.0241659430493801,0.0278656122289691
NMR metabolomics,X23408.Triglycerides in VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.0130922485392926,0.00595894691957468,0.00141271257692621,0.0247717845016589,0.0280245993746819
NMR metabolomics,X23408.Triglycerides in VLDL,RLN2,Prorelaxin H2,24326,0.0176449169535657,0.0080489223905888,0.00186902906801161,0.0334208048391197,0.0283738933939964
NMR metabolomics,X23408.Triglycerides in VLDL,GDF15,Growth/differentiation factor 15,29820,0.00688505728351428,0.00314077919395112,0.00072913006337008,0.0130409845036585,0.0283764248360473
NMR metabolomics,X23408.Triglycerides in VLDL,TFF3,Trefoil factor 3,29426,0.00717659497132531,0.00327653623240193,0.000754583955817518,0.0135986059868331,0.0285103613995847
NMR metabolomics,X23408.Triglycerides in VLDL,CBX2,Chromobox protein homolog 2,24111,-0.00624870109831603,0.00285917261164936,-0.0118526794171488,-0.000644722779483277,0.0288623279750304
NMR metabolomics,X23408.Triglycerides in VLDL,ERVV_1,,24111,-0.00715514991053635,0.00327498934570231,-0.0135741290281129,-0.000736170792959815,0.0289141623447725
NMR metabolomics,X23408.Triglycerides in VLDL,TLR1,Toll-like receptor 1,24229,0.00406943800064185,0.00187231297903187,0.000399704561739394,0.00773917143954431,0.0297537389499708
NMR metabolomics,X23408.Triglycerides in VLDL,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.0151775355678868,0.00699046509290487,-0.0288788471499803,-0.00147622398579321,0.0299275371035073
NMR metabolomics,X23408.Triglycerides in VLDL,BEX3,Protein BEX3,24016,-0.00727846548765,0.00335255753019011,-0.0138494782468226,-0.000707452728477389,0.0299395159147347
NMR metabolomics,X23408.Triglycerides in VLDL,SELENOP,Selenoprotein P,24966,0.00347003073951358,0.00160351990188477,0.000327131731819438,0.00661292974720772,0.0304731516874358
NMR metabolomics,X23408.Triglycerides in VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.00576791580223306,0.00266858497847332,0.000537489244425356,0.0109983423600408,0.0306731135852284
NMR metabolomics,X23408.Triglycerides in VLDL,PLAUR,Urokinase plasminogen activator surface receptor,29278,0.00417013663499944,0.00194610642295674,0.000355768046004221,0.00798450522399466,0.03213656718152
NMR metabolomics,X23408.Triglycerides in VLDL,SCARB1,Scavenger receptor class B member 1,28774,0.00871194340065114,0.00407089252038,0.000732994060706349,0.0166908927405959,0.0323585213028806
NMR metabolomics,X23408.Triglycerides in VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.00583267625889687,0.00273201593461029,0.000477925027060714,0.011187427490733,0.0327763568995659
NMR metabolomics,X23408.Triglycerides in VLDL,FRMD7,FERM domain-containing protein 7,24195,0.00505460178785304,0.00238045722349785,0.000388905629797242,0.00972029794590883,0.0337326216988302
NMR metabolomics,X23408.Triglycerides in VLDL,YY1,Transcriptional repressor protein YY1,24229,0.00420728886412624,0.00198259485532192,0.000321402947695289,0.0080931747805572,0.0338384345822507
NMR metabolomics,X23408.Triglycerides in VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,24229,0.00986813635377771,0.00465632369318454,0.000741741915136014,0.0189945307924194,0.034075459339325
NMR metabolomics,X23408.Triglycerides in VLDL,NGF,Beta-nerve growth factor,29218,0.00182016005535672,0.000860506260165643,0.000133567785432054,0.00350675232528138,0.0344196451994076
NMR metabolomics,X23408.Triglycerides in VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,-0.00450204410207264,0.00213513143166633,-0.00868690170813865,-0.000317186496006628,0.034993225411434
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,0.0125823213502383,0.006013628455539,0.000795609577381904,0.0243690331230948,0.0364201385160182
NMR metabolomics,X23408.Triglycerides in VLDL,MUCL3,Mucin-like protein 3,24016,-0.00650095694038538,0.00311603658446449,-0.0126083886459358,-0.000393525234834983,0.0369628636487835
NMR metabolomics,X23408.Triglycerides in VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.00723070384907106,0.00347746815919107,-0.0140465414410855,-0.000414866257056569,0.037600183697082
NMR metabolomics,X23408.Triglycerides in VLDL,MTR,Methionine synthase,24111,0.00962396481113175,0.0046296471470035,0.000549856403004884,0.0186980732192586,0.0376491838996519
NMR metabolomics,X23408.Triglycerides in VLDL,DOCK9,Dedicator of cytokinesis protein 9,24101,0.0174337652899526,0.0084027363858447,0.00096440197369696,0.0339031286062082,0.0380182287133889
NMR metabolomics,X23408.Triglycerides in VLDL,NECTIN4,Nectin-4,29566,-0.00468976571891407,0.00226086396784007,-0.00912105909588061,-0.000258472341947527,0.0380578123030291
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB7,Integrin beta-7,29725,0.00672091913611436,0.0032416384830868,0.000367307709264227,0.0130745305629645,0.0381521033914292
NMR metabolomics,X23408.Triglycerides in VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,24938,-0.00316139851967055,0.00152796455780995,-0.00615620905297805,-0.000166587986363048,0.0385539235195858
NMR metabolomics,X23408.Triglycerides in VLDL,CRNN,Cornulin,28580,0.00973392495366135,0.00473150933686677,0.000460166653402478,0.0190076832539202,0.0396706851514144
NMR metabolomics,X23408.Triglycerides in VLDL,REG1B,Lithostathine-1-beta,29820,0.00817011723640768,0.00398545970541027,0.000358616213803548,0.0159816182590118,0.0403750007689007
NMR metabolomics,X23408.Triglycerides in VLDL,TEX33,Testis-expressed protein 33,24445,-0.00566740472983754,0.00276780154138526,-0.0110922957509527,-0.000242513708722436,0.0406079554414822
NMR metabolomics,X23408.Triglycerides in VLDL,INHBB,Inhibin beta B chain,24381,0.00752524442346989,0.0036764271547368,0.000319447200185763,0.014731041646754,0.0406795246064106
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB118,Beta-defensin 118,24101,0.00833014122334148,0.00408807795509542,0.000317508431354458,0.0163427740153285,0.0415941589788366
NMR metabolomics,X23408.Triglycerides in VLDL,EDNRB,Endothelin receptor type B,24229,0.00653544205091597,0.00324348067769594,0.000178219922631933,0.0128926641792,0.0439212206644518
NMR metabolomics,X23408.Triglycerides in VLDL,NXPE4,NXPE family member 4,24111,-0.00491645067931535,0.00244007877442445,-0.00969900507718727,-0.000133896281443424,0.0439289639183168
NMR metabolomics,X23408.Triglycerides in VLDL,DNAJA1,DnaJ homolog subfamily A member 1,24016,-0.00668103666541239,0.00332351832464434,-0.0131951325817153,-0.000166940749109474,0.0444180044436893
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,0.0111502342735542,0.0055564830320413,0.000259527530753277,0.0220409410163552,0.0447901957614973
NMR metabolomics,X23408.Triglycerides in VLDL,SPRING1,SREBP regulating gene protein,24016,0.00846455931585904,0.00422656751854735,0.000180486979506234,0.0167486316522119,0.0452204060742434
NMR metabolomics,X23408.Triglycerides in VLDL,CDH22,Cadherin-22,24445,-0.00405458398983846,0.00202822199701905,-0.00802989910399579,-7.926887568112e-05,0.0456104378054367
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN1,Tetraspanin-1,28916,0.00801494846812375,0.00401448528108667,0.000146557317193886,0.0158833396190536,0.0458881142406461
NMR metabolomics,X23408.Triglycerides in VLDL,IFNL1,Interferon lambda-1,28774,0.00637479353605445,0.00320789404237412,8.73212130011762e-05,0.0126622658591077,0.0469074115552808
NMR metabolomics,X23408.Triglycerides in VLDL,DENND2B,DENN domain-containing protein 2B,24111,-0.00710676443170798,0.0036064838501522,-0.0141754727780063,-3.80560854096705e-05,0.0487865556733636
NMR metabolomics,X23408.Triglycerides in VLDL,AMIGO1,Amphoterin-induced protein 1,24195,0.00701410981945387,0.00356317235812413,3.02919975305781e-05,0.0139979276413772,0.0490217783149539
NMR metabolomics,X23408.Triglycerides in VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,0.00507604570698378,0.00258542343088832,8.6157824426749e-06,0.0101434756315249,0.0496188835438777
NMR metabolomics,X23408.Triglycerides in VLDL,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.00849113915211092,0.00432712897741761,9.96635637241089e-06,0.0169723119478494,0.0497386822188767
NMR metabolomics,X23408.Triglycerides in VLDL,CD82,CD82 antigen,24445,-0.00579139173825789,0.00295205058324112,-0.0115774108814105,-5.37259510529405e-06,0.0497947865533369
NMR metabolomics,X23408.Triglycerides in VLDL,DUSP29,Dual specificity phosphatase 29,24195,-0.00930367127909043,0.00474448065346654,-0.0186028533598848,-4.48919829601491e-06,0.0498967603240336
NMR metabolomics,X23408.Triglycerides in VLDL,PAPPA,Pappalysin-1,28931,0.00653753015265322,0.00333836911430087,-5.67331137647873e-06,0.0130807336166829,0.0502043531694009
NMR metabolomics,X23408.Triglycerides in VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00413828768137215,0.00212131568364295,-1.94910585680358e-05,0.00829606642131233,0.0510890820379994
NMR metabolomics,X23408.Triglycerides in VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.00820259096556218,0.00420611393942877,-4.13923557182061e-05,0.0164465742868426,0.0511666747330701
NMR metabolomics,X23408.Triglycerides in VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.00836775702027711,0.00432794867485396,-0.0168505364229909,0.000115022382436658,0.053195765811817
NMR metabolomics,X23408.Triglycerides in VLDL,DEFB116,Beta-defensin 116,24101,-0.0105755227123648,0.00547861002905149,-0.0213135983693057,0.00016255294457611,0.0535777456872814
NMR metabolomics,X23408.Triglycerides in VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,-0.00504346730618392,0.00263450670379401,-0.0102071004456202,0.000120165833252347,0.0555824619900411
NMR metabolomics,X23408.Triglycerides in VLDL,WIF1,Wnt inhibitory factor 1,29725,-0.00459485486760756,0.00240882184839794,-0.00931614569046751,0.000126435955252396,0.0564640424914343
NMR metabolomics,X23408.Triglycerides in VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.00554453417762012,0.00290832198051185,-0.000155776904183104,0.0112448452594233,0.0566030701132173
NMR metabolomics,X23408.Triglycerides in VLDL,FGF9,Fibroblast growth factor 9,23970,0.00551683770248584,0.00289668433283711,-0.00016066358987489,0.0111943389948466,0.0568524632558708
NMR metabolomics,X23408.Triglycerides in VLDL,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.00541602000734229,0.00286180462559689,-0.0110251570735122,0.000193117058827625,0.0584317253400734
NMR metabolomics,X23408.Triglycerides in VLDL,CA3,Carbonic anhydrase 3,29761,0.0079161757150182,0.00424372159367909,-0.00040151860859282,0.0162338700386292,0.0621372585542443
NMR metabolomics,X23408.Triglycerides in VLDL,ANGPT2,Angiopoietin-2,29725,-0.00502218850009502,0.00269602684640081,-0.0103064011190406,0.000262024118850572,0.0624987213541998
NMR metabolomics,X23408.Triglycerides in VLDL,RETN,Resistin,29362,0.00555873357698706,0.00298629948670071,-0.000294413416946325,0.0114118805709204,0.0626960131949832
NMR metabolomics,X23408.Triglycerides in VLDL,TMEM132A,Transmembrane protein 132A,24240,0.00826002849328308,0.00444831275834611,-0.000458664513075292,0.0169787214996414,0.063338902070038
NMR metabolomics,X23408.Triglycerides in VLDL,H2AP,Huntingtin-interacting protein M,24016,-0.00672841289353947,0.00363689384549709,-0.0138567248307138,0.000399899043634812,0.0643195199260722
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,24101,-0.009205901904779,0.00497862814212265,-0.0189640130633394,0.000552209253781391,0.0644579211658759
NMR metabolomics,X23408.Triglycerides in VLDL,RELB,Transcription factor RelB,24229,0.00647420541795378,0.00350511836207771,-0.000395826571718529,0.0133442374076261,0.0647489206090162
NMR metabolomics,X23408.Triglycerides in VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,-0.00539499723047783,0.00292729472611,-0.0111324948936534,0.000342500432697765,0.0653416364531709
NMR metabolomics,X23408.Triglycerides in VLDL,CPLX2,Complexin-2,24016,-0.00401678313348589,0.00218485836453447,-0.00829910552797345,0.000265539261001668,0.0660064316013078
NMR metabolomics,X23408.Triglycerides in VLDL,DHODH,Dihydroorotate dehydrogenase,24111,0.00616927459077336,0.00336277911763877,-0.000421772479798624,0.0127603216613453,0.0665808267237787
NMR metabolomics,X23408.Triglycerides in VLDL,DNLZ,DNL-type zinc finger protein,24101,-0.0116764710809851,0.00641064790329896,-0.024241340971451,0.000888398809480915,0.0685557010794913
NMR metabolomics,X23408.Triglycerides in VLDL,ADA2,Adenosine deaminase 2,29328,-0.00550854088168293,0.00302662846916176,-0.01144073268124,0.000423650917874122,0.0687653205514334
NMR metabolomics,X23408.Triglycerides in VLDL,SLC44A4,Choline transporter-like protein 4,24195,-0.00895671375740259,0.00492385645334992,-0.0186074724059684,0.000694044891163256,0.0689170110072855
NMR metabolomics,X23408.Triglycerides in VLDL,HIP1,Huntingtin-interacting protein 1,24111,0.00430049317437594,0.00237487903776782,-0.000354269739648989,0.00895525608840087,0.0701802079724057
NMR metabolomics,X23408.Triglycerides in VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.00628945145251305,0.00348833556194433,-0.000547686248897832,0.0131265891539239,0.0714014984042137
NMR metabolomics,X23408.Triglycerides in VLDL,AKAP12,A-kinase anchor protein 12,24381,-0.00273853396336309,0.00152746428759209,-0.00573236396704359,0.000255296040317418,0.0730072566656237
NMR metabolomics,X23408.Triglycerides in VLDL,TCN1,Transcobalamin-1,24546,0.00434022806607927,0.00242347700412646,-0.000409786862008593,0.00909024299416714,0.073320138209469
NMR metabolomics,X23408.Triglycerides in VLDL,FBN2,Fibrillin-2,24195,0.00766892059245193,0.00428916611503331,-0.000737844993013355,0.0160756861779172,0.0737926032904851
NMR metabolomics,X23408.Triglycerides in VLDL,IL36A,Interleukin-36 alpha,24229,-0.00737600314241891,0.00413343986802866,-0.0154775452837551,0.000725538998917259,0.074359695936668
NMR metabolomics,X23408.Triglycerides in VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.00414172834668333,0.00232656477462425,-0.00870179530494686,0.000418338611580202,0.0750574033033408
NMR metabolomics,X23408.Triglycerides in VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.0105961889900674,0.00595731566081641,-0.0222725276852676,0.00108014970513276,0.0753040464633725
NMR metabolomics,X23408.Triglycerides in VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,0.00978331909715094,0.00552631536067697,-0.00104825900977593,0.0206148972040778,0.0766852168576291
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN15,Tetraspanin-15,24111,-0.00634718394538454,0.003589902024259,-0.0133833919129322,0.000689024022163095,0.0770625111386148
NMR metabolomics,X23408.Triglycerides in VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,-0.00813118423641408,0.00461371378761314,-0.0171740632601358,0.000911694787307678,0.0780153325329318
NMR metabolomics,X23408.Triglycerides in VLDL,DPEP2,Dipeptidase 2,29349,-0.0036495979014123,0.00207099578662188,-0.0077087496431912,0.000409553840366586,0.0780386568211427
NMR metabolomics,X23408.Triglycerides in VLDL,DCUN1D1,DCN1-like protein 1,24101,-0.00937022648167365,0.00531839583061089,-0.019794282309671,0.00105382934632369,0.0781069849437723
NMR metabolomics,X23408.Triglycerides in VLDL,CD2,T-cell surface antigen CD2,24111,0.00476496576513966,0.00272682108056539,-0.000579603552768505,0.0101095350830478,0.0805731754657161
NMR metabolomics,X23408.Triglycerides in VLDL,CRTAC1,Cartilage acidic protein 1,29820,0.00371376934940358,0.00212692739324239,-0.000455008341351495,0.00788254704015866,0.0808086635030172
NMR metabolomics,X23408.Triglycerides in VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00436715755329374,0.00250868016110761,-0.000549855562477167,0.00928417066906465,0.0817280492246239
NMR metabolomics,X23408.Triglycerides in VLDL,TOP1,DNA topoisomerase 1,24805,0.0139649477491041,0.00803055253689335,-0.00177493522320682,0.0297048307214151,0.0820511869224399
NMR metabolomics,X23408.Triglycerides in VLDL,TNNI3,"Troponin I, cardiac muscle",28916,0.010354446369618,0.00595906640264256,-0.00132532377956143,0.0220342165187974,0.0822927828071132
NMR metabolomics,X23408.Triglycerides in VLDL,NPHS2,Podocin,24229,-0.0126750029918192,0.00733282352315161,-0.0270473370971964,0.00169733111355796,0.0839060543033431
NMR metabolomics,X23408.Triglycerides in VLDL,ENDOU,Poly(U)-specific endoribonuclease,23037,0.00652366129620411,0.00377509524141318,-0.000875525376965732,0.013922847969374,0.0839875425528156
NMR metabolomics,X23408.Triglycerides in VLDL,IGLC2,Immunoglobulin lambda constant 2,24915,-0.00303766588833371,0.00176192090804164,-0.00649103086809532,0.000415699091427892,0.0847085499207413
NMR metabolomics,X23408.Triglycerides in VLDL,CTSV,Cathepsin L2,29618,0.00504136210419384,0.00293051141898966,-0.000702440277025898,0.0107851644854136,0.0853881686735466
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,29478,-0.00328246183343725,0.0019170254488634,-0.00703983171320951,0.000474908046335009,0.0868577650793412
NMR metabolomics,X23408.Triglycerides in VLDL,HTR1A,5-hydroxytryptamine receptor 1A,24101,-0.00935203733923947,0.00546860684207457,-0.0200705067497056,0.00136643207122668,0.0872544198283824
NMR metabolomics,X23408.Triglycerides in VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.0105359844020903,0.00616161906438154,-0.0226127577682781,0.00154078896409752,0.0872899232077543
NMR metabolomics,X23408.Triglycerides in VLDL,IL33,Interleukin-33,28931,0.00469776201970264,0.00275895466817822,-0.000709789129926659,0.0101053131693319,0.0886288705153158
NMR metabolomics,X23408.Triglycerides in VLDL,PGM2,Phosphoglucomutase-2,24195,0.0072689493589623,0.00427190192854646,-0.00110397842098876,0.0156418771389134,0.0888484569008025
NMR metabolomics,X23408.Triglycerides in VLDL,TCN2,Transcobalamin-2,29757,-0.00359649011090448,0.0021217231285618,-0.00775506744288561,0.000562087221076656,0.0900707425469674
NMR metabolomics,X23408.Triglycerides in VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.00597292048778599,0.00357340230740286,-0.0129767890102956,0.00103094803472362,0.094637128762718
NMR metabolomics,X23408.Triglycerides in VLDL,DCLRE1C,Protein artemis,24016,-0.00369066210020575,0.00220837349018706,-0.0080190741409724,0.00063774994056089,0.0946926842794099
NMR metabolomics,X23408.Triglycerides in VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.0147772789211439,0.00885402824646703,-0.0025766164419315,0.0321311742842193,0.0951303644329635
NMR metabolomics,X23408.Triglycerides in VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00676796293590426,0.00406809800953611,-0.014741435034595,0.00120550916278652,0.0961918790086174
NMR metabolomics,X23408.Triglycerides in VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,0.00409405853056413,0.0024656629360711,-0.000738640824135227,0.00892675788526348,0.0968387657720019
NMR metabolomics,X23408.Triglycerides in VLDL,RASA1,Ras GTPase-activating protein 1,28774,0.00380850133569055,0.00230314437105636,-0.000705661631579905,0.00832266430296101,0.0982178016734405
NMR metabolomics,X23408.Triglycerides in VLDL,COPE,Coatomer subunit epsilon,28774,0.00553148573718616,0.00335369273472563,-0.00104175202287607,0.0121047234972484,0.0990824390915277
NMR metabolomics,X23408.Triglycerides in VLDL,ESPL1,Separin,24016,-0.00644399729773502,0.00393684896612133,-0.0141602212713328,0.00127222667586279,0.101676726903383
NMR metabolomics,X23408.Triglycerides in VLDL,ACTN4,Alpha-actinin-4,28931,0.00370102196093762,0.00226583785209964,-0.000740020229177664,0.00814206415105291,0.102395559945847
NMR metabolomics,X23408.Triglycerides in VLDL,KIRREL1,Kin of IRRE-like protein 1,24101,-0.00684360850779064,0.00419010771479419,-0.0150562196287872,0.00136900261320596,0.102423724020888
NMR metabolomics,X23408.Triglycerides in VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,0.0133462888079089,0.00818967651452391,-0.00270547716055792,0.0293980547763758,0.103188615997251
NMR metabolomics,X23408.Triglycerides in VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,24016,-0.00293948493923895,0.00180513920954965,-0.00647755778995626,0.000598587911478362,0.103453662179393
NMR metabolomics,X23408.Triglycerides in VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00410661492081717,0.00253219742834665,-0.000856492038742272,0.00906972188037661,0.104867917239045
NMR metabolomics,X23408.Triglycerides in VLDL,AXL,Tyrosine-protein kinase receptor UFO,29594,0.00316410693711098,0.00195232324545371,-0.000662446623978297,0.00699066049820025,0.105095218603718
NMR metabolomics,X23408.Triglycerides in VLDL,KRT14,"Keratin, type I cytoskeletal 14",27986,0.00332279258323019,0.00206241310208632,-0.000719537096858998,0.00736512226331938,0.107165107812626
NMR metabolomics,X23408.Triglycerides in VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,24101,-0.00837697106616147,0.00520351850042693,-0.0185758673269983,0.0018219251946753,0.107440067983419
NMR metabolomics,X23408.Triglycerides in VLDL,CCNE1,G1/S-specific cyclin-E1,24229,0.0105620096164718,0.00656588323361364,-0.00230712152141098,0.0234311407543545,0.107712543611339
NMR metabolomics,X23408.Triglycerides in VLDL,CORO6,Coronin-6,24101,-0.00428949138614278,0.00266738123525073,-0.00951755860723421,0.000938575834948644,0.107820177391289
NMR metabolomics,X23408.Triglycerides in VLDL,MB,Myoglobin,29820,-0.00594521128039019,0.00371074289084769,-0.0132182673464517,0.00132784478567128,0.109130385749635
NMR metabolomics,X23408.Triglycerides in VLDL,AGBL2,Cytosolic carboxypeptidase 2,24101,0.0103636438617549,0.00647922964244933,-0.00233564623744576,0.0230629339609556,0.109718687578843
NMR metabolomics,X23408.Triglycerides in VLDL,THY1,Thy-1 membrane glycoprotein,29694,0.00321729562032406,0.00201967128522659,-0.000741260098720052,0.00717585133936816,0.111175364807801
NMR metabolomics,X23408.Triglycerides in VLDL,TSLP,Thymic stromal lymphopoietin,28916,0.00681312267586176,0.00428029142776183,-0.00157624852255142,0.0152024938742749,0.111453463862091
NMR metabolomics,X23408.Triglycerides in VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,0.00419332463874762,0.00263604532322081,-0.000973324194765163,0.0093599734722604,0.111673745385479
NMR metabolomics,X23408.Triglycerides in VLDL,PPT1,Palmitoyl-protein thioesterase 1,24195,0.00874401787574545,0.00551036347517599,-0.00205629453559949,0.0195443302870904,0.112563906765243
NMR metabolomics,X23408.Triglycerides in VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.00553258364371518,0.00349789204215515,-0.0123884520463393,0.00132328475890891,0.113733253827323
NMR metabolomics,X23408.Triglycerides in VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,24101,-0.00789781343971457,0.00502686024983922,-0.0177504595293994,0.00195483264997029,0.116167322989746
NMR metabolomics,X23408.Triglycerides in VLDL,IL1A,Interleukin-1 alpha,28931,0.00618142908799468,0.00393997995900762,-0.00154093163166026,0.0139037898076496,0.116682507025181
NMR metabolomics,X23408.Triglycerides in VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.00554618115588632,0.00353948551738316,-0.00139121045818467,0.0124835727699573,0.117140545249159
NMR metabolomics,X23408.Triglycerides in VLDL,UPK3BL1,Uroplakin-3b-like protein 1,24404,-0.00604402963219045,0.00385740251980571,-0.0136045385710096,0.00151647930662875,0.117159184869173
NMR metabolomics,X23408.Triglycerides in VLDL,SLC51B,Organic solute transporter subunit beta,24111,0.00845359743474629,0.00542030148396254,-0.00217019347382028,0.0190773883433129,0.11886341398642
NMR metabolomics,X23408.Triglycerides in VLDL,HMCN2,Hemicentin-2,24343,0.00635773665558674,0.00408824857410522,-0.00165523054965949,0.014370703860833,0.119929362271649
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA2013,Uncharacterized protein KIAA2013,24793,0.00614418902253184,0.00395168590180879,-0.00160111534501339,0.0138894933900771,0.119999982585821
NMR metabolomics,X23408.Triglycerides in VLDL,S100A3,Protein S100-A3,24793,0.00487393020836159,0.00314956054050367,-0.0012992084510256,0.0110470688677488,0.121756622000222
NMR metabolomics,X23408.Triglycerides in VLDL,CSF2RB,Cytokine receptor common subunit beta,24229,-0.004748043939157,0.00308143155853401,-0.0107876497938837,0.00129156191556966,0.123364774373534
NMR metabolomics,X23408.Triglycerides in VLDL,DOC2B,Double C2-like domain-containing protein beta,24195,0.00389838210058893,0.00257405540267661,-0.00114676648865722,0.00894353068983508,0.129914586508543
NMR metabolomics,X23408.Triglycerides in VLDL,GUCY2C,Heat-stable enterotoxin receptor,24445,-0.00896147614256053,0.00591760988724852,-0.0205599915215676,0.00263703923644657,0.129943878146993
NMR metabolomics,X23408.Triglycerides in VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,-0.00452456194178114,0.00299530730667963,-0.0103953642628732,0.00134624037931093,0.13091581292237
NMR metabolomics,X23408.Triglycerides in VLDL,SMC3,Structural maintenance of chromosomes protein 3,24016,0.00579213441922453,0.00383854781098629,-0.0017314192903086,0.0133156881287577,0.131327539804417
NMR metabolomics,X23408.Triglycerides in VLDL,BMP10,Bone morphogenetic protein 10,24381,-0.00304075604959204,0.00202285513063706,-0.00700555210564067,0.000924040006456592,0.132800409380452
NMR metabolomics,X23408.Triglycerides in VLDL,PRR5,Proline-rich protein 5,24229,0.00508006519814632,0.00338231759544232,-0.00154927728892063,0.0117094076852133,0.13312357443506
NMR metabolomics,X23408.Triglycerides in VLDL,GSTM4,Glutathione S-transferase Mu 4,24111,-0.00775469745007217,0.00517095079632245,-0.0178897610108642,0.00238036611071984,0.133714125182931
NMR metabolomics,X23408.Triglycerides in VLDL,CLNS1A,Methylosome subunit pICln,24195,0.0035616353121883,0.00237954212026113,-0.00110226724352351,0.00822553786790012,0.13446528567845
NMR metabolomics,X23408.Triglycerides in VLDL,L1CAM,Neural cell adhesion molecule L1,29566,0.00306120461739291,0.00204789483042655,-0.000952669250243131,0.00707507848502896,0.134975867481124
NMR metabolomics,X23408.Triglycerides in VLDL,SPINT1,Kunitz-type protease inhibitor 1,29333,0.00275529964921309,0.00184579068812242,-0.000862450099506853,0.00637304939793303,0.135514024328468
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAV,Integrin alpha-V,29725,0.00173585760857575,0.00117389004076351,-0.000564966871320735,0.00403668208847224,0.139225099197087
NMR metabolomics,X23408.Triglycerides in VLDL,RRP15,RRP15-like protein,24101,-0.0095532204004706,0.00646172510287788,-0.0222182016021112,0.00311176080117004,0.139305293303694
NMR metabolomics,X23408.Triglycerides in VLDL,MSMB,Beta-microseminoprotein,29313,0.00727559425326945,0.00492172455201202,-0.00237098586867411,0.016922174375213,0.139348638639456
NMR metabolomics,X23408.Triglycerides in VLDL,RAB6B,Ras-related protein Rab-6B,28774,0.0050231984580082,0.00340198520737777,-0.00164469254845224,0.0116910894644686,0.139807472549429
NMR metabolomics,X23408.Triglycerides in VLDL,TFRC,Transferrin receptor protein 1,29565,-0.00402012836382464,0.00272671682781188,-0.00936449334633593,0.00132423661868665,0.140398682485463
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,29169,-0.00350696688040085,0.00237879504630165,-0.00816940517115208,0.00115547141035038,0.140421889174477
NMR metabolomics,X23408.Triglycerides in VLDL,SPINT3,Kunitz-type protease inhibitor 3,24805,0.0153886965179757,0.0104432458915606,-0.00508006542948313,0.0358574584654345,0.140614159226625
NMR metabolomics,X23408.Triglycerides in VLDL,DCUN1D2,DCN1-like protein 2,24016,-0.0083898113214673,0.00569588117727763,-0.0195537384289315,0.00277411578599685,0.140774642081581
NMR metabolomics,X23408.Triglycerides in VLDL,NCAM1,Neural cell adhesion molecule 1,29594,-0.00313167062207861,0.00213584173373179,-0.00731792042019291,0.00105457917603569,0.142591755041801
NMR metabolomics,X23408.Triglycerides in VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.00647215399075737,0.00442168945176896,-0.00219435733470979,0.0151386653162245,0.143280760815089
NMR metabolomics,X23408.Triglycerides in VLDL,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.00880667495410977,0.00603181917263096,-0.0206290405324664,0.0030156906242469,0.144293064599044
NMR metabolomics,X23408.Triglycerides in VLDL,LY96,Lymphocyte antigen 96,29218,-0.00367162395771036,0.00251617494513105,-0.00860332685016722,0.00126007893474651,0.144518475595291
NMR metabolomics,X23408.Triglycerides in VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00574463906434507,0.00394886778967177,-0.0134844199321017,0.00199514180341159,0.14574980665888
NMR metabolomics,X23408.Triglycerides in VLDL,IL4,Interleukin-4,28931,0.00939551436677739,0.00650010754341522,-0.00334469641831643,0.0221357251518712,0.148345218169446
NMR metabolomics,X23408.Triglycerides in VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00303712186535575,0.00210285535366435,-0.00715871835853788,0.00108447462782638,0.148671506918341
NMR metabolomics,X23408.Triglycerides in VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,29581,0.00288046935294464,0.0019958996248938,-0.0010314939118472,0.00679243261773648,0.148976565922459
NMR metabolomics,X23408.Triglycerides in VLDL,CNTN5,Contactin-5,29511,-0.00376930293487898,0.0026210438460954,-0.00890654887322597,0.00136794300346802,0.150418480184306
NMR metabolomics,X23408.Triglycerides in VLDL,PRRT3,Proline-rich transmembrane protein 3,24240,0.00386401764705627,0.00269958766039632,-0.00142717416732051,0.00915520946143306,0.152346772475248
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINB5,Serpin B5,28916,0.00490379515927511,0.00344350321468986,-0.00184547114151703,0.0116530614600672,0.154436540333726
NMR metabolomics,X23408.Triglycerides in VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.013862872113139,0.0097795459988485,-0.0330307822708821,0.00530503804460403,0.156338371356608
NMR metabolomics,X23408.Triglycerides in VLDL,LYPLA2,Acyl-protein thioesterase 2,24101,0.010827259966682,0.0076807879950771,-0.00422708450366912,0.0258816044370331,0.158654536752418
NMR metabolomics,X23408.Triglycerides in VLDL,MERTK,Tyrosine-protein kinase Mer,29786,0.00253588521096856,0.00180012967996733,-0.000992368961767409,0.00606413938370452,0.158927349171298
NMR metabolomics,X23408.Triglycerides in VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.00464150345660938,0.00332502945935297,-0.00187555428372244,0.0111585611969412,0.162748881380372
NMR metabolomics,X23408.Triglycerides in VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0065753877737977,0.00472466150577666,-0.01583572432512,0.00268494877752455,0.164018912793011
NMR metabolomics,X23408.Triglycerides in VLDL,GID8,Glucose-induced degradation protein 8 homolog,24867,0.00333350950181545,0.00239918278635812,-0.00136888875944647,0.00803590776307737,0.164712838259854
NMR metabolomics,X23408.Triglycerides in VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.00348541013374234,0.00251455497441639,-0.00144311761611379,0.00841393788359846,0.16573078323198
NMR metabolomics,X23408.Triglycerides in VLDL,MORC3,MORC family CW-type zinc finger protein 3,24845,0.00275078234251,0.00199394663362982,-0.00115735305940444,0.00665891774442445,0.167732524680719
NMR metabolomics,X23408.Triglycerides in VLDL,FZD10,Frizzled-10,24195,0.00589643435819411,0.00427505991958438,-0.00248268308419128,0.0142755518005795,0.167826263616784
NMR metabolomics,X23408.Triglycerides in VLDL,GAD1,Glutamate decarboxylase 1,24016,-0.00253809647620691,0.00184740082161567,-0.00615900208657363,0.00108280913415981,0.16949354534895
NMR metabolomics,X23408.Triglycerides in VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.0048734464347931,0.00354765245163562,-0.00207995237041271,0.0118268452399989,0.169544777036809
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGAP30,Rho GTPase-activating protein 30,24445,0.00376023416419888,0.00275205775346248,-0.00163379903258757,0.00915426736098533,0.171846263397003
NMR metabolomics,X23408.Triglycerides in VLDL,RBM25,RNA-binding protein 25,24016,-0.00449880677986709,0.00329814382823467,-0.010963168683207,0.00196555512347286,0.172567130632829
NMR metabolomics,X23408.Triglycerides in VLDL,CRISP2,Cysteine-rich secretory protein 2,29725,-0.0055153305773078,0.00407289479793572,-0.0134982043812618,0.00246754322664622,0.175697253008852
NMR metabolomics,X23408.Triglycerides in VLDL,IL25,Interleukin-25,23913,0.00331864461438741,0.00245632807878614,-0.00149575842003343,0.00813304764880825,0.176689264256932
NMR metabolomics,X23408.Triglycerides in VLDL,CDC123,Cell division cycle protein 123 homolog,24016,0.00606802464565057,0.0044998224835187,-0.00275162742204609,0.0148876767133472,0.177509342109482
NMR metabolomics,X23408.Triglycerides in VLDL,TGFBR1,TGF-beta receptor type-1,24229,0.00207132218548949,0.00153933500834315,-0.000945774430863095,0.00508841880184207,0.178445618376767
NMR metabolomics,X23408.Triglycerides in VLDL,CD27,CD27 antigen,29566,-0.00395798358219452,0.00294227297727855,-0.00972483861766048,0.00180887145327143,0.17856681184407
NMR metabolomics,X23408.Triglycerides in VLDL,GAMT,Guanidinoacetate N-methyltransferase,24111,-0.00355812758838669,0.00264586077312807,-0.0087440147037177,0.00162775952694433,0.178705659073935
NMR metabolomics,X23408.Triglycerides in VLDL,CHP1,Calcineurin B homologous protein 1,24101,0.00697093026656608,0.00519840344066828,-0.00321794047714375,0.0171598010102759,0.179941138807234
NMR metabolomics,X23408.Triglycerides in VLDL,PMCH,Pro-MCH,24111,-0.007957250842603,0.00593816864119543,-0.019596061379346,0.00368155969414004,0.180252239106173
NMR metabolomics,X23408.Triglycerides in VLDL,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00351423179630913,0.00262304864793791,-0.00865540714626744,0.00162694355364918,0.180339026270992
NMR metabolomics,X23408.Triglycerides in VLDL,NPTN,Neuroplastin,28797,0.00773073200421947,0.00577921893063715,-0.00359653709982935,0.0190580011082683,0.181012108526785
NMR metabolomics,X23408.Triglycerides in VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,-0.00420688169214581,0.0031485902497689,-0.0103781185816929,0.00196435519740123,0.181523929009588
NMR metabolomics,X23408.Triglycerides in VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,-0.00334700005206351,0.00250527600659849,-0.00825734102499655,0.00156334092086953,0.181568242681545
NMR metabolomics,X23408.Triglycerides in VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,-0.00247731014737133,0.00185809549804782,-0.00611917732354506,0.00116455702880241,0.182461232706094
NMR metabolomics,X23408.Triglycerides in VLDL,ANXA5,Annexin A5,28650,0.00285140229027824,0.00215539562033302,-0.00137317312557448,0.00707597770613096,0.18587465862547
NMR metabolomics,X23408.Triglycerides in VLDL,PITHD1,PITH domain-containing protein 1,23970,-0.00747297963623359,0.00566377812245764,-0.0185739847562506,0.00362802548378339,0.18703677658719
NMR metabolomics,X23408.Triglycerides in VLDL,PRND,Prion-like protein doppel,24845,-0.00479161209801895,0.00365460261041883,-0.0119546332144399,0.00237140901840196,0.189830317331535
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP3,Microfibril-associated glycoprotein 3,28916,0.00452100536457654,0.00345383726698815,-0.00224851567872023,0.0112905264078733,0.190551389668955
NMR metabolomics,X23408.Triglycerides in VLDL,SEPTIN7,Septin-7,24445,0.00487687378624459,0.00374089570516128,-0.00245528179587152,0.0122090293683607,0.192360204241942
NMR metabolomics,X23408.Triglycerides in VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.00528795434378834,0.00407506407478109,-0.00269917124278259,0.0132750799303593,0.194424536748351
NMR metabolomics,X23408.Triglycerides in VLDL,COL4A4,Collagen alpha-4(IV) chain,24405,-0.0048586655595392,0.00375289253432308,-0.0122143349268124,0.00249700380773404,0.195454792611373
NMR metabolomics,X23408.Triglycerides in VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.00428605229575476,0.00332520631358815,-0.00223135207887802,0.0108034566703875,0.197422628105491
NMR metabolomics,X23408.Triglycerides in VLDL,CGN,Cingulin,24195,0.00363022417135461,0.00283308294971072,-0.0019226184100784,0.00918306675278763,0.200076436035007
NMR metabolomics,X23408.Triglycerides in VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,-0.00289779382955602,0.00226784177903873,-0.00734276371647193,0.00154717605735989,0.20134072830156
NMR metabolomics,X23408.Triglycerides in VLDL,ENOPH1,Enolase-phosphatase E1,24793,0.00500778093510535,0.00393111485612584,-0.0026972041829013,0.012712766053112,0.202716782721938
NMR metabolomics,X23408.Triglycerides in VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,-0.00513471291783909,0.00403297828507551,-0.0130393503565871,0.00276992452090892,0.20296601186327
NMR metabolomics,X23408.Triglycerides in VLDL,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.00429247582636551,0.00341261182233148,-0.0109811949981352,0.00239624334540419,0.208466395801779
NMR metabolomics,X23408.Triglycerides in VLDL,CD58,Lymphocyte function-associated antigen 3,29409,-0.00156833453764299,0.00124784307992495,-0.0040141069742959,0.000877437899009925,0.208822888513274
NMR metabolomics,X23408.Triglycerides in VLDL,HDAC8,Histone deacetylase 8,24229,0.00545558352222645,0.00435450188012938,-0.00307924016282714,0.01399040720728,0.210268567508812
NMR metabolomics,X23408.Triglycerides in VLDL,IL10,Interleukin-10,28931,0.00723910957897271,0.00579295788866159,-0.00411508788280401,0.0185933070407494,0.211441344414039
NMR metabolomics,X23408.Triglycerides in VLDL,SOX2,Transcription factor SOX-2,24826,0.00210318694089847,0.00169069934423054,-0.00121058377379338,0.00541695765559033,0.213520684828782
NMR metabolomics,X23408.Triglycerides in VLDL,DLL1,Delta-like protein 1,29566,-0.00262708468851554,0.00211470968453059,-0.00677191567019549,0.00151774629316441,0.214139093698691
NMR metabolomics,X23408.Triglycerides in VLDL,FZD8,Frizzled-8,24101,0.00386585812992001,0.00312371840299018,-0.00225662993994074,0.00998834619978076,0.21588310094778
NMR metabolomics,X23408.Triglycerides in VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.00755870308361132,0.00613302350296665,-0.00446202298220331,0.0195794291494259,0.21778934639351
NMR metabolomics,X23408.Triglycerides in VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-0.00428677970875475,0.00348056520409117,-0.0111086875087734,0.00253512809126394,0.218098194570603
NMR metabolomics,X23408.Triglycerides in VLDL,CD177,CD177 antigen,29413,-0.0111268447475438,0.00905980514472128,-0.0288840628311975,0.00663037333610995,0.219398629819716
NMR metabolomics,X23408.Triglycerides in VLDL,FGF7,Fibroblast growth factor 7,24016,-0.00692243046103847,0.00563732596671095,-0.0179715893557919,0.004126728433715,0.219472716037313
NMR metabolomics,X23408.Triglycerides in VLDL,INSL4,Early placenta insulin-like peptide,24793,-0.00445539783767118,0.0036461973707102,-0.0116019446842632,0.00269114900892081,0.221745735391631
NMR metabolomics,X23408.Triglycerides in VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.00569775355427846,0.00467841930966246,-0.0148674554012169,0.00347194829265996,0.223281529625124
NMR metabolomics,X23408.Triglycerides in VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,24111,-0.00428213500738533,0.003523480270182,-0.0111881563369421,0.0026238863221714,0.224258249752202
NMR metabolomics,X23408.Triglycerides in VLDL,GAD2,Glutamate decarboxylase 2,24229,-0.00399379839580437,0.00328906467511965,-0.0104403651590389,0.00245276836743015,0.224658123540413
NMR metabolomics,X23408.Triglycerides in VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,-0.00537185404402247,0.00444077404126108,-0.0140757711648942,0.00333206307684925,0.226418895232029
NMR metabolomics,X23408.Triglycerides in VLDL,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.00273570618811213,0.00226389592124363,-0.00717294219374965,0.00170152981752538,0.226902906721101
NMR metabolomics,X23408.Triglycerides in VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,-0.00532918541674684,0.00444120570761871,-0.0140339486036795,0.00337557777018583,0.230173999953881
NMR metabolomics,X23408.Triglycerides in VLDL,KLHL41,Kelch-like protein 41,24867,0.00422872520472197,0.00352663518117503,-0.00268347975038108,0.011140930159825,0.23050744629079
NMR metabolomics,X23408.Triglycerides in VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00354595733408503,0.00297283238351471,-0.0022807941376038,0.00937270880577386,0.232963990522144
NMR metabolomics,X23408.Triglycerides in VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,24229,-0.00406817942203005,0.00343114222535957,-0.0107932181837348,0.0026568593396747,0.235766926837178
NMR metabolomics,X23408.Triglycerides in VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.00257921666956683,0.00218425869721467,-0.00170193037697393,0.00686036371610758,0.237685490204283
NMR metabolomics,X23408.Triglycerides in VLDL,NELL1,Protein kinase C-binding protein NELL1,29566,-0.00351415835166503,0.00299087643862162,-0.0093762761713634,0.00234795946803335,0.24002043068008
NMR metabolomics,X23408.Triglycerides in VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,0.00369574104214644,0.00316601103723957,-0.00250964059084312,0.009901122675136,0.243091401395399
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC11A,C-type lectin domain family 11 member A,29388,-0.00395747371006999,0.00340648363785054,-0.010634181640257,0.00271923422011708,0.245347501424669
NMR metabolomics,X23408.Triglycerides in VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.0026831004113073,0.00231679237953382,-0.00185781265257899,0.00722401347519359,0.246830629525324
NMR metabolomics,X23408.Triglycerides in VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,-0.00413135828517706,0.00359133093623643,-0.0111703669202005,0.00290765034984634,0.250001054531721
NMR metabolomics,X23408.Triglycerides in VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00287209000676098,0.00250846082840023,-0.00204449321690347,0.00778867323042543,0.252234802449753
NMR metabolomics,X23408.Triglycerides in VLDL,FGF12,Fibroblast growth factor 12,24229,0.00379642537103014,0.00332278575693575,-0.00271623471256393,0.0103090854546242,0.253239709102676
NMR metabolomics,X23408.Triglycerides in VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,0.00337587397335204,0.00296202010343794,-0.00242968542938632,0.00918143337609041,0.254414202112065
NMR metabolomics,X23408.Triglycerides in VLDL,DUOX2,Dual oxidase 2,28916,0.00565378638123288,0.00505037565030661,-0.00424494989336807,0.0155525226558338,0.262945409989883
NMR metabolomics,X23408.Triglycerides in VLDL,MORF4L1,Mortality factor 4-like protein 1,24445,-0.00316641437890036,0.00284893247891824,-0.00875032203758011,0.00241749327977939,0.266390413735826
NMR metabolomics,X23408.Triglycerides in VLDL,IL31,Interleukin-31,24229,-0.00448871857432105,0.00404000964849236,-0.0124071374853661,0.00342970033672396,0.266550843806954
NMR metabolomics,X23408.Triglycerides in VLDL,CXCL12,Stromal cell-derived factor 1,28931,0.00312900650181046,0.00283451122708123,-0.00242663550326874,0.00868464850688967,0.269647302804512
NMR metabolomics,X23408.Triglycerides in VLDL,MYOC,Myocilin,29443,-0.00353982234575398,0.00323121410853751,-0.00987300199848749,0.00279335730697953,0.273302912679512
NMR metabolomics,X23408.Triglycerides in VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,-0.00389387861750569,0.00357902022863119,-0.0109087582656228,0.00312100103061144,0.276617628199993
NMR metabolomics,X23408.Triglycerides in VLDL,MAPT,Microtubule-associated protein tau,28774,0.00406980412003717,0.00374570364185049,-0.00327177501798979,0.0114113832580641,0.27725548307758
NMR metabolomics,X23408.Triglycerides in VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,-0.00227475249443655,0.00209717399603661,-0.0063852135266683,0.0018357085377952,0.27807636167942
NMR metabolomics,X23408.Triglycerides in VLDL,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.00536964923726303,0.00495289326245809,-0.0150773200316809,0.00433802155715483,0.278311474932066
NMR metabolomics,X23408.Triglycerides in VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.00288902283241787,0.00268286770565098,-0.00814744353549379,0.00236939787065804,0.281561899838512
NMR metabolomics,X23408.Triglycerides in VLDL,CNTF,Ciliary neurotrophic factor,24101,-0.00258827095926618,0.00242206263093985,-0.00733551371590829,0.00215897179737593,0.285250452528879
NMR metabolomics,X23408.Triglycerides in VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,24445,0.00329900326407605,0.00309745284106668,-0.00277200430441464,0.00937001083256674,0.286854901495847
NMR metabolomics,X23408.Triglycerides in VLDL,NENF,Neudesin,24793,0.00828580441787583,0.0077948780638373,-0.00699215658724528,0.0235637654229969,0.287801093338933
NMR metabolomics,X23408.Triglycerides in VLDL,SHH,Sonic hedgehog protein,24229,-0.00324062559103414,0.00305151151370933,-0.00922158815790442,0.00274033697583614,0.288258123926755
NMR metabolomics,X23408.Triglycerides in VLDL,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.00328033111207467,0.00308919003690143,-0.00277448136025214,0.00933514358440147,0.288303155865841
NMR metabolomics,X23408.Triglycerides in VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.00535750841880657,0.00506113162743026,-0.00456230957095673,0.0152773264085699,0.289811062896023
NMR metabolomics,X23408.Triglycerides in VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,-0.0031018035608859,0.00294245450832877,-0.00886901439721029,0.00266540727543848,0.291822424747887
NMR metabolomics,X23408.Triglycerides in VLDL,RAP1A,Ras-related protein Rap-1A,24229,-0.00518059078906247,0.00491925900993863,-0.0148223384485422,0.00446115687041725,0.292294573748157
NMR metabolomics,X23408.Triglycerides in VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,0.00593851109652041,0.00566251889842842,-0.00516002594439929,0.0170370481374401,0.29430827525141
NMR metabolomics,X23408.Triglycerides in VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,-0.00380567030351372,0.00363982554675352,-0.0109397283751506,0.00332838776812318,0.295772897786689
NMR metabolomics,X23408.Triglycerides in VLDL,DLGAP5,Disks large-associated protein 5,24867,-0.00383039839716605,0.00366927448503218,-0.0110221763878291,0.00336137959349703,0.296536419321177
NMR metabolomics,X23408.Triglycerides in VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.00495445132453159,0.00475492165379048,-0.0142740977659609,0.00436519511689775,0.297439394864186
NMR metabolomics,X23408.Triglycerides in VLDL,PROK1,Prokineticin-1,29434,0.00449136558484838,0.00434362104572189,-0.00402213166476652,0.0130048628344633,0.301138051818564
NMR metabolomics,X23408.Triglycerides in VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.00356256546158094,0.00347301050384526,-0.00324453512595577,0.0103696660491177,0.305002725653178
NMR metabolomics,X23408.Triglycerides in VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.00420037600191703,0.00409563057463199,-0.00382705992436168,0.0122278119281957,0.305102329466451
NMR metabolomics,X23408.Triglycerides in VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,0.00514851877198167,0.00503323068188396,-0.0047166133645109,0.0150136509084742,0.306360937395325
NMR metabolomics,X23408.Triglycerides in VLDL,NME3,Nucleoside diphosphate kinase 3,29497,0.00172642751442561,0.00169073548271202,-0.00158741403168994,0.00504026906054116,0.307210534547964
NMR metabolomics,X23408.Triglycerides in VLDL,DKKL1,Dickkopf-like protein 1,29349,-0.0061869422111123,0.00607183226378083,-0.0180877334481227,0.00571384902589813,0.308231297844363
NMR metabolomics,X23408.Triglycerides in VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,0.0018678519539778,0.00183846358878917,-0.00173553668004897,0.00547124058800456,0.309646250698884
NMR metabolomics,X23408.Triglycerides in VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,-0.00182904319339795,0.00180223155575121,-0.00536141704267034,0.00170333065587443,0.310174357379157
NMR metabolomics,X23408.Triglycerides in VLDL,VASN,Vasorin,29065,-0.00196969099852081,0.0019454265562144,-0.00578272704870104,0.00184334505165942,0.311320594324638
NMR metabolomics,X23408.Triglycerides in VLDL,TCP11,T-complex protein 11 homolog,24445,-0.00425720361697958,0.00421366850695079,-0.0125159938906031,0.00400158665664397,0.312346319029929
NMR metabolomics,X23408.Triglycerides in VLDL,PSCA,Prostate stem cell antigen,24805,0.018454807810486,0.0183922122506754,-0.0175939282008378,0.0545035438218097,0.315676070787124
NMR metabolomics,X23408.Triglycerides in VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,-0.00564592083434952,0.00564655972653284,-0.0167131778983539,0.00542133622965484,0.31737517058777
NMR metabolomics,X23408.Triglycerides in VLDL,BTLA,B- and T-lymphocyte attenuator,24016,0.00618247497070059,0.00619606870042235,-0.00596181968212722,0.0183267696235284,0.318383464353828
NMR metabolomics,X23408.Triglycerides in VLDL,TAP1,Antigen peptide transporter 1,24445,-0.0042453099664058,0.00426266506250766,-0.0126001334889208,0.00410951355610921,0.319294711087267
NMR metabolomics,X23408.Triglycerides in VLDL,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.0023505909942581,0.00236231184769264,-0.00227954022721947,0.00698072221573568,0.319725920272091
NMR metabolomics,X23408.Triglycerides in VLDL,OSTN,Osteocrin,24195,-0.00295293422714069,0.00296824428993354,-0.00877069303541042,0.00286482458112904,0.319823047100164
NMR metabolomics,X23408.Triglycerides in VLDL,SEZ6L,Seizure 6-like protein,29566,0.001917018206856,0.00194480142025504,-0.00189479257684387,0.00572882899055587,0.324281492131589
NMR metabolomics,X23408.Triglycerides in VLDL,HRAS,GTPase Hras,24421,0.00688103981241532,0.00699396256671565,-0.00682712681834736,0.020589206443178,0.325196932336365
NMR metabolomics,X23408.Triglycerides in VLDL,SLK,STE20-like serine/threonine-protein kinase,24445,0.00544150981322911,0.00554458826618874,-0.00542588318850082,0.016308902814959,0.326400720268074
NMR metabolomics,X23408.Triglycerides in VLDL,EVI2B,Protein EVI2B,24016,-0.00282066270780914,0.00291703747738715,-0.00853805616348796,0.00289673074786967,0.333573062117728
NMR metabolomics,X23408.Triglycerides in VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,0.0040779488667129,0.00422151775688615,-0.00419622593678395,0.0123521236702097,0.334058295114137
NMR metabolomics,X23408.Triglycerides in VLDL,SLC39A14,Zinc transporter ZIP14,28774,0.00228835333312905,0.00237270439048968,-0.00236214727223073,0.00693885393848883,0.33482877306371
NMR metabolomics,X23408.Triglycerides in VLDL,FGF20,Fibroblast growth factor 20,24229,-0.00299554661771679,0.00311699248346575,-0.00910485188530966,0.00311375864987607,0.336542916382355
NMR metabolomics,X23408.Triglycerides in VLDL,CA8,Carbonic anhydrase-related protein,24229,0.00185236652734437,0.00193311419981202,-0.0019365373042872,0.00564127035897594,0.337956748771375
NMR metabolomics,X23408.Triglycerides in VLDL,CBLN1,Cerebellin-1,24101,-0.006452132138358,0.00678175589880341,-0.0197443737000127,0.00684010942329669,0.341413183033679
NMR metabolomics,X23408.Triglycerides in VLDL,CNTNAP4,Contactin-associated protein-like 4,24195,0.0069633747526585,0.00732144147664824,-0.00738665054157205,0.021313400046889,0.341566464864204
NMR metabolomics,X23408.Triglycerides in VLDL,KDM3A,Lysine-specific demethylase 3A,24229,-0.00611640815809596,0.00643321935311664,-0.0187255180902046,0.00649270177401265,0.341738826907985
NMR metabolomics,X23408.Triglycerides in VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,-0.00281060550158848,0.00295623831894426,-0.00860483260671924,0.00298362160354228,0.341747329302293
NMR metabolomics,X23408.Triglycerides in VLDL,GH2,Growth hormone variant,28797,0.0110893833818856,0.0117158980858404,-0.0118737768663616,0.0340525436301329,0.343889130110329
NMR metabolomics,X23408.Triglycerides in VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00294928435642687,0.00314171513188334,-0.00910704601491822,0.00320847730206448,0.34786868021279
NMR metabolomics,X23408.Triglycerides in VLDL,DAND5,DAN domain family member 5,24229,-0.00362073823538781,0.00386348575426197,-0.0111931703137413,0.00395169384296565,0.348681092234166
NMR metabolomics,X23408.Triglycerides in VLDL,ERCC1,DNA excision repair protein ERCC-1,24016,0.00221580119724838,0.00237464391470218,-0.00243850087556789,0.00687010327006465,0.350773168478448
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC4C,C-type lectin domain family 4 member C,29434,0.00305215937782985,0.00331740192839541,-0.00344994840182515,0.00955426715748485,0.357556737014772
NMR metabolomics,X23408.Triglycerides in VLDL,EVPL,Envoplakin,24445,-0.00221250338027257,0.00240888969599921,-0.00693392718443103,0.00250892042388589,0.358379652790177
NMR metabolomics,X23408.Triglycerides in VLDL,DBH,Dopamine beta-hydroxylase,24919,0.00710196931040797,0.00774545642262274,-0.00807912527793261,0.0222830638987485,0.359193075662371
NMR metabolomics,X23408.Triglycerides in VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00154830451657575,0.00168938479530424,-0.00485949871537205,0.00176288968222056,0.359418766626354
NMR metabolomics,X23408.Triglycerides in VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,-0.00174615257165684,0.00192594489139988,-0.0055210045588006,0.00202869941548691,0.364600714662563
NMR metabolomics,X23408.Triglycerides in VLDL,FOLR3,Folate receptor gamma,29461,-0.0119588712218415,0.0132643177351464,-0.0379569339827284,0.0140391915390454,0.367286285776382
NMR metabolomics,X23408.Triglycerides in VLDL,CA11,Carbonic anhydrase-related protein 11,28797,0.0020333588589641,0.00225770911593918,-0.00239175100827668,0.00645846872620489,0.3677930146345
NMR metabolomics,X23408.Triglycerides in VLDL,PYDC1,Pyrin domain-containing protein 1,24240,-0.00266396392574992,0.00297945411708883,-0.00850369399524403,0.00317576614374419,0.371271166652946
NMR metabolomics,X23408.Triglycerides in VLDL,CNTNAP2,Contactin-associated protein-like 2,29434,-0.00260355819642708,0.00292854810637905,-0.00834351248493003,0.00313639609207586,0.373995864000575
NMR metabolomics,X23408.Triglycerides in VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,-0.00437454495699382,0.00492244788883367,-0.0140225428191078,0.00527345290512017,0.374176967692906
NMR metabolomics,X23408.Triglycerides in VLDL,IGFL4,Insulin growth factor-like family member 4,24229,0.00470200788677295,0.00534774606837126,-0.00577957440723472,0.0151835901807806,0.379274245913186
NMR metabolomics,X23408.Triglycerides in VLDL,HLA_A,,24867,0.00201679776882085,0.00231857245632396,-0.00252760424557411,0.0065611997832158,0.384393726135762
NMR metabolomics,X23408.Triglycerides in VLDL,EXOSC10,Exosome component 10,24111,-0.00373282504167617,0.00430574873386685,-0.0121720925600552,0.00470644247670286,0.385983615204069
NMR metabolomics,X23408.Triglycerides in VLDL,IL9,Interleukin-9,24445,-0.00349372608388745,0.00403017708434217,-0.0113928731691981,0.0044054210014232,0.386009998688559
NMR metabolomics,X23408.Triglycerides in VLDL,CHGB,Secretogranin-1,29590,0.00252351128792136,0.00291119666098621,-0.0031824341676116,0.00822945674345433,0.386042441540375
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC1A,C-type lectin domain family 1 member A,28916,-0.00203878286435742,0.00236943006968659,-0.00668286580094313,0.00260530007222829,0.389546599341921
NMR metabolomics,X23408.Triglycerides in VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00335663902469107,0.00390786583651804,-0.0110160560642664,0.00430277801488428,0.39037983350583
NMR metabolomics,X23408.Triglycerides in VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,0.00379949372892617,0.00447687093222632,-0.00497517329823743,0.0125741607560898,0.396059872449225
NMR metabolomics,X23408.Triglycerides in VLDL,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00329645569760806,0.00389411216217478,-0.00433600414025451,0.0109289155354706,0.397268065265324
NMR metabolomics,X23408.Triglycerides in VLDL,ANK2,Ankyrin-2,24111,-0.00433211779516877,0.00512039814148596,-0.0143680981524812,0.0057038625621437,0.397532714135418
NMR metabolomics,X23408.Triglycerides in VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,-0.00190218372796684,0.00225183782115233,-0.00631578585742541,0.00251141840149172,0.398271250612694
NMR metabolomics,X23408.Triglycerides in VLDL,APOH,Beta-2-glycoprotein 1,29443,-0.00213963174829319,0.00254243128435373,-0.0071227970656265,0.00284353356904012,0.400035998816736
NMR metabolomics,X23408.Triglycerides in VLDL,IGLON5,IgLON family member 5,24016,-0.00557307998590919,0.00662540179100867,-0.0185588674962862,0.00741270752446781,0.400261865461201
NMR metabolomics,X23408.Triglycerides in VLDL,HEBP1,Heme-binding protein 1,28916,-0.00314885328539258,0.00376979618799338,-0.0105376538138596,0.00423994724307444,0.403564303488276
NMR metabolomics,X23408.Triglycerides in VLDL,ZNF75D,Zinc finger protein 75D,24445,0.0035563427504898,0.00426853819796421,-0.00480999211752004,0.0119226776184996,0.404766941257299
NMR metabolomics,X23408.Triglycerides in VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00266503734108637,0.00323433520708101,-0.00900433434696516,0.00367425966479242,0.409957356029897
NMR metabolomics,X23408.Triglycerides in VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,-0.00416824302611081,0.0050744117577061,-0.0141140900712148,0.00577760401899314,0.411412877991453
NMR metabolomics,X23408.Triglycerides in VLDL,TSPAN7,Tetraspanin-7,24101,-0.00547263744373384,0.00668603224820885,-0.0185772606502232,0.00763198576275551,0.413069591244168
NMR metabolomics,X23408.Triglycerides in VLDL,CRYBB2,Beta-crystallin B2,24845,0.00401484999337066,0.00490576012296194,-0.00560043984763475,0.0136301398343761,0.413139478433438
NMR metabolomics,X23408.Triglycerides in VLDL,UGDH,UDP-glucose 6-dehydrogenase,24111,0.00566761694896286,0.00696493651452039,-0.00798365861949711,0.0193188925174228,0.41580446289488
NMR metabolomics,X23408.Triglycerides in VLDL,ZPR1,Zinc finger protein ZPR1,24101,0.00557061774970953,0.0068614035503542,-0.0078777332089847,0.0190189687084038,0.416870067294113
NMR metabolomics,X23408.Triglycerides in VLDL,NCAN,Neurocan core protein,29694,0.00214480129234233,0.00264294471342866,-0.00303537034597785,0.00732497293066251,0.417073881029294
NMR metabolomics,X23408.Triglycerides in VLDL,KRT17,"Keratin, type I cytoskeletal 17",24111,0.00224793875808071,0.00277993337603008,-0.00320073065893824,0.00769660817509966,0.418735731522784
NMR metabolomics,X23408.Triglycerides in VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.0041857127695192,0.00523102637636888,-0.00606709892816381,0.0144385244672022,0.423619935106562
NMR metabolomics,X23408.Triglycerides in VLDL,KLK12,Kallikrein-12,28797,-0.00780815771127747,0.00981158614742474,-0.02703886656023,0.011422551137675,0.426149080562216
NMR metabolomics,X23408.Triglycerides in VLDL,NEB,Nebulin,24111,-0.00212196875402185,0.00269019365807864,-0.00739474832385598,0.00315081081581227,0.430248838815749
NMR metabolomics,X23408.Triglycerides in VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.00366084269481006,0.00467068974520473,-0.0128153945954113,0.00549370920579121,0.433170697098977
NMR metabolomics,X23408.Triglycerides in VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.00327379524635999,0.00420567323039943,-0.0049693242852229,0.0115169147779429,0.436325672508794
NMR metabolomics,X23408.Triglycerides in VLDL,ENG,Endoglin,29820,0.000944836497557171,0.00121739323384228,-0.00144125424077369,0.00333092723588803,0.43768756227827
NMR metabolomics,X23408.Triglycerides in VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,-0.00513167425893679,0.006639853141741,-0.0181457864167491,0.00788243789887556,0.439613085539805
NMR metabolomics,X23408.Triglycerides in VLDL,S100A16,Protein S100-A16,28722,0.003365011280377,0.00435491457295946,-0.00517062128262354,0.0119006438433775,0.439710550410624
NMR metabolomics,X23408.Triglycerides in VLDL,BSND,Barttin,24016,-0.00184599374125881,0.00240582822801202,-0.00656141706816236,0.00286942958564475,0.442910285588181
NMR metabolomics,X23408.Triglycerides in VLDL,STC2,Stanniocalcin-2,29396,0.00140106657021368,0.00183581782111847,-0.00219713635917853,0.00499926949960589,0.445359867647044
NMR metabolomics,X23408.Triglycerides in VLDL,FAM171A2,Protein FAM171A2,24867,0.00855378801295831,0.0112370905483691,-0.0134709094618452,0.0305784854877618,0.44653874557321
NMR metabolomics,X23408.Triglycerides in VLDL,WNT9A,Protein Wnt-9a,28931,0.00155109091416189,0.00204288714821887,-0.0024529678963471,0.00555514972467088,0.447700764982429
NMR metabolomics,X23408.Triglycerides in VLDL,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.0142112669281919,0.0187352801634541,-0.0509324160485619,0.0225098821921781,0.448141303643911
NMR metabolomics,X23408.Triglycerides in VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.00372502604101471,0.00493493835068262,-0.00594745312632323,0.0133975052083526,0.450359980713718
NMR metabolomics,X23408.Triglycerides in VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,-0.00280435605707141,0.00372559279393604,-0.010106517933186,0.00449780581904323,0.451621049242097
NMR metabolomics,X23408.Triglycerides in VLDL,CD5L,CD5 antigen-like,24833,0.00252070590497892,0.00335038210678461,-0.00404604302431893,0.00908745483427676,0.45183950055919
NMR metabolomics,X23408.Triglycerides in VLDL,MMP15,Matrix metalloproteinase-15,24922,0.00262354997244683,0.00349104264539564,-0.00421889361252863,0.00946599355742229,0.452353485968018
NMR metabolomics,X23408.Triglycerides in VLDL,PDCL2,Phosducin-like protein 2,24016,0.00282090423450101,0.0037664630619595,-0.00456136336693961,0.0102031718359416,0.453892805515119
NMR metabolomics,X23408.Triglycerides in VLDL,FH,"Fumarate hydratase, mitochondrial",24101,0.00441412417553392,0.00596018982023359,-0.00726784787212391,0.0160960962231917,0.45894245429707
NMR metabolomics,X23408.Triglycerides in VLDL,GJA8,Gap junction alpha-8 protein,24016,0.00324659643382694,0.00441639206550245,-0.00540953201455786,0.0119027248822117,0.462271074295951
NMR metabolomics,X23408.Triglycerides in VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,-0.00256004232142197,0.00350845893488903,-0.00943662183380447,0.00431653719096053,0.465594671349504
NMR metabolomics,X23408.Triglycerides in VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,24111,-0.00289092164985999,0.00402465902059009,-0.0107792533302166,0.00499741003049659,0.472577904274206
NMR metabolomics,X23408.Triglycerides in VLDL,EPB41L5,Band 4.1-like protein 5,24195,0.00320215689409299,0.00446473993722225,-0.00554873338286263,0.0119530471710486,0.473251352039416
NMR metabolomics,X23408.Triglycerides in VLDL,PCNA,Proliferating cell nuclear antigen,24016,0.00319952529934311,0.00449321705692988,-0.00560718013223946,0.0120062307309257,0.476422807526689
NMR metabolomics,X23408.Triglycerides in VLDL,PALLD,Palladin,24229,-0.00200573690003432,0.00283403813794485,-0.00756045165040623,0.0035489778503376,0.479119078209026
NMR metabolomics,X23408.Triglycerides in VLDL,SHC1,SHC-transforming protein 1,24016,-0.00584740405868212,0.00828296348428389,-0.0220820124878785,0.0103872043705143,0.480222631002032
NMR metabolomics,X23408.Triglycerides in VLDL,CDAN1,Codanin-1,24845,0.0011238496433733,0.00160062473984724,-0.0020133748467273,0.00426107413347389,0.482603509375039
NMR metabolomics,X23408.Triglycerides in VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,0.00284703168777823,0.00405549992434405,-0.00510174816393611,0.0107958115394926,0.482673821480279
NMR metabolomics,X23408.Triglycerides in VLDL,RANGAP1,Ran GTPase-activating protein 1,28797,-0.00241731253101976,0.00346743390751976,-0.0092134829897585,0.00437885792771898,0.485716183968297
NMR metabolomics,X23408.Triglycerides in VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,-0.00126577408121255,0.00183664243552755,-0.00486559325484654,0.00233404509242144,0.490717716888531
NMR metabolomics,X23408.Triglycerides in VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00313270515550727,0.00458069411630357,-0.0121108656234623,0.00584545531244771,0.494049150060002
NMR metabolomics,X23408.Triglycerides in VLDL,EPHA10,Ephrin type-A receptor 10,28774,0.00315890113437124,0.00463274276935073,-0.00592127469355618,0.0122390769622987,0.495330357386723
NMR metabolomics,X23408.Triglycerides in VLDL,SLITRK1,SLIT and NTRK-like protein 1,24229,-0.00156245041329724,0.00229809766437071,-0.00606672183546384,0.00294182100886935,0.496581497261335
NMR metabolomics,X23408.Triglycerides in VLDL,TBR1,T-box brain protein 1,24195,0.00232143777431586,0.00343029120713596,-0.00440193299167062,0.00904480854030234,0.49857324312204
NMR metabolomics,X23408.Triglycerides in VLDL,CYTH3,Cytohesin-3,24016,0.00351358270559512,0.00520679578072006,-0.0066917370246162,0.0137189024358064,0.499804835486786
NMR metabolomics,X23408.Triglycerides in VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.00196286271547856,0.00291344213369388,-0.00374748386656145,0.00767320929751857,0.500491684161975
NMR metabolomics,X23408.Triglycerides in VLDL,BCAN,Brevican core protein,29218,-0.00160840935046234,0.00240516578888271,-0.00632253429667246,0.00310571559574777,0.503672261233106
NMR metabolomics,X23408.Triglycerides in VLDL,KHDC3L,KH domain-containing protein 3,24016,-0.00318832956638042,0.00479831646205128,-0.0125930298320009,0.00621637069924007,0.506396963538883
NMR metabolomics,X23408.Triglycerides in VLDL,RBP1,Retinol-binding protein 1,24195,0.00327178566460537,0.00492555762534311,-0.00638230728106712,0.0129258786102779,0.506538727513533
NMR metabolomics,X23408.Triglycerides in VLDL,SUSD4,Sushi domain-containing protein 4,24793,-0.00195715588879965,0.00297120300777256,-0.00778071378403387,0.00386640200643456,0.510089264374268
NMR metabolomics,X23408.Triglycerides in VLDL,TAGLN3,Transgelin-3,24016,-0.00279769246036436,0.00429081526243899,-0.0112076903747448,0.00561230545401607,0.514395251639746
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.0020727287682971,0.00320099857415746,-0.00420122843705152,0.00834668597364571,0.51729681194337
NMR metabolomics,X23408.Triglycerides in VLDL,OGN,Mimecan,29443,0.00191948943466365,0.00297910155774612,-0.00391954961851875,0.00775852848784605,0.519374120124045
NMR metabolomics,X23408.Triglycerides in VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,-0.0013923729371936,0.00216601651402644,-0.00563776530468542,0.00285301943029823,0.520341769727966
NMR metabolomics,X23408.Triglycerides in VLDL,VNN2,Vascular non-inflammatory molecule 2,29349,0.00207322471012734,0.00324860472422164,-0.00429404054934707,0.00844048996960175,0.52335545631091
NMR metabolomics,X23408.Triglycerides in VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,-0.00154138345999343,0.00241539438989261,-0.00627555646418294,0.00319278954419609,0.523382256203253
NMR metabolomics,X23408.Triglycerides in VLDL,EDDM3B,Epididymal secretory protein E3-beta,24793,0.00235210953064118,0.00369262999372347,-0.00488544525705681,0.00958966431833918,0.524147622843837
NMR metabolomics,X23408.Triglycerides in VLDL,GIPR,Gastric inhibitory polypeptide receptor,24229,0.00212073088425741,0.00334659706651702,-0.00443859936611596,0.00868006113463078,0.526284107625478
NMR metabolomics,X23408.Triglycerides in VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.00335021528973882,0.0052929353565475,-0.0137243685885719,0.00702393800909427,0.526765905827305
NMR metabolomics,X23408.Triglycerides in VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,-0.00281859853906076,0.00447004207582892,-0.0115798810076854,0.00594268392956392,0.528338721818196
NMR metabolomics,X23408.Triglycerides in VLDL,ITGAX,Integrin alpha-X,24445,0.00238711073971138,0.00380026338745545,-0.00506140549970129,0.00983562697912406,0.529915811381157
NMR metabolomics,X23408.Triglycerides in VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.00241720687932138,0.00385440342040428,-0.00513742382467101,0.00997183758331378,0.530580841373645
NMR metabolomics,X23408.Triglycerides in VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,0.00520094117181256,0.0084034023506195,-0.0112697274354016,0.0216716097790268,0.535981113374054
NMR metabolomics,X23408.Triglycerides in VLDL,KCNIP4,Kv channel-interacting protein 4,28774,0.00223428065287702,0.00361512216863218,-0.00485135879764204,0.00931992010339608,0.536555589020749
NMR metabolomics,X23408.Triglycerides in VLDL,NLGN1,Neuroligin-1,24195,-0.00297523591787008,0.00485783874840561,-0.0124965998647451,0.00654612802900491,0.540238669904964
NMR metabolomics,X23408.Triglycerides in VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,-0.00129414042563351,0.00211370317805345,-0.00543699865461828,0.00284871780335126,0.540369921451096
NMR metabolomics,X23408.Triglycerides in VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.00332067156607646,0.0054363634803866,-0.0139759439876342,0.00733460085548128,0.541320453729393
NMR metabolomics,X23408.Triglycerides in VLDL,AMY2B,Alpha-amylase 2B,27585,-0.00210913773889778,0.00347302727272426,-0.00891627119343733,0.00469799571564178,0.543662900419899
NMR metabolomics,X23408.Triglycerides in VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,0.00207295051954943,0.0034492704300122,-0.00468761952327447,0.00883352056237333,0.547857419869545
NMR metabolomics,X23408.Triglycerides in VLDL,PLAU,Urokinase-type plasminogen activator,29443,-0.00121462132935493,0.00205794322137014,-0.00524819004324041,0.00281894738453056,0.555053533794812
NMR metabolomics,X23408.Triglycerides in VLDL,CCDC50,Coiled-coil domain-containing protein 50,24867,0.00317640420071165,0.00542502269049412,-0.00745664027265683,0.0138094486740801,0.558210264327114
NMR metabolomics,X23408.Triglycerides in VLDL,IL2RB,Interleukin-2 receptor subunit beta,28931,-0.00155438545896677,0.00266642594255183,-0.00678058030636835,0.00367180938843481,0.559933410462861
NMR metabolomics,X23408.Triglycerides in VLDL,RSPO1,R-spondin-1,29218,-0.00144434995370498,0.00247999091985748,-0.00630513215662565,0.00341643224921569,0.560300897417369
NMR metabolomics,X23408.Triglycerides in VLDL,ACTA2,"Actin, aortic smooth muscle",28916,-0.00178433340834159,0.00308270520953775,-0.00782643561903557,0.00425776880235239,0.5627147120403
NMR metabolomics,X23408.Triglycerides in VLDL,SLAMF1,Signaling lymphocytic activation molecule,28931,0.00240057345711187,0.00421283504705078,-0.00585658323510766,0.0106577301493314,0.56880167327405
NMR metabolomics,X23408.Triglycerides in VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,-0.00205284506715124,0.00364156466116394,-0.00919031180303256,0.00508462166873008,0.572945775334589
NMR metabolomics,X23408.Triglycerides in VLDL,TPSG1,Tryptase gamma,24229,0.00106733293536733,0.0018980426066008,-0.00265283057357025,0.0047874964443049,0.573894025710012
NMR metabolomics,X23408.Triglycerides in VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,-0.00144891157907367,0.0025908070820184,-0.00652689345982974,0.00362907030168241,0.5759954371437
NMR metabolomics,X23408.Triglycerides in VLDL,CLEC2L,C-type lectin domain family 2 member L,24195,0.00199432572823171,0.00356690720080363,-0.0049968123853434,0.00898546384180681,0.576085659565249
NMR metabolomics,X23408.Triglycerides in VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00222840639415866,0.00400930279866607,-0.0100866398795442,0.00562982709122684,0.578346626271309
NMR metabolomics,X23408.Triglycerides in VLDL,IL5,Interleukin-5,28931,0.00553830659119127,0.010064497179518,-0.014188107880664,0.0252647210630466,0.582130562515255
NMR metabolomics,X23408.Triglycerides in VLDL,PLB1,"Phospholipase B1, membrane-associated",24845,0.00233796886768616,0.0042529159533405,-0.00599774640086122,0.0106736841362335,0.582507362875868
NMR metabolomics,X23408.Triglycerides in VLDL,HSP90B1,Endoplasmin,28626,0.00260481030984291,0.00475063056457196,-0.00670642559671814,0.011916046216404,0.583484486723097
NMR metabolomics,X23408.Triglycerides in VLDL,CHIT1,Chitotriosidase-1,29579,0.00580818325419119,0.0107822866421261,-0.015325098564376,0.0269414650727584,0.590112942532953
NMR metabolomics,X23408.Triglycerides in VLDL,SLC1A4,Neutral amino acid transporter A,24195,0.00196137991807128,0.00366713628460764,-0.00522620719975968,0.00914896703590225,0.592756225830854
NMR metabolomics,X23408.Triglycerides in VLDL,SPRR1B,Cornifin-B,24445,0.00324503828249644,0.006074634874835,-0.00866124607218016,0.015151322637173,0.593211636164775
NMR metabolomics,X23408.Triglycerides in VLDL,CDC25A,M-phase inducer phosphatase 1,24016,-0.00152751239014719,0.00287350010135387,-0.00715957258880077,0.0041045478085064,0.595017691210706
NMR metabolomics,X23408.Triglycerides in VLDL,HDAC9,Histone deacetylase 9,24101,-0.00241322200292302,0.00460233045005965,-0.0114337896850399,0.00660734567919389,0.60004145753377
NMR metabolomics,X23408.Triglycerides in VLDL,ISM2,Isthmin-2,24938,-0.00163411785943626,0.00311884366871517,-0.007747051450118,0.00447881573124547,0.600318038419615
NMR metabolomics,X23408.Triglycerides in VLDL,CASP4,Caspase-4,24445,-0.00621631240731157,0.0119487659094715,-0.0296358935898757,0.0172032687752525,0.602895982305051
NMR metabolomics,X23408.Triglycerides in VLDL,SCGN,Secretagogin,28931,-0.0015914388864572,0.00312195209365242,-0.00771046499001595,0.00452758721710155,0.610225166153017
NMR metabolomics,X23408.Triglycerides in VLDL,UPK3A,Uroplakin-3a,24101,-0.00175795308092145,0.00349641009381801,-0.00861091686480474,0.00509501070296185,0.615117919714008
NMR metabolomics,X23408.Triglycerides in VLDL,AREG,Amphiregulin,29349,-0.00159944508210203,0.00322819640887732,-0.00792671004350158,0.00472781987929751,0.620278530387887
NMR metabolomics,X23408.Triglycerides in VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.0020192180390184,0.00410082557722316,-0.006018400092339,0.0100568361703758,0.62244597122573
NMR metabolomics,X23408.Triglycerides in VLDL,GPHA2,Glycoprotein hormone alpha-2,24805,-0.00159007444451091,0.00330219442917921,-0.00806237552570216,0.00488222663668035,0.630150835325943
NMR metabolomics,X23408.Triglycerides in VLDL,TXNDC15,Thioredoxin domain-containing protein 15,29566,0.000895032258995237,0.00193390780969036,-0.00289542704799788,0.00468549156598835,0.643503827559399
NMR metabolomics,X23408.Triglycerides in VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.0010232639781701,0.00221593135458928,-0.00331996147682489,0.00536648943316508,0.644245419248975
NMR metabolomics,X23408.Triglycerides in VLDL,ESR1,Estrogen receptor,24229,0.00185242611717141,0.00408805625018981,-0.00616016413320062,0.00986501636754344,0.650458280376196
NMR metabolomics,X23408.Triglycerides in VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,-0.00156117889854509,0.00346701477442331,-0.00835652785641477,0.00523417005932459,0.652501918812383
NMR metabolomics,X23408.Triglycerides in VLDL,SHD,SH2 domain-containing adapter protein D,24059,0.00270509920562555,0.00604959295817887,-0.00915210299240505,0.0145623014036561,0.654767957339155
NMR metabolomics,X23408.Triglycerides in VLDL,SCIN,Adseverin,24101,0.00231917610998448,0.00521514551038837,-0.00790250909037673,0.0125408613103457,0.656540440039987
NMR metabolomics,X23408.Triglycerides in VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.00158257961274449,0.00356470384544644,-0.00540423992433054,0.00856939914981952,0.657076770994662
NMR metabolomics,X23408.Triglycerides in VLDL,TPBGL,Trophoblast glycoprotein-like,24195,-0.0012966735207145,0.00292320446854502,-0.00702615427906274,0.00443280723763374,0.657350612328594
NMR metabolomics,X23408.Triglycerides in VLDL,PXDNL,Peroxidasin-like protein,24793,0.00180180628762212,0.00410414410826001,-0.0062423161645675,0.00984592873981174,0.660650000263856
NMR metabolomics,X23408.Triglycerides in VLDL,ENPEP,Glutamyl aminopeptidase,24111,0.00136936994140995,0.00316100196249273,-0.00482619390507581,0.0075649337878957,0.664867866015837
NMR metabolomics,X23408.Triglycerides in VLDL,ZNF830,Zinc finger protein 830,24793,-0.00242676252840435,0.00562045426704005,-0.0134428528918029,0.00858932783499415,0.665909886444388
NMR metabolomics,X23408.Triglycerides in VLDL,ALMS1,Alstrom syndrome protein 1,24445,-0.00136244978880434,0.00317105424079436,-0.00757771610076129,0.00485281652315261,0.667452595726886
NMR metabolomics,X23408.Triglycerides in VLDL,GAGE2A,G antigen 2A,24016,0.00193581381474168,0.00451212648910671,-0.00690795410390748,0.0107795817333908,0.667909083771593
NMR metabolomics,X23408.Triglycerides in VLDL,TEX101,Testis-expressed protein 101,24195,0.00154038955056084,0.00359498953542619,-0.0055057899388745,0.00858656903999617,0.668303800317222
NMR metabolomics,X23408.Triglycerides in VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.000962149311374455,0.00224960878246721,-0.00344708390226127,0.00537138252501018,0.668875443957408
NMR metabolomics,X23408.Triglycerides in VLDL,NOS1,"Nitric oxide synthase, brain",28774,-0.0016388396488046,0.00383250096035084,-0.00915054153109225,0.00587286223348305,0.668933742334986
NMR metabolomics,X23408.Triglycerides in VLDL,CSH1,Chorionic somatomammotropin hormone 1,24951,0.000949522173001272,0.00227819504306408,-0.00351574011140432,0.00541478445740686,0.676837768787041
NMR metabolomics,X23408.Triglycerides in VLDL,CDH4,Cadherin-4,24101,0.00138905060075958,0.00341504202597964,-0.0053044317701605,0.00808253297167967,0.684199043590619
NMR metabolomics,X23408.Triglycerides in VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,0.00183823764662205,0.00453014691866794,-0.00704085031396712,0.0107173256072112,0.684908743337692
NMR metabolomics,X23408.Triglycerides in VLDL,PFDN4,Prefoldin subunit 4,24016,0.00152947628471836,0.00380049342550728,-0.00591949082927591,0.00897844339871262,0.6873627152651
NMR metabolomics,X23408.Triglycerides in VLDL,RGS8,Regulator of G-protein signaling 8,28931,0.00180174248065864,0.00461608119466641,-0.00724577666088753,0.0108492616222048,0.696303825114528
NMR metabolomics,X23408.Triglycerides in VLDL,SERPINA3,Alpha-1-antichymotrypsin,24883,0.000409039959357941,0.00105024091704466,-0.0016494322380496,0.00246751215676548,0.69692998204402
NMR metabolomics,X23408.Triglycerides in VLDL,LCN15,Lipocalin-15,24867,-0.00171085532286372,0.00441675874575726,-0.0103677024645479,0.0069459918188205,0.698496438765862
NMR metabolomics,X23408.Triglycerides in VLDL,EPGN,Epigen,24793,-0.00131319319293807,0.00340377324774205,-0.00798458875851249,0.00535820237263635,0.699644305060386
NMR metabolomics,X23408.Triglycerides in VLDL,PSMA1,Proteasome subunit alpha type-1,28797,0.00125926929720319,0.00328215176567103,-0.00517374816351203,0.00769228675791841,0.701224500107172
NMR metabolomics,X23408.Triglycerides in VLDL,IFNL2,Interferon lambda-2,24101,0.00167546814520079,0.00439513869254074,-0.00693900369217906,0.0102899399825807,0.703051243404452
NMR metabolomics,X23408.Triglycerides in VLDL,BTNL10,Butyrophilin-like protein 10,24016,-0.00109799183772534,0.00290347654969192,-0.0067888058751215,0.00459282219967083,0.705311719384421
NMR metabolomics,X23408.Triglycerides in VLDL,PRC1,Protein regulator of cytokinesis 1,24793,0.00120876273076803,0.00322159225261967,-0.00510555808436652,0.00752308354590258,0.707510020782857
NMR metabolomics,X23408.Triglycerides in VLDL,DIPK1C,Divergent protein kinase domain 1C,24195,0.00111725575487678,0.00301208491360811,-0.00478643067579512,0.00702094218554868,0.710697098807917
NMR metabolomics,X23408.Triglycerides in VLDL,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.000960596623461969,0.00260328797647774,-0.00606304105735833,0.00414184781043439,0.712135144471774
NMR metabolomics,X23408.Triglycerides in VLDL,MLLT1,Protein ENL,24016,-0.00180537746939969,0.00491100137386486,-0.0114309401621748,0.00782018522337542,0.713160578499235
NMR metabolomics,X23408.Triglycerides in VLDL,UBQLN3,Ubiquilin-3,24111,-0.00130919486408874,0.00357258036045512,-0.00831145237058077,0.00569306264240329,0.714027773697257
NMR metabolomics,X23408.Triglycerides in VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,0.00123375244213121,0.00336685614387514,-0.00536528559986407,0.00783279048412648,0.714039100586989
NMR metabolomics,X23408.Triglycerides in VLDL,RUVBL1,RuvB-like 1,28797,0.00268389482634966,0.00732502306338133,-0.0116731503778777,0.0170409400305771,0.714068663436721
NMR metabolomics,X23408.Triglycerides in VLDL,ITGB2,Integrin beta-2,29274,0.000744652578142338,0.00203400817353549,-0.00324200344198722,0.00473130859827189,0.714292302483026
NMR metabolomics,X23408.Triglycerides in VLDL,TMPRSS11B,Transmembrane protease serine 11B,24101,-0.00200531771142897,0.00548422945273133,-0.0127544074387824,0.00874377201592443,0.714628217618452
NMR metabolomics,X23408.Triglycerides in VLDL,MORN4,MORN repeat-containing protein 4,24016,0.00199233856760603,0.0055704767037094,-0.00892579577166439,0.0129104729068765,0.720600664508294
NMR metabolomics,X23408.Triglycerides in VLDL,TNPO1,Transportin-1,24445,0.000889505418451616,0.00251302662313022,-0.00403602676288361,0.00581503759978684,0.723373550734793
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,0.000686620682346402,0.00195223244082068,-0.00313975490166212,0.00451299626635493,0.725057868816117
NMR metabolomics,X23408.Triglycerides in VLDL,MYL4,Myosin light chain 4,24240,0.00129314342723288,0.00369351034301744,-0.00594613684508131,0.00853242369954707,0.726257458751701
NMR metabolomics,X23408.Triglycerides in VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,0.00073321236348365,0.00210791180465235,-0.00339829477363497,0.00486471950060227,0.72796459760175
NMR metabolomics,X23408.Triglycerides in VLDL,FOS,Proto-oncogene c-Fos,23970,-0.000856028763565669,0.00251969873097832,-0.00579463827628317,0.00408258074915183,0.734059404228785
NMR metabolomics,X23408.Triglycerides in VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00410028279494818,0.0122304388652393,-0.0280719429708171,0.0198713773809208,0.737437607197309
NMR metabolomics,X23408.Triglycerides in VLDL,ICAM2,Intercellular adhesion molecule 2,29820,0.000728986094069638,0.00225184486034527,-0.00368462983220708,0.00514260202034636,0.74614595230227
NMR metabolomics,X23408.Triglycerides in VLDL,ABO,Histo-blood group ABO system transferase,24951,-0.00327402269638236,0.0102269406495959,-0.0233188263695904,0.0167707809768257,0.748867116350608
NMR metabolomics,X23408.Triglycerides in VLDL,OMP,Olfactory marker protein,24101,-0.00112072127522718,0.00350413435496667,-0.00798882461096184,0.00574738206050749,0.749101279797149
NMR metabolomics,X23408.Triglycerides in VLDL,BRD2,Bromodomain-containing protein 2,24101,0.000783011429583266,0.00246329242258791,-0.00404504171868903,0.00561106457785556,0.750584868060329
NMR metabolomics,X23408.Triglycerides in VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,24229,0.000907577960477411,0.00289780549725075,-0.00477212081413406,0.00658727673508888,0.754135275191492
NMR metabolomics,X23408.Triglycerides in VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.00167338288917417,0.00547620732063748,-0.0124067492376236,0.00905998345927529,0.759931741546663
NMR metabolomics,X23408.Triglycerides in VLDL,IL17A,Interleukin-17A,28879,-0.000903269381679,0.00302378215449384,-0.00682988240448692,0.00502334364112892,0.765154539724041
NMR metabolomics,X23408.Triglycerides in VLDL,IL13,Interleukin-13,28931,-0.00101502897786983,0.00341102404471479,-0.00770063610551083,0.00567057814977116,0.766031150464023
NMR metabolomics,X23408.Triglycerides in VLDL,FGF6,Fibroblast growth factor 6,24229,-0.000866893693176571,0.00292306175523997,-0.00659609473344691,0.00486230734709376,0.766797029630426
NMR metabolomics,X23408.Triglycerides in VLDL,CAPN3,Calpain-3,24793,0.000795902882652508,0.00269093236421001,-0.00447832455119911,0.00607013031650412,0.767406562390268
NMR metabolomics,X23408.Triglycerides in VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.000757873701874676,0.00257435963516182,-0.00428787118304249,0.00580361858679184,0.768460069301835
NMR metabolomics,X23408.Triglycerides in VLDL,SAP18,Histone deacetylase complex subunit SAP18,24445,-0.00151457317136507,0.00521405960678682,-0.0117341300006672,0.00870498365793708,0.771452521567885
NMR metabolomics,X23408.Triglycerides in VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.000661599078953159,0.0023097104408258,-0.00386543338506542,0.00518863154297174,0.774541741001929
NMR metabolomics,X23408.Triglycerides in VLDL,DCDC2C,Doublecortin domain-containing protein 2C,24016,0.00125383832605464,0.00449851461616301,-0.00756325032162485,0.0100709269737341,0.780460009924795
NMR metabolomics,X23408.Triglycerides in VLDL,CDH17,Cadherin-17,29478,0.00129365475037157,0.00480411618510542,-0.00812241297243506,0.0107097224731782,0.787715731778479
NMR metabolomics,X23408.Triglycerides in VLDL,IL3,Interleukin-3,24016,-0.00115627705463704,0.00429944996478583,-0.00958319898561726,0.00727064487634319,0.787981212696917
NMR metabolomics,X23408.Triglycerides in VLDL,IL17F,Interleukin-17F,28931,-0.0014554679165528,0.00542689137236553,-0.0120921750063892,0.00918123917328364,0.788550741533164
NMR metabolomics,X23408.Triglycerides in VLDL,SKIV2L,Helicase SKI2W,24111,-0.000761683318011755,0.00284141088990393,-0.00633084866222347,0.00480748202619996,0.78865144305307
NMR metabolomics,X23408.Triglycerides in VLDL,UNC5D,Netrin receptor UNC5D,24229,-0.000501157688077298,0.00187386521399057,-0.00417393350749881,0.00317161813134422,0.789128091594389
NMR metabolomics,X23408.Triglycerides in VLDL,MYL6B,Myosin light chain 6B,24195,0.00174181738583784,0.0065144135853933,-0.011026433241533,0.0145100680132087,0.789179647421386
NMR metabolomics,X23408.Triglycerides in VLDL,WFDC12,WAP four-disulfide core domain protein 12,29662,0.00118232128219237,0.0045064809425772,-0.00765038136525893,0.0100150239296437,0.793045569836766
NMR metabolomics,X23408.Triglycerides in VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,-0.000885372711340748,0.00345664124301417,-0.00766038954764852,0.00588964412496703,0.797847464128222
NMR metabolomics,X23408.Triglycerides in VLDL,PODXL2,Podocalyxin-like protein 2,29566,0.000500207730762686,0.00197379798015451,-0.00336843631034015,0.00436885177186552,0.799942365422383
NMR metabolomics,X23408.Triglycerides in VLDL,TP53BP1,TP53-binding protein 1,24229,0.00152875401811538,0.00620377261245264,-0.0106306403022918,0.0136881483385226,0.805356672885485
NMR metabolomics,X23408.Triglycerides in VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,-0.0014988515324623,0.00612521490031578,-0.0135042727370812,0.0105065696721566,0.806689364550082
NMR metabolomics,X23408.Triglycerides in VLDL,OFD1,Oral-facial-digital syndrome 1 protein,24445,-0.00115831531124138,0.00475623897136459,-0.010480543695116,0.00816391307263322,0.807592261960528
NMR metabolomics,X23408.Triglycerides in VLDL,PRTN3,Myeloblastin,28671,-0.000795055112547073,0.00336003801887712,-0.00738072962954624,0.00579061940445209,0.812952620788013
NMR metabolomics,X23408.Triglycerides in VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.000776298193550219,0.00330500234406144,-0.0057015064008102,0.00725410278791064,0.81429928894631
NMR metabolomics,X23408.Triglycerides in VLDL,CRX,Cone-rod homeobox protein,28916,-0.00175950477178471,0.007593767508048,-0.0166432890875588,0.0131242795439894,0.816769721729125
NMR metabolomics,X23408.Triglycerides in VLDL,AMY2A,Pancreatic alpha-amylase,28334,-0.000758830200159635,0.00339200246990574,-0.00740715504117489,0.00588949464085562,0.822983355719528
NMR metabolomics,X23408.Triglycerides in VLDL,FGF3,Fibroblast growth factor 3,24229,0.000474690043789561,0.00213111073473979,-0.00370228699630042,0.00465166708387955,0.823737394908521
NMR metabolomics,X23408.Triglycerides in VLDL,SELL,L-selectin,24966,0.000362405587527079,0.0016444491613741,-0.00286071476876616,0.00358552594382032,0.825576132304234
NMR metabolomics,X23408.Triglycerides in VLDL,NOS2,"Nitric oxide synthase, inducible",24111,-0.000617037893992171,0.00281508739072829,-0.00613460917981961,0.00490053339183527,0.826504208846011
NMR metabolomics,X23408.Triglycerides in VLDL,PDIA2,Protein disulfide-isomerase A2,24016,-0.000632946497523659,0.00289546233453864,-0.00630805267321939,0.00504215967817207,0.826963933454371
NMR metabolomics,X23408.Triglycerides in VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,28586,0.000579330236505721,0.00271591932968825,-0.00474387164968326,0.0059025321226947,0.831087418532571
NMR metabolomics,X23408.Triglycerides in VLDL,ANKRA2,Ankyrin repeat family A protein 2,24016,-0.000841846059882659,0.00395454331301803,-0.008592750953398,0.00690905883363268,0.831421802477218
NMR metabolomics,X23408.Triglycerides in VLDL,LMOD2,Leiomodin-2,24101,0.000950405590996113,0.00449619115016605,-0.00786212906332934,0.00976294024532157,0.832592427687395
NMR metabolomics,X23408.Triglycerides in VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,24111,-0.00165813424585853,0.00804235499464872,-0.01742115003537,0.014104881543653,0.836655791654062
NMR metabolomics,X23408.Triglycerides in VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,-0.000793484061315032,0.00386497025615563,-0.00836882576338006,0.00678185764074999,0.837338324101024
NMR metabolomics,X23408.Triglycerides in VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,-0.00113453248303754,0.0055508774969185,-0.0120142523769978,0.00974518741092272,0.838052064562055
NMR metabolomics,X23408.Triglycerides in VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,-0.00130819284420776,0.00643938490408647,-0.0139293872562172,0.0113130015678017,0.839015639160896
NMR metabolomics,X23408.Triglycerides in VLDL,CD164L2,CD164 sialomucin-like 2 protein,24195,-0.000528207492180899,0.00260095483709255,-0.00562607897288229,0.00456966398852049,0.839072534441797
NMR metabolomics,X23408.Triglycerides in VLDL,TLR2,Toll-like receptor 2,24445,0.000326846682051163,0.0016332966297017,-0.00287441471216417,0.0035281080762665,0.841392534428589
NMR metabolomics,X23408.Triglycerides in VLDL,LTA4H,Leukotriene A-4 hydrolase,29725,0.000816668065749466,0.00414626880649875,-0.00731001879498809,0.00894335492648702,0.843856608454031
NMR metabolomics,X23408.Triglycerides in VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,24751,0.000545657714157773,0.00286099221005563,-0.00506188701755125,0.0061532024458668,0.848743992349793
NMR metabolomics,X23408.Triglycerides in VLDL,CDSN,Corneodesmosin,29676,-0.000580669936003326,0.00306890750505825,-0.00659572864591749,0.00543438877391084,0.849929027720327
NMR metabolomics,X23408.Triglycerides in VLDL,PCARE,Photoreceptor cilium actin regulator,24101,0.00113000972780541,0.0060125169906023,-0.0106545235737751,0.0129145430293859,0.850923015524451
NMR metabolomics,X23408.Triglycerides in VLDL,IL18RAP,Interleukin-18 receptor accessory protein,29038,-0.00224220460020699,0.0121612715717318,-0.0260782968808013,0.0215938876803874,0.853722493964552
NMR metabolomics,X23408.Triglycerides in VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,0.000418507925119486,0.00243583108352894,-0.00435572099859723,0.0051927368488362,0.863585564155085
NMR metabolomics,X23408.Triglycerides in VLDL,LAYN,Layilin,29163,0.000418087488564787,0.00247329754251857,-0.0044295756947716,0.00526575067190117,0.865765947074643
NMR metabolomics,X23408.Triglycerides in VLDL,GFRA3,GDNF family receptor alpha-3,29157,-0.000331916174557195,0.0019929218936755,-0.00423804308616118,0.00357421073704679,0.867727254823456
NMR metabolomics,X23408.Triglycerides in VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,-0.000801804445871301,0.00488098749661133,-0.0103685399392295,0.00876493104748691,0.869519209645168
NMR metabolomics,X23408.Triglycerides in VLDL,MAG,Myelin-associated glycoprotein,24195,0.000540563475723013,0.00336835728741571,-0.00606141680761178,0.00714254375905781,0.872502094551298
NMR metabolomics,X23408.Triglycerides in VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,0.000661096571310857,0.00422796499257681,-0.0076257148141397,0.00894790795676141,0.875748344545449
NMR metabolomics,X23408.Triglycerides in VLDL,HMMR,Hyaluronan mediated motility receptor,23975,0.000536911460028541,0.00343956347865799,-0.00620463295814112,0.00727845587819821,0.875956521483794
NMR metabolomics,X23408.Triglycerides in VLDL,TPSD1,Tryptase delta,24867,0.000407593092100632,0.00265267128421116,-0.00479164262495323,0.0056068288091545,0.877883941305653
NMR metabolomics,X23408.Triglycerides in VLDL,PI16,Peptidase inhibitor 16,24951,-0.000261671578295672,0.00173937355708156,-0.00367084375017554,0.00314750059358419,0.880418601717796
NMR metabolomics,X23408.Triglycerides in VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-0.000693747241485638,0.00470061379549306,-0.00990695028065203,0.00851945579768076,0.882670310369956
NMR metabolomics,X23408.Triglycerides in VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,-0.000631976414677754,0.00447107978434818,-0.00939529279200018,0.00813133996264467,0.887596334544734
NMR metabolomics,X23408.Triglycerides in VLDL,MAGEA3,Melanoma-associated antigen 3,24445,0.00084934720031892,0.00604057743535483,-0.0109901845729766,0.0126888789736144,0.888181612627502
NMR metabolomics,X23408.Triglycerides in VLDL,LRP2BP,LRP2-binding protein,24195,0.000807264997815004,0.00586991832834414,-0.0106977749257395,0.0123123049213695,0.890616375186064
NMR metabolomics,X23408.Triglycerides in VLDL,TXK,Tyrosine-protein kinase TXK,24445,-0.000682207021284063,0.00529046055641857,-0.0110515097118645,0.00968709566929633,0.897397955142306
NMR metabolomics,X23408.Triglycerides in VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,0.00124158416363633,0.0101943444959466,-0.018739331048419,0.0212224993756917,0.903065192160336
NMR metabolomics,X23408.Triglycerides in VLDL,NRN1,Neuritin,24867,-0.000304296813245055,0.0025342113080422,-0.00527135097700777,0.00466275735051766,0.90442427216691
NMR metabolomics,X23408.Triglycerides in VLDL,SLC4A1,Band 3 anion transport protein,24938,0.000389249662941192,0.00331704210775796,-0.00611215286826442,0.0068906521941468,0.906584899006874
NMR metabolomics,X23408.Triglycerides in VLDL,IL22,Interleukin-22,24793,0.000538919935672228,0.00479626996476063,-0.0088617691952586,0.00993960906660306,0.910537054573739
NMR metabolomics,X23408.Triglycerides in VLDL,CEP350,Centrosome-associated protein 350,24016,0.00028520322511334,0.00262626023260102,-0.00486226683078465,0.00543267328101133,0.913523276852616
NMR metabolomics,X23408.Triglycerides in VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,24445,0.000407474380076713,0.00383297990996689,-0.0071051662434584,0.00792011500361182,0.915339281259027
NMR metabolomics,X23408.Triglycerides in VLDL,IL20RB,Interleukin-20 receptor subunit beta,24229,0.000310992836417871,0.00299799030890337,-0.00556506816903273,0.00618705384186847,0.917381485890678
NMR metabolomics,X23408.Triglycerides in VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.000271216354209276,0.00266230118206001,-0.00494689396262835,0.0054893266710469,0.918858404707121
NMR metabolomics,X23408.Triglycerides in VLDL,IL2,Interleukin-2,28931,0.000227599675425371,0.0022357155193031,-0.0041544027424087,0.00460960209325944,0.918914769728875
NMR metabolomics,X23408.Triglycerides in VLDL,SCN3B,Sodium channel subunit beta-3,24101,-0.000322794098049687,0.00327466685140543,-0.00674114112680434,0.00609555293070497,0.921478040814609
NMR metabolomics,X23408.Triglycerides in VLDL,NCLN,Nicalin,28931,-0.000342991078680415,0.00370440351119523,-0.00760362196062306,0.00691763980326224,0.926229853184058
NMR metabolomics,X23408.Triglycerides in VLDL,TET2,Methylcytosine dioxygenase TET2,24421,0.000653902092727251,0.00712484342648782,-0.0133107910231889,0.0146185952086434,0.926875376249183
NMR metabolomics,X23408.Triglycerides in VLDL,IL20,Interleukin-20,28931,-0.000309513094028921,0.00346804070065246,-0.00710687286730774,0.0064878466792499,0.928886033483906
NMR metabolomics,X23408.Triglycerides in VLDL,TFAP2A,Transcription factor AP-2-alpha,24101,0.000379470282629807,0.00426146891858807,-0.00797300879780281,0.00873194936306242,0.929045436210328
NMR metabolomics,X23408.Triglycerides in VLDL,ACRV1,Acrosomal protein SP-10,24229,0.000464486173649176,0.00544940689846929,-0.0102163513473506,0.011145323694649,0.932074398594407
NMR metabolomics,X23408.Triglycerides in VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.00046089795289798,0.00551816670552367,-0.0103547087899284,0.0112765046957244,0.933435788363978
NMR metabolomics,X23408.Triglycerides in VLDL,SEMA4C,Semaphorin-4C,29349,-0.000162653404745132,0.00198972782012876,-0.00406251993219751,0.00373721312270725,0.934848810361909
NMR metabolomics,X23408.Triglycerides in VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,-0.000364055275867862,0.00457694403375668,-0.00933486558203095,0.00860675503029522,0.936602761604583
NMR metabolomics,X23408.Triglycerides in VLDL,IL21R,Interleukin-21 receptor,24229,0.000296960286526593,0.00390676755087908,-0.0073603041131964,0.00795422468624959,0.939410368237802
NMR metabolomics,X23408.Triglycerides in VLDL,HK2,Hexokinase-2,28916,-0.000145585385394918,0.00194228801301419,-0.00395246989090272,0.00366129912011289,0.94025054827814
NMR metabolomics,X23408.Triglycerides in VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.000260989122729335,0.003486326460821,-0.00657221074047982,0.00709418898593849,0.940326102616891
NMR metabolomics,X23408.Triglycerides in VLDL,TPT1,Translationally-controlled tumor protein,28931,0.000322812840807049,0.00462316549251724,-0.00873859152452674,0.00938421720614084,0.944333378019326
NMR metabolomics,X23408.Triglycerides in VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.000171042323137657,0.00248832723398832,-0.00504816370175476,0.00470607905547944,0.94519873763418
NMR metabolomics,X23408.Triglycerides in VLDL,IL24,Interleukin-24,28931,-0.00022772848569529,0.0034510783934974,-0.0069918421369502,0.00653638516555962,0.947388129630548
NMR metabolomics,X23408.Triglycerides in VLDL,HBZ,Hemoglobin subunit zeta,24922,0.000482186174136307,0.0075107873305935,-0.0142389569938269,0.0152033293420996,0.948812168144612
NMR metabolomics,X23408.Triglycerides in VLDL,CASQ2,Calsequestrin-2,24111,0.000220780049199722,0.00346941466240045,-0.00657927268910516,0.0070208327875046,0.949260507101011
NMR metabolomics,X23408.Triglycerides in VLDL,IKZF2,Zinc finger protein Helios,28797,-0.000401140204184246,0.00646841484666189,-0.0130792333036416,0.0122769528952731,0.95055113788477
NMR metabolomics,X23408.Triglycerides in VLDL,OMG,Oligodendrocyte-myelin glycoprotein,29349,-0.000259595607339583,0.00464332445519053,-0.00936051153951302,0.00884132032483385,0.955416057729048
NMR metabolomics,X23408.Triglycerides in VLDL,EFNB2,Ephrin-B2,24195,-0.00022276901960209,0.00410043814956527,-0.00825962779275002,0.00781408975354584,0.956674209738872
NMR metabolomics,X23408.Triglycerides in VLDL,ARG2,"Arginase-2, mitochondrial",24793,0.000155433920736805,0.00307426408204806,-0.00587012368007738,0.00618099152155099,0.959676770766574
NMR metabolomics,X23408.Triglycerides in VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.000109512543301401,0.0024441424658262,-0.00468100668971795,0.00490003177632075,0.96426221813579
NMR metabolomics,X23408.Triglycerides in VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,0.000113236483438806,0.00258483631416453,-0.00495304269232367,0.00517951565920129,0.965057755306094
NMR metabolomics,X23408.Triglycerides in VLDL,CLINT1,Clathrin interactor 1,24016,0.000145919008085584,0.00338630021250067,-0.00649122940841573,0.0067830674245869,0.965629364838061
NMR metabolomics,X23408.Triglycerides in VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,-0.000132947654994603,0.00350017626894095,-0.00699329314211887,0.00672739783212966,0.969701441891611
NMR metabolomics,X23408.Triglycerides in VLDL,PGR,Progesterone receptor,24229,0.000265556905341809,0.00722698494891326,-0.0138993335945282,0.0144304474052118,0.970688482716455
NMR metabolomics,X23408.Triglycerides in VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",24111,0.000102558040617651,0.00282346410077293,-0.0054314315968973,0.0056365476781326,0.971024729167667
NMR metabolomics,X23408.Triglycerides in VLDL,MFAP3L,Microfibrillar-associated protein 3-like,24195,-0.000158074815275858,0.00467161779285065,-0.00931444568926314,0.00899829605871142,0.973007191202609
NMR metabolomics,X23408.Triglycerides in VLDL,LPO,Lactoperoxidase,28452,-0.00012308884058174,0.00426410400420032,-0.00848073268881437,0.00823455500765089,0.97697143780449
NMR metabolomics,X23408.Triglycerides in VLDL,TP73,Tumor protein p73,24195,6.91224818960972e-05,0.0024549344920199,-0.00474254912246291,0.0048807940862551,0.977537525164314
NMR metabolomics,X23408.Triglycerides in VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.000112242088958493,0.00418414970604272,-0.00808869133488524,0.00831317551280223,0.978599102197075
NMR metabolomics,X23408.Triglycerides in VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,-0.000106174667654594,0.00398289492013249,-0.00791264871111427,0.00770029937580508,0.978733002568172
NMR metabolomics,X23408.Triglycerides in VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,-4.77093939329686e-05,0.00201492018436277,-0.003996952955284,0.00390153416741807,0.981109570664763
NMR metabolomics,X23408.Triglycerides in VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,-6.38871377175075e-05,0.00316464534536316,-0.0062665920146293,0.00613881773919428,0.98389374521958
NMR metabolomics,X23408.Triglycerides in VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-3.791941274478e-05,0.00214008599486919,-0.00423248796268839,0.00415664913719883,0.985863453211497
NMR metabolomics,X23408.Triglycerides in VLDL,PFDN6,Prefoldin subunit 6,24195,5.47429148714301e-05,0.00464477292234037,-0.00904901201291569,0.00915849784265855,0.990596512570717
NMR metabolomics,X23408.Triglycerides in VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,24101,8.37163268786242e-06,0.00285065917948253,-0.0055789203590979,0.00559566362447363,0.997656851583865
NMR metabolomics,X23408.Triglycerides in VLDL,STEAP4,Metalloreductase STEAP4,24101,3.35007971677978e-06,0.00525887246226115,-0.0103040399463151,0.0103107401057486,0.999491725844453
NMR metabolomics,X23408.Triglycerides in VLDL,ZNF174,Zinc finger protein 174,24229,-9.71266068197162e-07,0.00268439123018743,-0.00526237807723556,0.00526043554509916,0.999711312503984
